TW202321213A - Kif18a抑制劑化合物之鹽和固態形式 - Google Patents
Kif18a抑制劑化合物之鹽和固態形式 Download PDFInfo
- Publication number
- TW202321213A TW202321213A TW111126873A TW111126873A TW202321213A TW 202321213 A TW202321213 A TW 202321213A TW 111126873 A TW111126873 A TW 111126873A TW 111126873 A TW111126873 A TW 111126873A TW 202321213 A TW202321213 A TW 202321213A
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- ser
- leu
- glu
- solvate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 767
- 150000003839 salts Chemical class 0.000 title claims abstract description 80
- 239000007787 solid Substances 0.000 title claims description 128
- 239000003112 inhibitor Substances 0.000 title description 6
- 229940126062 Compound A Drugs 0.000 claims abstract description 265
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims abstract description 265
- 239000012453 solvate Substances 0.000 claims abstract description 203
- 239000013078 crystal Substances 0.000 claims abstract description 163
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 137
- 238000000034 method Methods 0.000 claims abstract description 86
- 201000011510 cancer Diseases 0.000 claims abstract description 70
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 64
- 201000010099 disease Diseases 0.000 claims abstract description 59
- 101001091231 Homo sapiens Kinesin-like protein KIF18A Proteins 0.000 claims abstract description 36
- 102100034895 Kinesin-like protein KIF18A Human genes 0.000 claims abstract description 31
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 26
- 230000005764 inhibitory process Effects 0.000 claims abstract description 8
- 230000001404 mediated effect Effects 0.000 claims abstract description 6
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 238
- 108090000623 proteins and genes Proteins 0.000 claims description 148
- 238000002411 thermogravimetry Methods 0.000 claims description 111
- 238000000113 differential scanning calorimetry Methods 0.000 claims description 96
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 76
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 76
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 73
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 72
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 64
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 62
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 49
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 42
- 206010006187 Breast cancer Diseases 0.000 claims description 36
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 36
- 229960001948 caffeine Drugs 0.000 claims description 34
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 33
- 230000005855 radiation Effects 0.000 claims description 33
- 239000004202 carbamide Substances 0.000 claims description 32
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 31
- 229940081974 saccharin Drugs 0.000 claims description 31
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 31
- 101150056334 Ccne1 gene Proteins 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 27
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 26
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 25
- 208000026310 Breast neoplasm Diseases 0.000 claims description 23
- 206010033128 Ovarian cancer Diseases 0.000 claims description 22
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 22
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 22
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 21
- 101150080074 TP53 gene Proteins 0.000 claims description 20
- 108700025694 p53 Genes Proteins 0.000 claims description 20
- 206010014733 Endometrial cancer Diseases 0.000 claims description 19
- 206010014759 Endometrial neoplasm Diseases 0.000 claims description 19
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 19
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 18
- 230000007704 transition Effects 0.000 claims description 18
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 17
- 238000001228 spectrum Methods 0.000 claims description 16
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 15
- 238000011521 systemic chemotherapy Methods 0.000 claims description 15
- 238000005481 NMR spectroscopy Methods 0.000 claims description 14
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 12
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 11
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 10
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 10
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 10
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 claims description 10
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 9
- 229940011051 isopropyl acetate Drugs 0.000 claims description 8
- 235000019204 saccharin Nutrition 0.000 claims description 8
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 7
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 7
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 6
- 201000005202 lung cancer Diseases 0.000 claims description 6
- 208000020816 lung neoplasm Diseases 0.000 claims description 6
- MVIOINXPSFUJEN-UHFFFAOYSA-N benzenesulfonic acid;hydrate Chemical compound O.OS(=O)(=O)C1=CC=CC=C1 MVIOINXPSFUJEN-UHFFFAOYSA-N 0.000 claims description 5
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims description 3
- 150000003840 hydrochlorides Chemical class 0.000 claims description 3
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 claims description 2
- 108700025701 Retinoblastoma Genes Proteins 0.000 claims description 2
- 229940044613 1-propanol Drugs 0.000 claims 2
- 229940126262 KIF18A Drugs 0.000 claims 2
- FOEYUNAOXWGLLO-UHFFFAOYSA-N dodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC FOEYUNAOXWGLLO-UHFFFAOYSA-N 0.000 claims 1
- 230000001613 neoplastic effect Effects 0.000 abstract description 47
- 238000002360 preparation method Methods 0.000 abstract description 11
- 239000012458 free base Substances 0.000 abstract description 5
- KBDGEJDIHZDPHN-UHFFFAOYSA-N 2-(6-azaspiro[2.5]octan-6-yl)-N-[2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl]-4-(2-hydroxyethylsulfonylamino)benzamide Chemical compound FC1(CCN(CC1)C1=NC(=CC(=N1)NC(C1=C(C=C(C=C1)NS(=O)(=O)CCO)N1CCC2(CC2)CC1)=O)C)F KBDGEJDIHZDPHN-UHFFFAOYSA-N 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 54
- 238000011282 treatment Methods 0.000 description 46
- 238000002844 melting Methods 0.000 description 41
- 230000008018 melting Effects 0.000 description 41
- 239000000203 mixture Substances 0.000 description 38
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 36
- 239000000047 product Substances 0.000 description 35
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 34
- 239000000523 sample Substances 0.000 description 34
- 230000004580 weight loss Effects 0.000 description 34
- 102000004169 proteins and genes Human genes 0.000 description 28
- 238000002076 thermal analysis method Methods 0.000 description 28
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 27
- 235000018102 proteins Nutrition 0.000 description 27
- 230000001965 increasing effect Effects 0.000 description 24
- 238000001179 sorption measurement Methods 0.000 description 24
- 230000014509 gene expression Effects 0.000 description 23
- 239000000243 solution Substances 0.000 description 21
- 239000010949 copper Substances 0.000 description 19
- 230000003902 lesion Effects 0.000 description 19
- 239000000463 material Substances 0.000 description 19
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 18
- 230000004044 response Effects 0.000 description 18
- 101150002130 Rb1 gene Proteins 0.000 description 17
- 229960004592 isopropanol Drugs 0.000 description 17
- 230000001394 metastastic effect Effects 0.000 description 17
- 206010061289 metastatic neoplasm Diseases 0.000 description 17
- 229910052697 platinum Inorganic materials 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 16
- 108091008039 hormone receptors Proteins 0.000 description 16
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 15
- 230000009467 reduction Effects 0.000 description 15
- 210000001082 somatic cell Anatomy 0.000 description 15
- 238000002560 therapeutic procedure Methods 0.000 description 15
- -1 2-hydroxyethanesulfonyl Chemical group 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 14
- 108010050848 glycylleucine Proteins 0.000 description 14
- 230000035772 mutation Effects 0.000 description 14
- 206010055113 Breast cancer metastatic Diseases 0.000 description 13
- 241000880493 Leptailurus serval Species 0.000 description 13
- 241000124008 Mammalia Species 0.000 description 13
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 12
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 12
- 230000003321 amplification Effects 0.000 description 12
- 108010034529 leucyl-lysine Proteins 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 101001062114 Zea mays Retinoblastoma-related protein 1 Proteins 0.000 description 11
- 235000019439 ethyl acetate Nutrition 0.000 description 11
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 11
- 150000004677 hydrates Chemical class 0.000 description 11
- 238000003364 immunohistochemistry Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000003350 DNA copy number gain Effects 0.000 description 10
- 206010061818 Disease progression Diseases 0.000 description 10
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 description 10
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 10
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 238000002425 crystallisation Methods 0.000 description 10
- 230000008025 crystallization Effects 0.000 description 10
- 230000037430 deletion Effects 0.000 description 10
- 238000012217 deletion Methods 0.000 description 10
- 230000005750 disease progression Effects 0.000 description 10
- 230000002018 overexpression Effects 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 230000000306 recurrent effect Effects 0.000 description 10
- 230000004584 weight gain Effects 0.000 description 10
- 235000019786 weight gain Nutrition 0.000 description 10
- 241000701806 Human papillomavirus Species 0.000 description 9
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 9
- 108010087924 alanylproline Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 108020004635 Complementary DNA Proteins 0.000 description 8
- 229940123237 Taxane Drugs 0.000 description 8
- 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000010804 cDNA synthesis Methods 0.000 description 8
- 239000002299 complementary DNA Substances 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 108010026333 seryl-proline Proteins 0.000 description 8
- 238000001757 thermogravimetry curve Methods 0.000 description 8
- 208000022679 triple-negative breast carcinoma Diseases 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 102100037858 G1/S-specific cyclin-E1 Human genes 0.000 description 7
- 101000738568 Homo sapiens G1/S-specific cyclin-E1 Proteins 0.000 description 7
- 108010013835 arginine glutamate Proteins 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 7
- 231100000371 dose-limiting toxicity Toxicity 0.000 description 7
- 201000003914 endometrial carcinoma Diseases 0.000 description 7
- 108010054155 lysyllysine Proteins 0.000 description 7
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 7
- 238000011275 oncology therapy Methods 0.000 description 7
- 239000002002 slurry Substances 0.000 description 7
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 7
- 108010073969 valyllysine Proteins 0.000 description 7
- 101150072950 BRCA1 gene Proteins 0.000 description 6
- 229910002483 Cu Ka Inorganic materials 0.000 description 6
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 6
- 102000029749 Microtubule Human genes 0.000 description 6
- 108091022875 Microtubule Proteins 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 108010067390 Viral Proteins Proteins 0.000 description 6
- 208000037844 advanced solid tumor Diseases 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 108010062796 arginyllysine Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000009261 endocrine therapy Methods 0.000 description 6
- 229940034984 endocrine therapy antineoplastic and immunomodulating agent Drugs 0.000 description 6
- 102000015694 estrogen receptors Human genes 0.000 description 6
- 108010038795 estrogen receptors Proteins 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 108010009298 lysylglutamic acid Proteins 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 210000004688 microtubule Anatomy 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 108010051242 phenylalanylserine Proteins 0.000 description 6
- 238000010583 slow cooling Methods 0.000 description 6
- 230000004614 tumor growth Effects 0.000 description 6
- 102000010638 Kinesin Human genes 0.000 description 5
- 108010063296 Kinesin Proteins 0.000 description 5
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 5
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 5
- 108090000704 Tubulin Proteins 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 description 5
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 5
- 108010093581 aspartyl-proline Proteins 0.000 description 5
- 108010038633 aspartylglutamate Proteins 0.000 description 5
- 108010092854 aspartyllysine Proteins 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 238000002447 crystallographic data Methods 0.000 description 5
- 238000004807 desolvation Methods 0.000 description 5
- 238000002050 diffraction method Methods 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000030279 gene silencing Effects 0.000 description 5
- 210000004602 germ cell Anatomy 0.000 description 5
- 108010049041 glutamylalanine Proteins 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 208000014829 head and neck neoplasm Diseases 0.000 description 5
- 108010018006 histidylserine Proteins 0.000 description 5
- 229910052738 indium Inorganic materials 0.000 description 5
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 210000001165 lymph node Anatomy 0.000 description 5
- 108010003700 lysyl aspartic acid Proteins 0.000 description 5
- 108010017391 lysylvaline Proteins 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 108010077112 prolyl-proline Proteins 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 238000001752 temperature-resolved X-ray diffraction Methods 0.000 description 5
- 238000003828 vacuum filtration Methods 0.000 description 5
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 4
- 102000036365 BRCA1 Human genes 0.000 description 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- 206010005003 Bladder cancer Diseases 0.000 description 4
- 101150008921 Brca2 gene Proteins 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 4
- 206010009944 Colon cancer Diseases 0.000 description 4
- 230000004544 DNA amplification Effects 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- 101150095705 FBXW7 gene Proteins 0.000 description 4
- 201000001342 Fallopian tube cancer Diseases 0.000 description 4
- 208000013452 Fallopian tube neoplasm Diseases 0.000 description 4
- PYNPBMCLAKTHJL-SRVKXCTJSA-N His-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O PYNPBMCLAKTHJL-SRVKXCTJSA-N 0.000 description 4
- 108010065920 Insulin Lispro Proteins 0.000 description 4
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 4
- 206010027476 Metastases Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 4
- 208000026149 Primary peritoneal carcinoma Diseases 0.000 description 4
- QKQDTEYDEIJPNK-GUBZILKMSA-N Ser-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO QKQDTEYDEIJPNK-GUBZILKMSA-N 0.000 description 4
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 4
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- 102000004243 Tubulin Human genes 0.000 description 4
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 4
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 4
- 108010005233 alanylglutamic acid Proteins 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 230000006907 apoptotic process Effects 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 230000005907 cancer growth Effects 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 201000010881 cervical cancer Diseases 0.000 description 4
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 4
- 206010017758 gastric cancer Diseases 0.000 description 4
- 230000009477 glass transition Effects 0.000 description 4
- 108010078144 glutaminyl-glycine Proteins 0.000 description 4
- 201000010536 head and neck cancer Diseases 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000001794 hormone therapy Methods 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 4
- 108010064235 lysylglycine Proteins 0.000 description 4
- 208000037843 metastatic solid tumor Diseases 0.000 description 4
- 238000007481 next generation sequencing Methods 0.000 description 4
- 239000012454 non-polar solvent Substances 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 201000011549 stomach cancer Diseases 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 229910052718 tin Inorganic materials 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 201000005112 urinary bladder cancer Diseases 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 108091006112 ATPases Proteins 0.000 description 3
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 3
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 3
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 3
- ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 3
- AMGQTNHANMRPOE-LKXGYXEUSA-N Asn-Thr-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O AMGQTNHANMRPOE-LKXGYXEUSA-N 0.000 description 3
- HJCGDIGVVWETRO-ZPFDUUQYSA-N Asp-Lys-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O)C(O)=O HJCGDIGVVWETRO-ZPFDUUQYSA-N 0.000 description 3
- 108700020463 BRCA1 Proteins 0.000 description 3
- 108700040618 BRCA1 Genes Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229940124297 CDK 4/6 inhibitor Drugs 0.000 description 3
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 3
- BYKZWDGMJLNFJY-XKBZYTNZSA-N Gln-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)O BYKZWDGMJLNFJY-XKBZYTNZSA-N 0.000 description 3
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 3
- PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 description 3
- VGBSZQSKQRMLHD-MNXVOIDGSA-N Glu-Leu-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VGBSZQSKQRMLHD-MNXVOIDGSA-N 0.000 description 3
- CBOVGULVQSVMPT-CIUDSAMLSA-N Glu-Pro-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O CBOVGULVQSVMPT-CIUDSAMLSA-N 0.000 description 3
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 3
- CQGBSALYGOXQPE-HTUGSXCWSA-N Glu-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O CQGBSALYGOXQPE-HTUGSXCWSA-N 0.000 description 3
- MXJYXYDREQWUMS-XKBZYTNZSA-N Glu-Thr-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O MXJYXYDREQWUMS-XKBZYTNZSA-N 0.000 description 3
- QSVCIFZPGLOZGH-WDSKDSINSA-N Gly-Glu-Ser Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QSVCIFZPGLOZGH-WDSKDSINSA-N 0.000 description 3
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 3
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 3
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 3
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 3
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 3
- 108010033040 Histones Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- ADDYYRVQQZFIMW-MNXVOIDGSA-N Ile-Lys-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ADDYYRVQQZFIMW-MNXVOIDGSA-N 0.000 description 3
- 208000008839 Kidney Neoplasms Diseases 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- KVRKAGGMEWNURO-CIUDSAMLSA-N Leu-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N KVRKAGGMEWNURO-CIUDSAMLSA-N 0.000 description 3
- OGCQGUIWMSBHRZ-CIUDSAMLSA-N Leu-Asn-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OGCQGUIWMSBHRZ-CIUDSAMLSA-N 0.000 description 3
- WQWSMEOYXJTFRU-GUBZILKMSA-N Leu-Glu-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O WQWSMEOYXJTFRU-GUBZILKMSA-N 0.000 description 3
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 3
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 3
- JIHDFWWRYHSAQB-GUBZILKMSA-N Leu-Ser-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JIHDFWWRYHSAQB-GUBZILKMSA-N 0.000 description 3
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 3
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 3
- 206010025323 Lymphomas Diseases 0.000 description 3
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 3
- PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 3
- IZJGPPIGYTVXLB-FQUUOJAGSA-N Lys-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IZJGPPIGYTVXLB-FQUUOJAGSA-N 0.000 description 3
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 3
- HBGFEEQFVBWYJQ-KBPBESRZSA-N Phe-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HBGFEEQFVBWYJQ-KBPBESRZSA-N 0.000 description 3
- WLYPRKLMRIYGPP-JYJNAYRXSA-N Phe-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 WLYPRKLMRIYGPP-JYJNAYRXSA-N 0.000 description 3
- UREQLMJCKFLLHM-NAKRPEOUSA-N Pro-Ile-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UREQLMJCKFLLHM-NAKRPEOUSA-N 0.000 description 3
- SBVPYBFMIGDIDX-SRVKXCTJSA-N Pro-Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H]2NCCC2)CCC1 SBVPYBFMIGDIDX-SRVKXCTJSA-N 0.000 description 3
- SEZGGSHLMROBFX-CIUDSAMLSA-N Pro-Ser-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O SEZGGSHLMROBFX-CIUDSAMLSA-N 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 206010038389 Renal cancer Diseases 0.000 description 3
- FIDMVVBUOCMMJG-CIUDSAMLSA-N Ser-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO FIDMVVBUOCMMJG-CIUDSAMLSA-N 0.000 description 3
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 3
- SQBLRDDJTUJDMV-ACZMJKKPSA-N Ser-Glu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQBLRDDJTUJDMV-ACZMJKKPSA-N 0.000 description 3
- GYDFRTRSSXOZCR-ACZMJKKPSA-N Ser-Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O GYDFRTRSSXOZCR-ACZMJKKPSA-N 0.000 description 3
- OZPDGESCTGGNAD-CIUDSAMLSA-N Ser-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO OZPDGESCTGGNAD-CIUDSAMLSA-N 0.000 description 3
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 3
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 3
- HGJRMXOWUWVUOA-GVXVVHGQSA-N Val-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N HGJRMXOWUWVUOA-GVXVVHGQSA-N 0.000 description 3
- PGQUDQYHWICSAB-NAKRPEOUSA-N Val-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N PGQUDQYHWICSAB-NAKRPEOUSA-N 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 108010044940 alanylglutamine Proteins 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 206010065867 alveolar rhabdomyosarcoma Diseases 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940078010 arimidex Drugs 0.000 description 3
- 108010077245 asparaginyl-proline Proteins 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 208000024119 breast tumor luminal A or B Diseases 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 238000005564 crystal structure determination Methods 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 229960004679 doxorubicin Drugs 0.000 description 3
- 238000003633 gene expression assay Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 108010010147 glycylglutamine Proteins 0.000 description 3
- 108010025306 histidylleucine Proteins 0.000 description 3
- 102000050994 human KIF18A Human genes 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000007901 in situ hybridization Methods 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 201000010982 kidney cancer Diseases 0.000 description 3
- 108010057821 leucylproline Proteins 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 3
- 101150024228 mdm2 gene Proteins 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000031864 metaphase Effects 0.000 description 3
- 230000009401 metastasis Effects 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- 230000000394 mitotic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 201000002528 pancreatic cancer Diseases 0.000 description 3
- 208000008443 pancreatic carcinoma Diseases 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 108010012581 phenylalanylglutamate Proteins 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 108010031719 prolyl-serine Proteins 0.000 description 3
- 108010070643 prolylglutamic acid Proteins 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 108010048818 seryl-histidine Proteins 0.000 description 3
- 238000000371 solid-state nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 3
- 206010043554 thrombocytopenia Diseases 0.000 description 3
- 108010080629 tryptophan-leucine Proteins 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 2
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 2
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 2
- WCBVQNZTOKJWJS-ACZMJKKPSA-N Ala-Cys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O WCBVQNZTOKJWJS-ACZMJKKPSA-N 0.000 description 2
- VIGKUFXFTPWYER-BIIVOSGPSA-N Ala-Cys-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N VIGKUFXFTPWYER-BIIVOSGPSA-N 0.000 description 2
- HHRAXZAYZFFRAM-CIUDSAMLSA-N Ala-Leu-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O HHRAXZAYZFFRAM-CIUDSAMLSA-N 0.000 description 2
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 2
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 2
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 2
- OLVCTPPSXNRGKV-GUBZILKMSA-N Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OLVCTPPSXNRGKV-GUBZILKMSA-N 0.000 description 2
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 2
- NABSCJGZKWSNHX-RCWTZXSCSA-N Arg-Arg-Thr Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NABSCJGZKWSNHX-RCWTZXSCSA-N 0.000 description 2
- ZTKHZAXGTFXUDD-VEVYYDQMSA-N Arg-Asn-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZTKHZAXGTFXUDD-VEVYYDQMSA-N 0.000 description 2
- YSUVMPICYVWRBX-VEVYYDQMSA-N Arg-Asp-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YSUVMPICYVWRBX-VEVYYDQMSA-N 0.000 description 2
- UFBURHXMKFQVLM-CIUDSAMLSA-N Arg-Glu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UFBURHXMKFQVLM-CIUDSAMLSA-N 0.000 description 2
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 description 2
- LEFKSBYHUGUWLP-ACZMJKKPSA-N Asn-Ala-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LEFKSBYHUGUWLP-ACZMJKKPSA-N 0.000 description 2
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 2
- UGXVKHRDGLYFKR-CIUDSAMLSA-N Asn-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O UGXVKHRDGLYFKR-CIUDSAMLSA-N 0.000 description 2
- XQQVCUIBGYFKDC-OLHMAJIHSA-N Asn-Asp-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XQQVCUIBGYFKDC-OLHMAJIHSA-N 0.000 description 2
- UEONJSPBTSWKOI-CIUDSAMLSA-N Asn-Gln-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O UEONJSPBTSWKOI-CIUDSAMLSA-N 0.000 description 2
- GFFRWIJAFFMQGM-NUMRIWBASA-N Asn-Glu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFFRWIJAFFMQGM-NUMRIWBASA-N 0.000 description 2
- DMLSCRJBWUEALP-LAEOZQHASA-N Asn-Glu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O DMLSCRJBWUEALP-LAEOZQHASA-N 0.000 description 2
- XVBDDUPJVQXDSI-PEFMBERDSA-N Asn-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVBDDUPJVQXDSI-PEFMBERDSA-N 0.000 description 2
- ACKNRKFVYUVWAC-ZPFDUUQYSA-N Asn-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ACKNRKFVYUVWAC-ZPFDUUQYSA-N 0.000 description 2
- SEKBHZJLARBNPB-GHCJXIJMSA-N Asn-Ile-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O SEKBHZJLARBNPB-GHCJXIJMSA-N 0.000 description 2
- HDHZCEDPLTVHFZ-GUBZILKMSA-N Asn-Leu-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O HDHZCEDPLTVHFZ-GUBZILKMSA-N 0.000 description 2
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 2
- FBODFHMLALOPHP-GUBZILKMSA-N Asn-Lys-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O FBODFHMLALOPHP-GUBZILKMSA-N 0.000 description 2
- YUOXLJYVSZYPBJ-CIUDSAMLSA-N Asn-Pro-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O YUOXLJYVSZYPBJ-CIUDSAMLSA-N 0.000 description 2
- AWXDRZJQCVHCIT-DCAQKATOSA-N Asn-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O AWXDRZJQCVHCIT-DCAQKATOSA-N 0.000 description 2
- NCXTYSVDWLAQGZ-ZKWXMUAHSA-N Asn-Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O NCXTYSVDWLAQGZ-ZKWXMUAHSA-N 0.000 description 2
- BCADFFUQHIMQAA-KKHAAJSZSA-N Asn-Thr-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BCADFFUQHIMQAA-KKHAAJSZSA-N 0.000 description 2
- CBHVAFXKOYAHOY-NHCYSSNCSA-N Asn-Val-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O CBHVAFXKOYAHOY-NHCYSSNCSA-N 0.000 description 2
- VIRHEUMYXXLCBF-WDSKDSINSA-N Asp-Gly-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O VIRHEUMYXXLCBF-WDSKDSINSA-N 0.000 description 2
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 2
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 2
- KFAFUJMGHVVYRC-DCAQKATOSA-N Asp-Leu-Met Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O KFAFUJMGHVVYRC-DCAQKATOSA-N 0.000 description 2
- ORRJQLIATJDMQM-HJGDQZAQSA-N Asp-Leu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O ORRJQLIATJDMQM-HJGDQZAQSA-N 0.000 description 2
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 2
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 2
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 2
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 2
- 108700020462 BRCA2 Proteins 0.000 description 2
- 102000052609 BRCA2 Human genes 0.000 description 2
- 108700010154 BRCA2 Genes Proteins 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- VXLXATVURDNDCG-CIUDSAMLSA-N Cys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N VXLXATVURDNDCG-CIUDSAMLSA-N 0.000 description 2
- DQUWSUWXPWGTQT-DCAQKATOSA-N Cys-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS DQUWSUWXPWGTQT-DCAQKATOSA-N 0.000 description 2
- KVCJEMHFLGVINV-ZLUOBGJFSA-N Cys-Ser-Asn Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KVCJEMHFLGVINV-ZLUOBGJFSA-N 0.000 description 2
- NXQCSPVUPLUTJH-WHFBIAKZSA-N Cys-Ser-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O NXQCSPVUPLUTJH-WHFBIAKZSA-N 0.000 description 2
- 102100037709 Desmocollin-3 Human genes 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 101001008993 Dictyostelium discoideum Kinesin-related protein 10 Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 101150029707 ERBB2 gene Proteins 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PSERKXGRRADTKA-MNXVOIDGSA-N Gln-Leu-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PSERKXGRRADTKA-MNXVOIDGSA-N 0.000 description 2
- MLSKFHLRFVGNLL-WDCWCFNPSA-N Gln-Leu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MLSKFHLRFVGNLL-WDCWCFNPSA-N 0.000 description 2
- QKWBEMCLYTYBNI-GVXVVHGQSA-N Gln-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O QKWBEMCLYTYBNI-GVXVVHGQSA-N 0.000 description 2
- SFAFZYYMAWOCIC-KKUMJFAQSA-N Gln-Phe-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SFAFZYYMAWOCIC-KKUMJFAQSA-N 0.000 description 2
- MFORDNZDKAVNSR-SRVKXCTJSA-N Gln-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O MFORDNZDKAVNSR-SRVKXCTJSA-N 0.000 description 2
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 2
- WZZSKAJIHTUUSG-ACZMJKKPSA-N Glu-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O WZZSKAJIHTUUSG-ACZMJKKPSA-N 0.000 description 2
- IYAUFWMUCGBFMQ-CIUDSAMLSA-N Glu-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)CN=C(N)N IYAUFWMUCGBFMQ-CIUDSAMLSA-N 0.000 description 2
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 2
- RJONUNZIMUXUOI-GUBZILKMSA-N Glu-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N RJONUNZIMUXUOI-GUBZILKMSA-N 0.000 description 2
- JPHYJQHPILOKHC-ACZMJKKPSA-N Glu-Asp-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O JPHYJQHPILOKHC-ACZMJKKPSA-N 0.000 description 2
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 2
- CJWANNXUTOATSJ-DCAQKATOSA-N Glu-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N CJWANNXUTOATSJ-DCAQKATOSA-N 0.000 description 2
- ILGFBUGLBSAQQB-GUBZILKMSA-N Glu-Glu-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ILGFBUGLBSAQQB-GUBZILKMSA-N 0.000 description 2
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 2
- OPAINBJQDQTGJY-JGVFFNPUSA-N Glu-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)O)N)C(=O)O OPAINBJQDQTGJY-JGVFFNPUSA-N 0.000 description 2
- XOFYVODYSNKPDK-AVGNSLFASA-N Glu-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XOFYVODYSNKPDK-AVGNSLFASA-N 0.000 description 2
- ZHNHJYYFCGUZNQ-KBIXCLLPSA-N Glu-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O ZHNHJYYFCGUZNQ-KBIXCLLPSA-N 0.000 description 2
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 2
- DNPCBMNFQVTHMA-DCAQKATOSA-N Glu-Leu-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O DNPCBMNFQVTHMA-DCAQKATOSA-N 0.000 description 2
- NWOUBJNMZDDGDT-AVGNSLFASA-N Glu-Leu-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NWOUBJNMZDDGDT-AVGNSLFASA-N 0.000 description 2
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 2
- QJVZSVUYZFYLFQ-CIUDSAMLSA-N Glu-Pro-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O QJVZSVUYZFYLFQ-CIUDSAMLSA-N 0.000 description 2
- BPLNJYHNAJVLRT-ACZMJKKPSA-N Glu-Ser-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O BPLNJYHNAJVLRT-ACZMJKKPSA-N 0.000 description 2
- MRWYPDWDZSLWJM-ACZMJKKPSA-N Glu-Ser-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O MRWYPDWDZSLWJM-ACZMJKKPSA-N 0.000 description 2
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 2
- SYAYROHMAIHWFB-KBIXCLLPSA-N Glu-Ser-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYAYROHMAIHWFB-KBIXCLLPSA-N 0.000 description 2
- XUDLUKYPXQDCRX-BQBZGAKWSA-N Gly-Arg-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O XUDLUKYPXQDCRX-BQBZGAKWSA-N 0.000 description 2
- LRQXRHGQEVWGPV-NHCYSSNCSA-N Gly-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN LRQXRHGQEVWGPV-NHCYSSNCSA-N 0.000 description 2
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 2
- VEPBEGNDJYANCF-QWRGUYRKSA-N Gly-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN VEPBEGNDJYANCF-QWRGUYRKSA-N 0.000 description 2
- CSMYMGFCEJWALV-WDSKDSINSA-N Gly-Ser-Gln Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O CSMYMGFCEJWALV-WDSKDSINSA-N 0.000 description 2
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 2
- FFALDIDGPLUDKV-ZDLURKLDSA-N Gly-Thr-Ser Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O FFALDIDGPLUDKV-ZDLURKLDSA-N 0.000 description 2
- GWNIGUKSRJBIHX-STQMWFEESA-N Gly-Tyr-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)CN)O GWNIGUKSRJBIHX-STQMWFEESA-N 0.000 description 2
- KOYUSMBPJOVSOO-XEGUGMAKSA-N Gly-Tyr-Ile Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KOYUSMBPJOVSOO-XEGUGMAKSA-N 0.000 description 2
- 208000017891 HER2 positive breast carcinoma Diseases 0.000 description 2
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 2
- DZMVESFTHXSSPZ-XVYDVKMFSA-N His-Ala-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DZMVESFTHXSSPZ-XVYDVKMFSA-N 0.000 description 2
- FHKZHRMERJUXRJ-DCAQKATOSA-N His-Ser-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 FHKZHRMERJUXRJ-DCAQKATOSA-N 0.000 description 2
- 102000006947 Histones Human genes 0.000 description 2
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 2
- 101000968042 Homo sapiens Desmocollin-2 Proteins 0.000 description 2
- 101000880960 Homo sapiens Desmocollin-3 Proteins 0.000 description 2
- 101100288060 Homo sapiens KIF18A gene Proteins 0.000 description 2
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 2
- RWIKBYVJQAJYDP-BJDJZHNGSA-N Ile-Ala-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RWIKBYVJQAJYDP-BJDJZHNGSA-N 0.000 description 2
- RGSOCXHDOPQREB-ZPFDUUQYSA-N Ile-Asp-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N RGSOCXHDOPQREB-ZPFDUUQYSA-N 0.000 description 2
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 2
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 2
- XMYURPUVJSKTMC-KBIXCLLPSA-N Ile-Ser-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N XMYURPUVJSKTMC-KBIXCLLPSA-N 0.000 description 2
- ZNOBVZFCHNHKHA-KBIXCLLPSA-N Ile-Ser-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZNOBVZFCHNHKHA-KBIXCLLPSA-N 0.000 description 2
- PELCGFMHLZXWBQ-BJDJZHNGSA-N Ile-Ser-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N PELCGFMHLZXWBQ-BJDJZHNGSA-N 0.000 description 2
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 2
- CNMOKANDJMLAIF-CIQUZCHMSA-N Ile-Thr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O CNMOKANDJMLAIF-CIQUZCHMSA-N 0.000 description 2
- COWHUQXTSYTKQC-RWRJDSDZSA-N Ile-Thr-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N COWHUQXTSYTKQC-RWRJDSDZSA-N 0.000 description 2
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 description 2
- 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 description 2
- 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 description 2
- 101150085629 KIF18A gene Proteins 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 2
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 2
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 2
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 2
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 2
- DLCXCECTCPKKCD-GUBZILKMSA-N Leu-Gln-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DLCXCECTCPKKCD-GUBZILKMSA-N 0.000 description 2
- RSFGIMMPWAXNML-MNXVOIDGSA-N Leu-Gln-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RSFGIMMPWAXNML-MNXVOIDGSA-N 0.000 description 2
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 2
- GPICTNQYKHHHTH-GUBZILKMSA-N Leu-Gln-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GPICTNQYKHHHTH-GUBZILKMSA-N 0.000 description 2
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 2
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 2
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 2
- HNDWYLYAYNBWMP-AJNGGQMLSA-N Leu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N HNDWYLYAYNBWMP-AJNGGQMLSA-N 0.000 description 2
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 2
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 2
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 2
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 2
- ONPJGOIVICHWBW-BZSNNMDCSA-N Leu-Lys-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ONPJGOIVICHWBW-BZSNNMDCSA-N 0.000 description 2
- BJWKOATWNQJPSK-SRVKXCTJSA-N Leu-Met-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N BJWKOATWNQJPSK-SRVKXCTJSA-N 0.000 description 2
- RRVCZCNFXIFGRA-DCAQKATOSA-N Leu-Pro-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O RRVCZCNFXIFGRA-DCAQKATOSA-N 0.000 description 2
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 2
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 2
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 2
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 2
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 2
- KLSUAWUZBMAZCL-RHYQMDGZSA-N Leu-Thr-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O KLSUAWUZBMAZCL-RHYQMDGZSA-N 0.000 description 2
- VHTIZYYHIUHMCA-JYJNAYRXSA-N Leu-Tyr-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O VHTIZYYHIUHMCA-JYJNAYRXSA-N 0.000 description 2
- WXJKFRMKJORORD-DCAQKATOSA-N Lys-Arg-Ala Chemical compound NC(=N)NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CCCCN WXJKFRMKJORORD-DCAQKATOSA-N 0.000 description 2
- SJNZALDHDUYDBU-IHRRRGAJSA-N Lys-Arg-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O SJNZALDHDUYDBU-IHRRRGAJSA-N 0.000 description 2
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 2
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 2
- YKIRNDPUWONXQN-GUBZILKMSA-N Lys-Asn-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKIRNDPUWONXQN-GUBZILKMSA-N 0.000 description 2
- LZWNAOIMTLNMDW-NHCYSSNCSA-N Lys-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N LZWNAOIMTLNMDW-NHCYSSNCSA-N 0.000 description 2
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 2
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 2
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 2
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 2
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 2
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 2
- PYFNONMJYNJENN-AVGNSLFASA-N Lys-Lys-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PYFNONMJYNJENN-AVGNSLFASA-N 0.000 description 2
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 2
- SKUOQDYMJFUMOE-ULQDDVLXSA-N Lys-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCCN)N SKUOQDYMJFUMOE-ULQDDVLXSA-N 0.000 description 2
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 2
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 2
- JMNRXRPBHFGXQX-GUBZILKMSA-N Lys-Ser-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JMNRXRPBHFGXQX-GUBZILKMSA-N 0.000 description 2
- CUHGAUZONORRIC-HJGDQZAQSA-N Lys-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N)O CUHGAUZONORRIC-HJGDQZAQSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 102100023123 Mucin-16 Human genes 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 239000012661 PARP inhibitor Substances 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- CGOMLCQJEMWMCE-STQMWFEESA-N Phe-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 CGOMLCQJEMWMCE-STQMWFEESA-N 0.000 description 2
- KAGCQPSEVAETCA-JYJNAYRXSA-N Phe-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N KAGCQPSEVAETCA-JYJNAYRXSA-N 0.000 description 2
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 2
- ZUQACJLOHYRVPJ-DKIMLUQUSA-N Phe-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 ZUQACJLOHYRVPJ-DKIMLUQUSA-N 0.000 description 2
- XZQYIJALMGEUJD-OEAJRASXSA-N Phe-Lys-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XZQYIJALMGEUJD-OEAJRASXSA-N 0.000 description 2
- RGMLUHANLDVMPB-ULQDDVLXSA-N Phe-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RGMLUHANLDVMPB-ULQDDVLXSA-N 0.000 description 2
- 229940121906 Poly ADP ribose polymerase inhibitor Drugs 0.000 description 2
- HQVPQXMCQKXARZ-FXQIFTODSA-N Pro-Cys-Ser Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O HQVPQXMCQKXARZ-FXQIFTODSA-N 0.000 description 2
- DIFXZGPHVCIVSQ-CIUDSAMLSA-N Pro-Gln-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O DIFXZGPHVCIVSQ-CIUDSAMLSA-N 0.000 description 2
- VOZIBWWZSBIXQN-SRVKXCTJSA-N Pro-Glu-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O VOZIBWWZSBIXQN-SRVKXCTJSA-N 0.000 description 2
- PTLOFJZJADCNCD-DCAQKATOSA-N Pro-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 PTLOFJZJADCNCD-DCAQKATOSA-N 0.000 description 2
- MRYUJHGPZQNOAD-IHRRRGAJSA-N Pro-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 MRYUJHGPZQNOAD-IHRRRGAJSA-N 0.000 description 2
- VTFXTWDFPTWNJY-RHYQMDGZSA-N Pro-Leu-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VTFXTWDFPTWNJY-RHYQMDGZSA-N 0.000 description 2
- SPLBRAKYXGOFSO-UNQGMJICSA-N Pro-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]2CCCN2)O SPLBRAKYXGOFSO-UNQGMJICSA-N 0.000 description 2
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 2
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 2
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 2
- JXVXYRZQIUPYSA-NHCYSSNCSA-N Pro-Val-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JXVXYRZQIUPYSA-NHCYSSNCSA-N 0.000 description 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
- 238000003559 RNA-seq method Methods 0.000 description 2
- 208000006265 Renal cell carcinoma Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- WXWDPFVKQRVJBJ-CIUDSAMLSA-N Ser-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N WXWDPFVKQRVJBJ-CIUDSAMLSA-N 0.000 description 2
- MMAPOBOTRUVNKJ-ZLUOBGJFSA-N Ser-Asp-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N)C(=O)O MMAPOBOTRUVNKJ-ZLUOBGJFSA-N 0.000 description 2
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 2
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 2
- CJINPXGSKSZQNE-KBIXCLLPSA-N Ser-Ile-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O CJINPXGSKSZQNE-KBIXCLLPSA-N 0.000 description 2
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 2
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 2
- BYCVMHKULKRVPV-GUBZILKMSA-N Ser-Lys-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O BYCVMHKULKRVPV-GUBZILKMSA-N 0.000 description 2
- KJKQUQXDEKMPDK-FXQIFTODSA-N Ser-Met-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O KJKQUQXDEKMPDK-FXQIFTODSA-N 0.000 description 2
- MQUZANJDFOQOBX-SRVKXCTJSA-N Ser-Phe-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O MQUZANJDFOQOBX-SRVKXCTJSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 2
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 2
- HKHCTNFKZXAMIF-KKUMJFAQSA-N Ser-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CC=C(O)C=C1 HKHCTNFKZXAMIF-KKUMJFAQSA-N 0.000 description 2
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 206010041067 Small cell lung cancer Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- PQLXHSACXPGWPD-GSSVUCPTSA-N Thr-Asn-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PQLXHSACXPGWPD-GSSVUCPTSA-N 0.000 description 2
- LGNBRHZANHMZHK-NUMRIWBASA-N Thr-Glu-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O LGNBRHZANHMZHK-NUMRIWBASA-N 0.000 description 2
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 2
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 2
- DCRHJDRLCFMEBI-RHYQMDGZSA-N Thr-Lys-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O DCRHJDRLCFMEBI-RHYQMDGZSA-N 0.000 description 2
- NZRUWPIYECBYRK-HTUGSXCWSA-N Thr-Phe-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O NZRUWPIYECBYRK-HTUGSXCWSA-N 0.000 description 2
- VEIKMWOMUYMMMK-FCLVOEFKSA-N Thr-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VEIKMWOMUYMMMK-FCLVOEFKSA-N 0.000 description 2
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 2
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 2
- CYCGARJWIQWPQM-YJRXYDGGSA-N Thr-Tyr-Ser Chemical compound C[C@@H](O)[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CO)C([O-])=O)CC1=CC=C(O)C=C1 CYCGARJWIQWPQM-YJRXYDGGSA-N 0.000 description 2
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- CXUFDWZBHKUGKK-CABZTGNLSA-N Trp-Ala-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O)=CNC2=C1 CXUFDWZBHKUGKK-CABZTGNLSA-N 0.000 description 2
- SCCKSNREWHMKOJ-SRVKXCTJSA-N Tyr-Asn-Ser Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O SCCKSNREWHMKOJ-SRVKXCTJSA-N 0.000 description 2
- WVRUKYLYMFGKAN-IHRRRGAJSA-N Tyr-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 WVRUKYLYMFGKAN-IHRRRGAJSA-N 0.000 description 2
- DMWNPLOERDAHSY-MEYUZBJRSA-N Tyr-Leu-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DMWNPLOERDAHSY-MEYUZBJRSA-N 0.000 description 2
- YYLHVUCSTXXKBS-IHRRRGAJSA-N Tyr-Pro-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YYLHVUCSTXXKBS-IHRRRGAJSA-N 0.000 description 2
- JLFKWDAZBRYCGX-ZKWXMUAHSA-N Val-Asn-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N JLFKWDAZBRYCGX-ZKWXMUAHSA-N 0.000 description 2
- PVPAOIGJYHVWBT-KKHAAJSZSA-N Val-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N)O PVPAOIGJYHVWBT-KKHAAJSZSA-N 0.000 description 2
- SZTTYWIUCGSURQ-AUTRQRHGSA-N Val-Glu-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SZTTYWIUCGSURQ-AUTRQRHGSA-N 0.000 description 2
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 2
- YTUABZMPYKCWCQ-XQQFMLRXSA-N Val-His-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N YTUABZMPYKCWCQ-XQQFMLRXSA-N 0.000 description 2
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 2
- SVFRYKBZHUGKLP-QXEWZRGKSA-N Val-Met-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SVFRYKBZHUGKLP-QXEWZRGKSA-N 0.000 description 2
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 2
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 2
- SDHZOOIGIUEPDY-JYJNAYRXSA-N Val-Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 SDHZOOIGIUEPDY-JYJNAYRXSA-N 0.000 description 2
- UVHFONIHVHLDDQ-IFFSRLJSSA-N Val-Thr-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O UVHFONIHVHLDDQ-IFFSRLJSSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 108010041407 alanylaspartic acid Proteins 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 229960002932 anastrozole Drugs 0.000 description 2
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 2
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 2
- 229940087620 aromasin Drugs 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000004611 cancer cell death Effects 0.000 description 2
- 229960004562 carboplatin Drugs 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 210000002230 centromere Anatomy 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000002487 chromatin immunoprecipitation Methods 0.000 description 2
- 230000024321 chromosome segregation Effects 0.000 description 2
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 2
- 229960004316 cisplatin Drugs 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000002559 cytogenic effect Effects 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000001973 epigenetic effect Effects 0.000 description 2
- 201000004101 esophageal cancer Diseases 0.000 description 2
- 230000005772 establishment of chromosome localization Effects 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 229940087476 femara Drugs 0.000 description 2
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003517 fume Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 2
- 229960005277 gemcitabine Drugs 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 238000012226 gene silencing method Methods 0.000 description 2
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 2
- 108010008237 glutamyl-valyl-glycine Proteins 0.000 description 2
- 108010079547 glutamylmethionine Proteins 0.000 description 2
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 231100000226 haematotoxicity Toxicity 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 2
- 230000002055 immunohistochemical effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 108010043612 kentsin Proteins 0.000 description 2
- 108010053037 kyotorphin Proteins 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 description 2
- 108010047926 leucyl-lysyl-tyrosine Proteins 0.000 description 2
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 2
- 108010091871 leucylmethionine Proteins 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 238000011528 liquid biopsy Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 108010038320 lysylphenylalanine Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 108010005942 methionylglycine Proteins 0.000 description 2
- 230000008600 mitotic progression Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000007838 multiplex ligation-dependent probe amplification Methods 0.000 description 2
- 210000003739 neck Anatomy 0.000 description 2
- 208000004235 neutropenia Diseases 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000009117 preventive therapy Methods 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000013557 residual solvent Substances 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 108010071207 serylmethionine Proteins 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 208000000587 small cell lung carcinoma Diseases 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000007046 spindle assembly involved in mitosis Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000009121 systemic therapy Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 230000004797 therapeutic response Effects 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 108010009962 valyltyrosine Proteins 0.000 description 2
- 230000028604 virus induced gene silencing Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000001238 wet grinding Methods 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- GJLXVWOMRRWCIB-MERZOTPQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanamide Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=C(O)C=C1 GJLXVWOMRRWCIB-MERZOTPQSA-N 0.000 description 1
- JNTMAZFVYNDPLB-PEDHHIEDSA-N (2S,3S)-2-[[[(2S)-1-[(2S,3S)-2-amino-3-methyl-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JNTMAZFVYNDPLB-PEDHHIEDSA-N 0.000 description 1
- CWFMWBHMIMNZLN-NAKRPEOUSA-N (2s)-1-[(2s)-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CWFMWBHMIMNZLN-NAKRPEOUSA-N 0.000 description 1
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 1
- RBMGJIZCEWRQES-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;hydrate Chemical compound O.OC(=O)[C@@H](N)CC(N)=O RBMGJIZCEWRQES-DKWTVANSSA-N 0.000 description 1
- PAHHYDSPOXDASW-VGWMRTNUSA-N (2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO PAHHYDSPOXDASW-VGWMRTNUSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 108010036211 5-HT-moduline Proteins 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- DKJPOZOEBONHFS-ZLUOBGJFSA-N Ala-Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O DKJPOZOEBONHFS-ZLUOBGJFSA-N 0.000 description 1
- WQVFQXXBNHHPLX-ZKWXMUAHSA-N Ala-Ala-His Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O WQVFQXXBNHHPLX-ZKWXMUAHSA-N 0.000 description 1
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- LWUWMHIOBPTZBA-DCAQKATOSA-N Ala-Arg-Lys Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O LWUWMHIOBPTZBA-DCAQKATOSA-N 0.000 description 1
- ZIBWKCRKNFYTPT-ZKWXMUAHSA-N Ala-Asn-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZIBWKCRKNFYTPT-ZKWXMUAHSA-N 0.000 description 1
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 1
- ZIWWTZWAKYBUOB-CIUDSAMLSA-N Ala-Asp-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O ZIWWTZWAKYBUOB-CIUDSAMLSA-N 0.000 description 1
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 1
- YSMPVONNIWLJML-FXQIFTODSA-N Ala-Asp-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O YSMPVONNIWLJML-FXQIFTODSA-N 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- IKKVASZHTMKJIR-ZKWXMUAHSA-N Ala-Asp-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IKKVASZHTMKJIR-ZKWXMUAHSA-N 0.000 description 1
- HWPXGQCMZITGFN-XVYDVKMFSA-N Ala-Cys-His Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HWPXGQCMZITGFN-XVYDVKMFSA-N 0.000 description 1
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 1
- JPGBXANAQYHTLA-DRZSPHRISA-N Ala-Gln-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JPGBXANAQYHTLA-DRZSPHRISA-N 0.000 description 1
- PAIHPOGPJVUFJY-WDSKDSINSA-N Ala-Glu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PAIHPOGPJVUFJY-WDSKDSINSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- OMMDTNGURYRDAC-NRPADANISA-N Ala-Glu-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OMMDTNGURYRDAC-NRPADANISA-N 0.000 description 1
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 1
- OKEWAFFWMHBGPT-XPUUQOCRSA-N Ala-His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CN=CN1 OKEWAFFWMHBGPT-XPUUQOCRSA-N 0.000 description 1
- CBCCCLMNOBLBSC-XVYDVKMFSA-N Ala-His-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CBCCCLMNOBLBSC-XVYDVKMFSA-N 0.000 description 1
- NMXKFWOEASXOGB-QSFUFRPTSA-N Ala-Ile-His Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NMXKFWOEASXOGB-QSFUFRPTSA-N 0.000 description 1
- VNYMOTCMNHJGTG-JBDRJPRFSA-N Ala-Ile-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O VNYMOTCMNHJGTG-JBDRJPRFSA-N 0.000 description 1
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 1
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 1
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 1
- NINQYGGNRIBFSC-CIUDSAMLSA-N Ala-Lys-Ser Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CO)C(O)=O NINQYGGNRIBFSC-CIUDSAMLSA-N 0.000 description 1
- MDNAVFBZPROEHO-DCAQKATOSA-N Ala-Lys-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MDNAVFBZPROEHO-DCAQKATOSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- VHEVVUZDDUCAKU-FXQIFTODSA-N Ala-Met-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O VHEVVUZDDUCAKU-FXQIFTODSA-N 0.000 description 1
- PVQLRJRPUTXFFX-CIUDSAMLSA-N Ala-Met-Gln Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(N)=O)C(O)=O PVQLRJRPUTXFFX-CIUDSAMLSA-N 0.000 description 1
- DWYROCSXOOMOEU-CIUDSAMLSA-N Ala-Met-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DWYROCSXOOMOEU-CIUDSAMLSA-N 0.000 description 1
- BFMIRJBURUXDRG-DLOVCJGASA-N Ala-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 BFMIRJBURUXDRG-DLOVCJGASA-N 0.000 description 1
- CNQAFFMNJIQYGX-DRZSPHRISA-N Ala-Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 CNQAFFMNJIQYGX-DRZSPHRISA-N 0.000 description 1
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- VJVQKGYHIZPSNS-FXQIFTODSA-N Ala-Ser-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N VJVQKGYHIZPSNS-FXQIFTODSA-N 0.000 description 1
- KLALXKYLOMZDQT-ZLUOBGJFSA-N Ala-Ser-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KLALXKYLOMZDQT-ZLUOBGJFSA-N 0.000 description 1
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 1
- YYAVDNKUWLAFCV-ACZMJKKPSA-N Ala-Ser-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYAVDNKUWLAFCV-ACZMJKKPSA-N 0.000 description 1
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 1
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 1
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 1
- HCBKAOZYACJUEF-XQXXSGGOSA-N Ala-Thr-Gln Chemical compound N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O HCBKAOZYACJUEF-XQXXSGGOSA-N 0.000 description 1
- SAHQGRZIQVEJPF-JXUBOQSCSA-N Ala-Thr-Lys Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN SAHQGRZIQVEJPF-JXUBOQSCSA-N 0.000 description 1
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
- YXXPVUOMPSZURS-ZLIFDBKOSA-N Ala-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 YXXPVUOMPSZURS-ZLIFDBKOSA-N 0.000 description 1
- ZJLORAAXDAJLDC-CQDKDKBSSA-N Ala-Tyr-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O ZJLORAAXDAJLDC-CQDKDKBSSA-N 0.000 description 1
- XAXMJQUMRJAFCH-CQDKDKBSSA-N Ala-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 XAXMJQUMRJAFCH-CQDKDKBSSA-N 0.000 description 1
- BVLPIIBTWIYOML-ZKWXMUAHSA-N Ala-Val-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BVLPIIBTWIYOML-ZKWXMUAHSA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- XCIGOVDXZULBBV-DCAQKATOSA-N Ala-Val-Lys Chemical compound CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O XCIGOVDXZULBBV-DCAQKATOSA-N 0.000 description 1
- 208000007860 Anus Neoplasms Diseases 0.000 description 1
- PEFFAAKJGBZBKL-NAKRPEOUSA-N Arg-Ala-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PEFFAAKJGBZBKL-NAKRPEOUSA-N 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 1
- OVVUNXXROOFSIM-SDDRHHMPSA-N Arg-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O OVVUNXXROOFSIM-SDDRHHMPSA-N 0.000 description 1
- WESHVRNMNFMVBE-FXQIFTODSA-N Arg-Asn-Asp Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)CN=C(N)N WESHVRNMNFMVBE-FXQIFTODSA-N 0.000 description 1
- RVDVDRUZWZIBJQ-CIUDSAMLSA-N Arg-Asn-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RVDVDRUZWZIBJQ-CIUDSAMLSA-N 0.000 description 1
- NUBPTCMEOCKWDO-DCAQKATOSA-N Arg-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N NUBPTCMEOCKWDO-DCAQKATOSA-N 0.000 description 1
- BVBKBQRPOJFCQM-DCAQKATOSA-N Arg-Asn-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BVBKBQRPOJFCQM-DCAQKATOSA-N 0.000 description 1
- DXQIQUIQYAGRCC-CIUDSAMLSA-N Arg-Asp-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)CN=C(N)N DXQIQUIQYAGRCC-CIUDSAMLSA-N 0.000 description 1
- OZNSCVPYWZRQPY-CIUDSAMLSA-N Arg-Asp-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OZNSCVPYWZRQPY-CIUDSAMLSA-N 0.000 description 1
- PTVGLOCPAVYPFG-CIUDSAMLSA-N Arg-Gln-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O PTVGLOCPAVYPFG-CIUDSAMLSA-N 0.000 description 1
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 1
- QAODJPUKWNNNRP-DCAQKATOSA-N Arg-Glu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QAODJPUKWNNNRP-DCAQKATOSA-N 0.000 description 1
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 1
- AQPVUEJJARLJHB-BQBZGAKWSA-N Arg-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N AQPVUEJJARLJHB-BQBZGAKWSA-N 0.000 description 1
- HQIZDMIGUJOSNI-IUCAKERBSA-N Arg-Gly-Arg Chemical compound N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQIZDMIGUJOSNI-IUCAKERBSA-N 0.000 description 1
- OQCWXQJLCDPRHV-UWVGGRQHSA-N Arg-Gly-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O OQCWXQJLCDPRHV-UWVGGRQHSA-N 0.000 description 1
- OCDJOVKIUJVUMO-SRVKXCTJSA-N Arg-His-Gln Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N OCDJOVKIUJVUMO-SRVKXCTJSA-N 0.000 description 1
- ZJEDSBGPBXVBMP-PYJNHQTQSA-N Arg-His-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZJEDSBGPBXVBMP-PYJNHQTQSA-N 0.000 description 1
- NVCIXQYNWYTLDO-IHRRRGAJSA-N Arg-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCN=C(N)N)N NVCIXQYNWYTLDO-IHRRRGAJSA-N 0.000 description 1
- RKQRHMKFNBYOTN-IHRRRGAJSA-N Arg-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N RKQRHMKFNBYOTN-IHRRRGAJSA-N 0.000 description 1
- CRCCTGPNZUCAHE-DCAQKATOSA-N Arg-His-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CN=CN1 CRCCTGPNZUCAHE-DCAQKATOSA-N 0.000 description 1
- YQGZIRIYGHNSQO-ZPFDUUQYSA-N Arg-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YQGZIRIYGHNSQO-ZPFDUUQYSA-N 0.000 description 1
- GNYUVVJYGJFKHN-RVMXOQNASA-N Arg-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N GNYUVVJYGJFKHN-RVMXOQNASA-N 0.000 description 1
- UHFUZWSZQKMDSX-DCAQKATOSA-N Arg-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UHFUZWSZQKMDSX-DCAQKATOSA-N 0.000 description 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 1
- FSNVAJOPUDVQAR-AVGNSLFASA-N Arg-Lys-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FSNVAJOPUDVQAR-AVGNSLFASA-N 0.000 description 1
- SSZGOKWBHLOCHK-DCAQKATOSA-N Arg-Lys-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N SSZGOKWBHLOCHK-DCAQKATOSA-N 0.000 description 1
- CVXXSWQORBZAAA-SRVKXCTJSA-N Arg-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N CVXXSWQORBZAAA-SRVKXCTJSA-N 0.000 description 1
- MTYLORHAQXVQOW-AVGNSLFASA-N Arg-Lys-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O MTYLORHAQXVQOW-AVGNSLFASA-N 0.000 description 1
- RIQBRKVTFBWEDY-RHYQMDGZSA-N Arg-Lys-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RIQBRKVTFBWEDY-RHYQMDGZSA-N 0.000 description 1
- LCBSSOCDWUTQQV-SDDRHHMPSA-N Arg-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LCBSSOCDWUTQQV-SDDRHHMPSA-N 0.000 description 1
- BSGSDLYGGHGMND-IHRRRGAJSA-N Arg-Phe-Cys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N BSGSDLYGGHGMND-IHRRRGAJSA-N 0.000 description 1
- DPLFNLDACGGBAK-KKUMJFAQSA-N Arg-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N DPLFNLDACGGBAK-KKUMJFAQSA-N 0.000 description 1
- YCYXHLZRUSJITQ-SRVKXCTJSA-N Arg-Pro-Pro Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 YCYXHLZRUSJITQ-SRVKXCTJSA-N 0.000 description 1
- KXOPYFNQLVUOAQ-FXQIFTODSA-N Arg-Ser-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KXOPYFNQLVUOAQ-FXQIFTODSA-N 0.000 description 1
- ADPACBMPYWJJCE-FXQIFTODSA-N Arg-Ser-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O ADPACBMPYWJJCE-FXQIFTODSA-N 0.000 description 1
- KMFPQTITXUKJOV-DCAQKATOSA-N Arg-Ser-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O KMFPQTITXUKJOV-DCAQKATOSA-N 0.000 description 1
- LRPZJPMQGKGHSG-XGEHTFHBSA-N Arg-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)O LRPZJPMQGKGHSG-XGEHTFHBSA-N 0.000 description 1
- HRCIIMCTUIAKQB-XGEHTFHBSA-N Arg-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O HRCIIMCTUIAKQB-XGEHTFHBSA-N 0.000 description 1
- INOIAEUXVVNJKA-XGEHTFHBSA-N Arg-Thr-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O INOIAEUXVVNJKA-XGEHTFHBSA-N 0.000 description 1
- VJIQPOJMISSUPO-BVSLBCMMSA-N Arg-Trp-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VJIQPOJMISSUPO-BVSLBCMMSA-N 0.000 description 1
- NMTANZXPDAHUKU-ULQDDVLXSA-N Arg-Tyr-Lys Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=C(O)C=C1 NMTANZXPDAHUKU-ULQDDVLXSA-N 0.000 description 1
- PSUXEQYPYZLNER-QXEWZRGKSA-N Arg-Val-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PSUXEQYPYZLNER-QXEWZRGKSA-N 0.000 description 1
- FTMRPIVPSDVGCC-GUBZILKMSA-N Arg-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FTMRPIVPSDVGCC-GUBZILKMSA-N 0.000 description 1
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 1
- XEOXPCNONWHHSW-AVGNSLFASA-N Arg-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N XEOXPCNONWHHSW-AVGNSLFASA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- RZVVKNIACROXRM-ZLUOBGJFSA-N Asn-Ala-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N RZVVKNIACROXRM-ZLUOBGJFSA-N 0.000 description 1
- SLKLLQWZQHXYSV-CIUDSAMLSA-N Asn-Ala-Lys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O SLKLLQWZQHXYSV-CIUDSAMLSA-N 0.000 description 1
- ORXCYAFUCSTQGY-FXQIFTODSA-N Asn-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N ORXCYAFUCSTQGY-FXQIFTODSA-N 0.000 description 1
- XWGJDUSDTRPQRK-ZLUOBGJFSA-N Asn-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O XWGJDUSDTRPQRK-ZLUOBGJFSA-N 0.000 description 1
- QEYJFBMTSMLPKZ-ZKWXMUAHSA-N Asn-Ala-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O QEYJFBMTSMLPKZ-ZKWXMUAHSA-N 0.000 description 1
- VDCIPFYVCICPEC-FXQIFTODSA-N Asn-Arg-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O VDCIPFYVCICPEC-FXQIFTODSA-N 0.000 description 1
- GMRGSBAMMMVDGG-GUBZILKMSA-N Asn-Arg-Arg Chemical compound C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N GMRGSBAMMMVDGG-GUBZILKMSA-N 0.000 description 1
- XHFXZQHTLJVZBN-FXQIFTODSA-N Asn-Arg-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N XHFXZQHTLJVZBN-FXQIFTODSA-N 0.000 description 1
- GXMSVVBIAMWMKO-BQBZGAKWSA-N Asn-Arg-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CCCN=C(N)N GXMSVVBIAMWMKO-BQBZGAKWSA-N 0.000 description 1
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 1
- KSBHCUSPLWRVEK-ZLUOBGJFSA-N Asn-Asn-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KSBHCUSPLWRVEK-ZLUOBGJFSA-N 0.000 description 1
- RCENDENBBJFJHZ-ACZMJKKPSA-N Asn-Asn-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RCENDENBBJFJHZ-ACZMJKKPSA-N 0.000 description 1
- IOTKDTZEEBZNCM-UGYAYLCHSA-N Asn-Asn-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOTKDTZEEBZNCM-UGYAYLCHSA-N 0.000 description 1
- QHBMKQWOIYJYMI-BYULHYEWSA-N Asn-Asn-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O QHBMKQWOIYJYMI-BYULHYEWSA-N 0.000 description 1
- GMCOADLDNLGOFE-ZLUOBGJFSA-N Asn-Asp-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N)C(=O)N GMCOADLDNLGOFE-ZLUOBGJFSA-N 0.000 description 1
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 1
- QISZHYWZHJRDAO-CIUDSAMLSA-N Asn-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N QISZHYWZHJRDAO-CIUDSAMLSA-N 0.000 description 1
- VYLVOMUVLMGCRF-ZLUOBGJFSA-N Asn-Asp-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VYLVOMUVLMGCRF-ZLUOBGJFSA-N 0.000 description 1
- YQNBILXAUIAUCF-CIUDSAMLSA-N Asn-Cys-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)N YQNBILXAUIAUCF-CIUDSAMLSA-N 0.000 description 1
- SPIPSJXLZVTXJL-ZLUOBGJFSA-N Asn-Cys-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O SPIPSJXLZVTXJL-ZLUOBGJFSA-N 0.000 description 1
- QRHYAUYXBVVDSB-LKXGYXEUSA-N Asn-Cys-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QRHYAUYXBVVDSB-LKXGYXEUSA-N 0.000 description 1
- XWFPGQVLOVGSLU-CIUDSAMLSA-N Asn-Gln-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N XWFPGQVLOVGSLU-CIUDSAMLSA-N 0.000 description 1
- AYKKKGFJXIDYLX-ACZMJKKPSA-N Asn-Gln-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O AYKKKGFJXIDYLX-ACZMJKKPSA-N 0.000 description 1
- VJTWLBMESLDOMK-WDSKDSINSA-N Asn-Gln-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O VJTWLBMESLDOMK-WDSKDSINSA-N 0.000 description 1
- WPOLSNAQGVHROR-GUBZILKMSA-N Asn-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N WPOLSNAQGVHROR-GUBZILKMSA-N 0.000 description 1
- QNJIRRVTOXNGMH-GUBZILKMSA-N Asn-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O QNJIRRVTOXNGMH-GUBZILKMSA-N 0.000 description 1
- SRUUBQBAVNQZGJ-LAEOZQHASA-N Asn-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SRUUBQBAVNQZGJ-LAEOZQHASA-N 0.000 description 1
- XVAPVJNJGLWGCS-ACZMJKKPSA-N Asn-Glu-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVAPVJNJGLWGCS-ACZMJKKPSA-N 0.000 description 1
- QYXNFROWLZPWPC-FXQIFTODSA-N Asn-Glu-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QYXNFROWLZPWPC-FXQIFTODSA-N 0.000 description 1
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 1
- UBKOVSLDWIHYSY-ACZMJKKPSA-N Asn-Glu-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UBKOVSLDWIHYSY-ACZMJKKPSA-N 0.000 description 1
- CTQIOCMSIJATNX-WHFBIAKZSA-N Asn-Gly-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O CTQIOCMSIJATNX-WHFBIAKZSA-N 0.000 description 1
- JQSWHKKUZMTOIH-QWRGUYRKSA-N Asn-Gly-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N JQSWHKKUZMTOIH-QWRGUYRKSA-N 0.000 description 1
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 1
- AITGTTNYKAWKDR-CIUDSAMLSA-N Asn-His-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O AITGTTNYKAWKDR-CIUDSAMLSA-N 0.000 description 1
- SUEIIIFUBHDCCS-PBCZWWQYSA-N Asn-His-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SUEIIIFUBHDCCS-PBCZWWQYSA-N 0.000 description 1
- FVKHEKVYFTZWDX-GHCJXIJMSA-N Asn-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N FVKHEKVYFTZWDX-GHCJXIJMSA-N 0.000 description 1
- PHJPKNUWWHRAOC-PEFMBERDSA-N Asn-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N PHJPKNUWWHRAOC-PEFMBERDSA-N 0.000 description 1
- KMCRKVOLRCOMBG-DJFWLOJKSA-N Asn-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N KMCRKVOLRCOMBG-DJFWLOJKSA-N 0.000 description 1
- PNHQRQTVBRDIEF-CIUDSAMLSA-N Asn-Leu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)N PNHQRQTVBRDIEF-CIUDSAMLSA-N 0.000 description 1
- HFPXZWPUVFVNLL-GUBZILKMSA-N Asn-Leu-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFPXZWPUVFVNLL-GUBZILKMSA-N 0.000 description 1
- BZWRLDPIWKOVKB-ZPFDUUQYSA-N Asn-Leu-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BZWRLDPIWKOVKB-ZPFDUUQYSA-N 0.000 description 1
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 1
- YVXRYLVELQYAEQ-SRVKXCTJSA-N Asn-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N YVXRYLVELQYAEQ-SRVKXCTJSA-N 0.000 description 1
- JLNFZLNDHONLND-GARJFASQSA-N Asn-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N JLNFZLNDHONLND-GARJFASQSA-N 0.000 description 1
- NCFJQJRLQJEECD-NHCYSSNCSA-N Asn-Leu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O NCFJQJRLQJEECD-NHCYSSNCSA-N 0.000 description 1
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 1
- ALHMNHZJBYBYHS-DCAQKATOSA-N Asn-Lys-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ALHMNHZJBYBYHS-DCAQKATOSA-N 0.000 description 1
- FODVBOKTYKYRFJ-CIUDSAMLSA-N Asn-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N FODVBOKTYKYRFJ-CIUDSAMLSA-N 0.000 description 1
- JWKDQOORUCYUIW-ZPFDUUQYSA-N Asn-Lys-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JWKDQOORUCYUIW-ZPFDUUQYSA-N 0.000 description 1
- ORJQQZIXTOYGGH-SRVKXCTJSA-N Asn-Lys-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ORJQQZIXTOYGGH-SRVKXCTJSA-N 0.000 description 1
- GIQCDTKOIPUDSG-GARJFASQSA-N Asn-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N)C(=O)O GIQCDTKOIPUDSG-GARJFASQSA-N 0.000 description 1
- COWITDLVHMZSIW-CIUDSAMLSA-N Asn-Lys-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O COWITDLVHMZSIW-CIUDSAMLSA-N 0.000 description 1
- HMUKKNAMNSXDBB-CIUDSAMLSA-N Asn-Met-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMUKKNAMNSXDBB-CIUDSAMLSA-N 0.000 description 1
- WCRQQIPFSXFIRN-LPEHRKFASA-N Asn-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N WCRQQIPFSXFIRN-LPEHRKFASA-N 0.000 description 1
- CDGHMJJJHYKMPA-DLOVCJGASA-N Asn-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)N)N CDGHMJJJHYKMPA-DLOVCJGASA-N 0.000 description 1
- MVXJBVVLACEGCG-PCBIJLKTSA-N Asn-Phe-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVXJBVVLACEGCG-PCBIJLKTSA-N 0.000 description 1
- YXVAESUIQFDBHN-SRVKXCTJSA-N Asn-Phe-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O YXVAESUIQFDBHN-SRVKXCTJSA-N 0.000 description 1
- JTXVXGXTRXMOFJ-FXQIFTODSA-N Asn-Pro-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O JTXVXGXTRXMOFJ-FXQIFTODSA-N 0.000 description 1
- YRTOMUMWSTUQAX-FXQIFTODSA-N Asn-Pro-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O YRTOMUMWSTUQAX-FXQIFTODSA-N 0.000 description 1
- GKKUBLFXKRDMFC-BQBZGAKWSA-N Asn-Pro-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O GKKUBLFXKRDMFC-BQBZGAKWSA-N 0.000 description 1
- XTMZYFMTYJNABC-ZLUOBGJFSA-N Asn-Ser-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N XTMZYFMTYJNABC-ZLUOBGJFSA-N 0.000 description 1
- DOURAOODTFJRIC-CIUDSAMLSA-N Asn-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N DOURAOODTFJRIC-CIUDSAMLSA-N 0.000 description 1
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 1
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 1
- HPNDKUOLNRVRAY-BIIVOSGPSA-N Asn-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N)C(=O)O HPNDKUOLNRVRAY-BIIVOSGPSA-N 0.000 description 1
- MYTHOBCLNIOFBL-SRVKXCTJSA-N Asn-Ser-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MYTHOBCLNIOFBL-SRVKXCTJSA-N 0.000 description 1
- QYRMBFWDSFGSFC-OLHMAJIHSA-N Asn-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QYRMBFWDSFGSFC-OLHMAJIHSA-N 0.000 description 1
- ZUFPUBYQYWCMDB-NUMRIWBASA-N Asn-Thr-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZUFPUBYQYWCMDB-NUMRIWBASA-N 0.000 description 1
- UXHYOWXTJLBEPG-GSSVUCPTSA-N Asn-Thr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UXHYOWXTJLBEPG-GSSVUCPTSA-N 0.000 description 1
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 1
- CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 1
- MYRLSKYSMXNLLA-LAEOZQHASA-N Asn-Val-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MYRLSKYSMXNLLA-LAEOZQHASA-N 0.000 description 1
- LMIWYCWRJVMAIQ-NHCYSSNCSA-N Asn-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N LMIWYCWRJVMAIQ-NHCYSSNCSA-N 0.000 description 1
- PQKSVQSMTHPRIB-ZKWXMUAHSA-N Asn-Val-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O PQKSVQSMTHPRIB-ZKWXMUAHSA-N 0.000 description 1
- SLHOOKXYTYAJGQ-XVYDVKMFSA-N Asp-Ala-His Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 SLHOOKXYTYAJGQ-XVYDVKMFSA-N 0.000 description 1
- ZVTDYGWRRPMFCL-WFBYXXMGSA-N Asp-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N ZVTDYGWRRPMFCL-WFBYXXMGSA-N 0.000 description 1
- OERMIMJQPQUIPK-FXQIFTODSA-N Asp-Arg-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O OERMIMJQPQUIPK-FXQIFTODSA-N 0.000 description 1
- CNKAZIGBGQIHLL-GUBZILKMSA-N Asp-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N CNKAZIGBGQIHLL-GUBZILKMSA-N 0.000 description 1
- MRQQMVZUHXUPEV-IHRRRGAJSA-N Asp-Arg-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MRQQMVZUHXUPEV-IHRRRGAJSA-N 0.000 description 1
- XYBJLTKSGFBLCS-QXEWZRGKSA-N Asp-Arg-Val Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O XYBJLTKSGFBLCS-QXEWZRGKSA-N 0.000 description 1
- YNQIDCRRTWGHJD-ZLUOBGJFSA-N Asp-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(O)=O YNQIDCRRTWGHJD-ZLUOBGJFSA-N 0.000 description 1
- ATYWBXGNXZYZGI-ACZMJKKPSA-N Asp-Asn-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O ATYWBXGNXZYZGI-ACZMJKKPSA-N 0.000 description 1
- JDHOJQJMWBKHDB-CIUDSAMLSA-N Asp-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N JDHOJQJMWBKHDB-CIUDSAMLSA-N 0.000 description 1
- LKIYSIYBKYLKPU-BIIVOSGPSA-N Asp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O LKIYSIYBKYLKPU-BIIVOSGPSA-N 0.000 description 1
- NURJSGZGBVJFAD-ZLUOBGJFSA-N Asp-Cys-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N)C(=O)O NURJSGZGBVJFAD-ZLUOBGJFSA-N 0.000 description 1
- DZQKLNLLWFQONU-LKXGYXEUSA-N Asp-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N)O DZQKLNLLWFQONU-LKXGYXEUSA-N 0.000 description 1
- NYQHSUGFEWDWPD-ACZMJKKPSA-N Asp-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N NYQHSUGFEWDWPD-ACZMJKKPSA-N 0.000 description 1
- WLKVEEODTPQPLI-ACZMJKKPSA-N Asp-Gln-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O WLKVEEODTPQPLI-ACZMJKKPSA-N 0.000 description 1
- SMZCLQGDQMGESY-ACZMJKKPSA-N Asp-Gln-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N SMZCLQGDQMGESY-ACZMJKKPSA-N 0.000 description 1
- YBMUFUWSMIKJQA-GUBZILKMSA-N Asp-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N YBMUFUWSMIKJQA-GUBZILKMSA-N 0.000 description 1
- PMEHKVHZQKJACS-PEFMBERDSA-N Asp-Gln-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PMEHKVHZQKJACS-PEFMBERDSA-N 0.000 description 1
- CSEJMKNZDCJYGJ-XHNCKOQMSA-N Asp-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O CSEJMKNZDCJYGJ-XHNCKOQMSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- XJQRWGXKUSDEFI-ACZMJKKPSA-N Asp-Glu-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XJQRWGXKUSDEFI-ACZMJKKPSA-N 0.000 description 1
- GHODABZPVZMWCE-FXQIFTODSA-N Asp-Glu-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GHODABZPVZMWCE-FXQIFTODSA-N 0.000 description 1
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 1
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 1
- XDGBFDYXZCMYEX-NUMRIWBASA-N Asp-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)O XDGBFDYXZCMYEX-NUMRIWBASA-N 0.000 description 1
- RRKCPMGSRIDLNC-AVGNSLFASA-N Asp-Glu-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RRKCPMGSRIDLNC-AVGNSLFASA-N 0.000 description 1
- DTNUIAJCPRMNBT-WHFBIAKZSA-N Asp-Gly-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O DTNUIAJCPRMNBT-WHFBIAKZSA-N 0.000 description 1
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 1
- CRNKLABLTICXDV-GUBZILKMSA-N Asp-His-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N CRNKLABLTICXDV-GUBZILKMSA-N 0.000 description 1
- YRBGRUOSJROZEI-NHCYSSNCSA-N Asp-His-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O YRBGRUOSJROZEI-NHCYSSNCSA-N 0.000 description 1
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 1
- JNNVNVRBYUJYGS-CIUDSAMLSA-N Asp-Leu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O JNNVNVRBYUJYGS-CIUDSAMLSA-N 0.000 description 1
- CLUMZOKVGUWUFD-CIUDSAMLSA-N Asp-Leu-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O CLUMZOKVGUWUFD-CIUDSAMLSA-N 0.000 description 1
- AYFVRYXNDHBECD-YUMQZZPRSA-N Asp-Leu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AYFVRYXNDHBECD-YUMQZZPRSA-N 0.000 description 1
- CJUKAWUWBZCTDQ-SRVKXCTJSA-N Asp-Leu-Lys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O CJUKAWUWBZCTDQ-SRVKXCTJSA-N 0.000 description 1
- IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 1
- QNIACYURSSCLRP-GUBZILKMSA-N Asp-Lys-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O QNIACYURSSCLRP-GUBZILKMSA-N 0.000 description 1
- DONWIPDSZZJHHK-HJGDQZAQSA-N Asp-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N)O DONWIPDSZZJHHK-HJGDQZAQSA-N 0.000 description 1
- MYLZFUMPZCPJCJ-NHCYSSNCSA-N Asp-Lys-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MYLZFUMPZCPJCJ-NHCYSSNCSA-N 0.000 description 1
- IDDMGSKZQDEDGA-SRVKXCTJSA-N Asp-Phe-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 IDDMGSKZQDEDGA-SRVKXCTJSA-N 0.000 description 1
- GWIJZUVQVDJHDI-AVGNSLFASA-N Asp-Phe-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GWIJZUVQVDJHDI-AVGNSLFASA-N 0.000 description 1
- PCJOFZYFFMBZKC-PCBIJLKTSA-N Asp-Phe-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PCJOFZYFFMBZKC-PCBIJLKTSA-N 0.000 description 1
- RPUYTJJZXQBWDT-SRVKXCTJSA-N Asp-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N RPUYTJJZXQBWDT-SRVKXCTJSA-N 0.000 description 1
- KESWRFKUZRUTAH-FXQIFTODSA-N Asp-Pro-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O KESWRFKUZRUTAH-FXQIFTODSA-N 0.000 description 1
- UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 1
- FAUPLTGRUBTXNU-FXQIFTODSA-N Asp-Pro-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O FAUPLTGRUBTXNU-FXQIFTODSA-N 0.000 description 1
- CUQDCPXNZPDYFQ-ZLUOBGJFSA-N Asp-Ser-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O CUQDCPXNZPDYFQ-ZLUOBGJFSA-N 0.000 description 1
- KGHLGJAXYSVNJP-WHFBIAKZSA-N Asp-Ser-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O KGHLGJAXYSVNJP-WHFBIAKZSA-N 0.000 description 1
- NBKLEMWHDLAUEM-CIUDSAMLSA-N Asp-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N NBKLEMWHDLAUEM-CIUDSAMLSA-N 0.000 description 1
- DRCOAZZDQRCGGP-GHCJXIJMSA-N Asp-Ser-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DRCOAZZDQRCGGP-GHCJXIJMSA-N 0.000 description 1
- ZQFRDAZBTSFGGW-SRVKXCTJSA-N Asp-Ser-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZQFRDAZBTSFGGW-SRVKXCTJSA-N 0.000 description 1
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 1
- IWLZBRTUIVXZJD-OLHMAJIHSA-N Asp-Thr-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O IWLZBRTUIVXZJD-OLHMAJIHSA-N 0.000 description 1
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 1
- GXHDGYOXPNQCKM-XVSYOHENSA-N Asp-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O GXHDGYOXPNQCKM-XVSYOHENSA-N 0.000 description 1
- OQMGSMNZVHYDTQ-ZKWXMUAHSA-N Asp-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N OQMGSMNZVHYDTQ-ZKWXMUAHSA-N 0.000 description 1
- QPDUWAUSSWGJSB-NGZCFLSTSA-N Asp-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N QPDUWAUSSWGJSB-NGZCFLSTSA-N 0.000 description 1
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 208000003170 Bronchiolo-Alveolar Adenocarcinoma Diseases 0.000 description 1
- 206010058354 Bronchioloalveolar carcinoma Diseases 0.000 description 1
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 description 1
- 241001466804 Carnivora Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 238000001353 Chip-sequencing Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 108091060290 Chromatid Proteins 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- 208000037051 Chromosomal Instability Diseases 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- QFMCHXSGIZPBKG-ZLUOBGJFSA-N Cys-Ala-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N QFMCHXSGIZPBKG-ZLUOBGJFSA-N 0.000 description 1
- GMXSSZUVDNPRMA-FXQIFTODSA-N Cys-Arg-Asp Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GMXSSZUVDNPRMA-FXQIFTODSA-N 0.000 description 1
- DEVDFMRWZASYOF-ZLUOBGJFSA-N Cys-Asn-Asp Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DEVDFMRWZASYOF-ZLUOBGJFSA-N 0.000 description 1
- WVJHEDOLHPZLRV-CIUDSAMLSA-N Cys-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N WVJHEDOLHPZLRV-CIUDSAMLSA-N 0.000 description 1
- NIPJKKSXHSBEMX-CIUDSAMLSA-N Cys-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N NIPJKKSXHSBEMX-CIUDSAMLSA-N 0.000 description 1
- YZKOXEJTLWZOQL-GUBZILKMSA-N Cys-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CS)N YZKOXEJTLWZOQL-GUBZILKMSA-N 0.000 description 1
- VKAWJBQTFCBHQY-GUBZILKMSA-N Cys-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CS)N VKAWJBQTFCBHQY-GUBZILKMSA-N 0.000 description 1
- RWGDABDXVXRLLH-ACZMJKKPSA-N Cys-Glu-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CS)N RWGDABDXVXRLLH-ACZMJKKPSA-N 0.000 description 1
- DZIGZIIJIGGANI-FXQIFTODSA-N Cys-Glu-Gln Chemical compound SC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O DZIGZIIJIGGANI-FXQIFTODSA-N 0.000 description 1
- ZEXHDOQQYZKOIB-ACZMJKKPSA-N Cys-Glu-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZEXHDOQQYZKOIB-ACZMJKKPSA-N 0.000 description 1
- XTHUKRLJRUVVBF-WHFBIAKZSA-N Cys-Gly-Ser Chemical compound SC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O XTHUKRLJRUVVBF-WHFBIAKZSA-N 0.000 description 1
- SBDVXRYCOIEYNV-YUMQZZPRSA-N Cys-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N SBDVXRYCOIEYNV-YUMQZZPRSA-N 0.000 description 1
- HKALUUKHYNEDRS-GUBZILKMSA-N Cys-Leu-Gln Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HKALUUKHYNEDRS-GUBZILKMSA-N 0.000 description 1
- SRIRHERUAMYIOQ-CIUDSAMLSA-N Cys-Leu-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SRIRHERUAMYIOQ-CIUDSAMLSA-N 0.000 description 1
- LHMSYHSAAJOEBL-CIUDSAMLSA-N Cys-Lys-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O LHMSYHSAAJOEBL-CIUDSAMLSA-N 0.000 description 1
- BBQIWFFTTQTNOC-AVGNSLFASA-N Cys-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CS)N BBQIWFFTTQTNOC-AVGNSLFASA-N 0.000 description 1
- CHRCKSPMGYDLIA-SRVKXCTJSA-N Cys-Phe-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O CHRCKSPMGYDLIA-SRVKXCTJSA-N 0.000 description 1
- CAXGCBSRJLADPD-FXQIFTODSA-N Cys-Pro-Asn Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O CAXGCBSRJLADPD-FXQIFTODSA-N 0.000 description 1
- XBELMDARIGXDKY-GUBZILKMSA-N Cys-Pro-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)N XBELMDARIGXDKY-GUBZILKMSA-N 0.000 description 1
- CMYVIUWVYHOLRD-ZLUOBGJFSA-N Cys-Ser-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O CMYVIUWVYHOLRD-ZLUOBGJFSA-N 0.000 description 1
- BCFXQBXXDSEHRS-FXQIFTODSA-N Cys-Ser-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BCFXQBXXDSEHRS-FXQIFTODSA-N 0.000 description 1
- ZGERHCJBLPQPGV-ACZMJKKPSA-N Cys-Ser-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N ZGERHCJBLPQPGV-ACZMJKKPSA-N 0.000 description 1
- LKHMGNHQULEPFY-ACZMJKKPSA-N Cys-Ser-Glu Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O LKHMGNHQULEPFY-ACZMJKKPSA-N 0.000 description 1
- YNJBLTDKTMKEET-ZLUOBGJFSA-N Cys-Ser-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O YNJBLTDKTMKEET-ZLUOBGJFSA-N 0.000 description 1
- UKHNKRGNFKSHCG-CUJWVEQBSA-N Cys-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CS)N)O UKHNKRGNFKSHCG-CUJWVEQBSA-N 0.000 description 1
- KFYPRIGJTICABD-XGEHTFHBSA-N Cys-Thr-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N)O KFYPRIGJTICABD-XGEHTFHBSA-N 0.000 description 1
- BOMGEMDZTNZESV-QWRGUYRKSA-N Cys-Tyr-Gly Chemical compound SC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 BOMGEMDZTNZESV-QWRGUYRKSA-N 0.000 description 1
- JRZMCSIUYGSJKP-ZKWXMUAHSA-N Cys-Val-Asn Chemical compound SC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O JRZMCSIUYGSJKP-ZKWXMUAHSA-N 0.000 description 1
- KZZYVYWSXMFYEC-DCAQKATOSA-N Cys-Val-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KZZYVYWSXMFYEC-DCAQKATOSA-N 0.000 description 1
- YQEHNIKPAOPBNH-DCAQKATOSA-N Cys-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N YQEHNIKPAOPBNH-DCAQKATOSA-N 0.000 description 1
- LPBUBIHAVKXUOT-FXQIFTODSA-N Cys-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N LPBUBIHAVKXUOT-FXQIFTODSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 1
- 230000004536 DNA copy number loss Effects 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 230000030933 DNA methylation on cytosine Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 229910005429 FeSSIF Inorganic materials 0.000 description 1
- 208000002633 Febrile Neutropenia Diseases 0.000 description 1
- 241000282323 Felidae Species 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- RZSLYUUFFVHFRQ-FXQIFTODSA-N Gln-Ala-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O RZSLYUUFFVHFRQ-FXQIFTODSA-N 0.000 description 1
- XXLBHPPXDUWYAG-XQXXSGGOSA-N Gln-Ala-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XXLBHPPXDUWYAG-XQXXSGGOSA-N 0.000 description 1
- YNNXQZDEOCYJJL-CIUDSAMLSA-N Gln-Arg-Asp Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)CN=C(N)N YNNXQZDEOCYJJL-CIUDSAMLSA-N 0.000 description 1
- PRBLYKYHAJEABA-SRVKXCTJSA-N Gln-Arg-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O PRBLYKYHAJEABA-SRVKXCTJSA-N 0.000 description 1
- OETQLUYCMBARHJ-CIUDSAMLSA-N Gln-Asn-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OETQLUYCMBARHJ-CIUDSAMLSA-N 0.000 description 1
- PHZYLYASFWHLHJ-FXQIFTODSA-N Gln-Asn-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PHZYLYASFWHLHJ-FXQIFTODSA-N 0.000 description 1
- ZPDVKYLJTOFQJV-WDSKDSINSA-N Gln-Asn-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O ZPDVKYLJTOFQJV-WDSKDSINSA-N 0.000 description 1
- PONUFVLSGMQFAI-AVGNSLFASA-N Gln-Asn-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PONUFVLSGMQFAI-AVGNSLFASA-N 0.000 description 1
- GMGKDVVBSVVKCT-NUMRIWBASA-N Gln-Asn-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GMGKDVVBSVVKCT-NUMRIWBASA-N 0.000 description 1
- BTSPOOHJBYJRKO-CIUDSAMLSA-N Gln-Asp-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BTSPOOHJBYJRKO-CIUDSAMLSA-N 0.000 description 1
- JKPGHIQCHIIRMS-AVGNSLFASA-N Gln-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N JKPGHIQCHIIRMS-AVGNSLFASA-N 0.000 description 1
- UZMWDBOHAOSCCH-ACZMJKKPSA-N Gln-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O UZMWDBOHAOSCCH-ACZMJKKPSA-N 0.000 description 1
- XFKUFUJECJUQTQ-CIUDSAMLSA-N Gln-Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XFKUFUJECJUQTQ-CIUDSAMLSA-N 0.000 description 1
- KVXVVDFOZNYYKZ-DCAQKATOSA-N Gln-Gln-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KVXVVDFOZNYYKZ-DCAQKATOSA-N 0.000 description 1
- MCAVASRGVBVPMX-FXQIFTODSA-N Gln-Glu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MCAVASRGVBVPMX-FXQIFTODSA-N 0.000 description 1
- LWDGZZGWDMHBOF-FXQIFTODSA-N Gln-Glu-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O LWDGZZGWDMHBOF-FXQIFTODSA-N 0.000 description 1
- SNLOOPZHAQDMJG-CIUDSAMLSA-N Gln-Glu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SNLOOPZHAQDMJG-CIUDSAMLSA-N 0.000 description 1
- PNENQZWRFMUZOM-DCAQKATOSA-N Gln-Glu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O PNENQZWRFMUZOM-DCAQKATOSA-N 0.000 description 1
- ZNZPKVQURDQFFS-FXQIFTODSA-N Gln-Glu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZNZPKVQURDQFFS-FXQIFTODSA-N 0.000 description 1
- DRDSQGHKTLSNEA-GLLZPBPUSA-N Gln-Glu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DRDSQGHKTLSNEA-GLLZPBPUSA-N 0.000 description 1
- JHPFPROFOAJRFN-IHRRRGAJSA-N Gln-Glu-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O JHPFPROFOAJRFN-IHRRRGAJSA-N 0.000 description 1
- HVQCEQTUSWWFOS-WDSKDSINSA-N Gln-Gly-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N HVQCEQTUSWWFOS-WDSKDSINSA-N 0.000 description 1
- CLPQUWHBWXFJOX-BQBZGAKWSA-N Gln-Gly-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O CLPQUWHBWXFJOX-BQBZGAKWSA-N 0.000 description 1
- FGYPOQPQTUNESW-IUCAKERBSA-N Gln-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N FGYPOQPQTUNESW-IUCAKERBSA-N 0.000 description 1
- NSORZJXKUQFEKL-JGVFFNPUSA-N Gln-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)N)N)C(=O)O NSORZJXKUQFEKL-JGVFFNPUSA-N 0.000 description 1
- ORYMMTRPKVTGSJ-XVKPBYJWSA-N Gln-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O ORYMMTRPKVTGSJ-XVKPBYJWSA-N 0.000 description 1
- DQPOBSRQNWOBNA-GUBZILKMSA-N Gln-His-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O DQPOBSRQNWOBNA-GUBZILKMSA-N 0.000 description 1
- NROSLUJMIQGFKS-IUCAKERBSA-N Gln-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N NROSLUJMIQGFKS-IUCAKERBSA-N 0.000 description 1
- KQOPMGBHNQBCEL-HVTMNAMFSA-N Gln-His-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KQOPMGBHNQBCEL-HVTMNAMFSA-N 0.000 description 1
- GLAPJAHOPFSLKL-SRVKXCTJSA-N Gln-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)N)N GLAPJAHOPFSLKL-SRVKXCTJSA-N 0.000 description 1
- GXMBDEGTXHQBAO-NKIYYHGXSA-N Gln-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)N)N)O GXMBDEGTXHQBAO-NKIYYHGXSA-N 0.000 description 1
- MWERYIXRDZDXOA-QEWYBTABSA-N Gln-Ile-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MWERYIXRDZDXOA-QEWYBTABSA-N 0.000 description 1
- QKCZZAZNMMVICF-DCAQKATOSA-N Gln-Leu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O QKCZZAZNMMVICF-DCAQKATOSA-N 0.000 description 1
- IOFDDSNZJDIGPB-GVXVVHGQSA-N Gln-Leu-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IOFDDSNZJDIGPB-GVXVVHGQSA-N 0.000 description 1
- HPCOBEHVEHWREJ-DCAQKATOSA-N Gln-Lys-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HPCOBEHVEHWREJ-DCAQKATOSA-N 0.000 description 1
- FKXCBKCOSVIGCT-AVGNSLFASA-N Gln-Lys-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FKXCBKCOSVIGCT-AVGNSLFASA-N 0.000 description 1
- JRHPEMVLTRADLJ-AVGNSLFASA-N Gln-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JRHPEMVLTRADLJ-AVGNSLFASA-N 0.000 description 1
- CELXWPDNIGWCJN-WDCWCFNPSA-N Gln-Lys-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CELXWPDNIGWCJN-WDCWCFNPSA-N 0.000 description 1
- QMVCEWKHIUHTSD-GUBZILKMSA-N Gln-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N QMVCEWKHIUHTSD-GUBZILKMSA-N 0.000 description 1
- LVRKAFPPFJRIOF-GARJFASQSA-N Gln-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N LVRKAFPPFJRIOF-GARJFASQSA-N 0.000 description 1
- JNVGVECJCOZHCN-DRZSPHRISA-N Gln-Phe-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O JNVGVECJCOZHCN-DRZSPHRISA-N 0.000 description 1
- YJSCHRBERYWPQL-DCAQKATOSA-N Gln-Pro-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N YJSCHRBERYWPQL-DCAQKATOSA-N 0.000 description 1
- SXFPZRRVWSUYII-KBIXCLLPSA-N Gln-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N SXFPZRRVWSUYII-KBIXCLLPSA-N 0.000 description 1
- SYZZMPFLOLSMHL-XHNCKOQMSA-N Gln-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)C(=O)O SYZZMPFLOLSMHL-XHNCKOQMSA-N 0.000 description 1
- PAOHIZNRJNIXQY-XQXXSGGOSA-N Gln-Thr-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PAOHIZNRJNIXQY-XQXXSGGOSA-N 0.000 description 1
- YRHZWVKUFWCEPW-GLLZPBPUSA-N Gln-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O YRHZWVKUFWCEPW-GLLZPBPUSA-N 0.000 description 1
- DUGYCMAIAKAQPB-GLLZPBPUSA-N Gln-Thr-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DUGYCMAIAKAQPB-GLLZPBPUSA-N 0.000 description 1
- WBBVTGIFQIZBHP-JBACZVJFSA-N Gln-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)N)N WBBVTGIFQIZBHP-JBACZVJFSA-N 0.000 description 1
- JKDBRTNMYXYLHO-JYJNAYRXSA-N Gln-Tyr-Leu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 JKDBRTNMYXYLHO-JYJNAYRXSA-N 0.000 description 1
- JTWZNMUVQWWGOX-SOUVJXGZSA-N Gln-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)N)N)C(=O)O JTWZNMUVQWWGOX-SOUVJXGZSA-N 0.000 description 1
- ZZLDMBMFKZFQMU-NRPADANISA-N Gln-Val-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O ZZLDMBMFKZFQMU-NRPADANISA-N 0.000 description 1
- KHHDJQRWIFHXHS-NRPADANISA-N Gln-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N KHHDJQRWIFHXHS-NRPADANISA-N 0.000 description 1
- SDSMVVSHLAAOJL-UKJIMTQDSA-N Gln-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N SDSMVVSHLAAOJL-UKJIMTQDSA-N 0.000 description 1
- SZXSSXUNOALWCH-ACZMJKKPSA-N Glu-Ala-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O SZXSSXUNOALWCH-ACZMJKKPSA-N 0.000 description 1
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 1
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 1
- WOMUDRVDJMHTCV-DCAQKATOSA-N Glu-Arg-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WOMUDRVDJMHTCV-DCAQKATOSA-N 0.000 description 1
- CVPXINNKRTZBMO-CIUDSAMLSA-N Glu-Arg-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)CN=C(N)N CVPXINNKRTZBMO-CIUDSAMLSA-N 0.000 description 1
- DIXKFOPPGWKZLY-CIUDSAMLSA-N Glu-Arg-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O DIXKFOPPGWKZLY-CIUDSAMLSA-N 0.000 description 1
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 1
- VPKBCVUDBNINAH-GARJFASQSA-N Glu-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VPKBCVUDBNINAH-GARJFASQSA-N 0.000 description 1
- GLWXKFRTOHKGIT-ACZMJKKPSA-N Glu-Asn-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GLWXKFRTOHKGIT-ACZMJKKPSA-N 0.000 description 1
- YYOBUPFZLKQUAX-FXQIFTODSA-N Glu-Asn-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YYOBUPFZLKQUAX-FXQIFTODSA-N 0.000 description 1
- SVZIKUHLRKVZIF-GUBZILKMSA-N Glu-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N SVZIKUHLRKVZIF-GUBZILKMSA-N 0.000 description 1
- AFODTOLGSZQDSL-PEFMBERDSA-N Glu-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N AFODTOLGSZQDSL-PEFMBERDSA-N 0.000 description 1
- LXAUHIRMWXQRKI-XHNCKOQMSA-N Glu-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O LXAUHIRMWXQRKI-XHNCKOQMSA-N 0.000 description 1
- ZJICFHQSPWFBKP-AVGNSLFASA-N Glu-Asn-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZJICFHQSPWFBKP-AVGNSLFASA-N 0.000 description 1
- PCBBLFVHTYNQGG-LAEOZQHASA-N Glu-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N PCBBLFVHTYNQGG-LAEOZQHASA-N 0.000 description 1
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 1
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 1
- SAEBUDRWKUXLOM-ACZMJKKPSA-N Glu-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O SAEBUDRWKUXLOM-ACZMJKKPSA-N 0.000 description 1
- KLJMRPIBBLTDGE-ACZMJKKPSA-N Glu-Cys-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O KLJMRPIBBLTDGE-ACZMJKKPSA-N 0.000 description 1
- PKYAVRMYTBBRLS-FXQIFTODSA-N Glu-Cys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O PKYAVRMYTBBRLS-FXQIFTODSA-N 0.000 description 1
- OWVURWCRZZMAOZ-XHNCKOQMSA-N Glu-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)N)C(=O)O OWVURWCRZZMAOZ-XHNCKOQMSA-N 0.000 description 1
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 1
- APHGWLWMOXGZRL-DCAQKATOSA-N Glu-Glu-His Chemical compound N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O APHGWLWMOXGZRL-DCAQKATOSA-N 0.000 description 1
- YLJHCWNDBKKOEB-IHRRRGAJSA-N Glu-Glu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YLJHCWNDBKKOEB-IHRRRGAJSA-N 0.000 description 1
- KUTPGXNAAOQSPD-LPEHRKFASA-N Glu-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KUTPGXNAAOQSPD-LPEHRKFASA-N 0.000 description 1
- IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 description 1
- QJCKNLPMTPXXEM-AUTRQRHGSA-N Glu-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O QJCKNLPMTPXXEM-AUTRQRHGSA-N 0.000 description 1
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 1
- WRNAXCVRSBBKGS-BQBZGAKWSA-N Glu-Gly-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O WRNAXCVRSBBKGS-BQBZGAKWSA-N 0.000 description 1
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 1
- HPJLZFTUUJKWAJ-JHEQGTHGSA-N Glu-Gly-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HPJLZFTUUJKWAJ-JHEQGTHGSA-N 0.000 description 1
- BRKUZSLQMPNVFN-SRVKXCTJSA-N Glu-His-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BRKUZSLQMPNVFN-SRVKXCTJSA-N 0.000 description 1
- DRLVXRQFROIYTD-GUBZILKMSA-N Glu-His-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N DRLVXRQFROIYTD-GUBZILKMSA-N 0.000 description 1
- DVLZZEPUNFEUBW-AVGNSLFASA-N Glu-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N DVLZZEPUNFEUBW-AVGNSLFASA-N 0.000 description 1
- YVYVMJNUENBOOL-KBIXCLLPSA-N Glu-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N YVYVMJNUENBOOL-KBIXCLLPSA-N 0.000 description 1
- ITBHUUMCJJQUSC-LAEOZQHASA-N Glu-Ile-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O ITBHUUMCJJQUSC-LAEOZQHASA-N 0.000 description 1
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 1
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 1
- ZSWGJYOZWBHROQ-RWRJDSDZSA-N Glu-Ile-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZSWGJYOZWBHROQ-RWRJDSDZSA-N 0.000 description 1
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 1
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 1
- DWBBKNPKDHXIAC-SRVKXCTJSA-N Glu-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(O)=O DWBBKNPKDHXIAC-SRVKXCTJSA-N 0.000 description 1
- WNRZUESNGGDCJX-JYJNAYRXSA-N Glu-Leu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WNRZUESNGGDCJX-JYJNAYRXSA-N 0.000 description 1
- UGSVSNXPJJDJKL-SDDRHHMPSA-N Glu-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N UGSVSNXPJJDJKL-SDDRHHMPSA-N 0.000 description 1
- JJSVALISDCNFCU-SZMVWBNQSA-N Glu-Leu-Trp Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O JJSVALISDCNFCU-SZMVWBNQSA-N 0.000 description 1
- GJBUAAAIZSRCDC-GVXVVHGQSA-N Glu-Leu-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O GJBUAAAIZSRCDC-GVXVVHGQSA-N 0.000 description 1
- SJJHXJDSNQJMMW-SRVKXCTJSA-N Glu-Lys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O SJJHXJDSNQJMMW-SRVKXCTJSA-N 0.000 description 1
- SWRVAQHFBRZVNX-GUBZILKMSA-N Glu-Lys-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SWRVAQHFBRZVNX-GUBZILKMSA-N 0.000 description 1
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 1
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 1
- ZQYZDDXTNQXUJH-CIUDSAMLSA-N Glu-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)N ZQYZDDXTNQXUJH-CIUDSAMLSA-N 0.000 description 1
- JHSRJMUJOGLIHK-GUBZILKMSA-N Glu-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N JHSRJMUJOGLIHK-GUBZILKMSA-N 0.000 description 1
- LKOAAMXDJGEYMS-ZPFDUUQYSA-N Glu-Met-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LKOAAMXDJGEYMS-ZPFDUUQYSA-N 0.000 description 1
- YHOJJFFTSMWVGR-HJGDQZAQSA-N Glu-Met-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YHOJJFFTSMWVGR-HJGDQZAQSA-N 0.000 description 1
- FGSGPLRPQCZBSQ-AVGNSLFASA-N Glu-Phe-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O FGSGPLRPQCZBSQ-AVGNSLFASA-N 0.000 description 1
- ITVBKCZZLJUUHI-HTUGSXCWSA-N Glu-Phe-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ITVBKCZZLJUUHI-HTUGSXCWSA-N 0.000 description 1
- KXTAGESXNQEZKB-DZKIICNBSA-N Glu-Phe-Val Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 KXTAGESXNQEZKB-DZKIICNBSA-N 0.000 description 1
- DXVOKNVIKORTHQ-GUBZILKMSA-N Glu-Pro-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O DXVOKNVIKORTHQ-GUBZILKMSA-N 0.000 description 1
- JYXKPJVDCAWMDG-ZPFDUUQYSA-N Glu-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)N JYXKPJVDCAWMDG-ZPFDUUQYSA-N 0.000 description 1
- DCBSZJJHOTXMHY-DCAQKATOSA-N Glu-Pro-Pro Chemical compound OC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DCBSZJJHOTXMHY-DCAQKATOSA-N 0.000 description 1
- ARIORLIIMJACKZ-KKUMJFAQSA-N Glu-Pro-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ARIORLIIMJACKZ-KKUMJFAQSA-N 0.000 description 1
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 1
- ALMBZBOCGSVSAI-ACZMJKKPSA-N Glu-Ser-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ALMBZBOCGSVSAI-ACZMJKKPSA-N 0.000 description 1
- IDEODOAVGCMUQV-GUBZILKMSA-N Glu-Ser-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IDEODOAVGCMUQV-GUBZILKMSA-N 0.000 description 1
- BXSZPACYCMNKLS-AVGNSLFASA-N Glu-Ser-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BXSZPACYCMNKLS-AVGNSLFASA-N 0.000 description 1
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 1
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 1
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 1
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 1
- DTLLNDVORUEOTM-WDCWCFNPSA-N Glu-Thr-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DTLLNDVORUEOTM-WDCWCFNPSA-N 0.000 description 1
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 1
- DXMOIVCNJIJQSC-QEJZJMRPSA-N Glu-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N DXMOIVCNJIJQSC-QEJZJMRPSA-N 0.000 description 1
- HVKAAUOFFTUSAA-XDTLVQLUSA-N Glu-Tyr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O HVKAAUOFFTUSAA-XDTLVQLUSA-N 0.000 description 1
- KXRORHJIRAOQPG-SOUVJXGZSA-N Glu-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KXRORHJIRAOQPG-SOUVJXGZSA-N 0.000 description 1
- MLILEEIVMRUYBX-NHCYSSNCSA-N Glu-Val-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O MLILEEIVMRUYBX-NHCYSSNCSA-N 0.000 description 1
- UZWUBBRJWFTHTD-LAEOZQHASA-N Glu-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O UZWUBBRJWFTHTD-LAEOZQHASA-N 0.000 description 1
- HQTDNEZTGZUWSY-XVKPBYJWSA-N Glu-Val-Gly Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)NCC(O)=O HQTDNEZTGZUWSY-XVKPBYJWSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MZZSCEANQDPJER-ONGXEEELSA-N Gly-Ala-Phe Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MZZSCEANQDPJER-ONGXEEELSA-N 0.000 description 1
- CLODWIOAKCSBAN-BQBZGAKWSA-N Gly-Arg-Asp Chemical compound NC(N)=NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O CLODWIOAKCSBAN-BQBZGAKWSA-N 0.000 description 1
- RQZGFWKQLPJOEQ-YUMQZZPRSA-N Gly-Arg-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)CN)CN=C(N)N RQZGFWKQLPJOEQ-YUMQZZPRSA-N 0.000 description 1
- JVWPPCWUDRJGAE-YUMQZZPRSA-N Gly-Asn-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JVWPPCWUDRJGAE-YUMQZZPRSA-N 0.000 description 1
- QCTLGOYODITHPQ-WHFBIAKZSA-N Gly-Cys-Ser Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O QCTLGOYODITHPQ-WHFBIAKZSA-N 0.000 description 1
- QPDUVFSVVAOUHE-XVKPBYJWSA-N Gly-Gln-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(O)=O QPDUVFSVVAOUHE-XVKPBYJWSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- BEQGFMIBZFNROK-JGVFFNPUSA-N Gly-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)O BEQGFMIBZFNROK-JGVFFNPUSA-N 0.000 description 1
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 1
- QPCVIQJVRGXUSA-LURJTMIESA-N Gly-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QPCVIQJVRGXUSA-LURJTMIESA-N 0.000 description 1
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 1
- UUWOBINZFGTFMS-UWVGGRQHSA-N Gly-His-Met Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCSC)C(O)=O UUWOBINZFGTFMS-UWVGGRQHSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- LUJVWKKYHSLULQ-ZKWXMUAHSA-N Gly-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN LUJVWKKYHSLULQ-ZKWXMUAHSA-N 0.000 description 1
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 1
- HAXARWKYFIIHKD-ZKWXMUAHSA-N Gly-Ile-Ser Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HAXARWKYFIIHKD-ZKWXMUAHSA-N 0.000 description 1
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 1
- YKJUITHASJAGHO-HOTGVXAUSA-N Gly-Lys-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN YKJUITHASJAGHO-HOTGVXAUSA-N 0.000 description 1
- DHNXGWVNLFPOMQ-KBPBESRZSA-N Gly-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)CN DHNXGWVNLFPOMQ-KBPBESRZSA-N 0.000 description 1
- ZZJVYSAQQMDIRD-UWVGGRQHSA-N Gly-Pro-His Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O ZZJVYSAQQMDIRD-UWVGGRQHSA-N 0.000 description 1
- IALQAMYQJBZNSK-WHFBIAKZSA-N Gly-Ser-Asn Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O IALQAMYQJBZNSK-WHFBIAKZSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
- IMRNSEPSPFQNHF-STQMWFEESA-N Gly-Ser-Trp Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O IMRNSEPSPFQNHF-STQMWFEESA-N 0.000 description 1
- YXTFLTJYLIAZQG-FJXKBIBVSA-N Gly-Thr-Arg Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YXTFLTJYLIAZQG-FJXKBIBVSA-N 0.000 description 1
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- CQMFNTVQVLQRLT-JHEQGTHGSA-N Gly-Thr-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O CQMFNTVQVLQRLT-JHEQGTHGSA-N 0.000 description 1
- LLWQVJNHMYBLLK-CDMKHQONSA-N Gly-Thr-Phe Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLWQVJNHMYBLLK-CDMKHQONSA-N 0.000 description 1
- YJDALMUYJIENAG-QWRGUYRKSA-N Gly-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN)O YJDALMUYJIENAG-QWRGUYRKSA-N 0.000 description 1
- GJHWILMUOANXTG-WPRPVWTQSA-N Gly-Val-Arg Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GJHWILMUOANXTG-WPRPVWTQSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- 206010066476 Haematological malignancy Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- XINDHUAGVGCNSF-QSFUFRPTSA-N His-Ala-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XINDHUAGVGCNSF-QSFUFRPTSA-N 0.000 description 1
- VSLXGYMEHVAJBH-DLOVCJGASA-N His-Ala-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O VSLXGYMEHVAJBH-DLOVCJGASA-N 0.000 description 1
- HXKZJLWGSWQKEA-LSJOCFKGSA-N His-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CN=CN1 HXKZJLWGSWQKEA-LSJOCFKGSA-N 0.000 description 1
- JWTKVPMQCCRPQY-SRVKXCTJSA-N His-Asn-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JWTKVPMQCCRPQY-SRVKXCTJSA-N 0.000 description 1
- WGVPDSNCHDEDBP-KKUMJFAQSA-N His-Asp-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WGVPDSNCHDEDBP-KKUMJFAQSA-N 0.000 description 1
- ZZLWLWSUIBSMNP-CIUDSAMLSA-N His-Asp-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZZLWLWSUIBSMNP-CIUDSAMLSA-N 0.000 description 1
- IMPKSPYRPUXYAP-SZMVWBNQSA-N His-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CN=CN3)N IMPKSPYRPUXYAP-SZMVWBNQSA-N 0.000 description 1
- TVRMJKNELJKNRS-GUBZILKMSA-N His-Glu-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N TVRMJKNELJKNRS-GUBZILKMSA-N 0.000 description 1
- STWGDDDFLUFCCA-GVXVVHGQSA-N His-Glu-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O STWGDDDFLUFCCA-GVXVVHGQSA-N 0.000 description 1
- CTGZVVQVIBSOBB-AVGNSLFASA-N His-His-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O CTGZVVQVIBSOBB-AVGNSLFASA-N 0.000 description 1
- SYIPVNMWBZXKMU-HJPIBITLSA-N His-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)N SYIPVNMWBZXKMU-HJPIBITLSA-N 0.000 description 1
- NDKSHNQINMRKHT-PEXQALLHSA-N His-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N NDKSHNQINMRKHT-PEXQALLHSA-N 0.000 description 1
- BXOLYFJYQQRQDJ-MXAVVETBSA-N His-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CN=CN1)N BXOLYFJYQQRQDJ-MXAVVETBSA-N 0.000 description 1
- YAALVYQFVJNXIV-KKUMJFAQSA-N His-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 YAALVYQFVJNXIV-KKUMJFAQSA-N 0.000 description 1
- SKOKHBGDXGTDDP-MELADBBJSA-N His-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N SKOKHBGDXGTDDP-MELADBBJSA-N 0.000 description 1
- FHGVHXCQMJWQPK-SRVKXCTJSA-N His-Lys-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O FHGVHXCQMJWQPK-SRVKXCTJSA-N 0.000 description 1
- QEYUCKCWTMIERU-SRVKXCTJSA-N His-Lys-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N QEYUCKCWTMIERU-SRVKXCTJSA-N 0.000 description 1
- IGBBXBFSLKRHJB-BZSNNMDCSA-N His-Lys-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 IGBBXBFSLKRHJB-BZSNNMDCSA-N 0.000 description 1
- SVVULKPWDBIPCO-BZSNNMDCSA-N His-Phe-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O SVVULKPWDBIPCO-BZSNNMDCSA-N 0.000 description 1
- UOYGZBIPZYKGSH-SRVKXCTJSA-N His-Ser-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N UOYGZBIPZYKGSH-SRVKXCTJSA-N 0.000 description 1
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 1
- XHQYFGPIRUHQIB-PBCZWWQYSA-N His-Thr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CN=CN1 XHQYFGPIRUHQIB-PBCZWWQYSA-N 0.000 description 1
- IXQGOKWTQPCIQM-YJRXYDGGSA-N His-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O IXQGOKWTQPCIQM-YJRXYDGGSA-N 0.000 description 1
- UPJODPVSKKWGDQ-KLHWPWHYSA-N His-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O UPJODPVSKKWGDQ-KLHWPWHYSA-N 0.000 description 1
- QLBXWYXMLHAREM-PYJNHQTQSA-N His-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CN=CN1)N QLBXWYXMLHAREM-PYJNHQTQSA-N 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- AQCUAZTZSPQJFF-ZKWXMUAHSA-N Ile-Ala-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AQCUAZTZSPQJFF-ZKWXMUAHSA-N 0.000 description 1
- HDOYNXLPTRQLAD-JBDRJPRFSA-N Ile-Ala-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)N HDOYNXLPTRQLAD-JBDRJPRFSA-N 0.000 description 1
- PJLLMGWWINYQPB-PEFMBERDSA-N Ile-Asn-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PJLLMGWWINYQPB-PEFMBERDSA-N 0.000 description 1
- UMYZBHKAVTXWIW-GMOBBJLQSA-N Ile-Asp-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UMYZBHKAVTXWIW-GMOBBJLQSA-N 0.000 description 1
- IDAHFEPYTJJZFD-PEFMBERDSA-N Ile-Asp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N IDAHFEPYTJJZFD-PEFMBERDSA-N 0.000 description 1
- DCQMJRSOGCYKTR-GHCJXIJMSA-N Ile-Asp-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O DCQMJRSOGCYKTR-GHCJXIJMSA-N 0.000 description 1
- GYAFMRQGWHXMII-IUKAMOBKSA-N Ile-Asp-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N GYAFMRQGWHXMII-IUKAMOBKSA-N 0.000 description 1
- LOXMWQOKYBGCHF-JBDRJPRFSA-N Ile-Cys-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O LOXMWQOKYBGCHF-JBDRJPRFSA-N 0.000 description 1
- PPSQSIDMOVPKPI-BJDJZHNGSA-N Ile-Cys-Leu Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O PPSQSIDMOVPKPI-BJDJZHNGSA-N 0.000 description 1
- AWTDTFXPVCTHAK-BJDJZHNGSA-N Ile-Cys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N AWTDTFXPVCTHAK-BJDJZHNGSA-N 0.000 description 1
- HOLOYAZCIHDQNS-YVNDNENWSA-N Ile-Gln-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HOLOYAZCIHDQNS-YVNDNENWSA-N 0.000 description 1
- DMZOUKXXHJQPTL-GRLWGSQLSA-N Ile-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N DMZOUKXXHJQPTL-GRLWGSQLSA-N 0.000 description 1
- OVPYIUNCVSOVNF-ZPFDUUQYSA-N Ile-Gln-Pro Natural products CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O OVPYIUNCVSOVNF-ZPFDUUQYSA-N 0.000 description 1
- YBJWJQQBWRARLT-KBIXCLLPSA-N Ile-Gln-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O YBJWJQQBWRARLT-KBIXCLLPSA-N 0.000 description 1
- BEWFWZRGBDVXRP-PEFMBERDSA-N Ile-Glu-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O BEWFWZRGBDVXRP-PEFMBERDSA-N 0.000 description 1
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 1
- LPXHYGGZJOCAFR-MNXVOIDGSA-N Ile-Glu-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N LPXHYGGZJOCAFR-MNXVOIDGSA-N 0.000 description 1
- TVSPLSZTKTUYLV-ZPFDUUQYSA-N Ile-Glu-Met Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O TVSPLSZTKTUYLV-ZPFDUUQYSA-N 0.000 description 1
- SPQWWEZBHXHUJN-KBIXCLLPSA-N Ile-Glu-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O SPQWWEZBHXHUJN-KBIXCLLPSA-N 0.000 description 1
- LBRCLQMZAHRTLV-ZKWXMUAHSA-N Ile-Gly-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LBRCLQMZAHRTLV-ZKWXMUAHSA-N 0.000 description 1
- SJLVSMMIFYTSGY-GRLWGSQLSA-N Ile-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SJLVSMMIFYTSGY-GRLWGSQLSA-N 0.000 description 1
- PFPUFNLHBXKPHY-HTFCKZLJSA-N Ile-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)N PFPUFNLHBXKPHY-HTFCKZLJSA-N 0.000 description 1
- GLLAUPMJCGKPFY-BLMTYFJBSA-N Ile-Ile-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)=CNC2=C1 GLLAUPMJCGKPFY-BLMTYFJBSA-N 0.000 description 1
- TWYOYAKMLHWMOJ-ZPFDUUQYSA-N Ile-Leu-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O TWYOYAKMLHWMOJ-ZPFDUUQYSA-N 0.000 description 1
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 1
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 1
- PNTWNAXGBOZMBO-MNXVOIDGSA-N Ile-Lys-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PNTWNAXGBOZMBO-MNXVOIDGSA-N 0.000 description 1
- YSGBJIQXTIVBHZ-AJNGGQMLSA-N Ile-Lys-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O YSGBJIQXTIVBHZ-AJNGGQMLSA-N 0.000 description 1
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
- YTRFFJUOYBMLPN-UHFFFAOYSA-N Ile-Lys-Lys-Ser Chemical compound CCC(C)C(N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CO)C(O)=O YTRFFJUOYBMLPN-UHFFFAOYSA-N 0.000 description 1
- GLYJPWIRLBAIJH-UHFFFAOYSA-N Ile-Lys-Pro Natural products CCC(C)C(N)C(=O)NC(CCCCN)C(=O)N1CCCC1C(O)=O GLYJPWIRLBAIJH-UHFFFAOYSA-N 0.000 description 1
- AKOYRLRUFBZOSP-BJDJZHNGSA-N Ile-Lys-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)N AKOYRLRUFBZOSP-BJDJZHNGSA-N 0.000 description 1
- RCMNUBZKIIJCOI-ZPFDUUQYSA-N Ile-Met-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RCMNUBZKIIJCOI-ZPFDUUQYSA-N 0.000 description 1
- WSSGUVAKYCQSCT-XUXIUFHCSA-N Ile-Met-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)O)N WSSGUVAKYCQSCT-XUXIUFHCSA-N 0.000 description 1
- KTTMFLSBTNBAHL-MXAVVETBSA-N Ile-Phe-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N KTTMFLSBTNBAHL-MXAVVETBSA-N 0.000 description 1
- USXAYNCLFSUSBA-MGHWNKPDSA-N Ile-Phe-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N USXAYNCLFSUSBA-MGHWNKPDSA-N 0.000 description 1
- WYUHAXJAMDTOAU-IAVJCBSLSA-N Ile-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N WYUHAXJAMDTOAU-IAVJCBSLSA-N 0.000 description 1
- SVZFKLBRCYCIIY-CYDGBPFRSA-N Ile-Pro-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVZFKLBRCYCIIY-CYDGBPFRSA-N 0.000 description 1
- BATWGBRIZANGPN-ZPFDUUQYSA-N Ile-Pro-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)O)N BATWGBRIZANGPN-ZPFDUUQYSA-N 0.000 description 1
- BJECXJHLUJXPJQ-PYJNHQTQSA-N Ile-Pro-His Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N BJECXJHLUJXPJQ-PYJNHQTQSA-N 0.000 description 1
- CZWANIQKACCEKW-CYDGBPFRSA-N Ile-Pro-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)N CZWANIQKACCEKW-CYDGBPFRSA-N 0.000 description 1
- CAHCWMVNBZJVAW-NAKRPEOUSA-N Ile-Pro-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)N CAHCWMVNBZJVAW-NAKRPEOUSA-N 0.000 description 1
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 1
- JZNVOBUNTWNZPW-GHCJXIJMSA-N Ile-Ser-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N JZNVOBUNTWNZPW-GHCJXIJMSA-N 0.000 description 1
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 1
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 1
- WLRJHVNFGAOYPS-HJPIBITLSA-N Ile-Ser-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N WLRJHVNFGAOYPS-HJPIBITLSA-N 0.000 description 1
- SAEWJTCJQVZQNZ-IUKAMOBKSA-N Ile-Thr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SAEWJTCJQVZQNZ-IUKAMOBKSA-N 0.000 description 1
- QGXQHJQPAPMACW-PPCPHDFISA-N Ile-Thr-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QGXQHJQPAPMACW-PPCPHDFISA-N 0.000 description 1
- WXLYNEHOGRYNFU-URLPEUOOSA-N Ile-Thr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N WXLYNEHOGRYNFU-URLPEUOOSA-N 0.000 description 1
- QHUREMVLLMNUAX-OSUNSFLBSA-N Ile-Thr-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)O)N QHUREMVLLMNUAX-OSUNSFLBSA-N 0.000 description 1
- REXAUQBGSGDEJY-IGISWZIWSA-N Ile-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N REXAUQBGSGDEJY-IGISWZIWSA-N 0.000 description 1
- GVEODXUBBFDBPW-MGHWNKPDSA-N Ile-Tyr-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 GVEODXUBBFDBPW-MGHWNKPDSA-N 0.000 description 1
- NSPNUMNLZNOPAQ-SJWGOKEGSA-N Ile-Tyr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N NSPNUMNLZNOPAQ-SJWGOKEGSA-N 0.000 description 1
- WIYDLTIBHZSPKY-HJWJTTGWSA-N Ile-Val-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WIYDLTIBHZSPKY-HJWJTTGWSA-N 0.000 description 1
- APQYGMBHIVXFML-OSUNSFLBSA-N Ile-Val-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N APQYGMBHIVXFML-OSUNSFLBSA-N 0.000 description 1
- YHFPHRUWZMEOIX-CYDGBPFRSA-N Ile-Val-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)N YHFPHRUWZMEOIX-CYDGBPFRSA-N 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- OTAMFXXAGYBAQL-YXMSTPNBSA-N Kentsin Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O OTAMFXXAGYBAQL-YXMSTPNBSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 241000283953 Lagomorpha Species 0.000 description 1
- 206010023825 Laryngeal cancer Diseases 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 1
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 1
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 1
- HXWALXSAVBLTPK-NUTKFTJISA-N Leu-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N HXWALXSAVBLTPK-NUTKFTJISA-N 0.000 description 1
- SUPVSFFZWVOEOI-CQDKDKBSSA-N Leu-Ala-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-CQDKDKBSSA-N 0.000 description 1
- SUPVSFFZWVOEOI-UHFFFAOYSA-N Leu-Ala-Tyr Natural products CC(C)CC(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-UHFFFAOYSA-N 0.000 description 1
- RFUBXQQFJFGJFV-GUBZILKMSA-N Leu-Asn-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RFUBXQQFJFGJFV-GUBZILKMSA-N 0.000 description 1
- KKXDHFKZWKLYGB-GUBZILKMSA-N Leu-Asn-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKXDHFKZWKLYGB-GUBZILKMSA-N 0.000 description 1
- OXKYZSRZKBTVEY-ZPFDUUQYSA-N Leu-Asn-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OXKYZSRZKBTVEY-ZPFDUUQYSA-N 0.000 description 1
- USTCFDAQCLDPBD-XIRDDKMYSA-N Leu-Asn-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N USTCFDAQCLDPBD-XIRDDKMYSA-N 0.000 description 1
- TWQIYNGNYNJUFM-NHCYSSNCSA-N Leu-Asn-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O TWQIYNGNYNJUFM-NHCYSSNCSA-N 0.000 description 1
- BPANDPNDMJHFEV-CIUDSAMLSA-N Leu-Asp-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O BPANDPNDMJHFEV-CIUDSAMLSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 1
- ZDSNOSQHMJBRQN-SRVKXCTJSA-N Leu-Asp-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZDSNOSQHMJBRQN-SRVKXCTJSA-N 0.000 description 1
- MYGQXVYRZMKRDB-SRVKXCTJSA-N Leu-Asp-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN MYGQXVYRZMKRDB-SRVKXCTJSA-N 0.000 description 1
- CLVUXCBGKUECIT-HJGDQZAQSA-N Leu-Asp-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CLVUXCBGKUECIT-HJGDQZAQSA-N 0.000 description 1
- GBDMISNMNXVTNV-XIRDDKMYSA-N Leu-Asp-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GBDMISNMNXVTNV-XIRDDKMYSA-N 0.000 description 1
- QCSFMCFHVGTLFF-NHCYSSNCSA-N Leu-Asp-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O QCSFMCFHVGTLFF-NHCYSSNCSA-N 0.000 description 1
- KWURTLAFFDOTEQ-GUBZILKMSA-N Leu-Cys-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KWURTLAFFDOTEQ-GUBZILKMSA-N 0.000 description 1
- ZYLJULGXQDNXDK-GUBZILKMSA-N Leu-Gln-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ZYLJULGXQDNXDK-GUBZILKMSA-N 0.000 description 1
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 1
- LOLUPZNNADDTAA-AVGNSLFASA-N Leu-Gln-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LOLUPZNNADDTAA-AVGNSLFASA-N 0.000 description 1
- FQZPTCNSNPWHLJ-AVGNSLFASA-N Leu-Gln-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O FQZPTCNSNPWHLJ-AVGNSLFASA-N 0.000 description 1
- AXZGZMGRBDQTEY-SRVKXCTJSA-N Leu-Gln-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O AXZGZMGRBDQTEY-SRVKXCTJSA-N 0.000 description 1
- CIVKXGPFXDIQBV-WDCWCFNPSA-N Leu-Gln-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CIVKXGPFXDIQBV-WDCWCFNPSA-N 0.000 description 1
- KUEVMUXNILMJTK-JYJNAYRXSA-N Leu-Gln-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KUEVMUXNILMJTK-JYJNAYRXSA-N 0.000 description 1
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
- NEEOBPIXKWSBRF-IUCAKERBSA-N Leu-Glu-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O NEEOBPIXKWSBRF-IUCAKERBSA-N 0.000 description 1
- IWTBYNQNAPECCS-AVGNSLFASA-N Leu-Glu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IWTBYNQNAPECCS-AVGNSLFASA-N 0.000 description 1
- HPBCTWSUJOGJSH-MNXVOIDGSA-N Leu-Glu-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HPBCTWSUJOGJSH-MNXVOIDGSA-N 0.000 description 1
- LAGPXKYZCCTSGQ-JYJNAYRXSA-N Leu-Glu-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LAGPXKYZCCTSGQ-JYJNAYRXSA-N 0.000 description 1
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 1
- HVJVUYQWFYMGJS-GVXVVHGQSA-N Leu-Glu-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O HVJVUYQWFYMGJS-GVXVVHGQSA-N 0.000 description 1
- FMEICTQWUKNAGC-YUMQZZPRSA-N Leu-Gly-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O FMEICTQWUKNAGC-YUMQZZPRSA-N 0.000 description 1
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 1
- VBZOAGIPCULURB-QWRGUYRKSA-N Leu-Gly-His Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N VBZOAGIPCULURB-QWRGUYRKSA-N 0.000 description 1
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 1
- VZBIUJURDLFFOE-IHRRRGAJSA-N Leu-His-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VZBIUJURDLFFOE-IHRRRGAJSA-N 0.000 description 1
- KXODZBLFVFSLAI-AVGNSLFASA-N Leu-His-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 KXODZBLFVFSLAI-AVGNSLFASA-N 0.000 description 1
- SGIIOQQGLUUMDQ-IHRRRGAJSA-N Leu-His-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N SGIIOQQGLUUMDQ-IHRRRGAJSA-N 0.000 description 1
- KOSWSHVQIVTVQF-ZPFDUUQYSA-N Leu-Ile-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KOSWSHVQIVTVQF-ZPFDUUQYSA-N 0.000 description 1
- ORWTWZXGDBYVCP-BJDJZHNGSA-N Leu-Ile-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC(C)C ORWTWZXGDBYVCP-BJDJZHNGSA-N 0.000 description 1
- SEMUSFOBZGKBGW-YTFOTSKYSA-N Leu-Ile-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SEMUSFOBZGKBGW-YTFOTSKYSA-N 0.000 description 1
- KUIDCYNIEJBZBU-AJNGGQMLSA-N Leu-Ile-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O KUIDCYNIEJBZBU-AJNGGQMLSA-N 0.000 description 1
- OMHLATXVNQSALM-FQUUOJAGSA-N Leu-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(C)C)N OMHLATXVNQSALM-FQUUOJAGSA-N 0.000 description 1
- JKSIBWITFMQTOA-XUXIUFHCSA-N Leu-Ile-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O JKSIBWITFMQTOA-XUXIUFHCSA-N 0.000 description 1
- PDQDCFBVYXEFSD-SRVKXCTJSA-N Leu-Leu-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PDQDCFBVYXEFSD-SRVKXCTJSA-N 0.000 description 1
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 1
- UCNNZELZXFXXJQ-BZSNNMDCSA-N Leu-Leu-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UCNNZELZXFXXJQ-BZSNNMDCSA-N 0.000 description 1
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 1
- REPBGZHJKYWFMJ-KKUMJFAQSA-N Leu-Lys-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N REPBGZHJKYWFMJ-KKUMJFAQSA-N 0.000 description 1
- FKQPWMZLIIATBA-AJNGGQMLSA-N Leu-Lys-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FKQPWMZLIIATBA-AJNGGQMLSA-N 0.000 description 1
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 1
- LZHJZLHSRGWBBE-IHRRRGAJSA-N Leu-Lys-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LZHJZLHSRGWBBE-IHRRRGAJSA-N 0.000 description 1
- FZMNAYBEFGZEIF-AVGNSLFASA-N Leu-Met-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)O)N FZMNAYBEFGZEIF-AVGNSLFASA-N 0.000 description 1
- ZDBMWELMUCLUPL-QEJZJMRPSA-N Leu-Phe-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ZDBMWELMUCLUPL-QEJZJMRPSA-N 0.000 description 1
- KTOIECMYZZGVSI-BZSNNMDCSA-N Leu-Phe-His Chemical compound C([C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 KTOIECMYZZGVSI-BZSNNMDCSA-N 0.000 description 1
- SYRTUBLKWNDSDK-DKIMLUQUSA-N Leu-Phe-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYRTUBLKWNDSDK-DKIMLUQUSA-N 0.000 description 1
- PJWOOBTYQNNRBF-BZSNNMDCSA-N Leu-Phe-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)O)N PJWOOBTYQNNRBF-BZSNNMDCSA-N 0.000 description 1
- UHNQRAFSEBGZFZ-YESZJQIVSA-N Leu-Phe-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N UHNQRAFSEBGZFZ-YESZJQIVSA-N 0.000 description 1
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 1
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 1
- YRRCOJOXAJNSAX-IHRRRGAJSA-N Leu-Pro-Lys Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N YRRCOJOXAJNSAX-IHRRRGAJSA-N 0.000 description 1
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 1
- IDGZVZJLYFTXSL-DCAQKATOSA-N Leu-Ser-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IDGZVZJLYFTXSL-DCAQKATOSA-N 0.000 description 1
- ADJWHHZETYAAAX-SRVKXCTJSA-N Leu-Ser-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ADJWHHZETYAAAX-SRVKXCTJSA-N 0.000 description 1
- MVHXGBZUJLWZOH-BJDJZHNGSA-N Leu-Ser-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVHXGBZUJLWZOH-BJDJZHNGSA-N 0.000 description 1
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 1
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 1
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 1
- ODRREERHVHMIPT-OEAJRASXSA-N Leu-Thr-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ODRREERHVHMIPT-OEAJRASXSA-N 0.000 description 1
- HQBOMRTVKVKFMN-WDSOQIARSA-N Leu-Trp-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(O)=O HQBOMRTVKVKFMN-WDSOQIARSA-N 0.000 description 1
- WFCKERTZVCQXKH-KBPBESRZSA-N Leu-Tyr-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O WFCKERTZVCQXKH-KBPBESRZSA-N 0.000 description 1
- YIRIDPUGZKHMHT-ACRUOGEOSA-N Leu-Tyr-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YIRIDPUGZKHMHT-ACRUOGEOSA-N 0.000 description 1
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 1
- VKVDRTGWLVZJOM-DCAQKATOSA-N Leu-Val-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O VKVDRTGWLVZJOM-DCAQKATOSA-N 0.000 description 1
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 1
- 206010024291 Leukaemias acute myeloid Diseases 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 1
- WQWZXKWOEVSGQM-DCAQKATOSA-N Lys-Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN WQWZXKWOEVSGQM-DCAQKATOSA-N 0.000 description 1
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 1
- KNKHAVVBVXKOGX-JXUBOQSCSA-N Lys-Ala-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KNKHAVVBVXKOGX-JXUBOQSCSA-N 0.000 description 1
- NTEVEUCLFMWSND-SRVKXCTJSA-N Lys-Arg-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O NTEVEUCLFMWSND-SRVKXCTJSA-N 0.000 description 1
- YNNPKXBBRZVIRX-IHRRRGAJSA-N Lys-Arg-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O YNNPKXBBRZVIRX-IHRRRGAJSA-N 0.000 description 1
- CKSXSQUVEYCDIW-AVGNSLFASA-N Lys-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N CKSXSQUVEYCDIW-AVGNSLFASA-N 0.000 description 1
- NQCJGQHHYZNUDK-DCAQKATOSA-N Lys-Arg-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCN=C(N)N NQCJGQHHYZNUDK-DCAQKATOSA-N 0.000 description 1
- BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
- DEFGUIIUYAUEDU-ZPFDUUQYSA-N Lys-Asn-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DEFGUIIUYAUEDU-ZPFDUUQYSA-N 0.000 description 1
- FACUGMGEFUEBTI-SRVKXCTJSA-N Lys-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN FACUGMGEFUEBTI-SRVKXCTJSA-N 0.000 description 1
- ZQCVMVCVPFYXHZ-SRVKXCTJSA-N Lys-Asn-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN ZQCVMVCVPFYXHZ-SRVKXCTJSA-N 0.000 description 1
- DGWXCIORNLWGGG-CIUDSAMLSA-N Lys-Asn-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O DGWXCIORNLWGGG-CIUDSAMLSA-N 0.000 description 1
- FLCMXEFCTLXBTL-DCAQKATOSA-N Lys-Asp-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N FLCMXEFCTLXBTL-DCAQKATOSA-N 0.000 description 1
- KPJJOZUXFOLGMQ-CIUDSAMLSA-N Lys-Asp-Asn Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N KPJJOZUXFOLGMQ-CIUDSAMLSA-N 0.000 description 1
- OVIVOCSURJYCTM-GUBZILKMSA-N Lys-Asp-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O OVIVOCSURJYCTM-GUBZILKMSA-N 0.000 description 1
- WGCKDDHUFPQSMZ-ZPFDUUQYSA-N Lys-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCCN WGCKDDHUFPQSMZ-ZPFDUUQYSA-N 0.000 description 1
- LMVOVCYVZBBWQB-SRVKXCTJSA-N Lys-Asp-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LMVOVCYVZBBWQB-SRVKXCTJSA-N 0.000 description 1
- SVJRVFPSHPGWFF-DCAQKATOSA-N Lys-Cys-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVJRVFPSHPGWFF-DCAQKATOSA-N 0.000 description 1
- XTONYTDATVADQH-CIUDSAMLSA-N Lys-Cys-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O XTONYTDATVADQH-CIUDSAMLSA-N 0.000 description 1
- QQYRCUXKLDGCQN-SRVKXCTJSA-N Lys-Cys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)N QQYRCUXKLDGCQN-SRVKXCTJSA-N 0.000 description 1
- MWVUEPNEPWMFBD-SRVKXCTJSA-N Lys-Cys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCCN MWVUEPNEPWMFBD-SRVKXCTJSA-N 0.000 description 1
- BYEBKXRNDLTGFW-CIUDSAMLSA-N Lys-Cys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O BYEBKXRNDLTGFW-CIUDSAMLSA-N 0.000 description 1
- QQUJSUFWEDZQQY-AVGNSLFASA-N Lys-Gln-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN QQUJSUFWEDZQQY-AVGNSLFASA-N 0.000 description 1
- PGBPWPTUOSCNLE-JYJNAYRXSA-N Lys-Gln-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N PGBPWPTUOSCNLE-JYJNAYRXSA-N 0.000 description 1
- NNCDAORZCMPZPX-GUBZILKMSA-N Lys-Gln-Ser Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N NNCDAORZCMPZPX-GUBZILKMSA-N 0.000 description 1
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 1
- LLSUNJYOSCOOEB-GUBZILKMSA-N Lys-Glu-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O LLSUNJYOSCOOEB-GUBZILKMSA-N 0.000 description 1
- GRADYHMSAUIKPS-DCAQKATOSA-N Lys-Glu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O GRADYHMSAUIKPS-DCAQKATOSA-N 0.000 description 1
- KZOHPCYVORJBLG-AVGNSLFASA-N Lys-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N KZOHPCYVORJBLG-AVGNSLFASA-N 0.000 description 1
- LPAJOCKCPRZEAG-MNXVOIDGSA-N Lys-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN LPAJOCKCPRZEAG-MNXVOIDGSA-N 0.000 description 1
- PAMDBWYMLWOELY-SDDRHHMPSA-N Lys-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O PAMDBWYMLWOELY-SDDRHHMPSA-N 0.000 description 1
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 1
- ULUQBUKAPDUKOC-GVXVVHGQSA-N Lys-Glu-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ULUQBUKAPDUKOC-GVXVVHGQSA-N 0.000 description 1
- LCMWVZLBCUVDAZ-IUCAKERBSA-N Lys-Gly-Glu Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CCC([O-])=O LCMWVZLBCUVDAZ-IUCAKERBSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- VLMNBMFYRMGEMB-QWRGUYRKSA-N Lys-His-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 VLMNBMFYRMGEMB-QWRGUYRKSA-N 0.000 description 1
- OWRUUFUVXFREBD-KKUMJFAQSA-N Lys-His-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O OWRUUFUVXFREBD-KKUMJFAQSA-N 0.000 description 1
- KEPWSUPUFAPBRF-DKIMLUQUSA-N Lys-Ile-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KEPWSUPUFAPBRF-DKIMLUQUSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 1
- QKXZCUCBFPEXNK-KKUMJFAQSA-N Lys-Leu-His Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 QKXZCUCBFPEXNK-KKUMJFAQSA-N 0.000 description 1
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 1
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 1
- XOQMURBBIXRRCR-SRVKXCTJSA-N Lys-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN XOQMURBBIXRRCR-SRVKXCTJSA-N 0.000 description 1
- RIJCHEVHFWMDKD-SRVKXCTJSA-N Lys-Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RIJCHEVHFWMDKD-SRVKXCTJSA-N 0.000 description 1
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 1
- UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 1
- GAHJXEMYXKLZRQ-AJNGGQMLSA-N Lys-Lys-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GAHJXEMYXKLZRQ-AJNGGQMLSA-N 0.000 description 1
- YDDDRTIPNTWGIG-SRVKXCTJSA-N Lys-Lys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O YDDDRTIPNTWGIG-SRVKXCTJSA-N 0.000 description 1
- BXPHMHQHYHILBB-BZSNNMDCSA-N Lys-Lys-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BXPHMHQHYHILBB-BZSNNMDCSA-N 0.000 description 1
- QQPSCXKFDSORFT-IHRRRGAJSA-N Lys-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN QQPSCXKFDSORFT-IHRRRGAJSA-N 0.000 description 1
- GZGWILAQHOVXTD-DCAQKATOSA-N Lys-Met-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O GZGWILAQHOVXTD-DCAQKATOSA-N 0.000 description 1
- IPSDPDAOSAEWCN-RHYQMDGZSA-N Lys-Met-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IPSDPDAOSAEWCN-RHYQMDGZSA-N 0.000 description 1
- ALEVUGKHINJNIF-QEJZJMRPSA-N Lys-Phe-Ala Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ALEVUGKHINJNIF-QEJZJMRPSA-N 0.000 description 1
- JPYPRVHMKRFTAT-KKUMJFAQSA-N Lys-Phe-Cys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCCN)N JPYPRVHMKRFTAT-KKUMJFAQSA-N 0.000 description 1
- LMGNWHDWJDIOPK-DKIMLUQUSA-N Lys-Phe-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LMGNWHDWJDIOPK-DKIMLUQUSA-N 0.000 description 1
- AZOFEHCPMBRNFD-BZSNNMDCSA-N Lys-Phe-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 AZOFEHCPMBRNFD-BZSNNMDCSA-N 0.000 description 1
- AEIIJFBQVGYVEV-YESZJQIVSA-N Lys-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCCN)N)C(=O)O AEIIJFBQVGYVEV-YESZJQIVSA-N 0.000 description 1
- AFLBTVGQCQLOFJ-AVGNSLFASA-N Lys-Pro-Arg Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AFLBTVGQCQLOFJ-AVGNSLFASA-N 0.000 description 1
- HYSVGEAWTGPMOA-IHRRRGAJSA-N Lys-Pro-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O HYSVGEAWTGPMOA-IHRRRGAJSA-N 0.000 description 1
- JOSAKOKSPXROGQ-BJDJZHNGSA-N Lys-Ser-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JOSAKOKSPXROGQ-BJDJZHNGSA-N 0.000 description 1
- ZUGVARDEGWMMLK-SRVKXCTJSA-N Lys-Ser-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN ZUGVARDEGWMMLK-SRVKXCTJSA-N 0.000 description 1
- DYJOORGDQIGZAS-DCAQKATOSA-N Lys-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N DYJOORGDQIGZAS-DCAQKATOSA-N 0.000 description 1
- WZVSHTFTCYOFPL-GARJFASQSA-N Lys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N)C(=O)O WZVSHTFTCYOFPL-GARJFASQSA-N 0.000 description 1
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 1
- MEQLGHAMAUPOSJ-DCAQKATOSA-N Lys-Ser-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O MEQLGHAMAUPOSJ-DCAQKATOSA-N 0.000 description 1
- TVHCDSBMFQYPNA-RHYQMDGZSA-N Lys-Thr-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O TVHCDSBMFQYPNA-RHYQMDGZSA-N 0.000 description 1
- BDFHWFUAQLIMJO-KXNHARMFSA-N Lys-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N)O BDFHWFUAQLIMJO-KXNHARMFSA-N 0.000 description 1
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 1
- YFQSSOAGMZGXFT-MEYUZBJRSA-N Lys-Thr-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YFQSSOAGMZGXFT-MEYUZBJRSA-N 0.000 description 1
- RYOLKFYZBHMYFW-WDSOQIARSA-N Lys-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 RYOLKFYZBHMYFW-WDSOQIARSA-N 0.000 description 1
- XATKLFSXFINPSB-JYJNAYRXSA-N Lys-Tyr-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O XATKLFSXFINPSB-JYJNAYRXSA-N 0.000 description 1
- VWPJQIHBBOJWDN-DCAQKATOSA-N Lys-Val-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O VWPJQIHBBOJWDN-DCAQKATOSA-N 0.000 description 1
- MDDUIRLQCYVRDO-NHCYSSNCSA-N Lys-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN MDDUIRLQCYVRDO-NHCYSSNCSA-N 0.000 description 1
- HMZPYMSEAALNAE-ULQDDVLXSA-N Lys-Val-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMZPYMSEAALNAE-ULQDDVLXSA-N 0.000 description 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- HUKLXYYPZWPXCC-KZVJFYERSA-N Met-Ala-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HUKLXYYPZWPXCC-KZVJFYERSA-N 0.000 description 1
- CWFYZYQMUDWGTI-GUBZILKMSA-N Met-Arg-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O CWFYZYQMUDWGTI-GUBZILKMSA-N 0.000 description 1
- DCHHUGLTVLJYKA-FXQIFTODSA-N Met-Asn-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O DCHHUGLTVLJYKA-FXQIFTODSA-N 0.000 description 1
- IVCPHARVJUYDPA-FXQIFTODSA-N Met-Asn-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IVCPHARVJUYDPA-FXQIFTODSA-N 0.000 description 1
- DRXODWRPPUFIAY-DCAQKATOSA-N Met-Asn-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN DRXODWRPPUFIAY-DCAQKATOSA-N 0.000 description 1
- OSOLWRWQADPDIQ-DCAQKATOSA-N Met-Asp-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OSOLWRWQADPDIQ-DCAQKATOSA-N 0.000 description 1
- SDTSLIMYROCDNS-FXQIFTODSA-N Met-Cys-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O SDTSLIMYROCDNS-FXQIFTODSA-N 0.000 description 1
- CNUPMMXDISGXMU-CIUDSAMLSA-N Met-Cys-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O CNUPMMXDISGXMU-CIUDSAMLSA-N 0.000 description 1
- RMHHNLKYPOOKQN-FXQIFTODSA-N Met-Cys-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O RMHHNLKYPOOKQN-FXQIFTODSA-N 0.000 description 1
- GPAHWYRSHCKICP-GUBZILKMSA-N Met-Glu-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GPAHWYRSHCKICP-GUBZILKMSA-N 0.000 description 1
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 1
- BKIFWLQFOOKUCA-DCAQKATOSA-N Met-His-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N BKIFWLQFOOKUCA-DCAQKATOSA-N 0.000 description 1
- FTQOFRPGLYXRFM-CYDGBPFRSA-N Met-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCSC)N FTQOFRPGLYXRFM-CYDGBPFRSA-N 0.000 description 1
- RBGLBUDVQVPTEG-DCAQKATOSA-N Met-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCSC)N RBGLBUDVQVPTEG-DCAQKATOSA-N 0.000 description 1
- CHDYFPCQVUOJEB-ULQDDVLXSA-N Met-Leu-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CHDYFPCQVUOJEB-ULQDDVLXSA-N 0.000 description 1
- USBFEVBHEQBWDD-AVGNSLFASA-N Met-Leu-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O USBFEVBHEQBWDD-AVGNSLFASA-N 0.000 description 1
- LNXGEYIEEUZGGH-JYJNAYRXSA-N Met-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)CC1=CC=CC=C1 LNXGEYIEEUZGGH-JYJNAYRXSA-N 0.000 description 1
- PHKBGZKVOJCIMZ-SRVKXCTJSA-N Met-Pro-Arg Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PHKBGZKVOJCIMZ-SRVKXCTJSA-N 0.000 description 1
- QLESZRANMSYLCZ-CYDGBPFRSA-N Met-Pro-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QLESZRANMSYLCZ-CYDGBPFRSA-N 0.000 description 1
- XIGAHPDZLAYQOS-SRVKXCTJSA-N Met-Pro-Pro Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 XIGAHPDZLAYQOS-SRVKXCTJSA-N 0.000 description 1
- RDLSEGZJMYGFNS-FXQIFTODSA-N Met-Ser-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RDLSEGZJMYGFNS-FXQIFTODSA-N 0.000 description 1
- HLZORBMOISUNIV-DCAQKATOSA-N Met-Ser-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C HLZORBMOISUNIV-DCAQKATOSA-N 0.000 description 1
- FIZZULTXMVEIAA-IHRRRGAJSA-N Met-Ser-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FIZZULTXMVEIAA-IHRRRGAJSA-N 0.000 description 1
- QYIGOFGUOVTAHK-ZJDVBMNYSA-N Met-Thr-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QYIGOFGUOVTAHK-ZJDVBMNYSA-N 0.000 description 1
- CULGJGUDIJATIP-STQMWFEESA-N Met-Tyr-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 CULGJGUDIJATIP-STQMWFEESA-N 0.000 description 1
- FZDOBWIKRQORAC-ULQDDVLXSA-N Met-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCSC)N FZDOBWIKRQORAC-ULQDDVLXSA-N 0.000 description 1
- CNFMPVYIVQUJOO-NHCYSSNCSA-N Met-Val-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(N)=O CNFMPVYIVQUJOO-NHCYSSNCSA-N 0.000 description 1
- 206010059282 Metastases to central nervous system Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 101100288061 Mus musculus Kif18a gene Proteins 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 206010028729 Nasal cavity cancer Diseases 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 101100068676 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) gln-1 gene Proteins 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010059482 Neutropenic infection Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 208000010505 Nose Neoplasms Diseases 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 241000283089 Perissodactyla Species 0.000 description 1
- WSXKXSBOJXEZDV-DLOVCJGASA-N Phe-Ala-Asn Chemical compound NC(=O)C[C@@H](C([O-])=O)NC(=O)[C@H](C)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 WSXKXSBOJXEZDV-DLOVCJGASA-N 0.000 description 1
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 1
- FPTXMUIBLMGTQH-ONGXEEELSA-N Phe-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 FPTXMUIBLMGTQH-ONGXEEELSA-N 0.000 description 1
- MQWISMJKHOUEMW-ULQDDVLXSA-N Phe-Arg-His Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 MQWISMJKHOUEMW-ULQDDVLXSA-N 0.000 description 1
- LGBVMDMZZFYSFW-HJWJTTGWSA-N Phe-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CC=CC=C1)N LGBVMDMZZFYSFW-HJWJTTGWSA-N 0.000 description 1
- AGYXCMYVTBYGCT-ULQDDVLXSA-N Phe-Arg-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O AGYXCMYVTBYGCT-ULQDDVLXSA-N 0.000 description 1
- ZWJKVFAYPLPCQB-UNQGMJICSA-N Phe-Arg-Thr Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O ZWJKVFAYPLPCQB-UNQGMJICSA-N 0.000 description 1
- QCHNRQQVLJYDSI-DLOVCJGASA-N Phe-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 QCHNRQQVLJYDSI-DLOVCJGASA-N 0.000 description 1
- HTTYNOXBBOWZTB-SRVKXCTJSA-N Phe-Asn-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N HTTYNOXBBOWZTB-SRVKXCTJSA-N 0.000 description 1
- MECSIDWUTYRHRJ-KKUMJFAQSA-N Phe-Asn-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O MECSIDWUTYRHRJ-KKUMJFAQSA-N 0.000 description 1
- XMPUYNHKEPFERE-IHRRRGAJSA-N Phe-Asp-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 XMPUYNHKEPFERE-IHRRRGAJSA-N 0.000 description 1
- UEEVBGHEGJMDDV-AVGNSLFASA-N Phe-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 UEEVBGHEGJMDDV-AVGNSLFASA-N 0.000 description 1
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 1
- CSYVXYQDIVCQNU-QWRGUYRKSA-N Phe-Asp-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O CSYVXYQDIVCQNU-QWRGUYRKSA-N 0.000 description 1
- IUVYJBMTHARMIP-PCBIJLKTSA-N Phe-Asp-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IUVYJBMTHARMIP-PCBIJLKTSA-N 0.000 description 1
- RIYZXJVARWJLKS-KKUMJFAQSA-N Phe-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RIYZXJVARWJLKS-KKUMJFAQSA-N 0.000 description 1
- IILUKIJNFMUBNF-IHRRRGAJSA-N Phe-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O IILUKIJNFMUBNF-IHRRRGAJSA-N 0.000 description 1
- WYPVCIACUMJRIB-JYJNAYRXSA-N Phe-Gln-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N WYPVCIACUMJRIB-JYJNAYRXSA-N 0.000 description 1
- OPEVYHFJXLCCRT-AVGNSLFASA-N Phe-Gln-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O OPEVYHFJXLCCRT-AVGNSLFASA-N 0.000 description 1
- MGBRZXXGQBAULP-DRZSPHRISA-N Phe-Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGBRZXXGQBAULP-DRZSPHRISA-N 0.000 description 1
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 1
- LWPMGKSZPKFKJD-DZKIICNBSA-N Phe-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O LWPMGKSZPKFKJD-DZKIICNBSA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- ISYSEOWLRQKQEQ-JYJNAYRXSA-N Phe-His-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O ISYSEOWLRQKQEQ-JYJNAYRXSA-N 0.000 description 1
- WEMYTDDMDBLPMI-DKIMLUQUSA-N Phe-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N WEMYTDDMDBLPMI-DKIMLUQUSA-N 0.000 description 1
- BYAIIACBWBOJCU-URLPEUOOSA-N Phe-Ile-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BYAIIACBWBOJCU-URLPEUOOSA-N 0.000 description 1
- SMFGCTXUBWEPKM-KBPBESRZSA-N Phe-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 SMFGCTXUBWEPKM-KBPBESRZSA-N 0.000 description 1
- METZZBCMDXHFMK-BZSNNMDCSA-N Phe-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N METZZBCMDXHFMK-BZSNNMDCSA-N 0.000 description 1
- CMHTUJQZQXFNTQ-OEAJRASXSA-N Phe-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O CMHTUJQZQXFNTQ-OEAJRASXSA-N 0.000 description 1
- RMKGXGPQIPLTFC-KKUMJFAQSA-N Phe-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RMKGXGPQIPLTFC-KKUMJFAQSA-N 0.000 description 1
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 1
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 1
- BSHMIVKDJQGLNT-ACRUOGEOSA-N Phe-Lys-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 BSHMIVKDJQGLNT-ACRUOGEOSA-N 0.000 description 1
- GPSMLZQVIIYLDK-ULQDDVLXSA-N Phe-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O GPSMLZQVIIYLDK-ULQDDVLXSA-N 0.000 description 1
- FUAIIFPQELBNJF-ULQDDVLXSA-N Phe-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N FUAIIFPQELBNJF-ULQDDVLXSA-N 0.000 description 1
- GZGPMBKUJDRICD-ULQDDVLXSA-N Phe-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O GZGPMBKUJDRICD-ULQDDVLXSA-N 0.000 description 1
- ZLAKUZDMKVKFAI-JYJNAYRXSA-N Phe-Pro-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O ZLAKUZDMKVKFAI-JYJNAYRXSA-N 0.000 description 1
- BONHGTUEEPIMPM-AVGNSLFASA-N Phe-Ser-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O BONHGTUEEPIMPM-AVGNSLFASA-N 0.000 description 1
- UNBFGVQVQGXXCK-KKUMJFAQSA-N Phe-Ser-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O UNBFGVQVQGXXCK-KKUMJFAQSA-N 0.000 description 1
- IPFXYNKCXYGSSV-KKUMJFAQSA-N Phe-Ser-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N IPFXYNKCXYGSSV-KKUMJFAQSA-N 0.000 description 1
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 1
- BTAIJUBAGLVFKQ-BVSLBCMMSA-N Phe-Trp-Val Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C(C)C)C(O)=O)C1=CC=CC=C1 BTAIJUBAGLVFKQ-BVSLBCMMSA-N 0.000 description 1
- DBNGDEAQXGFGRA-ACRUOGEOSA-N Phe-Tyr-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DBNGDEAQXGFGRA-ACRUOGEOSA-N 0.000 description 1
- APMXLWHMIVWLLR-BZSNNMDCSA-N Phe-Tyr-Ser Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(O)=O)C1=CC=CC=C1 APMXLWHMIVWLLR-BZSNNMDCSA-N 0.000 description 1
- GOUWCZRDTWTODO-YDHLFZDLSA-N Phe-Val-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O GOUWCZRDTWTODO-YDHLFZDLSA-N 0.000 description 1
- VDTYRPWRWRCROL-UFYCRDLUSA-N Phe-Val-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VDTYRPWRWRCROL-UFYCRDLUSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- DZZCICYRSZASNF-FXQIFTODSA-N Pro-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 DZZCICYRSZASNF-FXQIFTODSA-N 0.000 description 1
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 1
- HFZNNDWPHBRNPV-KZVJFYERSA-N Pro-Ala-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HFZNNDWPHBRNPV-KZVJFYERSA-N 0.000 description 1
- LNLNHXIQPGKRJQ-SRVKXCTJSA-N Pro-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1 LNLNHXIQPGKRJQ-SRVKXCTJSA-N 0.000 description 1
- IHCXPSYCHXFXKT-DCAQKATOSA-N Pro-Arg-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O IHCXPSYCHXFXKT-DCAQKATOSA-N 0.000 description 1
- ZSKJPKFTPQCPIH-RCWTZXSCSA-N Pro-Arg-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZSKJPKFTPQCPIH-RCWTZXSCSA-N 0.000 description 1
- ILMLVTGTUJPQFP-FXQIFTODSA-N Pro-Asp-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ILMLVTGTUJPQFP-FXQIFTODSA-N 0.000 description 1
- VJLJGKQAOQJXJG-CIUDSAMLSA-N Pro-Asp-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJLJGKQAOQJXJG-CIUDSAMLSA-N 0.000 description 1
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 1
- SZZBUDVXWZZPDH-BQBZGAKWSA-N Pro-Cys-Gly Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1 SZZBUDVXWZZPDH-BQBZGAKWSA-N 0.000 description 1
- LSIWVWRUTKPXDS-DCAQKATOSA-N Pro-Gln-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LSIWVWRUTKPXDS-DCAQKATOSA-N 0.000 description 1
- ZPPVJIJMIKTERM-YUMQZZPRSA-N Pro-Gln-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]1CCCN1 ZPPVJIJMIKTERM-YUMQZZPRSA-N 0.000 description 1
- WGAQWMRJUFQXMF-ZPFDUUQYSA-N Pro-Gln-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WGAQWMRJUFQXMF-ZPFDUUQYSA-N 0.000 description 1
- HJSCRFZVGXAGNG-SRVKXCTJSA-N Pro-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 HJSCRFZVGXAGNG-SRVKXCTJSA-N 0.000 description 1
- LANQLYHLMYDWJP-SRVKXCTJSA-N Pro-Gln-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O LANQLYHLMYDWJP-SRVKXCTJSA-N 0.000 description 1
- PULPZRAHVFBVTO-DCAQKATOSA-N Pro-Glu-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PULPZRAHVFBVTO-DCAQKATOSA-N 0.000 description 1
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 1
- VDGTVWFMRXVQCT-GUBZILKMSA-N Pro-Glu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 VDGTVWFMRXVQCT-GUBZILKMSA-N 0.000 description 1
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 1
- LXVLKXPFIDDHJG-CIUDSAMLSA-N Pro-Glu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O LXVLKXPFIDDHJG-CIUDSAMLSA-N 0.000 description 1
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 1
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 1
- FKLSMYYLJHYPHH-UWVGGRQHSA-N Pro-Gly-Leu Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O FKLSMYYLJHYPHH-UWVGGRQHSA-N 0.000 description 1
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 1
- AJCRQOHDLCBHFA-SRVKXCTJSA-N Pro-His-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O AJCRQOHDLCBHFA-SRVKXCTJSA-N 0.000 description 1
- JUJGNDZIKKQMDJ-IHRRRGAJSA-N Pro-His-His Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O JUJGNDZIKKQMDJ-IHRRRGAJSA-N 0.000 description 1
- KWMUAKQOVYCQJQ-ZPFDUUQYSA-N Pro-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H]1CCCN1 KWMUAKQOVYCQJQ-ZPFDUUQYSA-N 0.000 description 1
- VZKBJNBZMZHKRC-XUXIUFHCSA-N Pro-Ile-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O VZKBJNBZMZHKRC-XUXIUFHCSA-N 0.000 description 1
- FKVNLUZHSFCNGY-RVMXOQNASA-N Pro-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 FKVNLUZHSFCNGY-RVMXOQNASA-N 0.000 description 1
- RUDOLGWDSKQQFF-DCAQKATOSA-N Pro-Leu-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O RUDOLGWDSKQQFF-DCAQKATOSA-N 0.000 description 1
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 1
- XYSXOCIWCPFOCG-IHRRRGAJSA-N Pro-Leu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XYSXOCIWCPFOCG-IHRRRGAJSA-N 0.000 description 1
- MCWHYUWXVNRXFV-RWMBFGLXSA-N Pro-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 MCWHYUWXVNRXFV-RWMBFGLXSA-N 0.000 description 1
- FKYKZHOKDOPHSA-DCAQKATOSA-N Pro-Leu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FKYKZHOKDOPHSA-DCAQKATOSA-N 0.000 description 1
- CDGABSWLRMECHC-IHRRRGAJSA-N Pro-Lys-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O CDGABSWLRMECHC-IHRRRGAJSA-N 0.000 description 1
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 1
- MHHQQZIFLWFZGR-DCAQKATOSA-N Pro-Lys-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O MHHQQZIFLWFZGR-DCAQKATOSA-N 0.000 description 1
- WOIFYRZPIORBRY-AVGNSLFASA-N Pro-Lys-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O WOIFYRZPIORBRY-AVGNSLFASA-N 0.000 description 1
- ZUZINZIJHJFJRN-UBHSHLNASA-N Pro-Phe-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 ZUZINZIJHJFJRN-UBHSHLNASA-N 0.000 description 1
- JIWJRKNYLSHONY-KKUMJFAQSA-N Pro-Phe-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JIWJRKNYLSHONY-KKUMJFAQSA-N 0.000 description 1
- WHNJMTHJGCEKGA-ULQDDVLXSA-N Pro-Phe-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WHNJMTHJGCEKGA-ULQDDVLXSA-N 0.000 description 1
- DSGSTPRKNYHGCL-JYJNAYRXSA-N Pro-Phe-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O DSGSTPRKNYHGCL-JYJNAYRXSA-N 0.000 description 1
- GFHXZNVJIKMAGO-IHRRRGAJSA-N Pro-Phe-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O GFHXZNVJIKMAGO-IHRRRGAJSA-N 0.000 description 1
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 1
- RFWXYTJSVDUBBZ-DCAQKATOSA-N Pro-Pro-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RFWXYTJSVDUBBZ-DCAQKATOSA-N 0.000 description 1
- PCWLNNZTBJTZRN-AVGNSLFASA-N Pro-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 PCWLNNZTBJTZRN-AVGNSLFASA-N 0.000 description 1
- QAAYIXYLEMRULP-SRVKXCTJSA-N Pro-Pro-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 QAAYIXYLEMRULP-SRVKXCTJSA-N 0.000 description 1
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 1
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 1
- OWQXAJQZLWHPBH-FXQIFTODSA-N Pro-Ser-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O OWQXAJQZLWHPBH-FXQIFTODSA-N 0.000 description 1
- FNGOXVQBBCMFKV-CIUDSAMLSA-N Pro-Ser-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O FNGOXVQBBCMFKV-CIUDSAMLSA-N 0.000 description 1
- ITUDDXVFGFEKPD-NAKRPEOUSA-N Pro-Ser-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ITUDDXVFGFEKPD-NAKRPEOUSA-N 0.000 description 1
- KWMZPPWYBVZIER-XGEHTFHBSA-N Pro-Ser-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWMZPPWYBVZIER-XGEHTFHBSA-N 0.000 description 1
- AIOWVDNPESPXRB-YTWAJWBKSA-N Pro-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2)O AIOWVDNPESPXRB-YTWAJWBKSA-N 0.000 description 1
- RMJZWERKFFNNNS-XGEHTFHBSA-N Pro-Thr-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O RMJZWERKFFNNNS-XGEHTFHBSA-N 0.000 description 1
- BNUKRHFCHHLIGR-JYJNAYRXSA-N Pro-Trp-Asp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(=O)O)C(=O)O BNUKRHFCHHLIGR-JYJNAYRXSA-N 0.000 description 1
- ZYJMLBCDFPIGNL-JYJNAYRXSA-N Pro-Tyr-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(O)=O ZYJMLBCDFPIGNL-JYJNAYRXSA-N 0.000 description 1
- LZHHZYDPMZEMRX-STQMWFEESA-N Pro-Tyr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O LZHHZYDPMZEMRX-STQMWFEESA-N 0.000 description 1
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 1
- XDKKMRPRRCOELJ-GUBZILKMSA-N Pro-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 XDKKMRPRRCOELJ-GUBZILKMSA-N 0.000 description 1
- WWXNZNWZNZPDIF-SRVKXCTJSA-N Pro-Val-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 WWXNZNWZNZPDIF-SRVKXCTJSA-N 0.000 description 1
- OOZJHTXCLJUODH-QXEWZRGKSA-N Pro-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 OOZJHTXCLJUODH-QXEWZRGKSA-N 0.000 description 1
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 108050002653 Retinoblastoma protein Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 1
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 1
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 description 1
- DWUIECHTAMYEFL-XVYDVKMFSA-N Ser-Ala-His Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 DWUIECHTAMYEFL-XVYDVKMFSA-N 0.000 description 1
- IDQFQFVEWMWRQQ-DLOVCJGASA-N Ser-Ala-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IDQFQFVEWMWRQQ-DLOVCJGASA-N 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- HBZBPFLJNDXRAY-FXQIFTODSA-N Ser-Ala-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O HBZBPFLJNDXRAY-FXQIFTODSA-N 0.000 description 1
- GXXTUIUYTWGPMV-FXQIFTODSA-N Ser-Arg-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O GXXTUIUYTWGPMV-FXQIFTODSA-N 0.000 description 1
- YUSRGTQIPCJNHQ-CIUDSAMLSA-N Ser-Arg-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YUSRGTQIPCJNHQ-CIUDSAMLSA-N 0.000 description 1
- HQTKVSCNCDLXSX-BQBZGAKWSA-N Ser-Arg-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O HQTKVSCNCDLXSX-BQBZGAKWSA-N 0.000 description 1
- VQBLHWSPVYYZTB-DCAQKATOSA-N Ser-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N VQBLHWSPVYYZTB-DCAQKATOSA-N 0.000 description 1
- KYKKKSWGEPFUMR-NAKRPEOUSA-N Ser-Arg-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KYKKKSWGEPFUMR-NAKRPEOUSA-N 0.000 description 1
- WDXYVIIVDIDOSX-DCAQKATOSA-N Ser-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N WDXYVIIVDIDOSX-DCAQKATOSA-N 0.000 description 1
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 1
- YMEXHZTVKDAKIY-GHCJXIJMSA-N Ser-Asn-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(O)=O YMEXHZTVKDAKIY-GHCJXIJMSA-N 0.000 description 1
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 1
- CNIIKZQXBBQHCX-FXQIFTODSA-N Ser-Asp-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O CNIIKZQXBBQHCX-FXQIFTODSA-N 0.000 description 1
- OHKLFYXEOGGGCK-ZLUOBGJFSA-N Ser-Asp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OHKLFYXEOGGGCK-ZLUOBGJFSA-N 0.000 description 1
- MESDJCNHLZBMEP-ZLUOBGJFSA-N Ser-Asp-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MESDJCNHLZBMEP-ZLUOBGJFSA-N 0.000 description 1
- BGOWRLSWJCVYAQ-CIUDSAMLSA-N Ser-Asp-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BGOWRLSWJCVYAQ-CIUDSAMLSA-N 0.000 description 1
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 1
- UCOYFSCEIWQYNL-FXQIFTODSA-N Ser-Cys-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(O)=O UCOYFSCEIWQYNL-FXQIFTODSA-N 0.000 description 1
- CDVFZMOFNJPUDD-ACZMJKKPSA-N Ser-Gln-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CDVFZMOFNJPUDD-ACZMJKKPSA-N 0.000 description 1
- GWMXFEMMBHOKDX-AVGNSLFASA-N Ser-Gln-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 GWMXFEMMBHOKDX-AVGNSLFASA-N 0.000 description 1
- BQWCDDAISCPDQV-XHNCKOQMSA-N Ser-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N)C(=O)O BQWCDDAISCPDQV-XHNCKOQMSA-N 0.000 description 1
- FMDHKPRACUXATF-ACZMJKKPSA-N Ser-Gln-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O FMDHKPRACUXATF-ACZMJKKPSA-N 0.000 description 1
- VQBCMLMPEWPUTB-ACZMJKKPSA-N Ser-Glu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VQBCMLMPEWPUTB-ACZMJKKPSA-N 0.000 description 1
- GZBKRJVCRMZAST-XKBZYTNZSA-N Ser-Glu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZBKRJVCRMZAST-XKBZYTNZSA-N 0.000 description 1
- OHKFXGKHSJKKAL-NRPADANISA-N Ser-Glu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OHKFXGKHSJKKAL-NRPADANISA-N 0.000 description 1
- SNVIOQXAHVORQM-WDSKDSINSA-N Ser-Gly-Gln Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O SNVIOQXAHVORQM-WDSKDSINSA-N 0.000 description 1
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 1
- IXCHOHLPHNGFTJ-YUMQZZPRSA-N Ser-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N IXCHOHLPHNGFTJ-YUMQZZPRSA-N 0.000 description 1
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 1
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 1
- OQPNSDWGAMFJNU-QWRGUYRKSA-N Ser-Gly-Tyr Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OQPNSDWGAMFJNU-QWRGUYRKSA-N 0.000 description 1
- QGAHMVHBORDHDC-YUMQZZPRSA-N Ser-His-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 QGAHMVHBORDHDC-YUMQZZPRSA-N 0.000 description 1
- UGHCUDLCCVVIJR-VGDYDELISA-N Ser-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)N UGHCUDLCCVVIJR-VGDYDELISA-N 0.000 description 1
- WEQAYODCJHZSJZ-KKUMJFAQSA-N Ser-His-Tyr Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 WEQAYODCJHZSJZ-KKUMJFAQSA-N 0.000 description 1
- LQESNKGTTNHZPZ-GHCJXIJMSA-N Ser-Ile-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O LQESNKGTTNHZPZ-GHCJXIJMSA-N 0.000 description 1
- JIPVNVNKXJLFJF-BJDJZHNGSA-N Ser-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N JIPVNVNKXJLFJF-BJDJZHNGSA-N 0.000 description 1
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- ZIFYDQAFEMIZII-GUBZILKMSA-N Ser-Leu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZIFYDQAFEMIZII-GUBZILKMSA-N 0.000 description 1
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- VZQRNAYURWAEFE-KKUMJFAQSA-N Ser-Leu-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VZQRNAYURWAEFE-KKUMJFAQSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 1
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 1
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 1
- JLPMFVAIQHCBDC-CIUDSAMLSA-N Ser-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N JLPMFVAIQHCBDC-CIUDSAMLSA-N 0.000 description 1
- GVMUJUPXFQFBBZ-GUBZILKMSA-N Ser-Lys-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GVMUJUPXFQFBBZ-GUBZILKMSA-N 0.000 description 1
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 1
- PTWIYDNFWPXQSD-GARJFASQSA-N Ser-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N)C(=O)O PTWIYDNFWPXQSD-GARJFASQSA-N 0.000 description 1
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 1
- XNXRTQZTFVMJIJ-DCAQKATOSA-N Ser-Met-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XNXRTQZTFVMJIJ-DCAQKATOSA-N 0.000 description 1
- ASGYVPAVFNDZMA-GUBZILKMSA-N Ser-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)N ASGYVPAVFNDZMA-GUBZILKMSA-N 0.000 description 1
- NQZFFLBPNDLTPO-DLOVCJGASA-N Ser-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)N NQZFFLBPNDLTPO-DLOVCJGASA-N 0.000 description 1
- FZEUTKVQGMVGHW-AVGNSLFASA-N Ser-Phe-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O FZEUTKVQGMVGHW-AVGNSLFASA-N 0.000 description 1
- BUYHXYIUQUBEQP-AVGNSLFASA-N Ser-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)N BUYHXYIUQUBEQP-AVGNSLFASA-N 0.000 description 1
- XVWDJUROVRQKAE-KKUMJFAQSA-N Ser-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CC=CC=C1 XVWDJUROVRQKAE-KKUMJFAQSA-N 0.000 description 1
- RWDVVSKYZBNDCO-MELADBBJSA-N Ser-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)N)C(=O)O RWDVVSKYZBNDCO-MELADBBJSA-N 0.000 description 1
- FBLNYDYPCLFTSP-IXOXFDKPSA-N Ser-Phe-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FBLNYDYPCLFTSP-IXOXFDKPSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- DINQYZRMXGWWTG-GUBZILKMSA-N Ser-Pro-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DINQYZRMXGWWTG-GUBZILKMSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- XGQKSRGHEZNWIS-IHRRRGAJSA-N Ser-Pro-Tyr Chemical compound N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O XGQKSRGHEZNWIS-IHRRRGAJSA-N 0.000 description 1
- CKDXFSPMIDSMGV-GUBZILKMSA-N Ser-Pro-Val Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O CKDXFSPMIDSMGV-GUBZILKMSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- VFWQQZMRKFOGLE-ZLUOBGJFSA-N Ser-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O VFWQQZMRKFOGLE-ZLUOBGJFSA-N 0.000 description 1
- FZXOPYUEQGDGMS-ACZMJKKPSA-N Ser-Ser-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O FZXOPYUEQGDGMS-ACZMJKKPSA-N 0.000 description 1
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 1
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 1
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 1
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 1
- RXUOAOOZIWABBW-XGEHTFHBSA-N Ser-Thr-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RXUOAOOZIWABBW-XGEHTFHBSA-N 0.000 description 1
- SOACHCFYJMCMHC-BWBBJGPYSA-N Ser-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N)O SOACHCFYJMCMHC-BWBBJGPYSA-N 0.000 description 1
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 1
- UYLKOSODXYSWMQ-XGEHTFHBSA-N Ser-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CO)N)O UYLKOSODXYSWMQ-XGEHTFHBSA-N 0.000 description 1
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 1
- STIAINRLUUKYKM-WFBYXXMGSA-N Ser-Trp-Ala Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CO)=CNC2=C1 STIAINRLUUKYKM-WFBYXXMGSA-N 0.000 description 1
- YXEYTHXDRDAIOJ-CWRNSKLLSA-N Ser-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CO)N)C(=O)O YXEYTHXDRDAIOJ-CWRNSKLLSA-N 0.000 description 1
- ZWSZBWAFDZRBNM-UBHSHLNASA-N Ser-Trp-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(O)=O ZWSZBWAFDZRBNM-UBHSHLNASA-N 0.000 description 1
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 1
- ZVBCMFDJIMUELU-BZSNNMDCSA-N Ser-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)N ZVBCMFDJIMUELU-BZSNNMDCSA-N 0.000 description 1
- LLSLRQOEAFCZLW-NRPADANISA-N Ser-Val-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LLSLRQOEAFCZLW-NRPADANISA-N 0.000 description 1
- BEBVVQPDSHHWQL-NRPADANISA-N Ser-Val-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BEBVVQPDSHHWQL-NRPADANISA-N 0.000 description 1
- ODRUTDLAONAVDV-IHRRRGAJSA-N Ser-Val-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ODRUTDLAONAVDV-IHRRRGAJSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000032383 Soft tissue cancer Diseases 0.000 description 1
- 241001493546 Suina Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 206010043298 Testicular atrophy Diseases 0.000 description 1
- 206010057644 Testis cancer Diseases 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- MQCPGOZXFSYJPS-KZVJFYERSA-N Thr-Ala-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MQCPGOZXFSYJPS-KZVJFYERSA-N 0.000 description 1
- DFTCYYILCSQGIZ-GCJQMDKQSA-N Thr-Ala-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFTCYYILCSQGIZ-GCJQMDKQSA-N 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 1
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 1
- GLQFKOVWXPPFTP-VEVYYDQMSA-N Thr-Arg-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GLQFKOVWXPPFTP-VEVYYDQMSA-N 0.000 description 1
- JMQUAZXYFAEOIH-XGEHTFHBSA-N Thr-Arg-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N)O JMQUAZXYFAEOIH-XGEHTFHBSA-N 0.000 description 1
- UKBSDLHIKIXJKH-HJGDQZAQSA-N Thr-Arg-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UKBSDLHIKIXJKH-HJGDQZAQSA-N 0.000 description 1
- XVNZSJIKGJLQLH-RCWTZXSCSA-N Thr-Arg-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)O)N)O XVNZSJIKGJLQLH-RCWTZXSCSA-N 0.000 description 1
- UTSWGQNAQRIHAI-UNQGMJICSA-N Thr-Arg-Phe Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 UTSWGQNAQRIHAI-UNQGMJICSA-N 0.000 description 1
- QGXCWPNQVCYJEL-NUMRIWBASA-N Thr-Asn-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QGXCWPNQVCYJEL-NUMRIWBASA-N 0.000 description 1
- SKHPKKYKDYULDH-HJGDQZAQSA-N Thr-Asn-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SKHPKKYKDYULDH-HJGDQZAQSA-N 0.000 description 1
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 1
- DCCGCVLVVSAJFK-NUMRIWBASA-N Thr-Asp-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O DCCGCVLVVSAJFK-NUMRIWBASA-N 0.000 description 1
- NOWXWJLVGTVJKM-PBCZWWQYSA-N Thr-Asp-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O NOWXWJLVGTVJKM-PBCZWWQYSA-N 0.000 description 1
- GKMYGVQDGVYCPC-IUKAMOBKSA-N Thr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)N GKMYGVQDGVYCPC-IUKAMOBKSA-N 0.000 description 1
- NLSNVZAREYQMGR-HJGDQZAQSA-N Thr-Asp-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NLSNVZAREYQMGR-HJGDQZAQSA-N 0.000 description 1
- JXKMXEBNZCKSDY-JIOCBJNQSA-N Thr-Asp-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O JXKMXEBNZCKSDY-JIOCBJNQSA-N 0.000 description 1
- DCLBXIWHLVEPMQ-JRQIVUDYSA-N Thr-Asp-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DCLBXIWHLVEPMQ-JRQIVUDYSA-N 0.000 description 1
- ZUUDNCOCILSYAM-KKHAAJSZSA-N Thr-Asp-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZUUDNCOCILSYAM-KKHAAJSZSA-N 0.000 description 1
- QILPDQCTQZDHFM-HJGDQZAQSA-N Thr-Gln-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QILPDQCTQZDHFM-HJGDQZAQSA-N 0.000 description 1
- WLDUCKSCDRIVLJ-NUMRIWBASA-N Thr-Gln-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O WLDUCKSCDRIVLJ-NUMRIWBASA-N 0.000 description 1
- ZQUKYJOKQBRBCS-GLLZPBPUSA-N Thr-Gln-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O ZQUKYJOKQBRBCS-GLLZPBPUSA-N 0.000 description 1
- GARULAKWZGFIKC-RWRJDSDZSA-N Thr-Gln-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GARULAKWZGFIKC-RWRJDSDZSA-N 0.000 description 1
- LIXBDERDAGNVAV-XKBZYTNZSA-N Thr-Gln-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O LIXBDERDAGNVAV-XKBZYTNZSA-N 0.000 description 1
- VGYBYGQXZJDZJU-XQXXSGGOSA-N Thr-Glu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VGYBYGQXZJDZJU-XQXXSGGOSA-N 0.000 description 1
- FHDLKMFZKRUQCE-HJGDQZAQSA-N Thr-Glu-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FHDLKMFZKRUQCE-HJGDQZAQSA-N 0.000 description 1
- VOHWDZNIESHTFW-XKBZYTNZSA-N Thr-Glu-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N)O VOHWDZNIESHTFW-XKBZYTNZSA-N 0.000 description 1
- GKWNLDNXMMLRMC-GLLZPBPUSA-N Thr-Glu-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O GKWNLDNXMMLRMC-GLLZPBPUSA-N 0.000 description 1
- SHOMROOOQBDGRL-JHEQGTHGSA-N Thr-Glu-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SHOMROOOQBDGRL-JHEQGTHGSA-N 0.000 description 1
- JMGJDTNUMAZNLX-RWRJDSDZSA-N Thr-Glu-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JMGJDTNUMAZNLX-RWRJDSDZSA-N 0.000 description 1
- BNGDYRRHRGOPHX-IFFSRLJSSA-N Thr-Glu-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O BNGDYRRHRGOPHX-IFFSRLJSSA-N 0.000 description 1
- SLUWOCTZVGMURC-BFHQHQDPSA-N Thr-Gly-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O SLUWOCTZVGMURC-BFHQHQDPSA-N 0.000 description 1
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 1
- NQVDGKYAUHTCME-QTKMDUPCSA-N Thr-His-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O NQVDGKYAUHTCME-QTKMDUPCSA-N 0.000 description 1
- ZBKDBZUTTXINIX-RWRJDSDZSA-N Thr-Ile-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZBKDBZUTTXINIX-RWRJDSDZSA-N 0.000 description 1
- XTCNBOBTROGWMW-RWRJDSDZSA-N Thr-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XTCNBOBTROGWMW-RWRJDSDZSA-N 0.000 description 1
- JRAUIKJSEAKTGD-TUBUOCAGSA-N Thr-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N JRAUIKJSEAKTGD-TUBUOCAGSA-N 0.000 description 1
- GMXIJHCBTZDAPD-QPHKQPEJSA-N Thr-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N GMXIJHCBTZDAPD-QPHKQPEJSA-N 0.000 description 1
- ADPHPKGWVDHWML-PPCPHDFISA-N Thr-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N ADPHPKGWVDHWML-PPCPHDFISA-N 0.000 description 1
- AMXMBCAXAZUCFA-RHYQMDGZSA-N Thr-Leu-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AMXMBCAXAZUCFA-RHYQMDGZSA-N 0.000 description 1
- ODXKUIGEPAGKKV-KATARQTJSA-N Thr-Leu-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)N)O ODXKUIGEPAGKKV-KATARQTJSA-N 0.000 description 1
- MEJHFIOYJHTWMK-VOAKCMCISA-N Thr-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O MEJHFIOYJHTWMK-VOAKCMCISA-N 0.000 description 1
- PRNGXSILMXSWQQ-OEAJRASXSA-N Thr-Leu-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PRNGXSILMXSWQQ-OEAJRASXSA-N 0.000 description 1
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 1
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 1
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 1
- CJXURNZYNHCYFD-WDCWCFNPSA-N Thr-Lys-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O CJXURNZYNHCYFD-WDCWCFNPSA-N 0.000 description 1
- SCSVNSNWUTYSFO-WDCWCFNPSA-N Thr-Lys-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O SCSVNSNWUTYSFO-WDCWCFNPSA-N 0.000 description 1
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 1
- SPVHQURZJCUDQC-VOAKCMCISA-N Thr-Lys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O SPVHQURZJCUDQC-VOAKCMCISA-N 0.000 description 1
- PUEWAXRPXOEQOW-HJGDQZAQSA-N Thr-Met-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(O)=O PUEWAXRPXOEQOW-HJGDQZAQSA-N 0.000 description 1
- ABWNZPOIUJMNKT-IXOXFDKPSA-N Thr-Phe-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O ABWNZPOIUJMNKT-IXOXFDKPSA-N 0.000 description 1
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 1
- WTMPKZWHRCMMMT-KZVJFYERSA-N Thr-Pro-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WTMPKZWHRCMMMT-KZVJFYERSA-N 0.000 description 1
- MUAFDCVOHYAFNG-RCWTZXSCSA-N Thr-Pro-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MUAFDCVOHYAFNG-RCWTZXSCSA-N 0.000 description 1
- NYQIZWROIMIQSL-VEVYYDQMSA-N Thr-Pro-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O NYQIZWROIMIQSL-VEVYYDQMSA-N 0.000 description 1
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 1
- LKJCABTUFGTPPY-HJGDQZAQSA-N Thr-Pro-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O LKJCABTUFGTPPY-HJGDQZAQSA-N 0.000 description 1
- VTMGKRABARCZAX-OSUNSFLBSA-N Thr-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O VTMGKRABARCZAX-OSUNSFLBSA-N 0.000 description 1
- GFRIEEKFXOVPIR-RHYQMDGZSA-N Thr-Pro-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O GFRIEEKFXOVPIR-RHYQMDGZSA-N 0.000 description 1
- GVMXJJAJLIEASL-ZJDVBMNYSA-N Thr-Pro-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O GVMXJJAJLIEASL-ZJDVBMNYSA-N 0.000 description 1
- YGZWVPBHYABGLT-KJEVXHAQSA-N Thr-Pro-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 YGZWVPBHYABGLT-KJEVXHAQSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 1
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 1
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 1
- QYDKSNXSBXZPFK-ZJDVBMNYSA-N Thr-Thr-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYDKSNXSBXZPFK-ZJDVBMNYSA-N 0.000 description 1
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 1
- MFMGPEKYBXFIRF-SUSMZKCASA-N Thr-Thr-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MFMGPEKYBXFIRF-SUSMZKCASA-N 0.000 description 1
- VGNLMPBYWWNQFS-ZEILLAHLSA-N Thr-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O VGNLMPBYWWNQFS-ZEILLAHLSA-N 0.000 description 1
- XGUAUKUYQHBUNY-SWRJLBSHSA-N Thr-Trp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O XGUAUKUYQHBUNY-SWRJLBSHSA-N 0.000 description 1
- JAWUQFCGNVEDRN-MEYUZBJRSA-N Thr-Tyr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N)O JAWUQFCGNVEDRN-MEYUZBJRSA-N 0.000 description 1
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 1
- XGFYGMKZKFRGAI-RCWTZXSCSA-N Thr-Val-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N XGFYGMKZKFRGAI-RCWTZXSCSA-N 0.000 description 1
- BKIOKSLLAAZYTC-KKHAAJSZSA-N Thr-Val-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O BKIOKSLLAAZYTC-KKHAAJSZSA-N 0.000 description 1
- SPIFGZFZMVLPHN-UNQGMJICSA-N Thr-Val-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SPIFGZFZMVLPHN-UNQGMJICSA-N 0.000 description 1
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 1
- VYVBSMCZNHOZGD-RCWTZXSCSA-N Thr-Val-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O VYVBSMCZNHOZGD-RCWTZXSCSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010062129 Tongue neoplasm Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- IUFQHOCOKQIOMC-XIRDDKMYSA-N Trp-Asn-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N IUFQHOCOKQIOMC-XIRDDKMYSA-N 0.000 description 1
- KVMZNMYZCKORIG-UBHSHLNASA-N Trp-Cys-Asp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KVMZNMYZCKORIG-UBHSHLNASA-N 0.000 description 1
- KULBQAVOXHQLIY-HSCHXYMDSA-N Trp-Ile-Leu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)=CNC2=C1 KULBQAVOXHQLIY-HSCHXYMDSA-N 0.000 description 1
- YDTKYBHPRULROG-LTHWPDAASA-N Trp-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N YDTKYBHPRULROG-LTHWPDAASA-N 0.000 description 1
- NWQCKAPDGQMZQN-IHPCNDPISA-N Trp-Lys-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O NWQCKAPDGQMZQN-IHPCNDPISA-N 0.000 description 1
- NFVQCNMGJILYMI-SZMVWBNQSA-N Trp-Met-Val Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O NFVQCNMGJILYMI-SZMVWBNQSA-N 0.000 description 1
- GIAMKIPJSRZVJB-IHPCNDPISA-N Trp-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GIAMKIPJSRZVJB-IHPCNDPISA-N 0.000 description 1
- NMOIRIIIUVELLY-WDSOQIARSA-N Trp-Val-Leu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)C(C)C)=CNC2=C1 NMOIRIIIUVELLY-WDSOQIARSA-N 0.000 description 1
- GFZQWWDXJVGEMW-ULQDDVLXSA-N Tyr-Arg-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GFZQWWDXJVGEMW-ULQDDVLXSA-N 0.000 description 1
- MBFJIHUHHCJBSN-AVGNSLFASA-N Tyr-Asn-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MBFJIHUHHCJBSN-AVGNSLFASA-N 0.000 description 1
- NSTPFWRAIDTNGH-BZSNNMDCSA-N Tyr-Asn-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NSTPFWRAIDTNGH-BZSNNMDCSA-N 0.000 description 1
- VFJIWSJKZJTQII-SRVKXCTJSA-N Tyr-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VFJIWSJKZJTQII-SRVKXCTJSA-N 0.000 description 1
- UABYBEBXFFNCIR-YDHLFZDLSA-N Tyr-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UABYBEBXFFNCIR-YDHLFZDLSA-N 0.000 description 1
- ZAGPDPNPWYPEIR-SRVKXCTJSA-N Tyr-Cys-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O ZAGPDPNPWYPEIR-SRVKXCTJSA-N 0.000 description 1
- RYSNTWVRSLCAJZ-RYUDHWBXSA-N Tyr-Gln-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RYSNTWVRSLCAJZ-RYUDHWBXSA-N 0.000 description 1
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 1
- ARSHSYUZHSIYKR-ACRUOGEOSA-N Tyr-His-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ARSHSYUZHSIYKR-ACRUOGEOSA-N 0.000 description 1
- HVPPEXXUDXAPOM-MGHWNKPDSA-N Tyr-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HVPPEXXUDXAPOM-MGHWNKPDSA-N 0.000 description 1
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 1
- BSCBBPKDVOZICB-KKUMJFAQSA-N Tyr-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BSCBBPKDVOZICB-KKUMJFAQSA-N 0.000 description 1
- ARJASMXQBRNAGI-YESZJQIVSA-N Tyr-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N ARJASMXQBRNAGI-YESZJQIVSA-N 0.000 description 1
- BYAKMYBZADCNMN-JYJNAYRXSA-N Tyr-Lys-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O BYAKMYBZADCNMN-JYJNAYRXSA-N 0.000 description 1
- GYKDRHDMGQUZPU-MGHWNKPDSA-N Tyr-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CC=C(C=C1)O)N GYKDRHDMGQUZPU-MGHWNKPDSA-N 0.000 description 1
- CWVHKVVKAQIJKY-ACRUOGEOSA-N Tyr-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=C(C=C2)O)N CWVHKVVKAQIJKY-ACRUOGEOSA-N 0.000 description 1
- PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 1
- BBSPTGPYIPGTKH-JYJNAYRXSA-N Tyr-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N BBSPTGPYIPGTKH-JYJNAYRXSA-N 0.000 description 1
- QPBJXNYYQTUTDD-KKUMJFAQSA-N Tyr-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QPBJXNYYQTUTDD-KKUMJFAQSA-N 0.000 description 1
- FASACHWGQBNSRO-ZEWNOJEFSA-N Tyr-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FASACHWGQBNSRO-ZEWNOJEFSA-N 0.000 description 1
- PSALWJCUIAQKFW-ACRUOGEOSA-N Tyr-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N PSALWJCUIAQKFW-ACRUOGEOSA-N 0.000 description 1
- VBFVQTPETKJCQW-RPTUDFQQSA-N Tyr-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VBFVQTPETKJCQW-RPTUDFQQSA-N 0.000 description 1
- PYJKETPLFITNKS-IHRRRGAJSA-N Tyr-Pro-Asn Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O PYJKETPLFITNKS-IHRRRGAJSA-N 0.000 description 1
- XUIOBCQESNDTDE-FQPOAREZSA-N Tyr-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O XUIOBCQESNDTDE-FQPOAREZSA-N 0.000 description 1
- ABSXSJZNRAQDDI-KJEVXHAQSA-N Tyr-Val-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ABSXSJZNRAQDDI-KJEVXHAQSA-N 0.000 description 1
- 208000023915 Ureteral Neoplasms Diseases 0.000 description 1
- 206010046392 Ureteric cancer Diseases 0.000 description 1
- 108010064997 VPY tripeptide Proteins 0.000 description 1
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 1
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 1
- VDPRBUOZLIFUIM-GUBZILKMSA-N Val-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N VDPRBUOZLIFUIM-GUBZILKMSA-N 0.000 description 1
- WGHVMKFREWGCGR-SRVKXCTJSA-N Val-Arg-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WGHVMKFREWGCGR-SRVKXCTJSA-N 0.000 description 1
- JYVKKBDANPZIAW-AVGNSLFASA-N Val-Arg-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N JYVKKBDANPZIAW-AVGNSLFASA-N 0.000 description 1
- DNOOLPROHJWCSQ-RCWTZXSCSA-N Val-Arg-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DNOOLPROHJWCSQ-RCWTZXSCSA-N 0.000 description 1
- BYOHPUZJVXWHAE-BYULHYEWSA-N Val-Asn-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N BYOHPUZJVXWHAE-BYULHYEWSA-N 0.000 description 1
- OGNMURQZFMHFFD-NHCYSSNCSA-N Val-Asn-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N OGNMURQZFMHFFD-NHCYSSNCSA-N 0.000 description 1
- QGFPYRPIUXBYGR-YDHLFZDLSA-N Val-Asn-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N QGFPYRPIUXBYGR-YDHLFZDLSA-N 0.000 description 1
- DBOXBUDEAJVKRE-LSJOCFKGSA-N Val-Asn-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N DBOXBUDEAJVKRE-LSJOCFKGSA-N 0.000 description 1
- KXUKIBHIVRYOIP-ZKWXMUAHSA-N Val-Asp-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N KXUKIBHIVRYOIP-ZKWXMUAHSA-N 0.000 description 1
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 1
- PFMAFMPJJSHNDW-ZKWXMUAHSA-N Val-Cys-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)N PFMAFMPJJSHNDW-ZKWXMUAHSA-N 0.000 description 1
- KOPBYUSPXBQIHD-NRPADANISA-N Val-Cys-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KOPBYUSPXBQIHD-NRPADANISA-N 0.000 description 1
- FBVUOEYVGNMRMD-NAKRPEOUSA-N Val-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)N FBVUOEYVGNMRMD-NAKRPEOUSA-N 0.000 description 1
- HIZMLPKDJAXDRG-FXQIFTODSA-N Val-Cys-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N HIZMLPKDJAXDRG-FXQIFTODSA-N 0.000 description 1
- OUUBKKIJQIAPRI-LAEOZQHASA-N Val-Gln-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OUUBKKIJQIAPRI-LAEOZQHASA-N 0.000 description 1
- VFOHXOLPLACADK-GVXVVHGQSA-N Val-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N VFOHXOLPLACADK-GVXVVHGQSA-N 0.000 description 1
- ZEVNVXYRZRIRCH-GVXVVHGQSA-N Val-Gln-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N ZEVNVXYRZRIRCH-GVXVVHGQSA-N 0.000 description 1
- JXGWQYWDUOWQHA-DZKIICNBSA-N Val-Gln-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N JXGWQYWDUOWQHA-DZKIICNBSA-N 0.000 description 1
- AGKDVLSDNSTLFA-UMNHJUIQSA-N Val-Gln-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N AGKDVLSDNSTLFA-UMNHJUIQSA-N 0.000 description 1
- NYTKXWLZSNRILS-IFFSRLJSSA-N Val-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N)O NYTKXWLZSNRILS-IFFSRLJSSA-N 0.000 description 1
- BRPKEERLGYNCNC-NHCYSSNCSA-N Val-Glu-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N BRPKEERLGYNCNC-NHCYSSNCSA-N 0.000 description 1
- CVIXTAITYJQMPE-LAEOZQHASA-N Val-Glu-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CVIXTAITYJQMPE-LAEOZQHASA-N 0.000 description 1
- ROLGIBMFNMZANA-GVXVVHGQSA-N Val-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N ROLGIBMFNMZANA-GVXVVHGQSA-N 0.000 description 1
- WDIGUPHXPBMODF-UMNHJUIQSA-N Val-Glu-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N WDIGUPHXPBMODF-UMNHJUIQSA-N 0.000 description 1
- OQWNEUXPKHIEJO-NRPADANISA-N Val-Glu-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N OQWNEUXPKHIEJO-NRPADANISA-N 0.000 description 1
- PMXBARDFIAPBGK-DZKIICNBSA-N Val-Glu-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PMXBARDFIAPBGK-DZKIICNBSA-N 0.000 description 1
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 1
- BEGDZYNDCNEGJZ-XVKPBYJWSA-N Val-Gly-Gln Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O BEGDZYNDCNEGJZ-XVKPBYJWSA-N 0.000 description 1
- KDKLLPMFFGYQJD-CYDGBPFRSA-N Val-Ile-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N KDKLLPMFFGYQJD-CYDGBPFRSA-N 0.000 description 1
- BZMIYHIJVVJPCK-QSFUFRPTSA-N Val-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N BZMIYHIJVVJPCK-QSFUFRPTSA-N 0.000 description 1
- WNZSAUMKZQXHNC-UKJIMTQDSA-N Val-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N WNZSAUMKZQXHNC-UKJIMTQDSA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- BMOFUVHDBROBSE-DCAQKATOSA-N Val-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N BMOFUVHDBROBSE-DCAQKATOSA-N 0.000 description 1
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 1
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 1
- XXWBHOWRARMUOC-NHCYSSNCSA-N Val-Lys-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O)N XXWBHOWRARMUOC-NHCYSSNCSA-N 0.000 description 1
- WBAJDGWKRIHOAC-GVXVVHGQSA-N Val-Lys-Gln Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O WBAJDGWKRIHOAC-GVXVVHGQSA-N 0.000 description 1
- IJGPOONOTBNTFS-GVXVVHGQSA-N Val-Lys-Glu Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O IJGPOONOTBNTFS-GVXVVHGQSA-N 0.000 description 1
- MLADEWAIYAPAAU-IHRRRGAJSA-N Val-Lys-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MLADEWAIYAPAAU-IHRRRGAJSA-N 0.000 description 1
- VENKIVFKIPGEJN-NHCYSSNCSA-N Val-Met-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N VENKIVFKIPGEJN-NHCYSSNCSA-N 0.000 description 1
- UEPLNXPLHJUYPT-AVGNSLFASA-N Val-Met-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O UEPLNXPLHJUYPT-AVGNSLFASA-N 0.000 description 1
- ZEBRMWPTJNHXAJ-JYJNAYRXSA-N Val-Phe-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)O)N ZEBRMWPTJNHXAJ-JYJNAYRXSA-N 0.000 description 1
- LGXUZJIQCGXKGZ-QXEWZRGKSA-N Val-Pro-Asn Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N LGXUZJIQCGXKGZ-QXEWZRGKSA-N 0.000 description 1
- RYQUMYBMOJYYDK-NHCYSSNCSA-N Val-Pro-Glu Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RYQUMYBMOJYYDK-NHCYSSNCSA-N 0.000 description 1
- SJRUJQFQVLMZFW-WPRPVWTQSA-N Val-Pro-Gly Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SJRUJQFQVLMZFW-WPRPVWTQSA-N 0.000 description 1
- QWCZXKIFPWPQHR-JYJNAYRXSA-N Val-Pro-Tyr Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QWCZXKIFPWPQHR-JYJNAYRXSA-N 0.000 description 1
- QSPOLEBZTMESFY-SRVKXCTJSA-N Val-Pro-Val Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O QSPOLEBZTMESFY-SRVKXCTJSA-N 0.000 description 1
- LTTQCQRTSHJPPL-ZKWXMUAHSA-N Val-Ser-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N LTTQCQRTSHJPPL-ZKWXMUAHSA-N 0.000 description 1
- VIKZGAUAKQZDOF-NRPADANISA-N Val-Ser-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O VIKZGAUAKQZDOF-NRPADANISA-N 0.000 description 1
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 1
- DLLRRUDLMSJTMB-GUBZILKMSA-N Val-Ser-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)O)N DLLRRUDLMSJTMB-GUBZILKMSA-N 0.000 description 1
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 1
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 1
- HWNYVQMOLCYHEA-IHRRRGAJSA-N Val-Ser-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N HWNYVQMOLCYHEA-IHRRRGAJSA-N 0.000 description 1
- DLRZGNXCXUGIDG-KKHAAJSZSA-N Val-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O DLRZGNXCXUGIDG-KKHAAJSZSA-N 0.000 description 1
- BZDGLJPROOOUOZ-XGEHTFHBSA-N Val-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N)O BZDGLJPROOOUOZ-XGEHTFHBSA-N 0.000 description 1
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 1
- DVLWZWNAQUBZBC-ZNSHCXBVSA-N Val-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N)O DVLWZWNAQUBZBC-ZNSHCXBVSA-N 0.000 description 1
- QTXGUIMEHKCPBH-FHWLQOOXSA-N Val-Trp-Lys Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 QTXGUIMEHKCPBH-FHWLQOOXSA-N 0.000 description 1
- PFMSJVIPEZMKSC-DZKIICNBSA-N Val-Tyr-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PFMSJVIPEZMKSC-DZKIICNBSA-N 0.000 description 1
- RLVTVHSDKHBFQP-ULQDDVLXSA-N Val-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 RLVTVHSDKHBFQP-ULQDDVLXSA-N 0.000 description 1
- ZNGPROMGGGFOAA-JYJNAYRXSA-N Val-Tyr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 ZNGPROMGGGFOAA-JYJNAYRXSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- ODUHAIXFXFACDY-SRVKXCTJSA-N Val-Val-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)C(C)C ODUHAIXFXFACDY-SRVKXCTJSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047741 Vulval cancer Diseases 0.000 description 1
- 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- HHGZUQPEIHGQST-UHFFFAOYSA-N [2-[(2-azaniumyl-2-carboxyethyl)disulfanyl]-1-carboxyethyl]azanium;dichloride Chemical compound Cl.Cl.OC(=O)C(N)CSSCC(N)C(O)=O HHGZUQPEIHGQST-UHFFFAOYSA-N 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- 108010081404 acein-2 Proteins 0.000 description 1
- RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 108010066829 alanyl-glutamyl-aspartylprolyine Proteins 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 210000002255 anal canal Anatomy 0.000 description 1
- 201000007696 anal canal cancer Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 239000003817 anthracycline antibiotic agent Substances 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000006217 arginine-methylation Effects 0.000 description 1
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 1
- 108010091818 arginyl-glycyl-aspartyl-valine Proteins 0.000 description 1
- 108010091092 arginyl-glycyl-proline Proteins 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 1
- 108010018691 arginyl-threonyl-arginine Proteins 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 201000010788 atrophy of testis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 201000000053 blastoma Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003793 centrosome Anatomy 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 210000004756 chromatid Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 210000003040 circulating cell Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000009109 curative therapy Methods 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- OKKJLVBELUTLKV-MZCSYVLQSA-N deuterated methanol Substances [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 108010054812 diprotin A Proteins 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000000959 ear middle Anatomy 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 201000008184 embryoma Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005496 eutectics Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 208000024519 eye neoplasm Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000005111 flow chemistry technique Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 231100000221 frame shift mutation induction Toxicity 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000007487 gallbladder carcinoma Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000011587 gastric lymphoma Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 1
- 108010040856 glutamyl-cysteinyl-alanine Proteins 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010075431 glycyl-alanyl-phenylalanine Proteins 0.000 description 1
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007031 hydroxymethylation reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 230000010189 intracellular transport Effects 0.000 description 1
- 201000007450 intrahepatic cholangiocarcinoma Diseases 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 206010023841 laryngeal neoplasm Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- WOSKHXYHFSIKNG-UHFFFAOYSA-N lenvatinib Chemical compound C=12C=C(C(N)=O)C(OC)=CC2=NC=CC=1OC(C=C1Cl)=CC=C1NC(=O)NC1CC1 WOSKHXYHFSIKNG-UHFFFAOYSA-N 0.000 description 1
- 229960003784 lenvatinib Drugs 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010051673 leucyl-glycyl-phenylalanine Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 208000016992 lung adenocarcinoma in situ Diseases 0.000 description 1
- 230000006216 lysine-methylation Effects 0.000 description 1
- 108010012988 lysyl-glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 208000006178 malignant mesothelioma Diseases 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 108700023046 methionyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 201000003956 middle ear cancer Diseases 0.000 description 1
- 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000006618 mitotic catastrophe Effects 0.000 description 1
- 210000000479 mitotic spindle apparatus Anatomy 0.000 description 1
- 238000007902 molecular cytogenetic technique Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 201000007425 nasal cavity carcinoma Diseases 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000037434 nonsense mutation Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 201000008106 ocular cancer Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000002747 omentum Anatomy 0.000 description 1
- 201000005443 oral cavity cancer Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000004228 ovarian endometrial cancer Diseases 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 238000010951 particle size reduction Methods 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 108010074082 phenylalanyl-alanyl-lysine Proteins 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 108010025488 pinealon Proteins 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 201000003437 pleural cancer Diseases 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 1
- 108010093296 prolyl-prolyl-alanine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 208000016691 refractory malignant neoplasm Diseases 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000009094 second-line therapy Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 1
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 1
- 108010015840 seryl-prolyl-lysyl-lysine Proteins 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 201000002314 small intestine cancer Diseases 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000020347 spindle assembly Effects 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000000547 structure data Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000010741 sumoylation Effects 0.000 description 1
- 238000004441 surface measurement Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 231100001044 testicular atrophy Toxicity 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- MYVIATVLJGTBFV-UHFFFAOYSA-M thiamine(1+) chloride Chemical compound [Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N MYVIATVLJGTBFV-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000009095 third-line therapy Methods 0.000 description 1
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 1
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M toluenesulfonate group Chemical group C=1(C(=CC=CC1)S(=O)(=O)[O-])C LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- 201000006134 tongue cancer Diseases 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 108700004896 tripeptide FEG Proteins 0.000 description 1
- 108010084932 tryptophyl-proline Proteins 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 1
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 230000034512 ubiquitination Effects 0.000 description 1
- 238000010798 ubiquitination Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 201000011294 ureter cancer Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 201000005102 vulva cancer Diseases 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000007482 whole exome sequencing Methods 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Abstract
本文揭露了游離鹼化合物2-(6-氮雜螺[2.5]辛-6-基)-
N-[2-(4,4-二氟哌啶-1-基)-6-甲基嘧啶-4-基]-4-[(2-羥基乙烷磺醯基)胺基]苯甲醯胺(化合物A)之鹽、結晶無水形式、水合物、溶劑合物或共晶體;製備方法、藥物組成物以及治療由馬達蛋白驅動蛋白家族成員18A(KIF18A)抑制介導的疾病之方法,其中所述疾病係腫瘤病,包括癌症或腫瘤。
Description
本揭露關於游離鹼化合物2-(6-氮雜螺[2.5]辛-6-基)-
N-[2-(4,4-二氟哌啶-1-基)-6-甲基嘧啶-4-基]-4-[(2-羥基乙烷磺醯基)胺基]苯甲醯胺(化合物A)之鹽、水合物、溶劑合物或共晶體;或該化合物A,包括其結晶無水形式、鹽、水合物、溶劑合物或共晶體之固體形式;製備方法、藥物組成物以及治療由馬達蛋白驅動蛋白家族成員18A(KIF18A)抑制介導的疾病之方法。
游離鹼化合物2-(6-氮雜螺[2.5]辛-6-基)-
N-[2-(4,4-二氟哌啶-1-基)-6-甲基嘧啶-4-基]-4-[(2-羥基乙烷磺醯基)胺基]苯甲醯胺(化合物A)可用作馬達蛋白驅動蛋白家族成員18A(KIF18A)之抑制劑:
(A)。
驅動蛋白係在細胞分裂和細胞內囊泡和細胞器運輸中起重要作用的分子馬達。有絲分裂驅動蛋白在紡錘體組裝、染色體分離、中心體分離和動力學之若干個方面起作用。基於所稱的「馬達結構域」內的序列同源性,人驅動蛋白被分類為14個亞家族;此結構域之ATP酶活性驅動沿著微管(MT)單向運動。該等蛋白質之非馬達結構域負責貨物附接;「貨物」可以包括多種不同的膜狀細胞器、訊息傳遞支架系統和染色體中之任一種。驅動蛋白使用ATP水解能量來沿著極化微管移動貨物。因此,驅動蛋白通常被稱為「正端」或「負端」定向馬達。
KIF18A基因屬於驅動蛋白-8亞家族並且是一種正端定向馬達。據信KIF18A影響著絲點微管之正端的動力學以控制正確的染色體定位和紡錘體張力。人KIF18A之耗盡在HeLa子宮頸癌細胞中導致更長的紡錘體,在中期增加的染色體振盪(chromosome oscillation)以及有絲分裂紡錘體組裝檢查點之活化。KIF18A看起來是癌症治療之可行靶標。KIF18A在各種類型的癌症中過表現,該等癌症包括但不限於結腸癌、乳癌、肺癌、胰臟癌、前列腺癌、膀胱癌、頭癌、頸癌、子宮頸癌和卵巢癌。此外,在癌細胞系中,KIF18A之基因缺失或敲除或者抑制影響有絲分裂紡錘體裝置。特別地,已發現抑制KIF18A誘導有絲分裂細胞停滯,這係一種已知的弱點,其可以經由細胞凋亡、有絲分裂災變或在分裂間期中有絲分裂滑脫之後的多極驅動致死性或死亡來促進有絲分裂中之細胞死亡。
人KIF18A基因序列、人KIF18A mRNA序列和編碼的KIF18A蛋白在本文中分別提供為SEQ ID NO: 12、13和11。
化合物A以及其示例性製備方法描述於國際專利申請公開案號WO 2020/132648中,將該國際專利申請藉由援引以其全文併入本文。然而,特別是對於化合物A之商業藥物生產而言,化合物A之穩定鹽、水合物、溶劑合物或共晶體,以及化合物A(包括結晶無水化合物A或無定形化合物A)、化合物A之穩定鹽、水合物、溶劑合物或共晶體之固體形式係期望的。
在一個方面,本文揭露了化合物A之鹽、水合物、溶劑合物或共晶體,該化合物A具有以下結構:
(化合物A);其化學名稱係2-(6-氮雜螺[2.5]辛-6-基)-
N-[2-(4,4-二氟哌啶-1-基)-6-甲基嘧啶-4-基]-4-[(2-羥基乙烷磺醯基)胺基]苯甲醯胺;或也稱為N-(2-(4,4-二氟哌啶-1-基)-6-甲基嘧啶-4-基)-4-((2-羥基乙基)磺醯胺基)-2-(6-氮雜螺[2.5]辛-6-基)苯甲醯胺;或化合物A(包括結晶無水化合物A或無定形化合物A)、其鹽、水合物、溶劑合物或共晶體之固體形式。
在另一個方面,本文揭露了化合物A,包括化合物A之結晶無水形式、鹽、水合物、溶劑合物或共晶體之固體形式。該固體形式可為結晶形式或無定形形式。
在各種實施方式中,本文揭露了選自以下的如請求項1所述之鹽、無水合物、水合物、溶劑合物或共晶體:鹽酸鹽(化合物A-HCl)、甲磺酸鹽(化合物A-MsA)、甲苯磺酸鹽(化合物A-TsA)、硫酸鹽(化合物A-硫酸鹽)、可變水合物(化合物A-可變水合物)、四氫呋喃溶劑合物(化合物A-THF)、乙醇溶劑合物(化合物A-乙醇)、1-丙醇溶劑合物(化合物A-1-丙醇)、異丙醇溶劑合物(化合物A-IPA)、甲醇溶劑合物(化合物A-甲醇)、乙酸異丙酯溶劑合物(化合物A-IPAc)、丙酮溶劑合物(化合物A-丙酮)、環戊基甲基醚溶劑合物(化合物A-CPME)、二㗁烷溶劑合物(化合物A-二㗁烷)、乙酸乙酯溶劑合物(化合物A-EtOAc)、乙腈溶劑合物(化合物A-MeCN)、甲基三級丁基醚溶劑合物(化合物A-MTBE)、甲苯溶劑合物(化合物A-甲苯)、十二烷基硫酸鹽(化合物A-十二烷基硫酸鹽)、二甲基甲醯胺(DMF)溶劑合物水合物(化合物A-DMF-水合物)、二甲基乙醯胺(DMAC)溶劑合物(化合物A-DMAC)、單苯磺酸鹽水合物(化合物A-苯磺酸鹽-水合物)、咖啡因共晶體(化合物A-咖啡因)、檸檬酸共晶體(化合物A-檸檬酸)、糖精共晶體(化合物A-糖精)、L-酒石酸共晶體(化合物A-L-酒石酸)或尿素共晶體(化合物A-尿素);或其固體形式。
在實施方式1a中,本發明提供了一種化合物A-HCl之固體形式。在子實施方式中,該固體形式係結晶形式1(化合物A-HCl-形式1)。在另一個子實施方式中,該固體形式係結晶形式2(化合物A-HCl-形式2)。
在實施方式1b中,本發明提供了一種結晶化合物A-HCl-形式1,其特徵在於在-91和-103 ppm處的固態
19F NMR峰。
在實施方式1c中,本發明提供了一種結晶化合物A-HCl-形式1,其特徵進一步在於使用Cu Kα輻射在7.5、16.9和20.2 ± 0.2° 2θ處的X射線粉末繞射(XRPD)圖譜峰。
在實施方式1d中,本發明提供了一種結晶化合物A-HCl-形式1,其特徵進一步在於使用Cu Kα輻射在12.8、18.2、22.7、23.6、24.8和26.1 ± 0.2° 2θ處的X射線粉末繞射(XRPD)圖譜峰。
在實施方式1e中,本發明提供了一種結晶化合物A-HCl-形式1,其特徵進一步在於使用Cu Kα輻射在10.9、14.5、15.7、15.9、19.8、20.6、21.6、23.2、26.1和26.8 ± 0.2° 2θ處的X射線粉末繞射(XRPD)圖譜峰。
在實施方式1f中,本發明提供了一種結晶化合物A-HCl-形式1,其具有基本上如圖1所示的XRPD圖譜。
在實施方式1g中,本發明提供了一種結晶化合物A-HCl-形式1,其具有在268.5°C至274.5°C處的吸熱轉變,此係藉由微差掃描熱量法測量。
在實施方式1h中,本發明提供了一種結晶化合物A-HCl-形式1,其中該吸熱轉變係在271.5°C ± 3°C處。
在實施方式1i中,本發明提供了一種結晶化合物A-HCl-形式1,其具有基本上如圖2所示的熱重分析(TGA)。
在實施方式1j中,本發明提供了一種結晶化合物A-HCl-形式1,其具有基本上如圖5所示的單晶結構。
在實施方式2a中,本發明提供了一種化合物A-MsA之固體形式。在子實施方式中,該固體形式係結晶形式1(化合物A-MsA-形式1)。在另一個子實施方式中,該固體形式係結晶形式2(化合物A-MsA-形式2)。
在實施方式2b中,本發明提供了一種結晶化合物A-MsA-形式1,其特徵在於在-95.2和-103.2 ± 0.5 ppm處的固態
19F NMR峰。自旋邊帶由(*)指示。
在實施方式2c中,本發明提供了一種結晶化合物A-MsA-形式1,其特徵進一步在於使用Cu Kα輻射在7.0、16.5和23.9 ± 0.2° 2θ處的X射線粉末繞射(XRPD)圖譜峰。
在實施方式2d中,本發明提供了一種結晶化合物A-MsA-形式1,其特徵進一步在於使用Cu Kα輻射在12.6、15.7、17.4、18.5、20.0和21.0 ± 0.2° 2θ處的XRPD圖譜峰。
在實施方式2e中,本發明提供了一種結晶化合物A-MsA-形式1,其特徵進一步在於使用Cu Kα輻射在5.8、11.8、13.5、15.3、16.1、18.0、20.6、25.2、28.0和30.5 ± 0.2° 2θ處的XRPD圖譜峰。
在實施方式2f中,本發明提供了一種結晶化合物A-MsA-形式1,其具有基本上如圖10所示的XRPD圖譜。
在實施方式2g中,本發明提供了一種結晶化合物A-MsA-形式1,其具有在247°C至253°C處的吸熱轉變,此係藉由微差掃描熱量法測量。
在實施方式2h中,本發明提供了一種結晶化合物A-MsA-形式1,其中該吸熱轉變係在250°C ± 3°C處。
在實施方式2i中,本發明提供了一種結晶化合物A-MsA-形式1,其具有基本上如圖11所示的熱重分析(TGA)。
在實施方式3a中,本發明提供了一種化合物A-TsA之固體形式。在子實施方式中,該固體形式係結晶形式1(化合物A-TsA-形式1)。在另一個子實施方式中,該固體形式係結晶形式2(化合物A-TsA-形式2)。在子實施方式中,該固體形式係結晶形式3(化合物A-TsA-形式3)。在另一個子實施方式中,該固體形式係結晶形式4(化合物A-TsA-形式4)。在另一個子實施方式中,該固體形式係結晶形式5(化合物A-TsA-形式5)。在又另一個子實施方式中,該固體形式係二甲苯磺酸鹽結晶形式6(化合物A-DiTsA-形式6)。
在實施方式3b中,本發明提供了一種結晶化合物A-TsA-形式4,其特徵在於使用Cu Kα輻射在6.2、14.7和23.5 ± 0.2° 2θ處的X射線粉末繞射(XRPD)圖譜峰。
在實施方式3c中,本發明提供了一種結晶化合物A-TsA-形式4,其特徵進一步在於使用Cu Kα輻射在10.5、12.4、14.2、19.1、21.5和29.0 ± 0.2° 2θ處的XRPD圖譜峰。
在實施方式3d中,本發明提供了一種結晶化合物A-TsA-形式4,其特徵進一步在於使用Cu Kα輻射在15.5、16.5、17.7、18.3、18.6、20.1、20.8、24.1和25.3 ± 0.2° 2θ處的XRPD圖譜峰。
在實施方式3e中,本發明提供了一種結晶化合物A-TsA-形式4,其具有基本上如圖24a所示的XRPD圖譜。
在實施方式3f中,本發明提供了一種結晶化合物A-TsA-形式4,其具有基本上如圖24b所示的單晶結構。
在實施方式3g中,本發明提供了一種結晶化合物A-TsA-形式4,其具有在250°C至256°C處的吸熱轉變,此係藉由微差掃描熱量法測量。
在實施方式3h中,本發明提供了一種結晶化合物A-TsA-形式4,其中該吸熱轉變係在253°C ± 3°C處。
在實施方式3i中,本發明提供了一種結晶化合物A-TsA-形式4,其具有基本上如圖25所示的熱重分析(TGA)。
在實施方式3j中,本發明提供了一種結晶化合物A-TsA-形式4,其特徵在於基本上如圖26所示的在-96.93和-101.60 ± 0.5 ppm處的固態
19F NMR峰。自旋邊帶由(*)指示。
在實施方式4中,本發明提供了一種化合物A之固體形式。在子實施方式中,該固體形式係無定形形式(化合物A-無定形)。在另一個子實施方式中,該固體形式係結晶化合物A-形式1(化合物A-形式1)。
在實施方式4a中,本發明提供了化合物A-無定形,其具有基本上如圖33所示的XRPD圖譜。
在實施方式4b中,本發明提供了化合物A-無定形,其具有在88°C至94°C處的熔融起始,此係藉由微差掃描熱量法測量。在子實施方式中,化合物A-無定形具有在91°C ± 3°C處的熔融起始。在子實施方式中,化合物A-無定形具有基本上如圖34所示的DSC熱譜圖圖譜。
在實施方式4c中,本發明提供了化合物A-無定形,其具有基本上如圖35所示的熱重分析(TGA)。
在實施方式4d中,本發明提供了結晶化合物A-形式1,其具有基本上如圖52所示的熱重分析(TGA)。
在實施方式5a中,本發明提供了一種化合物A-硫酸鹽之固體形式。在子實施方式中,該固體形式係結晶形式1(化合物A-硫酸鹽-形式1)。在另一個子實施方式中,化合物A-硫酸鹽-形式1具有基本上如圖30所示的XRPD圖譜。在另一個子實施方式中,化合物A-硫酸鹽-形式1具有在261°C至267°C處的吸熱轉變,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-硫酸鹽-形式1具有在264°C ± 3°C處的吸熱轉變。在又另一個子實施方式中,化合物A-硫酸鹽-形式1具有基本上如圖31所示的熱重分析(TGA)。
在實施方式6a中,本發明提供了一種化合物A-水合物之固體形式。
在實施方式6b中,本發明提供了結晶化合物A-可變水合物-形式2,其特徵在於使用Cu Kα輻射在13.9、16.2和19.6 ± 0.2° 2θ處的X射線粉末繞射(XRPD)圖譜峰。
在實施方式6c中,本發明提供了化合物A-可變水合物-形式2,其特徵進一步在於使用Cu Kα輻射在3.5、17.4,18.4、18.7、20.0、20.2、22.6、22.9、27.5和30.8 ± 0.2° 2θ處的XRPD圖譜峰。
在實施方式6d中,本發明提供了化合物A-可變水合物-形式2,其特徵進一步在於使用Cu Kα輻射在3.5、10.1、11.2、13.9、16.2、18.2、19.2、23.2和26.0 ± 0.2° 2θ處的XRPD圖譜峰。
在實施方式6e中,本發明提供了化合物A-可變水合物形式2,其具有基本上如圖36所示的XRPD圖譜。
在實施方式6f中,本發明提供了化合物A-可變水合物-形式2,其具有在48°C至54°C處的脫水起始和136°C的熔點,此係藉由微差掃描熱量法測量。在子實施方式中,化合物A-可變水合物-形式2具有基本上如圖37所示的DSC熱譜圖圖譜。
在實施方式6g中,本發明提供了化合物A-可變水合物-形式2,其具有在51°C ± 3°C處的吸熱轉變。
在實施方式6h中,本發明提供了化合物A-可變水合物-形式2,其具有基本上如圖38所示的熱重分析(TGA)。
在實施方式7中,本發明提供了一種化合物A之結晶無水形式(化合物A-無水)。
在實施方式7a中,該固體形式係結晶無水形式3(化合物A-無水-形式3)。在子實施方式中,化合物A-無水-形式3具有基本上如圖40所示的XRPD圖譜。在另一個子實施方式中,化合物A-無水-形式3具有在193.5°C至199.5°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-無水-形式3具有在196.5°C ± 3°C處的熔融起始。在又另一個子實施方式中,化合物A-無水-形式3具有基本上如圖42所示的動態蒸汽吸附(「DVS」)。
在實施方式7b中,該固體形式係結晶無水形式4(化合物A-無水-形式4)。在子實施方式中,化合物A-無水-形式4具有基本上如圖43所示的XRPD圖譜。
在實施方式7c中,該固體形式係結晶無水形式5(化合物A-無水-形式5)。在子實施方式中,化合物A-無水-形式5具有基本上如圖44所示的XRPD圖譜。在另一個子實施方式中,化合物A-無水-形式5具有基本上如圖45所示的在188.5°C至194.5°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-無水-形式5具有在191.5°C ± 3°C處的熔融起始。在又另一個子實施方式中,化合物A-無水-形式5具有基本上如圖46所示的動態蒸汽吸附(「DVS」),其顯示無水形式5再水合為化合物A-單水合物。
在實施方式7d中,該固體形式係結晶無水形式6(化合物A-無水-形式6)。在子實施方式中,化合物A-無水-形式6具有基本上如圖47所示的XRPD圖譜。在另一個子實施方式中,化合物A-無水-形式6具有在183.4°C至189.4°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-無水-形式6具有在186.4°C ± 3°C處的熔融起始。
在實施方式7e中,該固體形式係結晶無水形式7(化合物A-無水-形式7)。在子實施方式中,化合物A-無水-形式7具有基本上如圖49所示的XRPD圖譜。
在實施方式7f中,該固體形式係結晶無水形式8(化合物A-無水-形式8)。在子實施方式中,化合物A-無水-形式8具有基本上如圖50所示的XRPD圖譜。
在實施方式8a中,本發明提供了一種化合物A-THF之固體形式。在子實施方式中,化合物A-THF具有基本上如圖53所示的XRPD圖譜。在另一個子實施方式中,化合物A-THF具有在188.5°C至194.5°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-THF具有在191.5°C ± 3°C處的熔融起始。在又另一個子實施方式中,化合物A-THF具有基本上如圖54所示的熱重分析(TGA)。
在實施方式9中,本發明提供了一種化合物A之乙醇溶劑合物。在實施方式9a中,本發明提供了一種化合物A-乙醇之固體形式。在子實施方式中,化合物A-乙醇具有基本上如圖55所示的XRPD圖譜。在另一個子實施方式中,化合物A-乙醇具有在162.6°C至168.6°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-乙醇具有在165.6°C ± 3°C處的熔融起始。在又另一個子實施方式中,化合物A-乙醇具有基本上如圖56所示的熱重分析(TGA)。
在實施方式10中,本發明提供了一種1-丙醇溶劑合物(化合物A-1-丙醇)。在實施方式10a中,本發明提供了一種化合物A-1-丙醇之固體形式。在子實施方式中,化合物A-1-丙醇具有基本上如圖58所示的XRPD圖譜。在另一個子實施方式中,化合物A-1-丙醇具有在191.2°C至197.2°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-1-丙醇具有在194.2°C ± 3°C處的熔融起始。在又另一個子實施方式中,化合物A-1-丙醇具有基本上如圖59所示的熱重分析(TGA)。
在實施方式11中,本發明提供了一種化合物A之異丙醇溶劑合物(化合物A-IPA)。在實施方式11a中,本發明提供了一種化合物A-IPA之固體形式。在子實施方式中,化合物A-IPA具有基本上如圖60所示的XRPD圖譜。在另一個子實施方式中,化合物A-IPA具有在155.7°C至161.7°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-IPA具有在158.7°C ± 3°C處的熔融起始。在又另一個子實施方式中,化合物A-IPA具有基本上如圖61所示的熱重分析(TGA)。
在實施方式12中,本發明提供了一種化合物A之甲醇溶劑合物(化合物A-甲醇)。在實施方式12a中,本發明提供了一種化合物A-甲醇之固體形式。在子實施方式中,化合物A-甲醇具有基本上如圖62所示的XRPD圖譜。
在實施方式13中,本發明提供了一種化合物A之乙酸異丙酯溶劑合物(化合物A-IPAc)。在實施方式13a中,本發明提供了一種化合物A-IPAc之固體形式。在子實施方式中,化合物A-IPAc具有基本上如圖63所示的XRPD圖譜。
在實施方式14中,本發明提供了一種化合物A之丙酮溶劑合物(化合物A-丙酮)。在實施方式14a中,本發明提供了一種化合物A-丙酮之固體形式。在子實施方式中,化合物A-丙酮具有基本上如圖64所示的XRPD圖譜。
在實施方式15中,本發明提供了一種化合物A之環戊基甲基醚溶劑合物(化合物A-CPME)。在實施方式15a中,本發明提供了一種化合物A-CPME之固體形式。在子實施方式中,化合物A-CPME具有基本上如圖65所示的XRPD圖譜。
在實施方式16中,本發明提供了一種化合物A之二㗁烷溶劑合物(化合物A-二㗁烷)。在實施方式16a中,本發明提供了一種化合物A-二㗁烷之固體形式。在子實施方式中,化合物A-二㗁烷具有基本上如圖66所示的XRPD圖譜。
在實施方式17中,本發明提供了一種化合物A之乙酸乙酯溶劑合物(化合物A-EtOAc)。在實施方式17a中,本發明提供了一種化合物A-EtOAc之固體形式。在子實施方式中,化合物A-EtOAc具有基本上如圖67所示的XRPD圖譜。
在實施方式18中,本發明提供了一種化合物A之乙腈溶劑合物(化合物A-MeCN)。在實施方式18a中,本發明提供了一種化合物A-MeCN之固體形式。在子實施方式中,化合物A-MeCN具有基本上如圖68所示的XRPD圖譜。
在實施方式19中,本發明提供了一種化合物A之甲基三級丁基醚溶劑合物(化合物A-MTBE)。在實施方式19a中,本發明提供了一種化合物A-MTBE之固體形式。在子實施方式中,化合物A-MTBE具有基本上如圖69所示的XRPD圖譜。
在實施方式20中,本發明提供了一種化合物A之甲苯溶劑合物(化合物A-甲苯)。在實施方式20a中,本發明提供了一種化合物A-甲苯之固體形式。在子實施方式中,化合物A-甲苯具有基本上如圖70所示的XRPD圖譜。
在實施方式21中,本發明提供了一種化合物A之十二烷基硫酸鹽(化合物A-十二烷基硫酸鹽)。在實施方式21a中,本發明提供了一種十二烷基硫酸鹽之固體形式(化合物A-十二烷基硫酸鹽)。在子實施方式中,化合物A-十二烷基硫酸鹽具有基本上如圖71所示的XRPD圖譜。
在實施方式22中,本發明提供了一種化合物A之二甲基甲醯胺(DMF)溶劑合物水合物(化合物A-DMF-水合物)。在實施方式22a中,本發明提供了一種化合物A-DMF-水合物之固體形式。在子實施方式中,化合物A-DMF-水合物具有基本上如圖73所示的XRPD圖譜。在另一個子實施方式中,化合物A-DMF-水合物具有在104.8°C至110.8°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-DMF-水合物具有在107.8°C ± 3°C處的熔融起始。在又另一個子實施方式中,化合物A-DMF-水合物具有基本上如圖74所示的DSC圖譜。
在實施方式23中,本發明提供了一種化合物A之二甲基乙醯胺(DMAC)溶劑合物(化合物A-DMAC)。在實施方式23a中,本發明提供了一種化合物A-DMAC之固體形式。在子實施方式中,化合物A-DMAC具有基本上如圖75所示的XRPD圖譜。在另一個子實施方式中,化合物A-DMAC具有在147°C至153°C處的熔融起始,此係藉由微差掃描熱量法測量。在又另一個子實施方式中,化合物A-DMAC具有在150°C ± 3°C處的熔融起始。在又另一個子實施方式中,化合物A-DMAC具有基本上如圖76所示的DSC圖譜。
在實施方式24中,本發明提供了一種化合物A之單苯磺酸鹽水合物(化合物A-苯磺酸鹽-水合物)。在實施方式24a中,本發明提供了一種化合物A-苯磺酸鹽-水合物之固體形式。在實施方式24b中,本發明提供了一種化合物A-苯磺酸鹽-水合物形式1之固體形式。在子實施方式中,化合物A-苯磺酸鹽-水合物形式1具有基本上如圖77所示的XRPD圖譜。在又另一個子實施方式中,化合物A-苯磺酸鹽-水合物形式1具有基本上如圖78所示的DSC圖譜。
在實施方式25中,本發明提供了一種化合物A之咖啡因共晶體(化合物A-咖啡因)。在實施方式25a中,本發明提供了一種化合物A-咖啡因之固體形式。在實施方式25b中,該化合物A-咖啡因之固體形式係結晶化合物A-咖啡因共晶體形式1。在子實施方式中,化合物A-咖啡因共晶體形式1具有基本上如圖79所示的XRPD圖譜。在又另一個子實施方式中,化合物A-咖啡因共晶體形式1具有基本上如圖80所示的DSC圖譜。在又另一個子實施方式中,化合物A-咖啡因共晶體形式1具有基本上如圖81所示的DVS圖譜。
在實施方式26中,本發明提供了一種化合物A之檸檬酸共晶體(化合物A-檸檬酸)。在實施方式26a中,本發明提供了一種化合物A-檸檬酸之固體形式。在實施方式26b中,該化合物A-檸檬酸之固體形式係結晶化合物A-檸檬酸共晶體形式1。在子實施方式中,化合物A-檸檬酸共晶體形式1具有基本上如圖82所示的XRPD圖譜。在又另一個子實施方式中,化合物A-檸檬酸共晶體形式1具有基本上如圖83所示的DSC圖譜。
在實施方式26c中,該化合物A-檸檬酸之固體形式係結晶化合物A檸檬酸共晶體形式2。在子實施方式中,化合物A-檸檬酸共晶體形式2具有基本上如圖84所示的XRPD圖譜。在又另一個子實施方式中,化合物A-檸檬酸共晶體形式2具有基本上如圖85所示的DSC和TGA圖譜。
在實施方式27中,本發明提供了一種化合物A之糖精共晶體(化合物A-糖精)。在實施方式27a中,本發明提供了一種化合物A-糖精之固體形式。在實施方式27b中,該化合物A-糖精之固體形式係結晶化合物A-糖精共晶體形式1。在子實施方式中,化合物A-糖精共晶體形式1具有基本上如圖86所示的XRPD圖譜。在又另一個子實施方式中,化合物A-糖精共晶體形式1具有基本上如圖87所示的DSC圖譜。在又另一個子實施方式中,化合物A-糖精共晶體形式1具有基本上如圖88所示的DVS圖譜。
在實施方式28中,本發明提供了一種L-酒石酸共晶體(化合物A-L-酒石酸)。在實施方式28a中,本發明提供了一種化合物A-L-酒石酸之固體形式。在實施方式28b,該化合物A-L-酒石酸之固體形式係結晶化合物A-L-酒石酸共晶體形式1。在子實施方式中,化合物A-L-酒石酸共晶體形式1具有基本上如圖89所示的XRPD圖譜。在又另一個子實施方式中,化合物A-L-酒石酸共晶體形式1具有基本上如圖90所示的DSC圖譜。在又另一個子實施方式中,化合物A-L-酒石酸共晶體形式1具有基本上如圖91所示的DVS圖譜。
在實施方式29中,本發明提供了一種尿素共晶體(化合物A-尿素)。在實施方式29a中,本發明提供了一種化合物A-尿素之固體形式。在實施方式29b中,該化合物A-尿素之固體形式係結晶化合物A-尿素共晶體形式1。在子實施方式中,化合物A-尿素共晶體形式1具有基本上如圖92所示的XRPD圖譜。在又另一個子實施方式中,化合物A-尿素共晶體形式1具有基本上如圖93所示的DSC圖譜。在又另一個子實施方式中,化合物A-尿素共晶體形式1具有基本上如圖94所示的DVS圖譜。
在實施方式30中,本發明提供了一種藥物組成物,該藥物組成物包含化合物A之鹽、水合物、溶劑合物或共晶體;或化合物A、其鹽、水合物、溶劑合物或共晶體之固體形式。
在實施方式30a中,本發明提供了一種藥物組成物,該藥物組成物包含化合物A、化合物A之鹽、水合物、溶劑合物或共晶體之固體形式。在子實施方式中,該固體形式係結晶的或無定形的。在子實施方式中,該固體形式係結晶化合物A-形式1。在另一個子實施方式中,該固體形式係無水化合物A之結晶形式,包括結晶無水形式3、4、5、6、7或8。
在實施方式30b中,本發明提供了一種藥物組成物,該藥物組成物包含選自以下的化合物A之鹽、水合物、溶劑合物或共晶體:鹽酸鹽(化合物A-HCl)、甲磺酸鹽(化合物A-MsA)、甲苯磺酸鹽(化合物A-TsA)、硫酸鹽(化合物A-硫酸鹽)、可變水合物(化合物A-可變水合物)、四氫呋喃溶劑合物(化合物A-THF)、乙醇溶劑合物(化合物A-乙醇)、1-丙醇溶劑合物(化合物A-1-丙醇)、異丙醇溶劑合物(化合物A-IPA)、甲醇溶劑合物(化合物A-甲醇)、乙酸異丙酯溶劑合物(化合物A-IPAc)、丙酮溶劑合物(化合物A-丙酮)、環戊基甲基醚溶劑合物(化合物A-CPME)、二㗁烷溶劑合物(化合物A-二㗁烷)、乙酸乙酯溶劑合物(化合物A-EtOAc)、乙腈溶劑合物(化合物A-MeCN)、甲基三級丁基醚溶劑合物(化合物A-MTBE)、甲苯溶劑合物(化合物A-甲苯)、十二烷基硫酸鹽(化合物A-十二烷基硫酸鹽)、二甲基甲醯胺(DMF)溶劑合物水合物(化合物A-DMF-水合物)、二甲基乙醯胺(DMAC)溶劑合物(化合物A-DMAC)、單苯磺酸鹽水合物(化合物A-苯磺酸鹽-水合物)、咖啡因共晶體(化合物A-咖啡因)、檸檬酸共晶體(化合物A-檸檬酸)、糖精共晶體(化合物A-糖精)、L-酒石酸共晶體(化合物A-L-酒石酸)或尿素共晶體(化合物A-尿素);或其固體形式。
在實施方式30c中,本發明提供了一種藥物組成物,該藥物組成物包含如實施方式1a-1j中任一項或其任何子實施方式所述之化合物A-HCl之固體形式、和藥學上可接受的賦形劑。較佳的是,該化合物A-HCl之固體形式係化合物A-HCl之結晶形式1,其具有基本上如圖1所示的XRPD圖譜。
在實施方式30d中,本發明提供了一種藥物組成物,該藥物組成物包含如實施方式2a-2j中任一項或其任何子實施方式所述之化合物A-MsA之固體形式、和藥學上可接受的賦形劑。較佳的是,該化合物A-MsA之固體形式係化合物A-MsA之結晶形式1,其具有基本上如圖10所示的XRPD圖譜。
在實施方式30e中,本發明提供了一種藥物組成物,該藥物組成物包含如實施方式3a-3j中任一項或其任何子實施方式所述之化合物A-TsA之固體形式、和藥學上可接受的賦形劑。較佳的是,該化合物A-TsA之固體形式係化合物A-TsA之結晶形式4,其具有基本上如圖20所示的XRPD圖譜。
在實施方式30f中,本發明提供了一種藥物組成物,該藥物組成物包含如實施方式6a-6e中任一項或其任何子實施方式所述之化合物A-可變水合物之固體形式、和藥學上可接受的賦形劑。較佳的是,化合物A-可變水合物係化合物A-可變水合物形式2,其具有基本上如圖36所示的XRPD圖譜。
在實施方式30g中,本發明提供了一種藥物組成物,該藥物組成物包含化合物A之結晶無水形式、和藥學上可接受的賦形劑。較佳的是,化合物A之結晶無水形式具有基本上如圖40、43、44、47、49或50中任一個所示的XRPD圖譜。
在實施方式30h中,本發明提供了一種藥物組成物,該藥物組成物包含化合物A-檸檬酸共晶體形式1之固體形式、和藥學上可接受的賦形劑。較佳的是,化合物A-檸檬酸共晶體形式1具有基本上如圖82所示的XRPD圖譜。
在實施方式30i中,本發明提供了一種藥物組成物,該藥物組成物包含化合物A-檸檬酸共晶體形式2之固體形式、和藥學上可接受的賦形劑。較佳的是,化合物A-檸檬酸共晶體形式2具有基本上如圖84所示的XRPD圖譜。
在實施方式30j中,本發明提供了一種藥物組成物,該藥物組成物包含化合物A-十二烷基硫酸鹽之固體形式、和藥學上可接受的賦形劑。較佳的是,化合物A-十二烷基硫酸鹽具有基本上如圖71所示的XRPD圖譜。
在實施方式31中,本發明提供了一種治療罹患由KIF18A抑制介導的疾病的個體之方法,該方法包括向有需要的個體投與藥學有效量的如實施方式30-30j中任一項所述之藥物組成物。
在實施方式31a中,本發明提供了一種如實施方式31所述之方法,其中所述由KIF18A抑制介導的疾病係腫瘤病。在子實施方式中,該腫瘤病係癌症或腫瘤。在另一子實施方式中,該癌症係卵巢癌、乳癌、肺癌或子宮內膜癌。在另一子實施方式中,該卵巢癌係高分級漿液性卵巢癌(HGSOC)、視需要地轉移性或不可切除的HGSOC。在另一子實施方式中,該HGSOC係鉑抗性HGSOC或者其中該HGSOC在6個月的含鉑方案期間或之內進展。在另一子實施方式中,該癌症係原發性腹膜癌和/或輸卵管癌。在另一子實施方式中,該乳癌係三陰性乳癌。在另一子實施方式中,該子宮內膜癌係漿液性子宮內膜癌。在另一子實施方式中,該漿液性子宮內膜癌係轉移性或再發性漿液性子宮內膜癌。在另一子實施方式中,該漿液性子宮內膜癌對至少一線的全身性化學療法已復發或係難治性。在另一子實施方式中,該漿液性子宮內膜癌對至少一線的全身性化學療法已復發或係難治性。在另一子實施方式中,該肺癌係非小細胞肺癌。在另一子實施方式中,該腫瘤係晚期實性瘤。在另一子實施方式中,該腫瘤係不可切除的、轉移性的和/或非局部的。在另一子實施方式中,該腫瘤對至少一線的全身性化學療法已復發或係難治性。
在實施方式31b中,本發明提供了一種如實施方式31、31a或其任何子實施方式所述之方法,其中該個體對至少一線的全身性化學療法已復發或係難治性。在子實施方式中,該全身性化學療法包括紫杉烷、吉西他濱或多柔比星。在另一子實施方式中,該全身性化學療法包括順鉑、卡鉑或樂伐替尼(levantinib)。
在實施方式31c中,本發明提供了一種如實施方式31、31a、31b或其任何子實施方式所述之方法,其中該癌症或腫瘤包含對於失活的TP53基因呈陽性和/或對於以下中之至少一項呈陽性的細胞:(i) 失活的Rb基因,(ii) 擴增的CCNE1基因或過表現的CCNE1基因產物,(iii) 失活的BRCA基因或 (iv) 其組合。
在實施方式31c中,本發明提供了一種如實施方式31、31a、31b、31c或其任何子實施方式所述之方法,其中該個體係成年人。
在實施方式32中,本發明提供了一種用於製備如實施方式1-1j中任一項或其任何子實施方式所述之化合物A-HCl之方法,該方法包括:將鹽酸、化合物A和合適的溶劑合併以形成化合物A-HCl鹽或其固體形式。在子實施方式中,該合適的溶劑選自乙腈/水、乙腈/1,4-二㗁烷、四氫呋喃/水、N-甲基-2-吡咯啶酮/乙醇或丙酮/水。
在實施方式33中,本發明提供了一種用於製備如實施方式2-2j中任一項或其任何子實施方式所述之化合物A-MsA之方法,該方法包括:將甲磺酸、化合物A和合適的溶劑合併以形成化合物A-MsA鹽或其固體形式。在子實施方式中,該合適的溶劑選自乙腈或乙酸乙酯。
在實施方式34中,本發明提供了一種用於製備如實施方式3-3i中任一項或其任何子實施方式所述之化合物A-TsA之方法,該方法包括:將對甲苯磺酸、化合物A和合適的溶劑合併以形成化合物A-TsA鹽或其固體形式。在子實施方式中,該合適的溶劑選自乙醇或異丙醇。
在實施方式35中,本發明提供了一種用於製備如實施方式6b-6h中任一項或其任何子實施方式所述之化合物A-可變水合物-形式2之固體形式之方法,該方法包括:(a) 將水與化合物A-甲醇溶劑合物形式1和化合物A-乙醇溶劑合物形式1之混合物合併以形成化合物A-可變水合物-形式2;或 (b) 將混合物A合併在醇溶劑中,之後添加水、過濾並在升高的溫度下乾燥以除去該醇溶劑。在子實施方式中,該醇溶劑係甲醇和乙醇之混合物。在另一個子實施方式中,該升高的溫度係50°C。
除非另有定義,否則本文所用的所有技術及科學術語均具有與本揭露所屬領域的普通技術者通常所瞭解的含義相同的含義。本文描述了用於本揭露之方法和材料;還可以使用本領域已知的其他合適方法和材料。該等材料、方法和實例僅為說明性且不旨在進行限制。本文所提及的所有出版物、專利申請、專利、序列、數據庫專案及其他參考文獻均藉由援引以其全文併入。在出現衝突的情況下,將以本說明書(包括定義)為准。
根據以下詳細描述的綜述,結合附圖,其他方面及優勢對熟悉該項技術者將是清楚的。下文的描述包括具體實施方式,應理解,本揭露係說明性的,並且不旨在將本發明限於本文所述之具體實施方式。
藉由援引併入以電子方式提交的材料
藉由援引以其全文併入的是與本文同時提交的電腦可讀核苷酸/胺基酸序列表,並且其標識如下:名稱為「A-2832-US-PSP_Seq_Listing_072121.txt」的220 KB ASCII(文本)文件;創建於2021年7月21日。
本文提供了一種化合物A之鹽、水合物、溶劑合物或共晶體;一種化合物A、其鹽、水合物、溶劑合物或共晶體之固體形式;其藥物組成物;以及治療罹患癌症的個體之方法,該等方法包括向個體投與治療有效量的藥物組成物。
化合物A係KIF18A抑制劑,並且在各個方面,具有約0.071 μM的KIF18A ATP酶IC50。KIF18A基因屬於驅動蛋白-8亞家族並且是一種正端定向馬達。據信KIF18A影響著絲點微管之正端的動力學以控制正確的染色體定位和紡錘體張力。人KIF18A之耗盡在HeLa子宮頸癌細胞中導致更長的紡錘體,在中期增加的染色體振盪以及有絲分裂紡錘體組裝檢查點之活化(MI Mayr等人,Current Biology [當代生物學] 17, 488-98, 2007)。KIF18A在各種類型的癌症中過表現,該等癌症包括但不限於結腸癌、乳癌、肺癌、胰臟癌、前列腺癌、膀胱癌、頭癌、頸癌、子宮頸癌和卵巢癌。KIF18A之過表現抑制姊妹染色分體振盪,導致緊密的中期板。在KIF18A敲除小鼠中的或在KIF18A
gcd2/gcd2小鼠中藉由誘變甲磺酸乙酯(EMS)處理(馬達結構域中的錯義突變(R308K))進行的KIF18A馬達功能之失活導致在大部分器官中沒有重大異常(除了清楚的睪丸萎縮和不育症之外)的活小鼠(J Stumpff等人 Developmental Cell [發育細胞]. 2008;14:252-262;J Stumpff等人 Developmental Cell [發育細胞]. 2012;22:1017-1029;XS Liu等人 Genes & Cancer [基因和癌症]. 2010;1:26-39;CL Fonseca等人 J Cell Biol. [細胞生物學雜誌] 2019;1-16;A Czechanski等人 Developmental Biology [發育生物學]. 2015;402:253-262;O Rath, F Kozielski. Nature Reviews Cancer [自然-癌症綜述]. 2012;12:527-539)。正常人和小鼠KIF18A缺陷型體細胞顯示出完成細胞分裂,具有相對正常的有絲分裂進程但是沒有正確的染色體排列,從而導致具有正常核型的子細胞,注意到在正常細胞之子集中有一些在退出有絲分裂方面的缺陷,從而導致在更慢的增殖中之微核形成(CL Fonseca等人 J Cell Biol. [細胞生物學雜誌] 2019;1-16)。該等遺傳研究表明正常生殖細胞和體細胞對染色體排列的要求具有不同的依賴性並且表明KIF18A在正常整倍性體細胞分裂中可為不必須的(XS Liu等人 Genes & Cancer [基因和癌症]. 2010;1:26-39;A Czechanski等人 Developmental Biology [發育生物學]. 2015;402:253-262)。在正常的人體組織中,KIF18A之表現在具有活躍循環的細胞之組織中升高,在睪丸中具有最高表現(GTEx Portal [基因型組織表現], GTEx Portal [基因型組織表現], J Lonsdale等人 Nature Genetics [自然 遺傳學]. 2013:29;45:580)。在各個方面,化合物A抑制ATP酶活性。例如,化合物A抑制MT-ATP酶活性並且不是基礎ATP酶活性。
本文揭露的化合物可以在本文中藉由其化學結構和/或化學名稱標識。當化學結構和化學名稱衝突時,則化學結構將確定化合物之身份。
當針對物理特性(諸如分子量)或化學特性(諸如化學式)在本文中使用範圍時,旨在包括範圍和其中的具體實施方式之所有組合和子組合。
如本文所用,含有一或多個以虛鍵和粗鍵(即,
和
)描繪的立構中心之化學結構意在指示化學結構中存在的一或多個立構中心之絕對立體化學。如本文所用,藉由簡單線表示的鍵不指示立體偏好。除非另有相反指示,否則包括一或多個本文中說明的立構中心而不指示絕對或相對立體化學之化學結構涵蓋化合物之所有可能的立體異構形式(例如,非鏡像異構物、鏡像異構物)及其混合物。具有單一粗線或虛線和至少一條另外簡單線之結構涵蓋所有可能的非鏡像異構物之單一鏡像異構物系列。
術語「約」意在解釋由實驗誤差所致的變化。除非另有明確說明,否則應理解,本文所報告的所有測量值均由術語「約」修飾,不管該術語是否明確使用。除非上下文中另有明確指明,否則如本文所用,單數形式「一個/種(a/an)」和「該」包括複數個指示物。
如本文所用,術語「化合物」意在包括所描繪結構之所有立體異構物、幾何異構物、互變異構物和同位素。除非另有指定,否則本文中藉由名稱或結構標識為一種特定互變異構形式之化合物旨在包括其他互變異構形式。
術語「水合物」係指藉由水和化合物之相互作用形成的化學實體,包括例如半水合物、單水合物、二水合物、三水合物等。如本文所用,水合物可以具有可變量的水,通常每個化合物A分子從0.5至2個水分子,諸如0.5、1、1.5或2個水分子,稱為「可變水合物」。水分子之數目可以根據水合物形式之各種製備方法和儲存條件而變化。
除非提及特定結晶形式或無定形形式,否則術語「固體形式」和「物理形式」意在包括化合物之所有結晶形式和無定形形式,包括例如同質異晶物、假同質異晶物、溶劑合物、水合物、非溶劑化同質異晶物(包括無水合物)、構象同質異晶物和無定形形式以及其混合物。
如本文所用,術語「共晶體」係指藉由非共價相互作用(通常包括氫鍵)在晶格中結合在一起的中性分子成分和化合物A之結晶複合物。共晶體之實例包括咖啡因共晶體(化合物A-咖啡因)、檸檬酸共晶體(化合物A-檸檬酸)、糖精共晶體(化合物A-糖精)、L-酒石酸共晶體(化合物A-L-酒石酸)或尿素共晶體(化合物A-尿素)。
術語「玻璃轉換溫度」係指一個溫度範圍,其中隨著溫度增加,無定形固體形式經歷從硬且相對脆的「玻璃」態至黏性或橡膠態的逐漸和可逆轉變。
化合物A之鹽、水合物、溶劑合物、共晶體;以及化合物A,包括其結晶無水形式、鹽、溶劑合物和共晶體之固體形式之分離和純化。
化合物A具有可離子化官能基,其具有3.9的一個弱鹼性p
Ka值和7.3的一個弱酸性p
Ka值。藉由高通量和手動同質異晶物篩選,本發明諸位發明人產生了化合物A之各種鹽、水合物、溶劑合物、共晶體;以及化合物A,包括其結晶無水形式、鹽、水合物、溶劑合物和共晶體之固體形式。乙醇溶劑合物藉由乾燥進行的去溶劑化產生了相對穩定的化合物A-水合物-形式2,其在25°C下開始脫水並且具有非常低的溶解度。化合物A-THF溶劑合物之去溶劑化產生了無水-化合物-A-形式3,其在水性介質中或在吸收水分後快速轉化為化合物A水合物-形式2。基於化合物A之游離鹼形式的固態特性及其形成溶劑合物之傾向,本發明諸位發明人產生了可以適於原料藥放大和結晶以便藥物開發的化合物A之各種鹽、水合物、溶劑合物和共晶體。
藉由高通量和手動鹽篩選,測試了各種抗衡離子和溶劑,並且產生了化合物A之結晶鹽和溶劑合物。化合物A之若干種鹽、水合物、溶劑合物(包括硫酸鹽、苯磺酸鹽、甲磺酸鹽和甲苯磺酸鹽)形成為多種同質異晶物。在進一步的溶解度和穩定性測試之後,由於其可接受的溶解度和穩定性曲線、改善的生物醫藥特性和有利的結晶過程,優先將化合物A-HCl鹽形式1用於進一步評價。化合物A-HCl鹽形式1之同質異晶物篩選從384種結晶條件中回收了總共126個結晶樣本。在該等之中,90個樣本的XRPD圖譜與HCl鹽形式1之XRPD圖譜相同。其他樣本可以包括歧化的化合物A或化合物A溶劑合物形式。化合物-A-HCl鹽之同質異晶物篩選揭示化合物-A-HCl-形式1係最熱力學穩定的形式。也從共晶體篩選中產生了化合物A之多種共晶體,例如檸檬酸、酒石酸、咖啡因和尿素共晶體。
結晶化合物
A-
鹽酸鹽形式
1
(化合物
A-HCl
鹽形式
1
)。
本文還提供了一種結晶化合物A-HCl鹽形式1。結晶化合物A-HCl鹽形式1之特徵可以在於如實例中所述獲得的具有在-91和-103 ± 0.5 ppm處的峰之固態
19F NMR。在一些實施方式中,結晶化合物A-HCl鹽形式1具有基本上如圖4所示的固態
19F NMR,其中「基本上」意指所報告的峰可以變化約 ± 0.5 ppm。
結晶化合物A-HCl鹽形式1之特徵可以進一步在於如實例中所述獲得的使用Cu Kα輻射具有在7.5、16.9和20.2 ± 0.2° 2θ處的峰之X射線粉末繞射圖譜。結晶化合物A-HCl鹽形式1之特徵可以視需要地進一步在於使用Cu Kα輻射具有在12.8、18.2、22.7、23.6、24.8和26.1 ± 0.2° 2θ處的另外峰之X射線粉末繞射圖譜。結晶化合物A-HCl鹽形式1之特徵可以視需要地進一步在於使用Cu Kα輻射具有在10.9、14.5、15.7、15.9、19.8、20.6、21.6、23.2、26.1和26.8 ± 0.2° 2θ處的另外峰之X射線粉末繞射圖譜。在一些實施方式中,結晶化合物A-HCl鹽形式1具有基本上如圖1所示的X射線粉末繞射圖譜,其中「基本上」意指所報告的峰可以變化± 0.2°。熟悉該項技術者知道,在XRPD領域中,雖然光譜中的相對峰高取決於若干種因素,諸如樣本製備和儀器幾何結構,但是峰位置對實驗細節相對不敏感。
如實例中所述,獲得結晶化合物A-HCl鹽形式1之微差掃描熱量法(DSC)熱譜圖。DSC曲線指示在271.5°C ± 3°C處的吸熱轉變。因此,在一些實施方式中,結晶化合物A-HCl鹽形式1之特徵可以在於具有轉變吸熱的DSC熱譜圖,該轉變吸熱之起始在268.5°C至274.5°C。例如,在一些實施方式中,結晶化合物A-HCl鹽形式1之特徵在於如圖2所示的DSC。
結晶化合物A-HCl鹽形式1之特徵還可以在於熱重分析(TGA)。因此,結晶化合物A-HCl鹽形式1之特徵可以在於約4%的重量損失,起始溫度為268.3°C至273.7°C。例如,結晶化合物A-HCl鹽形式1之特徵可以在於高達約271°C下約4%的重量損失。在一些實施方式中,結晶化合物A-HCl鹽形式1具有基本上如圖2所描繪的熱重分析,其中「基本上」意指所報告的TGA特徵可以變化約4%重量損失之 ± 1%。
結晶化合物A-HCl鹽形式1之特徵可以在於水分吸附曲線。例如,在一些實施方式中,結晶化合物A-HCl鹽形式1之特徵在於如圖3所示的水分吸附曲線(DVS),其示出了在95% RH下小於0.5%的重量增加。
結晶化合物A-HCl鹽形式1之特徵進一步在於基本上如圖5所示或如實例中所述之單晶結構。
本文進一步提供了藥物組成物,該等藥物組成物包含如本文所述之結晶化合物A-HCl鹽形式1和藥學上可接受的賦形劑。
結晶化合物
A-
甲磺酸鹽形式
1
(化合物
A-MsA
鹽形式
1
)。
本文還提供了一種結晶化合物A-MsA鹽形式1。結晶化合物A-MsA鹽形式1之特徵可以在於如實例中所述獲得的具有在-95.2和-103.2 ± 0.5 ppm處的峰之固態
19F NMR。在一些實施方式中,結晶化合物A-MsA鹽形式1具有基本上如圖13所示的固態
19F NMR,其中「基本上」意指所報告的峰可以變化約 ± 0.5 ppm。
結晶化合物A-MsA鹽形式1之特徵可以進一步在於如實例中所述獲得的使用Cu Kα輻射具有在7.0、16.5和23.9 ± 0.2° 2θ處的峰之X射線粉末繞射圖譜。結晶化合物A-MsA鹽形式1之特徵可以視需要地進一步在於使用Cu Kα輻射具有在12.6、15.7、17.4、18.5、20.0和21.0 ± 0.2° 2θ處的另外峰之X射線粉末繞射圖譜。結晶化合物A-MsA鹽形式1之特徵可以視需要地進一步在於使用Cu Kα輻射具有在5.8、11.8、13.5、15.3、16.1、18.0、20.6、25.2、28.0和30.5 ± 0.2° 2θ處的另外峰之X射線粉末繞射圖譜。在一些實施方式中,結晶化合物A-MsA鹽形式1具有基本上如圖10所示的X射線粉末繞射圖譜,其中「基本上」意指所報告的峰可以變化± 0.2°。熟悉該項技術者知道,在XRPD領域中,雖然光譜中的相對峰高取決於若干種因素,諸如樣本製備和儀器幾何結構,但是峰位置對實驗細節相對不敏感。
如實例中所述,獲得結晶化合物A-MsA鹽形式1之微差掃描熱量法(DSC)熱譜圖。DSC曲線指示在250°C ± 3°C處的吸熱轉變。因此,在一些實施方式中,結晶化合物A-MsA鹽形式1之特徵可以在於具有轉變吸熱的DSC熱譜圖,該轉變吸熱之起始在247°C至253°C。例如,在一些實施方式中,結晶化合物A-MsA鹽形式1之特徵在於如圖11所示的DSC。
結晶化合物A-MsA鹽形式1之特徵還可以在於熱重分析(TGA)。因此,結晶化合物A-MsA鹽形式1之特徵可以在於約0.2%的重量損失,起始溫度為247°C至253°C。例如,結晶化合物A-MsA鹽形式1之特徵可以在於高達約250°C下約0.2%的重量損失。在一些實施方式中,結晶化合物A-MsA鹽形式1具有基本上如圖11所描繪的熱重分析,其中「基本上」意指所報告的TGA特徵可以變化0.2%重量損失之 ± 1%。
結晶化合物A-MsA鹽形式1之特徵可以在於水分吸附曲線。例如,在一些實施方式中,結晶化合物A-MsA鹽形式1之特徵在於如圖12所示的水分吸附曲線,其示出了在95% RH下小於1.2%的重量增加。
本文進一步提供了藥物組成物,該等藥物組成物包含如本文所述之結晶化合物A-MsA鹽形式1和藥學上可接受的賦形劑。
結晶化合物
A-
甲苯磺酸鹽形式
1
(化合物
-A-TsA
形式
4
)。
本文還提供了一種結晶化合物A-TsA鹽形式4。結晶化合物A-TsA鹽形式4之特徵可以在於如實例中所述獲得的使用Cu Kα輻射具有在6.2、14.7和23.5 ± 0.2° 2θ處的峰之X射線粉末繞射圖譜。結晶化合物A-TsA鹽形式4之特徵可以視需要地進一步在於使用Cu Kα輻射具有在10.5、12.4、14.2、19.1、21.5和29.0 ± 0.2° 2θ處的另外峰之X射線粉末繞射圖譜。結晶化合物A-TsA鹽形式4之特徵可以視需要地進一步在於使用Cu Kα輻射具有在15.5、16.5、17.7、18.3、18.6、20.1、20.8、24.1和25.3 ± 0.2° 2θ處的另外峰之X射線粉末繞射圖譜。在一些實施方式中,結晶化合物A-TsA鹽形式4具有基本上如圖24a所示的X射線粉末繞射圖譜,其中「基本上」意指所報告的峰可以變化± 0.2°。熟悉該項技術者知道,在XRPD領域中,雖然光譜中的相對峰高取決於若干種因素,諸如樣本製備和儀器幾何結構,但是峰位置對實驗細節相對不敏感。
結晶化合物A-TsA鹽形式4之特徵進一步在於基本上如圖24b所示或如實例中所述之單晶結構。
如實例中所述,獲得結晶化合物A-TsA鹽形式4之微差掃描熱量法(DSC)熱譜圖。DSC曲線指示在253°C ± 3°C處的吸熱轉變。因此,在一些實施方式中,結晶化合物A-TsA鹽形式4之特徵可以在於具有轉變吸熱的DSC熱譜圖,該轉變吸熱之起始在250°C至256°C。例如,在一些實施方式中,結晶化合物A-TsA鹽形式4之特徵在於如圖25所示的DSC。
結晶化合物A-TsA鹽形式4之特徵還可以在於熱重分析(TGA)。因此,結晶化合物A-TsA鹽形式4之特徵可以在於約0.07%的重量損失,起始溫度為250°C至256°C。例如,結晶化合物A-TsA鹽形式4之特徵可以在於高達約253°C下約0.07%的重量損失。在一些實施方式中,結晶化合物A-TsA鹽形式4具有基本上如圖25所描繪的熱重分析,其中「基本上」意指所報告的TGA特徵可以變化0.07%重量損失之 ± 1%。
結晶化合物A-TsA鹽形式4還具有基本上如圖26所示的具有在-96.93和-101.60 ppm處的峰之固態
19F NMR,其中「基本上」意指所報告的峰可以變化 ± 0.5 ppm。
本文進一步提供了藥物組成物,該等藥物組成物包含如本文所述之結晶化合物A-HCl鹽形式4和藥學上可接受的賦形劑。
藥物組成物
可以將如以上實施方式及其子實施方式中之任一項中所述之化合物A與藥學上可接受的賦形劑組合以提供藥物配製物(也可互換地稱為組成物)。賦形劑可為稀釋劑或載體。配製物可以影響所投與藥劑之物理狀態、穩定性、體內釋放速率和體內清除速率。短語「藥學上可接受的」或「藥理學上可接受的」係指在投與至動物或人時不產生不良反應、過敏反應或其他不利反應之分子實體和組成物。如本文所用,「藥學上可接受的」包括任何和所有溶劑、分散介質、包衣、抗菌劑和抗真菌劑、等滲劑和吸收延遲劑等。此類賦形劑用於藥學活性物質的使用係本領域所熟知的。除非任何常規介質或藥劑與治療性組成物不相容,否則設想將其用於治療性組成物中。還可以將補充性活性成分摻入組成物中。在示例性實施方式中,配製物可以包含玉米糖漿固體、高油酸紅花子油、椰子油、大豆油、L-白胺酸、磷酸三鈣、L-酪胺酸、L-脯胺酸、乙酸L-離胺酸、DATEM(乳化劑)、L-麩醯胺酸、L-纈胺酸、磷酸氫二鉀、L-異白胺酸、L-精胺酸、L-丙胺酸、甘胺酸、L-天冬醯胺單水合物、L-絲胺酸、檸檬酸鉀、L-蘇胺酸、檸檬酸鈉、氯化鎂、L-組胺酸、L-甲硫胺酸、抗壞血酸、碳酸鈣、L-麩胺酸、L-胱胺酸二鹽酸鹽、L-色胺酸、L-天冬胺酸、氯化膽鹼、牛磺酸、m-肌醇、硫酸亞鐵、抗壞血酸棕櫚酸酯、硫酸鋅、L-肉鹼、α-生育酚乙酸酯、氯化鈉、菸鹼醯胺、混合生育酚、泛酸鈣、硫酸酮、氯化硫胺素鹽酸鹽、維生素A棕櫚酸酯、硫酸錳、核黃素、鹽酸吡哆辛、葉酸、β-胡蘿蔔素、碘化鉀、葉醌、生物素、硒酸鈉、氯化鉻、鉬酸鈉、維生素D3和氰鈷胺。
對於口服投與,可以藉由將化合物A與本領域熟知的藥學上可接受的賦形劑(諸如載體)組合來配製合適的組成物。此類賦形劑和載體使得能夠將化合物A配製為片劑、丸劑、糖衣丸、膠囊、液體、凝膠、糖漿、漿料、懸浮液等,以供待治療的患者口服攝食。用於口服使用的藥物製劑可以藉由以下方式來獲得:向化合物A中添加固體賦形劑,視需要地研磨所得混合物,並且在添加合適的輔助劑之後(如果需要)加工顆粒混合物,以獲得片劑或糖衣丸核心。合適的賦形劑包括例如填充劑和纖維素製劑。如果需要,可以添加崩散劑。用於各種類型的配製物之藥學上可接受的成分係熟知的,並且可為例如用於各種配製物類型的黏合劑(例如,天然或合成聚合物)、潤滑劑、界面活性劑、甜味和調味劑、包衣材料、防腐劑、染料、增稠劑、佐劑、抗微生物劑、抗氧化劑和載體。
在口服投與治療有效量的化合物A時,組成物典型地呈固體(例如,片劑、膠囊、丸劑、粉末或糖錠)或液體配製物(例如,水性懸浮液、溶液、酏劑或糖漿)之形式。
在以片劑形式投與時,組成物可以另外含有功能性固體和/或固體載體,諸如明膠或佐劑。
在以液體或懸浮液形式投與時,可以添加功能性液體和/或液體載體,諸如水、石油或動物或植物來源的油。組成物之液體形式可以進一步含有生理鹽水溶液、糖醇溶液、右旋糖或其他糖溶液或二醇。在設想到的一個實施方式中,液體載體係非水性的或基本上非水性的。對於以液體形式投與,組成物可以作為快速溶解的固體配製物來供應,用於在即將投與前溶解或懸浮。
對於藉由吸入投與,化合物A可以以氣溶膠噴霧呈遞的形式從加壓包裝或霧化器使用合適的推進劑來遞送。在加壓氣溶膠之實施方式中,可以藉由提供閥來確定劑量單位,以遞送經計量的量。用於吸入器或吹入器的例如明膠的膠囊和藥筒可以經配製含有化合物與合適的粉末基質(諸如乳糖或澱粉)之粉末混合物。
特別地,化合物A可以以含有賦形劑(諸如澱粉或乳糖)的片劑之形式,或單獨地或與賦形劑混合地以膠囊或珠囊(ovule),或以含有調味劑或著色劑的酏劑或懸浮液之形式,口服、經頰或舌下投與。此類液體製劑可以用藥學上可接受的添加劑(諸如懸浮劑)來製備。
安全性
在一些方面,該方法包括以下述量投與化合物A或其藥學上可接受的鹽,該量在用化合物A或其鹽治療期間不引起劑量限制性毒性(DLT)。視需要地,個體在治療期期間未表現出與化合物A治療相關的DLT。在各種情況下,個體在治療期期間未表現出與化合物A治療相關的任何3級或4級不良事件。在各種情況下,治療期係至少兩週或至少一個月(如果不更長),例如2個月、3個月、4個月、5個月、6個月、7個月、8個月、9個月、10個月、11個月、12個月、1年、1.5年、2年。
在示例性方面,該方法進一步包括在化合物A治療之前、期間或之後,監測個體之全血計數。在各個方面,全血計數包括對以下中之一或多種的數目之計數:紅血球、白血球、血小板和嗜中性白血球。視需要地,全血計數包括對血細胞比容和/或血色素的測量。在示例性方面,每週一次進行監測,持續約兩個月。在各個方面,在化合物A治療期間,個體之血小板計數大於約100,000/μL血液。
在示例性實施方式中,本揭露之方法有利地對腫瘤病之細胞具有高度特異性。在各個方面,化合物A有效地治療腫瘤病、誘導或增加腫瘤消退、減少腫瘤或癌症生長或者誘導或增加腫瘤或癌細胞之死亡而對個體之正常體細胞具有很小的毒性或幾乎沒有毒性。在各個方面,以下述量投與化合物A或其藥學上可接受的鹽,該量有效地治療腫瘤病、誘導或增加腫瘤消退、減少腫瘤或癌症生長和/或誘導或增加腫瘤或癌細胞之死亡而不伴有個體之正常體細胞增殖之實質性減少。在示例性情況下,以下述量投與化合物A或其藥學上可接受的鹽,該量有效地治療腫瘤病、誘導或增加腫瘤消退、減少腫瘤或癌症生長或者誘導或增加腫瘤或癌細胞之死亡而不伴有正常體細胞的細胞凋亡之實質性增加。如本文所用,關於細胞的術語「正常」意指不是贅生性的和/或不是患病的細胞。在各個方面,正常體細胞係人骨髓單核細胞或T細胞。在各種情況下,正常體細胞在基因方面不表徵為TP53
MUT或者在基因方面表徵為TP53
WT。在各個方面,化合物A或其藥學上可接受的鹽在正常體細胞之細胞凋亡方面引起不超過25%的增加。在各個方面,化合物A或其藥學上可接受的鹽在個體之正常體細胞之增殖方面引起不超過25%的減少。視需要地,正常體細胞的細胞凋亡之增加或者正常體細胞的增殖之減少係小於約20%、小於約15%、小於約10%、小於約9%、小於約8%、小於約7%、小於約6%、小於約5%、小於約4%、小於約3%、小於約2%或小於約1%。
紫杉烷之主要副作用係骨髓抑制,主要地是嗜中性白血球減少症,而其他副作用包括周圍性水腫和神經毒性(周邊神經病變)。在示例性方面,本揭露之方法治療個體之腫瘤病而未引起在用紫杉烷治療的患者中觀察到的該等副作用中之任一種;或者治療腫瘤病,其中此類副作用相比於在用紫杉烷治療的患者中觀察到的在嚴重程度方面得以減輕。
治療功效
如本文所用,術語「治療」以及與其相關的詞不一定暗示100%或完全治療。更確切些,存在熟悉該項技術者認為具有潛在益處或治療作用的不同程度的治療。在此方面,本揭露之治療腫瘤病之方法可以提供任何量或任何水平的治療。此外,由本揭露之方法提供的治療可以包括治療所治療腫瘤病之一或多種病症或症狀或體征。另外,由本揭露之方法提供的治療可以涵蓋減緩腫瘤病之進展。例如,該等方法可以藉由增強T細胞活性或針對腫瘤病之免疫響應、減少腫瘤或癌症生長或腫瘤負荷、減少腫瘤細胞轉移、增加腫瘤或癌細胞之細胞死亡或增加腫瘤消退等而治療腫瘤病。根據前述,本文提供了在個體中減少腫瘤生長、腫瘤體積或腫瘤負荷或者增加腫瘤消退之方法。在示例性實施方式中,該方法包括向個體投與化合物A或其藥學上可接受的鹽。如本文所用,術語「治療(treat、treating和treatment)」係指療法,包括但不限於治癒性療法、預防性療法和預防療法。預防性治療通常包括完全預防個體障礙之發作或延遲個體障礙之臨床前明顯階段之發作。
在各個方面,該等方法藉由延遲腫瘤病之發作或再發或者延遲轉移之發生或發作而進行治療。在各個方面,該等方法藉由增加個體之存活而進行治療。在示例性情況下,將發作或再發或者發生延遲至少1天、2天、4天、6天、8天、10天、15天、30天、兩個月、3個月、4個月、6個月、1年、2年、3年、4年或更長時間。
在各個方面,由本揭露之方法提供的治療提供了根據實性瘤響應評價標準(RECIST)或其他類似標準的治療性響應。RECIST係由美國國家癌症研究所、加拿大國家癌症研究所臨床試驗組和歐洲癌症研究和治療組織共同建立的一組評價腫瘤和/或癌細胞之進展、穩定化或響應性的標準。根據RECIST,在評價(例如,臨床試驗)的開始測量某些腫瘤,以為與用藥物治療之後作比較提供基線。Eisenhauer等人, Eur J Cancer [歐洲癌症雜誌] 45:228-247 (2009)和Litière等人, Journal of Clinical Oncology [臨床腫瘤學雜誌] 37(13): 1102-1110 (2019) DOI: 10.1200/JCO.18.01100發表了腫瘤之響應評估和評價標準。在各種情況下,由本揭露之方法提供的治療提供了根據修改的RECIST腫瘤響應評估的治療性響應,如下:
CR = 完全響應;NA = 不可用;ND = 未檢;PR = 部分響應;RECIST = 實性瘤響應評價標準;UE = 無法評價
a相對於基線評估減少。相對於最低點評估增加。
b響應:CR和PR需要在 ≥ 4週之後的確認評估,也可以等待直到下一計畫成像
c進展:疾病進展需要在觀察到初始放射線照相疾病進展之後4至6週的確認評估
d僅具有非指標病變的個體
基於修改的 RECIST 1.1 的測量和腫瘤響應評估之匯總 | |
可測量病變 | 非結病變:≥ 10 mm(單維測量) 病理性淋巴結:最長直徑短軸 ≥ 15 mm |
每個病變之測量 | 非結病變:軸向平面中的最長直徑(mm) 病理性淋巴結:最長直徑:短軸(mm) |
腫瘤負荷 | 所有指標病變中的最長直徑總和(SLD) 多達5個病變/器官,總共多達10個 |
響應評估:指標病變(由腫瘤負荷之變化%計算) | CR:所有病變消失。病理性淋巴結短軸 < 10 mm。 PR:相對於基線的 ≥ 30%減少 SD:不滿足CR、PR或疾病進展之標準 疾病進展:相對於最低點的 ≥ 20%增加(且 ≥ 5 mm絕對增加) |
響應評估:非指標病變 | CR:所有病變消失。病理性淋巴結短軸 < 10 mm。 SD:持續一或多個非指標病變 疾病進展:現有非指標病變之明確進展 |
新病變 | 一或多個新病變之存在定義進展 |
確認 | 對於CR、PR和疾病進展需要在 ≥ 4週之後藉由後續評估進行確認 |
修改的 RECIST 1.1 總體響應評估之匯總 | |||
指標病變(腫瘤負荷) a,% | 非指標病變 | 新病變 | 使用修改的RECIST 1.1之總體響應 |
↓ 100% | 不存在 | 不存在 | CR b |
無 d | 不存在 | 不存在 | CR b |
↓ 100% | 存在 | 不存在 | PR b |
↓ ≥ 30% | 不存在/存在 | 不存在 | PR b |
↓ < 30%至↑ < 20% | 不存在/存在 | 不存在 | SD |
無 d | 存在 | 不存在 | SD |
↑ ≥ 20% | 任意 | 任意 | 疾病進展 c |
任意 | 明確的進展 | 任意 | 疾病進展 c |
任意 | 任意 | 存在 | 疾病進展 c |
NA/ND/UE | 不存在/存在 | 不存在 | UE |
無 d | NA/ND/UE | 不存在 | UE |
在各種情況下,個體在用化合物A或其藥學上可接受的鹽治療之後至少表現出疾病穩定(SD)。在各個方面,個體在用化合物A或其藥學上可接受的鹽治療之後至少表現出部分響應(PR)。在各個方面,相比於基線,個體表現出癌症抗原125(CA125)水平之至少10%、至少15%、至少25%、至少30%、至少40%或至少50%減少。在示例性情況下,個體在用化合物A治療之後表現出腫瘤體積之至少10%、至少15%、至少25%、至少30%、至少40%或至少50%減少。
腫瘤病
如本文所用,術語「腫瘤病」係指引起腫瘤生長的任何病症。在示例性方面,腫瘤係良性腫瘤。在示例性方面,腫瘤係惡性腫瘤。在各個方面,腫瘤病係腫瘤或癌症。在各個方面,癌症係急性淋巴細胞癌,急性骨髓性白血病,腺泡狀橫紋肌肉瘤,骨癌,腦癌,乳癌,肛門、肛管或肛門直腸之癌症,眼癌,肝內膽管癌,關節癌,頸、膽囊或胸膜之癌症,鼻、鼻腔或中耳之癌症,口腔癌,外陰癌,慢性淋巴球性白血病,慢性髓性癌,結腸癌,食管癌,子宮頸癌,胃腸道類癌腫瘤,何杰金氏淋巴瘤,舌癌,腎癌,喉癌,肝癌,肺癌,惡性間皮瘤,黑色素瘤,多發性骨髓瘤,鼻咽癌,非何杰金氏淋巴瘤,卵巢癌,胰臟癌,腹膜、網膜、腸系膜癌,咽癌,前列腺癌,直腸癌,腎癌(例如,腎細胞癌(RCC)),小腸癌,軟組織癌,胃癌、睪丸癌,甲狀腺癌,輸尿管癌或膀胱癌。在特定方面,癌症係頭頸癌、卵巢癌、子宮頸癌、膀胱癌、食管癌、胰臟癌、胃腸癌、胃癌、乳癌、子宮內膜癌、大腸直腸癌、肝細胞癌、神經膠質母細胞瘤、膀胱癌、肺癌(例如,非小細胞肺癌(NSCLC))或細支氣管肺泡癌。在特定實施方式中,腫瘤係非小細胞肺癌(NSCLC)、頭頸癌、腎癌、三陰性乳癌或胃癌。在示例性方面,個體患有腫瘤(例如,實性瘤、血液惡性腫瘤或淋巴惡性腫瘤)並且向個體投與有效治療個體之腫瘤的量的藥物組成物。在其他示例性方面,腫瘤係非小細胞肺癌(NSCLC)、小細胞肺癌(SCLC)、頭頸癌、腎癌、乳癌、黑色素瘤、卵巢癌、肝癌、胰臟癌、結腸癌、前列腺癌、胃癌、淋巴瘤或白血病,並且向個體投與有效治療個體之腫瘤的量的藥物組成物。
當在本文中使用時,術語「癌症」和「癌性的」係指或描述在哺乳動物中典型地以不受調控的細胞生長為特徵之生理病症。癌症之實例包括但不限於癌、淋巴瘤、肉瘤、母細胞瘤和白血病。此類癌症之更特定實例包括鱗狀細胞癌、肺癌、胰臟癌、子宮頸癌、膀胱癌、肝癌、乳癌、結腸癌以及頭頸癌、卵巢癌和子宮內膜癌。雖然如本文所用,術語「癌症」不限於疾病之任一具體形式,但是據信本發明之方法對於發現伴有不受調控的KIF18A水平或依賴於KIF18A以便在哺乳動物中正確染色體分離和存活的癌症特別有效。
在各個方面,癌症係轉移性的,腫瘤係不可切除的,或其組合。在各種情況下,癌症係染色體不穩定的非整倍性癌症。在各個方面,腫瘤病(例如,癌症或腫瘤)包含對於失活的
TP53基因呈陽性和/或對於以下中之至少一項呈陽性的細胞:(i) 失活的
Rb1基因,(ii) 擴增的
CCNE1基因
、 CCNE1基因之基因拷貝數增加
、或CCNE1基因產物之過表現,(iii) 失活的
BRCA基因或 (iv) 其組合。在各個方面,腫瘤病係三陰性乳癌(TNBC)、非管腔型乳癌(例如,基底樣間質的)或高分級漿液性卵巢癌(HGSOC)。在各個方面,腫瘤病對用CDK4/6抑制劑的治療具有抗性或不具有敏感性(不敏感)。在各個方面,腫瘤病對用CDK4/6抑制劑的治療具有抗性或不具有敏感性(不敏感)並且是Rb1功能正常(proficient)的(相對於Rb1缺陷的)。在各個方面,腫瘤病對用KIF18A抑制劑的治療具有抗性。在各個方面,腫瘤病對用KIF18A抑制劑的治療具有抗性並且是Rb1缺陷的(相對於Rb1功能正常的)。
在示例性方面,腫瘤病係乳癌、視需要地管腔型乳癌或TNBC。在各個方面,乳癌已經是 (a) 組織學或細胞學確認的轉移性或局部再發性的雌激素受體(ER)陰性的(例如,藉由免疫組織化學 [IHC] < 1%),(b) 黃體素受體(PR)陰性的(例如,< 1% IHC)和 (c) 人上皮生長因子受體2(Her2)陰性的(螢光原位雜交 [FISH] 陰性,藉由IHC為0或1+,或者根據ASCO/CAP定義,為IHC2+ 和FISH陰性。在示例性方面,腫瘤病在轉移性背景中對至少一線的全身性化學療法係復發和/或難治性或者不耐受已知為腫瘤病提供臨床益處的現有一或多種療法。在示例性情況下,癌症已用免疫檢查點抑制劑治療。在各種情況下,乳癌係激素受體(HR)陽性的和/或HER2陰性的。在各個方面,乳癌係晚期乳癌和/或轉移性乳癌。在各個方面,乳癌係在內分泌療法之後進展了的HR+/HER2- 晚期或轉移性乳癌。在一些方面,乳癌係在癌症已擴散/轉移之後用內分泌療法和化學療法進行先前治療過的激素受體陽性(HR+)/HER2陰性(HER2-)晚期或轉移性乳癌。在各種情況下,癌症係尚未用激素療法(瑞寧得(Arimidex)(化學名稱:阿那曲唑)、阿諾新(Aromasin)(化學名稱:伊析美斯坦)和弗隆(Femara)(化學名稱:利妥唑))治療過的HR+/HER2- 晚期或轉移性乳癌。在各種情況下,乳癌係在用激素療法治療之後生長了的HR+/HER2- 晚期或轉移性乳癌。在各種情況下,乳癌係HER2陽性乳癌,包括但不限於與表2之HER2陽性乳癌細胞相似的那些。視需要地,乳癌係HER2陽性的雌激素受體(ER)陰性乳癌。在各個方面,腫瘤病係卵巢癌、視需要地高分級漿液性卵巢癌(HGSOC)。視需要地,卵巢癌係鉑抗性HGSOC。在示例性方面,卵巢癌係原發性腹膜癌或輸卵管癌。在各個方面,腫瘤病係轉移性或不可切除的HGSOC,其具有鉑抗性,鉑抗性被定義為在6個月的含鉑方案期間或之內之進展。在各個方面,卵巢癌已用或正在用鉑抗性再發療法治療。在各個方面,腫瘤病係漿液性子宮內膜癌。視需要地,腫瘤病係轉移性或再發性漿液性子宮內膜癌。在各種情況下,子宮內膜癌在轉移性/再發性背景中對至少一個全身性療法線係復發的和/或難治性的或者不耐受已知為腫瘤病提供臨床益處的現有一或多種療法。在各種情況下,腫瘤病係晚期或轉移性實性瘤,其係不可切除的並且對至少一線的全身性化學療法係復發和/或難治性或不耐受的。視需要地,晚期或轉移性實性瘤係TP53
MUT。
在各個方面,癌症係卵巢癌、乳癌或子宮內膜癌。在各個方面,卵巢癌係透明細胞卵巢癌或高分級漿液性卵巢癌(HGSOC)、視需要地轉移性或不可切除的HGSOC 。視需要地,HGSOC係鉑抗性HGSOC或者其中HGSOC在6個月的含鉑方案期間或之內進展。在各種情況下,癌症係原發性腹膜癌和/或輸卵管癌。在示例性情況下,乳癌係三陰性乳癌。在一些方面,個體對至少一線的全身性化學療法已復發或係難治性 。視需要地,全身性化學療法包括紫杉烷、吉西他濱或多柔比星。在各種情況下,子宮內膜癌係漿液性子宮內膜癌、視需要地轉移性或再發性漿液性子宮內膜癌。在某些方面,漿液性子宮內膜癌對至少一線的全身性化學療法(例如,順鉑、卡鉑或樂伐替尼)已復發或係難治性。
在各個方面,腫瘤係晚期實性瘤 。在各種情況下,腫瘤係不可切除的、轉移性的和/或非局部的。在示例性方面,腫瘤對至少一線的全身性化學療法已復發或係難治性。
在各種情況下,腫瘤病對用一或多種藥物的治療具有抗性。在各個方面,腫瘤病表現出對用一或多種藥物的治療的降低敏感性。視需要地,腫瘤病係多藥抗性腫瘤病。在示例性情況下,腫瘤或癌細胞(例如,腫瘤病之腫瘤或癌細胞)係多藥抗性腫瘤或癌細胞和/或表現出多藥抗性1(MDR-1)基因和/或其基因產物之增加表現。在示例性情況下,腫瘤或癌細胞(例如,腫瘤病之腫瘤或癌細胞)表現出MDR-1基因編碼的P-醣蛋白(P-gp)之增加表現。在各個方面,腫瘤病表現出對用抗有絲分裂劑或蒽環抗生素(視需要地,紫杉醇或多柔比星)的治療的降低敏感性或抗性。在各個方面,腫瘤或癌細胞(例如,腫瘤病之腫瘤或癌細胞)表現出在微管蛋白基因中之突變、微管蛋白之過表現、微管蛋白擴增和/或同種型轉換的微管蛋白表現。在各個方面,α或β微管蛋白中之突變抑制紫杉烷與微管上的正確位置之結合,從而使得紫杉烷無效。在示例性方面,腫瘤病表現出對用鉑藥劑、蒽環抗生素、靶向療法(例如,TKI、PARP抑制劑)中之任何一或多種的治療的降低敏感性或抗性。
在各個方面,腫瘤病係包含一或多個全基因組重複或全基因組加倍(WGD)事件之癌症。在癌症之上下文中的WGD討論於Lens和Hemdema, Nature Reviews Cancer [自然 癌症綜述] 19: 32-45 (2019);Ganem 等人, Current Opinion in Genetics & Development [遺傳學與發育新見] 17, 157-162和Davoli等人, Annual Review of Cell and Developmental Biology [細胞和發育生物學年鑒] 27, 585-610中。
失活的基因、擴增的基因和表現水平
如本文所用,在基因之上下文中術語「失活的」係指基因或基因編碼的基因產物之功能的降低或喪失。基因之失活可以由一或多種已知的機制引起。例如,基因之失活可為由DNA序列、RNA序列或蛋白質序列相對於相應的野生型基因、RNA或蛋白質之變化(包括例如喪失)引起的或者可為由不涉及基因的DNA序列中之任何改變的表觀遺傳變化引起的。
在各個方面,癌症之細胞包含基因或基因編碼的基因產物中之變化或異常,該變化或異常係相對於相應的野生型基因或基因產物的,並且該變化之存在導致以下或與以下相關:基因之緘默化、基因或基因編碼的基因產物之表現的降低或喪失、基因或基因編碼的基因產物之功能的降低或喪失、或其組合。在各種情況下,基因產物係RNA轉錄物或蛋白質。在各種情況下,該變化至少導致基因或基因編碼的基因產物之功能的降低或喪失。在各種情況下,該變化至少導致
TP53基因或
TP53基因編碼的基因產物之功能的降低或喪失。在各種情況下,該變化至少導致
Rb1基因或
Rb1基因編碼的基因產物之功能的降低或喪失。在各種情況下,該變化至少導致
BRCA基因或
BRCA基因編碼的基因產物之功能的降低或喪失。
基因之變化可以出現在基因之任何部分,例如在內含子或外顯子內,在5’-非翻譯區(5’-UTR)或3’-非翻譯區(3’-UTR)內。該變化可以存在於基因編碼的轉錄物(例如,RNA轉錄物、初級轉錄物、前mRNA、mRNA)內或者其任何部分處,或者可以存在於基因編碼的蛋白質內或其任何部分處。
在各個方面,該變化係DNA序列、RNA序列或蛋白質序列中相對於相應的野生型基因、RNA或蛋白質之差異。在各個方面,藉由以下方式來檢測失活的基因:分析基因之核苷酸序列、分析基因編碼的RNA之核苷酸序列或分析基因編碼的蛋白質之胺基酸序列並且將樣本之基因序列與相應的野生型人基因、RNA或蛋白質序列進行比較。在示例性方面,該變化包含相對於相應的野生型基因、RNA、或蛋白質,在DNA序列或RNA序列中一或多個核苷酸之缺失、插入、或取代,在蛋白質序列中一或多個胺基酸之缺失、插入、或取代。在示例性方面,該變化包含相對於相應的野生型基因、RNA或蛋白質,在DNA序列或RNA序列中一或多個核苷酸之缺失、插入、或取代,在蛋白質序列中一或多個胺基酸之缺失、插入、或取代,其可以導致基因拷貝數增加或DNA、RNA或蛋白質之擴增。在各個方面,癌症之細胞包含基因中之基因突變。在各個方面,癌症之細胞包含基因中之基因突變或基因中核苷酸之喪失。在示例性情況下,基因突變係錯義突變、無義突變、插入、缺失、重複、框移突變、截短或重複擴增。在各種情況下,失活的
TP53基因包含突變、缺失或截短,失活的
Rb1基因包含突變、缺失或截短,和/或失活的
BRCA基因包含突變、缺失或截短。如本文所用,術語「
BRCA基因」係指
BRCA1或
BRCA2基因。在示例性情況下,
BRCA基因係
BRCA1 。在示例性方面,
BRCA基因係
BRCA2 。
在各種情況下,該變化係表觀遺傳的並且不涉及基因的DNA序列中之任何改變。在示例性方面,失活的基因係表觀遺傳緘默化的並且視需要地涉及DNA或組蛋白之共價修飾。DNA之共價修飾可為例如胞嘧啶甲基化或羥基甲基化。組蛋白之共價修飾可為例如離胺酸乙醯化、離胺酸或精胺酸甲基化、絲胺酸或蘇胺酸磷酸化或離胺酸泛蛋白化或蘇素化(sumoylation)。基因緘默化之機制可以在轉錄或翻譯期間發生。基因緘默化之示例性機制包括但不限於DNA甲基化、組蛋白修飾和RNA干擾(RNAi)。在各個方面,失活的基因係具有表觀遺傳緘默化的啟動子的表觀遺傳緘默化之基因。視需要地,失活的
TP53基因具有表觀遺傳緘默化的
TP53啟動子或者失活的
Rb1基因具有表觀遺傳緘默化的
Rb1啟動子或者失活的
BRCA基因具有表觀遺傳緘默化的
BRCA啟動子。測定表觀遺傳緘默化之合適技術包括但不限於染色質免疫沈澱(晶片上ChIP、ChIP-Seq)、螢光原位雜交(FISH)、甲基化敏感性限制酶、DNA腺嘌呤甲基轉移酶鑒定(DamID)和亞硫酸鹽定序。參見例如,Verma等人, Cancer Epidemiology, Biomarkers, and Prevention [腫瘤流行病學、生物標誌物和預防] 23: 223-233 (2014)。
在各個方面,失活的基因係由病毒誘導的基因緘默化(VIGS)失活的。在各種情況下,失活的
TP53基因係由病毒蛋白,例如人乳突病毒(HPV)E6蛋白失活的。視需要地,HPV E6蛋白與
TP53基因編碼的p53蛋白相互作用並且使得p53蛋白失活。在各種情況下,失活的
Rb1基因係由病毒蛋白,例如HPV E7蛋白失活的。視需要地,HPV E7蛋白與
Rb1基因編碼的Rb蛋白相互作用並且使得Rb蛋白失活。此類緘默化方式係本領域已知的。參見例如,Jiang和Milner, Oncogene [致癌基因] 21: 6041-6048 (2002)。
在本揭露之方法的各種實施方式中,癌症之細胞包含基因擴增(例如,
CCNE1擴增)或基因拷貝數增加(例如,基因之基因拷貝數增加)。在各種情況下,癌症之細胞包含基因拷貝數增加或擴增基因,其可以藉由基於DNA或RNA的技術(基因表現分析 [比較性基因組雜交、基於RNA的雜交]、NGS、PCR或DNA墨點)或藉由分子細胞遺傳學技術(具有基因特異性探針的FISH2、CISH(顯色原位雜交))來檢測。在各個方面,進行競爭性或定量PCR、與cDNA微陣列的基因組雜交、基因探針與RNA的雜交和定量以檢測基因擴增或基因拷貝數增加。參見例如,Harlow和Stewart, Genome Res [基因組研究] 3: 163-168 (1993);Heiskanen等人, Cancer Res [癌症研究] 60(4): 799-802 (2000)。在各種情況下,癌症之細胞包含
MDM2基因之基因拷貝數增加或擴增和/或
FBXW7基因之基因拷貝數增加或擴增或突變。在示例性方面,癌症之細胞包含
MDM2基因之基因拷貝數增加或擴增和p53蛋白水平之降低。在示例性方面,癌症之細胞包含
FBXW7基因中之突變和
CCNE1基因編碼的基因產物之過表現。下一代定序(NGS)也可以用作檢測基因拷貝數增加或喪失或基因擴增之方法,由此對基因區域進行定序,並且將定序讀段與其他基因進行比較以推斷目的基因之增加或喪失。
在示例性方面,失活的TP53基因 (i) 包含TP53基因突變、缺失、截短和/或表觀遺傳緘默化的
TP53啟動子,(ii) 由病毒蛋白或經由
MDM2基因之基因擴增來失活,或 (iii) 其組合。視需要地,病毒蛋白係人乳突病毒(HPV)E6蛋白。在示例性方面,失活的
Rb1基因 (i) 包含
Rb1基因突變、缺失、截短和/或表觀遺傳緘默化的
Rb1啟動子,(ii) 由病毒蛋白來失活或 (iii) 其組合。視需要地,病毒蛋白係人乳突病毒(HPV)E7蛋白。在示例性方面,失活的
BRCA基因 (i) 包含
BRCA基因突變、缺失、截短和/或表觀遺傳緘默化的
BRCA啟動子。視需要地,BRCA基因係BRCA1基因。替代性地,BRCA基因係BRCA2基因。
在各個方面,失活的
TP53基因、失活的
Rb1基因、
CCNE1基因拷貝數增加或擴增和/或失活的
BRCA基因存在於腫瘤病(例如,癌症)之生殖系列細胞中。在各個方面,失活的
TP53基因、失活的
Rb1基因、
CCNE1基因拷貝數增加或擴增和/或失活的
BRCA基因存在於腫瘤病(例如,癌症)之生殖系列細胞中並且不存在於腫瘤病(例如,癌症)之體細胞中。視需要地,由於腫瘤病之體細胞突變,腫瘤病之體細胞迴歸到了野生型基因型並且因此未表現出失活的
TP53基因、失活的
Rb1基因、
CCNE1基因拷貝數增加或擴增和/或失活的
BRCA基因,但是腫瘤病之生殖系列細胞仍然展示出失活的
TP53基因、失活的
Rb1基因、
CCNE1基因拷貝數增加或擴增和/或失活的
BRCA基因。例如,腫瘤病可為PARP抑制劑抗性癌症並且僅癌症之生殖系列細胞具有失活的BRCA1基因,而癌症之體細胞表現出恢復的BRCA1編碼區和功能。
細胞遺傳學方法和/或分子方法可以用於檢測失活的或擴增的基因之存在或基因拷貝數增加,例如失活的
TP53基因、失活的
Rb1基因、擴增的
CCNE1基因或失活的
BRCA基因。在示例性方面,使用了直接DNA定序、DNA雜交和/或限制性酶消化。視需要地,細胞遺傳學方法包括核型分析、螢光原位雜交(FISH)、比較性基因組雜交(CGH)或其組合。在各種情況下,分子方法包括限制性片段長度多態性(RFLP)、擴增受阻突變系統(ARMS)、聚合酶鏈反應(PCR)、多重連接依賴性探針擴增(MLPA)、變性梯度凝膠電泳(DGGE)、單股構象多態性(SSCP)、異源雙股體分析、誤配化學切割(CCM)、蛋白質截短測試(PTT)、寡核苷酸連接測定(OLA)或其組合。視需要地,PCR係多重PCR、嵌模式PCR、RT-PCR或即時定量PCR。在各個方面,測定TP53基因、
Rb1基因、CCNE1基因和/或BRCA基因編碼的RNA或蛋白質之表現水平。在各個方面,採用了ARMS、FISH、IHC或NGS。此類技術描述於Su等人, J Experimental Clin Cancer Research [實驗和臨床癌症研究雜誌] 36: 121 (2017)和He等人, Blood [血液] 127(24): 3004-3014 (2016)中。在各種情況下,使用全外顯子組定序或全基因組定序。在示例性方面,測定包括液體活組織檢查。液體活組織檢查在本領域已詳細描述。參見例如,Poulet等人, Acta Cytol [細胞學報] 63(6): 449-455 (2019), Chen和Zhao, Hum Genomics [人類基因組學] 13(1): 34 (2019)。
在各個方面,基因拷貝數增加或擴增導致過表現的或增加的基因編碼的基因產物(例如,RNA和/或蛋白質)水平。檢測增加的RNA和/或蛋白質水平之方法係本領域已知的。在示例性方面,
CCNE1基因之基因拷貝數增加或擴增導致過表現的或增加的由
CCNE1基因編碼的基因產物水平。在示例性方面,CCNE1基因產物之過表現係由
FBXW7基因中之突變導致的。在各個方面,樣本對於CCNE1基因產物之過表現和
FBXW7基因中之突變呈陽性。
確定核酸(例如,基因、RNA、mRNA)之表現水平的合適方法係本領域已知的並且包括但不限於定量聚合酶鏈反應(qPCR)(例如,定量即時PCR(qRT-PCR))、RNAseq、奈米串(Nanostring)和RNA墨點。用於測量基因表現之技術還包括例如使用或不使用基因晶片或基因表現微陣列之基因表現測定,描述於下列文獻中:Onken等人, J Molec Diag [分子診斷雜誌] 12(4): 461-468 (2010);和Kirby等人, Adv Clin Chem [臨床化學進展] 44: 247-292 (2007)。昂飛公司(Affymetrix)基因晶片和RNA晶片和基因表現測定套組(kit)(例如,Applied Biosystems™ TaqMan®基因表現測定)亦為可從諸如賽默飛世爾科技公司(ThermoFisher Scientific)(麻塞諸塞州沃爾瑟姆)和納斯瑞公司(Nanostring)(Geiss等人, Nature Biotechnology [自然生物技術] 26: 317-325 (2008))的公司商購獲得的。確定蛋白質表現水平之合適方法係本領域已知的並且包括免疫測定(例如,西方墨點法、酶聯免疫吸附測定(ELISA)、放射性免疫分析法(RIA)和免疫組化測定)或基於珠粒的多重測定,例如描述於下列文獻中的那些:Djoba Siawaya JF, Roberts T, Babb C, Black G, Golakai HJ, Stanley K等人 (2008) An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays [基於商業螢光珠粒的Luminex細胞介素測定的評估]. PLoS ONE [公共科學圖書館期刊] 3(7): e2535。對具有特定生物學系統的蛋白質之系統鑒定和定量之蛋白質組學分析係已知的。質譜法典型地是用於此目的的技術。
在示例性方面,該方法包括基於所述基因編碼的RNA測量互補DNA(cDNA)的水平。簡而言之,該方法包括從樣本中提取或分離RNA(例如,從樣本之一或多個腫瘤細胞中)並且基於從樣本中分離的RNA合成cDNA。替代性地或另外地,在一些方面,測量表現水平包括從樣本中分離RNA、從RNA產生互補DNA(cDNA)、擴增cDNA並且使cDNA與基因表現微陣列雜交。因此,在一些方面,測量表現水平包括從樣本中分離RNA並且藉由RNA-Seq定量RNA。在替代性或另外的方面,經由免疫組織化學測定確定表現之水平。在示例性方面,測量表現水平包括使樣本與針對
TP53、
Rb1、
BRCA、或
CCNE1、或其基因產物或其組合的結合劑接觸。在一些方面,結合劑係抗體或其抗原結合片段。在一些方面,結合劑係對於
TP53、
Rb1、
BRCA、或
CCNE1、或其RNA轉錄物或其互補序列具有特異性的核酸探針。
一旦測量了來自從個體獲得的樣本之
TP53、
Rb1、
BRCA、或
CCNE1、或其基因產物之表現水平,可以將測量的表現水平與參考水平進行比較,歸一化為管家基因,經數學變換。在示例性情況下,
TP53、
Rb1、
BRCA或
CCNE1或其基因產物之測量的表現水平被集中和縮放。集中和縮放生物數據之合適技術係本領域已知的。參見例如,van den Berg等人, BMC Genomics [BMC基因組學] 7: 142 (2006)。
野生型
TP53、
Rb1、
CCNE1和
BRCA基因以及該等基因編碼的RNA和蛋白質係本領域已知的。每一個的示例性序列可獲得自美國國家生物技術資訊中心(NCBI)之網站並且提供於本文提交的序列表中。
[表A]
基因名稱(縮寫,全稱) | NCBI、HUGO基因ID號 | mRNA登錄號 | SEQ ID NO: | 蛋白質登錄號 | SEQ ID NO: |
TP53 | 7157、11998 | NM_000546.6 | 1 | NP_000537.3 | 2 |
RB1 | 5925、9884 | NM_000321.3 | 3 | NP_000312.2 | 4 |
CCNE1 | 898、1589 | NM_001238.4 | 5 | NP_001229.1 | 6 |
BRCA1 | 672、1100 | NM_007294.4 | 7 | NP_009225.1 | 7 |
BRCA2 | 675、1101 | NM_000059.4 | 9 | NP_000050.3 | 10 |
癌症之細胞可以對於 (a) 失活的
TP53基因和/或 (b) 以下中之至少一項鑒定為「陽性」或「陰性」:(i) 失活的
Rb1基因,(ii) 擴增的
CCNE1基因、
CCNE1基因之基因拷貝數增加或
CCNE1基因產物之過表現,(iii) 失活的
BRCA基因或 (iv) 其組合。如本文所用,在樣本之上下文中的術語「陽性」係指失活的
TP53基因和/或 (b) 以下中之至少一項存在於樣本中:(i) 失活的
Rb1基因,(ii) 擴增的
CCNE1基因、
CCNE1基因之基因拷貝數增加或
CCNE1基因產物之過表現,(iii) 失活的
BRCA基因或 (iv) 其組合。如本文所用,在樣本之上下文中的術語「陰性」係指失活的
TP53基因和/或 (b) 以下中之至少一項不存在於樣本中:(i) 失活的
Rb1基因,(ii) 擴增的
CCNE1基因、
CCNE1基因之基因拷貝數增加或
CCNE1基因產物之過表現,(iii) 失活的
BRCA基因或 (iv) 其組合,例如,樣本不具有失活的
TP53基因和/或 (b) 以下中之至少一項存在於樣本中:(i) 失活的
Rb1基因,(ii) 擴增的
CCNE1基因、
CCNE1基因之基因拷貝數增加或
CCNE1基因產物之過表現,(iii) 失活的
BRCA基因或 (iv) 其組合。
個體
在本揭露之示例性實施方式中,個體係哺乳動物,包括但不限於嚙齒目哺乳動物,諸如小鼠和倉鼠;和兔目哺乳動物,諸如兔;來自食肉目的哺乳動物,包括貓科動物(貓)和犬科動物(犬);來自偶蹄目的哺乳動物,包括牛科動物(奶牛)和豬科動物(豬);或奇蹄目,包括馬科動物(馬)。在一些方面,哺乳動物屬於靈長目、闊鼻小目(Ceboid)或猴目(Simoid)(猴)或類人猿目(人類和猿類)。在一些方面,哺乳動物係人。在各個方面,個體患有腫瘤病,例如本文所述之那些中之任一種。如本文所用,術語「患者」、「個體」或「哺乳動物」係指任何「患者」、「個體」或「哺乳動物」,包括人、牛、馬、狗和貓。在本發明之一個實施方式中,哺乳動物係人。在各個方面,個體係成年人。視需要地,個體已接受過用至少一種化學治療劑的先前治療。
在示例性方面,個體患有具有轉移的癌症、不可切除的腫瘤或其組合。在各個方面,癌症或腫瘤表現出或已表現出對用CDK4/6抑制劑的治療之抗性或降低敏感性。在示例性方面,個體患有乳癌、視需要地管腔型乳癌或三陰性乳癌(TNBC)。在各個方面,乳癌已經是 (a) 組織學或細胞學確認的轉移性或局部再發性的雌激素受體(ER)陰性的(例如,藉由免疫組織化學 [IHC] < 1%),(b) 黃體素受體(PR)陰性的(例如,< 1% IHC)和 (c) 人上皮生長因子受體2(Her2)陰性的(螢光原位雜交 [FISH] 陰性,藉由IHC為0或1+,或者根據ASCO/CAP定義,為IHC2+ 和FISH陰性。在示例性方面,個體在轉移性背景中對至少一線的全身性化學療法係復發和/或難治性或者不耐受已知為他們的病症提供臨床益處的現有一或多種療法。在示例性情況下,個體先前已暴露於免疫檢查點抑制劑。在各種情況下,乳癌係激素受體(HR)陽性的和/或HER2陰性的。在各個方面,乳癌係晚期乳癌和/或轉移性乳癌。在各個方面,個體患有在接受內分泌療法之後進展了的HR+/HER2- 晚期或轉移性乳癌。在一些方面,個體係在癌症已擴散/轉移之後用內分泌療法和化學療法進行先前治療過的激素受體陽性(HR+)/HER2陰性(HER2-)晚期或轉移性乳癌患者。在各種情況下,個體患有HR+/HER2- 晚期或轉移性乳癌,在停經後婦女中其先前未用激素療法(瑞寧得(Arimidex)(化學名稱:阿那曲唑)、阿諾新(Aromasin)(化學名稱:伊析美斯坦)、和弗隆(Femara)(化學名稱:利妥唑))治療過。在各種情況下,個體係停經後婦女,其患有在用激素療法治療之後生長了的HR+/HER2- 晚期或轉移性乳癌。在某些方面,個體係停經前期/圍停經期或停經後婦女,其患有HR+、人上皮生長因子受體2(HER2)陰性晚期或轉移性乳癌,並且已接受過基於內分泌的療法。視需要地,個體係停經後婦女,其患有HR+、HER2- 晚期或轉移性乳癌,並且已接受過初始的基於內分泌的療法或在用內分泌療法治療後有疾病進展。在各個方面,個體患有卵巢癌、視需要地高分級漿液性卵巢癌(HGSOC)。視需要地,卵巢癌係鉑抗性HGSOC。在示例性方面,個體患有原發性腹膜癌和/或輸卵管癌。在各個方面,個體具有組織學或細胞學確認診斷的轉移性或不可切除的HGSOC,其具有鉑抗性,鉑抗性被定義為在6個月的含鉑方案期間或之內的進展。在各個方面,個體患有卵巢癌並且已接受過或正在接受鉑抗性再發療法。在各個方面,個體患有漿液性子宮內膜癌。視需要地,個體具有組織學或細胞學確認診斷的轉移性或再發性漿液性子宮內膜癌。在各種情況下,個體在轉移性/再發性背景中對至少一個全身性療法線係復發的和/或難治性的或者不耐受已知為他們的病症提供臨床益處的現有一或多種療法。在各種情況下,個體患有晚期或轉移性實性瘤,其是不可切除的並且對至少一線的全身性化學療法係復發和/或難治性或不耐受的。視需要地,晚期或轉移性實性瘤係TP53
MUT。
在示例性方面,個體不具有以下中之任一項:(a) 活動性腦轉移瘤,(b) 原發性中樞神經系統(CNS)腫瘤、血液惡性腫瘤或淋巴瘤,(c) 不受控的胸腔積液、心包積液或腹水,(d) 引起不能口服給藥的胃腸(GI)道疾病。
個體選擇和治療結果
在一些實施方式中,在所揭露的方法中用化合物A治療的個體係已經歷過一或多種先前全身性癌症療法(例如,化合物A係二線或三線療法)之個體。先前全身性癌症療法可為經監管機構(例如,FDA或EMA)批准為治療給定癌症類型和階段之療法。在一些情況下,先前全身性癌症療法係尚未經監管機構批准但正在進行臨床試驗之癌症療法。如果個體已進行了先前全身性癌症療法,在一些情況下,個體已在開始如本文所揭露的用化合物A的療法前之至少一個月、至少兩個月、至少三個月、至少四個月、至少五個月或至少六個月內沒有進行任何全身性癌症療法。
在療法過程中監測經歷療法的個體之不良事件(AE)。與治療相關的AE係與治療藥物相關的AE。治療突發性AE係個體在療法開始前不存在、在經歷治療中發生的AE。在一些情況下,治療期突發性AE與治療本身無關或被懷疑與治療本身無關。AE被表徵為以下五個級別之一:1級係輕度AE;2級係中度AE;3級係嚴重AE;4級係危及生命或致殘的AE;5級係AE相關死亡。在一些情況下,個體未表現出治療相關的任何3級AE。在一些情況下,個體未表現出任何3級AE。在一些情況下,個體未表現出治療相關的任何4級AE。在一些情況下,個體未表現出任何4級AE。在各種情況下,個體在投與化合物A至少一個月或至少三個月之後未表現出治療相關的3級或4級AE。
在各種情況下,在本文揭露的方法中用化合物A治療的個體在投與的劑量下未表現出任何劑量限制性毒性(DLT)。DLT係在化合物A之第一治療週期(第1天至第21天)期間發生的滿足以下列出的標準之任何AE,其中不能排除與藥物的關係。AE之分級係基於CTCAE 5.0版中提供的指南。用於DLT評估的AE:血液學毒性:發熱性嗜中性白血球減少症;嗜中性白血球減少性感染;4級嗜中性白血球減少症;持續 > 7天的≥ 3級血小板減少症;3級血小板減少症伴 ≥ 2級出血;4級血小板減少;4級貧血 非血液學毒性 ≥ 4級、嘔吐或腹瀉;儘管有最佳醫療支持,但3級腹瀉或3級嘔吐持續超過3天;儘管有最佳醫療支持,但 ≥ 3級噁心持續3天或更多天;任何其他 ≥ 3級AE。
在各種情況下,所揭露的方法之個體表現出對療法的響應。在一些情況下,個體由於化合物A之投與至少表現出疾病穩定(SD)。在一些情況下,個體由於化合物A之投與至少表現出部分響應(PR)。個體之響應藉由如由RECIST 1.1定義的標準來評估,例如如討論於Eisenhauer等人,
Eur J Cancer[歐洲癌症雜誌]
,45:228-247 (2009)中。完全響應(CR)係所有靶病變消失,並且任何病理性淋巴結之短軸降低至小於10 mm。部分響應(PR)係以基線直徑總和為參考,靶病變直徑總和減少至少30%。疾病進展係以研究中的最小總和(如果基線總和係研究中的最小總和,則包括基線總和)為參考,靶病變直徑總和增加至少20%,並且除了20%的相對增加之外,還必須有至少5 mm的絕對增加。疾病穩定係既未充分縮減以符合PR,也未充分增加以符合PD。受控的疾病狀態係患者可以在表現出疾病穩定和部分響應之間交替的情況。腫瘤大小可以藉由放射線照相掃描來測量。
其他實施方式
本文進一步提供了選自以下的化合物A之任何鹽、水合物、溶劑合物或共晶體之任何無定形或結晶形式:鹽酸鹽(化合物A-HCl)、甲磺酸鹽(化合物A-MsA)、甲苯磺酸鹽(化合物A-TsA)、硫酸鹽(化合物A-硫酸鹽)、可變水合物(化合物A-可變水合物)、四氫呋喃溶劑合物(化合物A-THF)、乙醇溶劑合物(化合物A-乙醇)、1-丙醇溶劑合物(化合物A-1-丙醇)、異丙醇溶劑合物(化合物A-IPA)、甲醇溶劑合物(化合物A-甲醇)、乙酸異丙酯溶劑合物(化合物A-IPAc)、丙酮溶劑合物(化合物A-丙酮)、環戊基甲基醚溶劑合物(化合物A-CPME)、二㗁烷溶劑合物(化合物A-二㗁烷)、乙酸乙酯溶劑合物(化合物A-EtOAc)、乙腈溶劑合物(化合物A-MeCN)、甲基三級丁基醚溶劑合物(化合物A-MTBE)、甲苯溶劑合物(化合物A-甲苯)、十二烷基硫酸鹽(化合物A-十二烷基硫酸鹽)、二甲基甲醯胺(DMF)溶劑合物水合物(化合物A-DMF-水合物)、二甲基乙醯胺(DMAC)溶劑合物(化合物A-DMAC)、單苯磺酸鹽水合物(化合物A-苯磺酸鹽-水合物)、咖啡因共晶體(化合物A-咖啡因)、檸檬酸共晶體(化合物A-檸檬酸)、糖精共晶體(化合物A-糖精)、L-酒石酸共晶體(化合物A-L-酒石酸)或尿素共晶體(化合物A-尿素),如藉由本文之圖和實例中XRPD、DSC、TGA、水分吸附(DVS)中之任一種表徵的;以及藥物組成物,該等藥物組成物包含化合物A之鹽、溶劑合物或共晶體中之任一種和藥學上可接受的賦形劑。
在各種實施方式中,有機溶劑可以選自以下群組,該群組由以下組成:醚溶劑、非極性溶劑及其任何組合。在一些情況下,有機溶劑可為醚溶劑。合適的醚溶劑可以包括例如四氫呋喃(THF)、2-甲基四氫呋喃(MeTHF)、環戊基甲基醚、三級丁基甲基醚、1,2-二甲氧基乙烷、1,4-二㗁烷、二乙醚、二異丙基醚、雙(2-甲氧基乙基)醚、丙二醇甲基醚及其任何組合。在實施方式中,醚溶劑可為THF或2-甲基四氫呋喃。在一些情況下,有機溶劑可為非極性溶劑。合適的非極性溶劑可以包括例如己烷、戊烷、甲苯、苯、庚烷、二甲苯及其任何組合。在實施方式中,非極性溶劑可為甲苯、己烷、庚烷或其任何組合。在實施方式中,有機溶劑可以選自以下群組,該群組由以下組成:THF、2-甲基四氫呋喃、環戊基甲基醚、三級丁基甲基醚、1,2-二甲氧基乙烷、甲苯、己烷、庚烷、1,4-二㗁烷及其任何組合。在一些實施方式中,有機溶劑係THF。
應理解,雖然本揭露結合其詳細描述來閱讀,但是前述描述旨在說明且不限制本揭露之範圍,該範圍藉由所附申請專利範圍之範圍來限定。其他方面、優點和修改在以下申請專利範圍之範圍內。例如,如實例1-45所示。
實例
提供以下實例用於說明而非旨在限制本發明之範圍。
材料與方法
除非指定,否則可商購獲得的試劑原樣使用而不進行進一步純化。製備按重量計1.0 M在THF中的MeI之溶液。分批和流動化學設備(反應器、管材、泵、連接件和配件)係來自可商購獲得的來源。
用於以下合成方法的起始材料(化合物A)之合成揭露在於2019年12月20日提交、於2020年7月30日公開為U.S. 2020-0239441的美國非臨時專利申請案號16/724,119中。反應之起始材料、中間體和終產物可以使用常規技術進行分離和純化(如果需要),該等常規技術包括但不限於過濾、蒸餾、結晶、層析法等。此類材料可以使用常規方式(包括物理常數和光譜數據)來表徵。
除非作出相反指定,否則本文所述之反應在大氣壓和以下範圍內的溫度下進行:約-78°C至約150°C、或約0°C至約50°C、或約15°C至約25°C。
帕納科公司(PANalytical)X’Pert PRO MPD繞射儀 - 透射幾何結構
除非作出相反指定,否則使用由Optix長、細焦點源產生的Cu輻射之入射光束,用帕納科公司X’Pert PRO MPD繞射儀收集XRPD圖譜。使用橢圓梯度多層反射鏡來將Cu Kα X射線聚焦通過試樣並且到檢測器上。在分析前,分析矽試樣(NIST SRM 640f)以證實Si 111峰位置。將樣本之試樣夾置在3 μm厚膜之間,並且以透射幾何結構進行分析。使用光束阻擋器和短防散射延伸來使空氣產生的背景最小化。使用用於入射和繞射光束的索勒狹縫來使來自軸向發散的增寬最小化。使用位於距試樣240 mm處的掃描位置敏感性檢測器(X'Celerator)和Data Collector軟體v.5.5收集繞射圖譜(原樣材料除外,其中使用Data Collector軟體v.2.2b)。每個圖譜之數據獲取參數在此報告的數據部分中之圖像上方展示。
帕納科公司X’Pert PRO MPD繞射儀 - 反射幾何結構
除非作出相反指定,否則使用由長、細焦點源和鎳濾光片產生的Cu Kα輻射之入射光束,用帕納科公司X'Pert PRO MPD繞射儀收集XRPD圖譜。使用對稱布拉格-布倫塔諾(Bragg-Brentano)幾何結構配置繞射儀。使用Data Collector軟體v. 2.2b收集和分析數據。在分析前,分析矽試樣(NIST SRM 640f)以證實所觀察到的Si 111峰位置與NIST證實的位置一致。將樣本之試樣裝填在鎳塗覆的銅孔中。使用防散射狹縫(SS)來使空氣產生的背景最小化。使用用於入射和繞射光束的索勒狹縫來使來自軸向發散的增寬最小化。使用位於距樣本240 mm處的掃描位置敏感性檢測器(X'Celerator)和Data Collector軟體v. 2.2b收集繞射圖譜。每個圖譜之數據獲取參數在此報告的數據部分中之圖像上方展示,包括發散狹縫(DS)和入射光束防散射狹縫(SS)。
在具有RTMS檢測器的帕納科公司X’Pert PRO X射線繞射系統上獲得X射線粉末繞射(XRPD)數據。在45 kV和40 mA下以每50 s步進一次0.0334°步長、以從5至45°(2θ)的連續模式在環境溫度下用CuKα輻射(1.541874 Å)掃描樣本。
用專有SSCI軟體進行XRPD指標化,TRIADS™由美國專利案號8,576,985涵蓋。
使用梅特勒-托利多公司(Mettler-Toledo)DSC3+差示掃描量熱儀進行微差掃描熱量法(DSC)。用銦、錫和鋅進行τ滯後調整。用辛烷、水楊酸苯酯、銦、錫和鋅調整溫度和焓。然後用辛烷、水楊酸苯酯、銦、錫和鋅驗證調整。將樣本放入氣密地密封的鋁DSC盤中,並且準確記錄重量。藉由工具刺穿盤蓋並且然後插入至DSC小室中進行分析。將配置為樣本盤的稱重鋁盤放置於小室之參考側上。
替代性地,還在乾氮氣下在鋁盤中以10°C/min從25°C至250°C至350°C在TA儀器公司(TA Instruments)Q和Discovery系列量熱儀上以50 ml/min進行微差掃描熱量法(DSC)分析。
使用梅特勒-托利多公司TGA/DSC3+分析儀進行熱重分析(TGA)和TGA/DSC組合分析。使用銦、錫和鋅進行溫度和焓調整,並且然後用銦驗證。用草酸鈣驗證平衡。將樣本放入開放鋁盤中。將盤氣密地密封,刺穿蓋,然後插入至TG爐中。將配置為樣本盤的稱重鋁盤放置於參考平臺上。在氮氣下加熱爐。
在乾氮氣下在鉑盤中以10°C/min從環境溫度在250°C至350°C之間在TA儀器公司Q和Discovery系列分析儀上以25 ml/min進行熱重分析(TGA)。
使用VTI SGA 100對稱蒸汽吸附分析儀收集水分吸附數據。在鉑盤中使用大約5 mg至10 mg的樣本量。以5% RH的增量從5% RH至95% RH評價吸濕性。收集吸附和解吸循環之數據。將平衡標準設定為10分鐘內重量變化0.001%,最大平衡時間為180分鐘。
藉由伊利諾州香檳城(Champaign)的波譜數據服務公司(Spectral Data Services)(SSCI)在25°C下用Varian UNITY
INOVA-400波譜儀採集溶液質子NMR波譜。將樣本溶解於DMSO-
d6中。在一些情況下,也在SSCI處用安捷倫DD2-400波譜儀使用氘化DMSO或甲醇採集溶液NMR波譜。
在於600 Mhz(
1H)下操作的布魯克公司(Bruker)DSX波譜儀上收集
19F SSNMR數據。所有實驗均使用以14 kHz旋轉頻率操作的4 mm H/F/X旋轉探針。以10 s的循環延遲使用HPDEC程式,並且以特氟隆作參考。使用2.5 µs的
1H 90°脈衝和5 µs的
19F 90°脈衝。使用spinal64序列進行去耦。採集256個暫態以進行訊息平均化。用Topspin 3.0軟體處理數據。
實例 1 :結晶化合物 A-HCl 形式 1 。
可以在用鹽酸對化合物A進行原位質子化後在多種溶劑體系中實現化合物A-HCl形式1之結晶化。最初,藉由在環境條件下將一當量HCl在乙腈/水90/10中漿化來製備化合物A-HCl形式1。後來,使用無水過程,即在升高的溫度下用鹽酸處理在乙腈/1,4-二㗁烷體系中之化合物A(表1,編目號1)。在NMP/EtOH、THF/水和丙酮/水中開發了使用不同鹽酸源的可替代反應性結晶過程(表1,編目號2-5)。由於原料藥始終如一高純度和根據ICH指南限制對殘餘溶劑量之控制而選擇丙酮/水作為最終結晶體系。該等批次之表徵結果匯總於表1中。
[表1]:用於產生化合物A-HCl形式1之各種結晶過程
編號 | 規模 | 溶劑 | HCl 源 | 當量 HCl | 產率( % ) | HPLC 純度 | 殘餘溶劑 | 氯化物含量 |
1. | 2.5 g | MeCN/ 1,4-二㗁烷 | 在1,4-二㗁烷中的4 M HCl | 1.0 | 95 | 97.98 LCAP | 6136 ppm MeCN | 5.5 |
2. | 5 g | THF/水 | 0.5 M HCl(水溶液) | 1.5 | 82 | 98.85 LCAP | 3649 ppm THF | 5.7 |
3. | 5 g | NMP/EtOH | 在EtOH中的1.25 M HCl | 1.5 | 84 | 99.07 LCAP | 15112 ppm NMP 1205 ppm EtOH | 5.7 |
4. | 0.5 g | 丙酮/ 水 | 1.5 M HCl(水溶液) | 2.0 | 89 | 98.97 LCAP | 4830 ppm丙酮 | N/A |
5. | 1 kg | 丙酮/ 水 | 1.5 M HCl(水溶液) | 2.0 | 78 | 98.99 LCAP | 1346 ppm丙酮 | 5.9 |
在環境溫度下將化合物A溶解於30體積丙酮中,之後精密過濾、添加5體積水和2.0當量鹽酸(2.5體積1.5 N HCl水溶液)。用於結晶和漿料老化的最終溶劑組成係80/20(v/v)丙酮/水,其為化合物A(即約18 mg/mL)和化合物A-HCl形式1(即約8 mg/mL)兩者提供了適當的溶解度以實現晶體生長和雜質排除。該過程係未加晶種的,並且在向化合物A溶液中添加鹽酸過程中發生晶體生長。將最終漿料在環境溫度下老化10 h,然後冷卻至10°C,之後濕法研磨。在10°C下進行研磨材料之分離,之後用8體積丙酮洗滌濾餅。將材料在真空下在40°C下乾燥。在THF/水和丙酮/水兩者中進行的濕法研磨實驗顯示出如表2中匯總的粒度減小至指定目標範圍,並且按XRPD、固態NMR和DSC,該形式純度 ≥ 95%。
[表2]. 從THF/水和丙酮/水漿料獲得的未研磨和研磨化合物A HCl粒度之比較。
溶劑 | THF/ 水 | 丙酮 / 水 | ||
粒度 | 研磨前 | 研磨後 | 研磨前 | 研磨後 |
D[4,3],µm | 54.2 | 28.1 | 50.6 | 26.9 |
D10,µm | 13.7 | 6.7 | 8.9 | 4.5 |
D50,µm | 47.6 | 26.2 | 41.7 | 24.6 |
D90,µm | 106.0 | 52.5 | 106.0 | 53.3 |
跨度 | 1.9 | 1.8 | 2.3 | 2.0 |
X射線粉末繞射:在具有RTMS檢測器的帕納科公司X’Pert PRO X射線繞射系統上獲得X射線粉末繞射數據。在45 kV和40 mA下以0.0334°的步長以從5-45°(2θ)的連續模式使用CuKα輻射(1.54 Å)掃描樣本。入射光束路徑配備有0.02弧度的索勒狹縫、15 mm掩模、4°固定防散射狹縫和可程式設計發散狹縫。繞射光束配備有0.02弧度的索勒狹縫、可程式設計防散射狹縫和0.02 mm鎳濾光片。在低背景樣本架上製備樣本並且將其放置於旋轉臺上,旋轉時間為2 s。對於可變溫度研究,在平板樣本架上製備樣本並且將其放置於TTK-450溫度控制台上。對於可變濕度研究,使用模組式濕度發生器(ProUmid)來控制THC濕度樣本室中的氣氛。結晶化合物A-HCl形式1材料之XRPD圖譜示出於圖1中,並且XRPD峰列出於表3中。
[表3]:結晶化合物A-HCl形式1之XRPD數據
位置 [°2θ] | FWHM [°2θ] | d- 間距 [Å] | 高度 [cts] | 相對強度 [%] |
7.46 | 0.12 | 11.85 | 4968.86 | 98.51 |
9.92 | 0.05 | 8.92 | 392.44 | 7.78 |
10.93 | 0.15 | 8.10 | 999.90 | 19.82 |
12.22 | 0.10 | 7.24 | 215.45 | 4.27 |
12.80 | 0.22 | 6.92 | 2194.48 | 43.51 |
13.65 | 0.17 | 6.49 | 156.86 | 3.11 |
14.45 | 0.13 | 6.13 | 1141.27 | 22.63 |
15.08 | 0.12 | 5.87 | 608.16 | 12.06 |
15.65 | 0.12 | 5.66 | 1160.06 | 23.00 |
15.91 | 0.13 | 5.57 | 1267.80 | 25.14 |
16.38 | 0.12 | 5.41 | 906.12 | 17.96 |
16.86 | 0.13 | 5.26 | 4628.60 | 91.77 |
17.60 | 0.13 | 5.04 | 694.56 | 13.77 |
18.22 | 0.17 | 4.87 | 3169.70 | 62.84 |
18.61 | 0.13 | 4.77 | 878.26 | 17.41 |
19.37 | 0.10 | 4.58 | 432.63 | 8.58 |
19.77 | 0.12 | 4.49 | 1876.76 | 37.21 |
20.19 | 0.15 | 4.40 | 5043.90 | 100.00 |
20.61 | 0.08 | 4.31 | 1142.70 | 22.66 |
20.93 | 0.10 | 4.24 | 357.31 | 7.08 |
21.15 | 0.10 | 4.20 | 195.64 | 3.88 |
21.63 | 0.15 | 4.11 | 1043.33 | 20.69 |
22.65 | 0.12 | 3.93 | 2116.42 | 41.96 |
23.15 | 0.08 | 3.84 | 876.92 | 17.39 |
23.55 | 0.15 | 3.78 | 4553.07 | 90.27 |
24.11 | 0.10 | 3.69 | 733.98 | 14.55 |
24.77 | 0.13 | 3.59 | 3403.62 | 67.48 |
25.94 | 0.14 | 3.43 | 1409.32 | 27.94 |
26.05 | 0.12 | 3.42 | 1700.20 | 33.71 |
26.25 | 0.08 | 3.39 | 608.23 | 12.06 |
26.76 | 0.10 | 3.33 | 1195.89 | 23.71 |
27.40 | 0.13 | 3.26 | 136.88 | 2.71 |
27.88 | 0.10 | 3.20 | 164.48 | 3.26 |
28.39 | 0.10 | 3.14 | 618.61 | 12.26 |
28.72 | 0.10 | 3.11 | 307.94 | 6.11 |
29.29 | 0.10 | 3.05 | 720.00 | 14.27 |
29.77 | 0.12 | 3.00 | 427.49 | 8.48 |
30.12 | 0.20 | 2.97 | 320.39 | 6.35 |
31.02 | 0.17 | 2.88 | 501.91 | 9.95 |
31.46 | 0.17 | 2.84 | 301.61 | 5.98 |
32.00 | 0.13 | 2.80 | 319.71 | 6.34 |
32.84 | 0.10 | 2.73 | 585.65 | 11.61 |
33.09 | 0.08 | 2.71 | 505.83 | 10.03 |
33.94 | 0.10 | 2.64 | 832.84 | 16.51 |
34.39 | 0.13 | 2.61 | 255.97 | 5.07 |
35.05 | 0.27 | 2.56 | 139.37 | 2.76 |
36.08 | 0.12 | 2.49 | 307.30 | 6.09 |
36.95 | 0.23 | 2.43 | 567.46 | 11.25 |
37.35 | 0.20 | 2.41 | 318.94 | 6.32 |
37.98 | 0.20 | 2.37 | 39.69 | 0.79 |
38.67 | 0.17 | 2.33 | 252.64 | 5.01 |
39.30 | 0.10 | 2.29 | 353.28 | 7.00 |
40.76 | 0.12 | 2.21 | 443.34 | 8.79 |
41.52 | 0.20 | 2.17 | 230.44 | 4.57 |
41.97 | 0.17 | 2.15 | 176.56 | 3.50 |
43.31 | 0.17 | 2.09 | 161.12 | 3.19 |
44.03 | 0.16 | 2.06 | 141.80 | 2.81 |
[表4]:結晶化合物A-HCl形式1之固態
19F NMR數據
峰 | ν(F1) [ppm] |
1 | -91 |
2 | -103 |
熱分析:在乾氮氣下在Tzero鋁盤中在TA儀器公司Q1000/2000熱量計上,以50 ml/min流動,進行微差掃描熱量法(DSC)。在乾氮氣下在鉑盤中在TA儀器公司Q500分析儀上,以60 ml/min流動,進行熱重分析(TGA)。結晶化合物A-HCl形式1之DSC和TGA示出於圖2中。結晶化合物A-HCl形式1之典型DSC和TGA指示出271.5°C的熔融起始和在熔融和分解之前的約4%重量損失。
動態蒸汽吸附(DVS):使用表面測量系統公司(Surface Measurement Systems)DVSAdvantage儀器收集水分吸附數據。將平衡標準設定為10分鐘內重量變化 ± 0.001%,最大平衡時間為360分鐘。結晶化合物A-HCl形式1之水分吸附曲線示出於圖3中。結晶化合物A-HCl形式1之典型DVS顯示出在95% RH下小於約0.5%的重量增加。
單晶數據:在室溫下,從具有過量HCl的DMF、DMAC或NMP中生長出結晶化合物A-HCl形式1之單晶。將化合物A-HCl形式1之單一無色針形晶體用於單晶結構確定。選擇用於數據收集的試樣係具有大約尺寸0.29 x 0.08 x 0.06 mm
3的針。將晶體藉由巴拉通油(paratone oil)安裝在布魯克公司APEX-II CCD繞射儀上的尼龍環上。在數據收集期間,使晶體保持在穩態
T= 173(2) K。使用Intrinsic Phasing解析方法並且藉由使用
Olex2(Dolomanov等人, 2009)作為圖形介面,用ShelXT(Sheldrick, G.M. (2015). Acta Cryst. [晶體學報] A71, 3-8)結構解析程式解析結構。用使用最小平方最小化的2018/3版ShelXL(Sheldrick, Acta Cryst. [晶體學報] A64 2008, 112-122)精修模型。表5示出了結晶化合物A-HCl形式1之晶體學數據匯總。如從X射線晶體結構確定發現的結晶化合物A-HCl形式1之分子結構示出於圖5中。
[表5]:結晶化合物A-HCl形式1之X射線單晶體學數據匯總:
*中心對稱的
波長 | 1.5418 Å |
晶系 | 單斜 |
空間群 | P2 1/n |
晶胞 | a = 8.9026 Å |
b = 13.8562 Å | |
c = 23.5472 Å | |
α = 90° | |
β = 94.987° | |
γ = 90° | |
體積 | 2893.7 Å 3 |
Z | 4 |
密度(計算值) | 1.380 Mg/m 3 |
絕對結構參數 | NA* |
實例
2
:結晶化合物
A-HCl
形式
2
。
在高通量漿化條件下用在90/10丙酮/水溶劑中之一當量HCl產生結晶化合物A-HCl形式2。此亞穩態形式具有低熔點並且不能放大或再現。
X射線粉末繞射:結晶化合物A-HCl形式2材料之XRPD圖譜示出於圖7中。
熱分析:結晶化合物A-HCl形式2之DSC示出於圖8中。結晶化合物A-HCl形式2之典型DSC指示出113.2°C的熔融起始。
實例
3
:無定形化合物
A-HCl
。
將無定形化合物A-HCl從在甲醇中的旋轉蒸發中分離出,並且顯示出具有一或多個寬峰之X射線無定形。玻璃轉換溫度(T
g)係124°C,如藉由調製DSC分析(MDSC)(圖9)所示的。化合物在165°C至180°C下加熱時轉化為結晶化合物A-HCl形式1。化合物在用水加壓力時轉化為結晶化合物A-HCl形式1和化合物A水合物形式2。
實例
4
:結晶化合物
A-MsA
形式
1
。
藉由在環境條件下將一莫耳當量甲磺酸和化合物A在乙腈中漿化來製備結晶化合物A-MsA形式1。藉由在具有頂置式攪拌器的梅特勒-托利多公司EasyMax控制的實驗室反應器中在60°C下將3 g化合物A溶解於乙酸乙酯(30 ml)中來以更大規模製備克水平。添加一莫耳當量甲磺酸(350 µl),並且觀察到沈澱。將漿料在60°C下老化8小時,並且然後以0.1°C/min冷卻至20°C。在20°C下老化過夜之後藉由真空過濾分離固體。將濕餅用乙酸乙酯(15 ml)洗滌。XRPD分析指示濕餅係化合物A-MsA形式1。然後將濕餅在環境溫度下真空乾燥4天並表徵。產率係89%。
X射線粉末繞射:結晶化合物A-MsA形式1材料之XRPD圖譜示出於圖10中,並且XRPD峰列出於表6中。
[表6]:結晶化合物A-MsA形式1之XRPD數據:
位置 [°2θ] | FWHM [°2θ] | d- 間距 [Å] | 高度 [cts] | 相對強度 [%] |
5.7617 | 0.1171 | 15.33923 | 3563.27 | 31.19 |
6.9624 | 0.1506 | 12.69635 | 7042.91 | 61.65 |
10.3789 | 0.1506 | 8.5234 | 1384.44 | 12.12 |
11.4149 | 0.1004 | 7.75206 | 1349.12 | 11.81 |
11.757 | 0.1004 | 7.52727 | 2469.54 | 21.62 |
12.6462 | 0.1171 | 6.99991 | 4221.79 | 36.96 |
13.2625 | 0.184 | 6.676 | 1562.02 | 13.67 |
13.5157 | 0.184 | 6.55151 | 2979.83 | 26.09 |
13.9748 | 0.1506 | 6.33726 | 1876.93 | 16.43 |
15.2984 | 0.2509 | 5.79185 | 4150.19 | 36.33 |
15.7192 | 0.1171 | 5.63773 | 6578.37 | 57.59 |
16.0526 | 0.1338 | 5.52139 | 3477.55 | 30.44 |
16.5226 | 0.1338 | 5.36536 | 11423.3 | 100 |
17.3718 | 0.1673 | 5.10495 | 6589.9 | 57.69 |
18.0232 | 0.1673 | 4.92188 | 3151.82 | 27.59 |
18.4749 | 0.1506 | 4.80257 | 4712.45 | 41.25 |
19.0636 | 0.1338 | 4.65555 | 986.66 | 8.64 |
20.0335 | 0.184 | 4.43231 | 6106.14 | 53.45 |
20.5715 | 0.1171 | 4.31758 | 3925.51 | 34.36 |
20.9518 | 0.2007 | 4.24007 | 5418.76 | 47.44 |
22.0197 | 0.1338 | 4.03679 | 1294.16 | 11.33 |
22.5862 | 0.1004 | 3.9368 | 1497.18 | 13.11 |
22.9684 | 0.1338 | 3.87216 | 1723.17 | 15.08 |
23.1804 | 0.2007 | 3.83722 | 2033.44 | 17.8 |
23.9206 | 0.184 | 3.72013 | 7336.95 | 64.23 |
25.1798 | 0.2007 | 3.53687 | 2531.92 | 22.16 |
25.9079 | 0.2007 | 3.43911 | 1506.44 | 13.19 |
26.783 | 0.368 | 3.32869 | 1541.01 | 13.49 |
28.0224 | 0.1673 | 3.18422 | 1898.47 | 16.62 |
28.5556 | 0.1338 | 3.12597 | 899.77 | 7.88 |
29.4476 | 0.2676 | 3.03328 | 499.68 | 4.37 |
30.4832 | 0.368 | 2.93255 | 1823.75 | 15.97 |
31.9437 | 0.2007 | 2.80173 | 433.97 | 3.8 |
32.4773 | 0.1338 | 2.7569 | 977.85 | 8.56 |
32.8882 | 0.2007 | 2.72339 | 757.89 | 6.63 |
33.4218 | 0.1338 | 2.68112 | 398.32 | 3.49 |
34.7631 | 0.4015 | 2.58069 | 207.81 | 1.82 |
36.3258 | 0.5353 | 2.47317 | 143.17 | 1.25 |
37.1502 | 0.2007 | 2.42017 | 108.9 | 0.95 |
38.7259 | 0.3346 | 2.32525 | 207.39 | 1.82 |
結晶化合物A-MsA形式1之指標化解析:XRPD指標化係可用於提取資訊並説明解釋XRPD圖譜之方法。XRPD指標化係確定負責XRPD圖譜中之一組峰之結晶組分的晶體學晶胞之大小、形狀和對稱性的過程。用Cu-Kα輻射收集結晶化合物A-MsA形式1,並且指標化結果製錶於下表7中。
[表7]:結晶化合物A-MsA形式1的XRPD數據之指標化結果:
布拉維(Bravais)晶格類型 | 簡單單斜 |
a [Å] | 16.157 |
b [Å] | 7.860 |
c [Å] | 26.462 |
α [度] | 90 |
β [度] | 106.71 |
γ [度] | 90 |
體積 [Å 3/晶胞] | 3,218.6 |
手性內容? | 未指定 |
消光符號 | P 1 2 1/n 1 |
空間群 | P2 1/n (14) |
熱分析:結晶化合物A-MsA形式1之DSC和TGA示出於圖11中。結晶化合物A-MsA形式1之典型DSC指示在250°C處的熔融起始。結晶化合物A-MsA形式1之TGA顯示出在分解前0.2%的重量損失。
吸濕性分析:結晶化合物A-MsA形式1之吸濕曲線示出於圖12中。結晶化合物A-MsA形式1之典型DVS顯示出在95% RH下約1.2%的重量增加。
實例
5
:結晶化合物
A-MsA
形式
2
。
藉由在環境條件下將一當量MSA和化合物A在90/10 THF/水v/v溶劑中漿化來製備結晶化合物A-MsA形式2。
X射線粉末繞射:結晶化合物A-MsA形式2材料之XRPD圖譜示出於圖14中。
熱分析:結晶化合物A-MsA形式2之DSC示出於圖15中。結晶化合物A-MsA形式2之典型DSC指示出38.0°C和177.1°C吸熱事件之熔融起始。結晶化合物A-MsA形式2之TGA顯示出在分解前約0.3%的重量損失(參見圖16)。
實例
6
:結晶化合物
A-TsA
形式
1
和形式
5
。
藉由在環境條件下將一莫耳當量對甲苯磺酸和化合物A在乙腈中漿化來製備結晶化合物A-TsA形式1。
X射線粉末繞射:結晶化合物A-TsA形式1材料之XRPD圖譜示出於圖17中。
結晶化合物A-TsA形式1之可變溫度X射線繞射(VTXRD)顯示出在 ≥ 180°C溫度處的重結晶,並且新的結晶形式被指定為結晶化合物A-TsA形式5。VTXRD圖譜示出於圖18中。
熱分析:結晶化合物A-TsA形式1之DSC和TGA圖譜示出於圖19中。結晶化合物A-TsA形式1之典型DSC指示出193.9°C和258.4°C吸熱事件之起始。結晶化合物A-TsA形式1之TGA顯示出在分解前約0.07%的重量損失。
實例
7
:結晶化合物
A-TsA
形式
3
。
藉由在環境條件下將一莫耳當量對甲苯磺酸和化合物A在90/10 EtOH/水v/v中漿化來製備結晶化合物A-TsA形式3。
X射線粉末繞射:結晶化合物A-TsA形式3之XRPD圖譜示出於圖22中。
熱分析:結晶化合物A-TsA形式3之DSC和TGA圖譜示出於圖23中。結晶化合物A-TsA形式3之典型DSC指示出161.0°C和248.9°C吸熱事件之起始。結晶化合物A-TsA形式3之TGA顯示出在分解前約0.48%的重量損失。
實例
8
:結晶化合物
A-TsA
形式
4
。
藉由在環境條件下將一莫耳當量對甲苯磺酸和化合物A在EtOH中漿化來製備結晶化合物A-TsA形式4。替代性地,該化合物還從化合物A-TsA形式1在以下條件下的真空乾燥中產生:在95°C至103°C的溫度下持續1天且然後在107°C至109°C的溫度下持續3天;或在150°C至170°C下持續1天。
藉由對TSA鹽形式1之化合物A-異丙醇溶劑合物進行去溶劑化來製備放大的化合物A-TsA鹽形式4。該程序涉及在具有頂置式攪拌器的梅特勒-托利多公司EasyMax控制的實驗室反應器中在60°C下將3.5 g化合物A和1莫耳當量對甲苯磺酸(1.08 g)在異丙醇(60 ml)中攪拌。將漿料在60°C下攪拌1天,並且以0.1°C/min冷卻至20°C。將固體藉由真空過濾分離並且用異丙醇(10 ml)洗滌兩次。XRPD分析指示材料由甲苯磺酸鹽形式1和微量游離形式異丙醇溶劑合物之混合物構成。為了試圖完成反應,在環境溫度下將固體在具有約0.15莫耳當量對甲苯磺酸(0.21 g)的異丙醇(30 ml)中再漿化4天。將固體藉由真空過濾分離並且用異丙醇(10 ml)洗滌兩次。XRPD分析指示固體由甲苯磺酸鹽形式1構成並且仍含有痕量的游離形式異丙醇溶劑合物。在60°C下將固體再次用在異丙醇(50 ml)中的0.25莫耳當量對甲苯磺酸(0.34 g)再漿化。在攪拌1天之後藉由真空過濾分離固體。將濕餅用異丙醇(15 ml)洗滌並且藉由XRPD分析。XRPD圖譜與化合物A-TsA鹽形式1和微量化合物A-TsA鹽形式4一致。在145°C下真空乾燥材料導致向化合物A-TsA鹽形式4之完全轉化(根據XRPD)。結晶化合物A-TsA形式4材料之XRPD圖譜示出於圖24a中,並且XRPD峰列出於表7中。
[表7]:結晶化合物A-TsA形式4之XRPD數據
位置 [°2θ] | FWHM [°2θ] | d- 間距 [Å] | 高度 [cts] | 相對強度 [%] |
6.202 | 0.0836 | 14.25126 | 11841.62 | 100 |
8.3596 | 0.0669 | 10.57727 | 862.73 | 7.29 |
10.485 | 0.1171 | 8.4374 | 1865.49 | 15.75 |
11.1414 | 0.0836 | 7.94174 | 551.39 | 4.66 |
12.1296 | 0.0669 | 7.29686 | 779.83 | 6.59 |
12.4404 | 0.0836 | 7.11527 | 1853.58 | 15.65 |
12.9743 | 0.0669 | 6.82362 | 774.13 | 6.54 |
13.129 | 0.0669 | 6.74358 | 977.91 | 8.26 |
14.2446 | 0.1004 | 6.21785 | 3903.03 | 32.96 |
14.6709 | 0.0836 | 6.03811 | 9322.96 | 78.73 |
14.8356 | 0.0502 | 5.97147 | 2122.89 | 17.93 |
15.5616 | 0.1004 | 5.69447 | 1034.9 | 8.74 |
16.4028 | 0.1004 | 5.40427 | 1127.73 | 9.52 |
16.7652 | 0.0836 | 5.28828 | 347.28 | 2.93 |
17.0513 | 0.0669 | 5.20018 | 378.6 | 3.2 |
17.6527 | 0.1004 | 5.02433 | 3101.72 | 26.19 |
18.331 | 0.1004 | 4.83993 | 1556.97 | 13.15 |
18.6311 | 0.1171 | 4.76264 | 2952.46 | 24.93 |
19.0787 | 0.1004 | 4.65191 | 4994.87 | 42.18 |
20.1393 | 0.1171 | 4.40924 | 1475.66 | 12.46 |
20.8195 | 0.1338 | 4.2667 | 1419.22 | 11.98 |
21.47 | 0.1004 | 4.13888 | 3668.99 | 30.98 |
21.8269 | 0.0836 | 4.07201 | 644.54 | 5.44 |
22.3718 | 0.1506 | 3.97404 | 2361.38 | 19.94 |
23.0541 | 0.0669 | 3.85796 | 516.62 | 4.36 |
23.4894 | 0.1338 | 3.78744 | 4553.16 | 38.45 |
24.1138 | 0.1673 | 3.69076 | 1930.58 | 16.3 |
24.3771 | 0.1171 | 3.65149 | 717.86 | 6.06 |
25.1314 | 0.0836 | 3.54357 | 990.68 | 8.37 |
25.2663 | 0.0836 | 3.52496 | 1313.91 | 11.1 |
25.4626 | 0.1004 | 3.49823 | 879.29 | 7.43 |
26.1153 | 0.1171 | 3.41226 | 751.94 | 6.35 |
26.5717 | 0.0836 | 3.35468 | 434.08 | 3.67 |
26.9761 | 0.0836 | 3.3053 | 711.31 | 6.01 |
28.6593 | 0.0836 | 3.11489 | 1044.32 | 8.82 |
29.0205 | 0.1506 | 3.07694 | 1315.89 | 11.11 |
29.5827 | 0.1004 | 3.01973 | 526.68 | 4.45 |
29.932 | 0.2007 | 2.98528 | 624.8 | 5.28 |
30.3779 | 0.2007 | 2.94247 | 321.63 | 2.72 |
30.7184 | 0.1171 | 2.91063 | 272.55 | 2.3 |
31.1915 | 0.1338 | 2.86755 | 235.81 | 1.99 |
32.7035 | 0.2342 | 2.73835 | 148.16 | 1.25 |
33.71 | 0.1171 | 2.65885 | 200.45 | 1.69 |
34.1773 | 0.1673 | 2.62357 | 235.65 | 1.99 |
35.1349 | 0.0836 | 2.55422 | 478.92 | 4.04 |
36.7215 | 0.1673 | 2.44742 | 226.97 | 1.92 |
37.7829 | 0.2007 | 2.38108 | 112.12 | 0.95 |
38.3197 | 0.2342 | 2.34895 | 204.82 | 1.73 |
38.6344 | 0.2007 | 2.33054 | 201.61 | 1.7 |
39.7904 | 0.0669 | 2.26546 | 288.15 | 2.43 |
單晶數據:表8示出了結晶化合物A-TsA形式4之晶體學數據匯總。如從X射線晶體結構確定發現的結晶化合物A-TsA形式4之分子結構示出於圖24b中。
[表8]:結晶化合物A-TsA形式4之X射線單晶體學數據匯總:
波長 | _1.542 Å |
晶系 | 正交晶 |
空間群 | Pbcn |
晶胞 | a = 24.7407 Å |
b = 10.7567 Å | |
c = 26.4846 Å | |
α = 90° | |
β = 90° | |
γ = 90° | |
體積 | 7048.3 Å 3 |
Z | 8 |
密度(計算值) | 1.391 Mg/m 3 |
熱分析:結晶化合物A-TsA形式4之DSC和TGA圖譜示出於圖25中。結晶化合物A-TsA形式4之典型DSC指示在253°C處的熔融起始。結晶化合物A-TsA形式4之TGA顯示出在分解前0.145%的重量損失。
固態NMR:結晶化合物A-TsA形式4之固態
19F NMR波譜示出於圖26中,該圖指示出在-96.93和-101.60 ppm處的2個峰。
實例
9
:結晶化合物
A-TsA
形式
5
。
藉由將結晶化合物A-TsA形式1加熱至高於180°C來製備結晶化合物A-TsA形式5。
X射線粉末繞射:XRPD圖譜示出於圖27中。
實例
10
:結晶化合物
A-DiTsA
形式
6
。
藉由在高通量背景中將兩莫耳當量對甲苯磺酸和化合物A在乙腈中漿化來製備結晶化合物A-DiTsA形式6。化合物之放大嘗試未成功。
X射線粉末繞射:XRPD圖譜示出於圖28中。
實例
11
:結晶化合物
A-
硫酸鹽形式
1
。
藉由在環境條件下將一當量硫酸和化合物A在乙腈中漿化來製備結晶化合物A-硫酸鹽形式1。
X射線粉末繞射:XRPD圖譜示出於圖30中。
熱分析:結晶化合物A-硫酸鹽形式1之DSC和TGA示出於圖31中。結晶化合物A-硫酸鹽形式1之典型DSC指示出在182.3°C和263.7°C吸熱事件處的起始。結晶化合物A-硫酸鹽形式1之TGA顯示出在分解前6.47%的重量損失。
吸濕性分析:結晶化合物A-硫酸鹽形式1之吸濕曲線示出於圖32中。結晶化合物A-硫酸鹽形式1之動態蒸汽吸附(DVS)表明硫酸鹽在90% RH下潮解。
實例
12
:無定形化合物
A
。
藉由將1.99 g化合物A-可變水合物形式2(參見實例# 13)溶解於100 mL丙酮中並且振盪以形成黃色溶液來製備無定形化合物A。然後將溶液以2 mL/min的噴霧速率噴霧乾燥,其中入口溫度為54°C,出口溫度為54°C,抽吸器在95%下,乾燥空氣流量為0.55 kg/min,噴嘴空氣在6.0 sL/min下並且噴嘴冷卻在20°C下。收集無定形產物,並且在40°C下、具有-10巴壓力的真空爐下乾燥2.5小時以除去殘餘丙酮。
X射線粉末繞射:無定形化合物A之XRPD圖譜示出於圖33中。
熱分析:無定形化合物A之DSC示出於圖38中。無定形化合物A之典型DSC指示出在91°C處的玻璃轉換溫度(T
g)。無定形化合物A之TGA-IR示出於圖34中。無定形化合物A之TGA-IR顯示出在100°C以下水分子之1.05%重量損失,如圖35所示。
實例
13
:化合物
A-
可變水合物形式
2
。
藉由將化合物A-甲醇形式1和化合物A-乙醇形式1產物的混合物在水中漿化24小時來製備化合物A-可變水合物形式2。然後過濾和空氣乾燥產物。
替代性地,藉由將化合物A在甲醇和乙醇溶劑混合物中混合來製備化合物A-可變水合物形式2。化合物A首先形成化合物A-甲醇和化合物A-乙醇溶劑合物混合物,然後將其在水中漿化以引發向化合物A-可變水合物形式2產物的轉化。為了實現完全轉化,將化合物A-可變水合物形式2產物過濾,並且在升高的溫度(例如50C)下乾燥過夜以除去所有剩餘有機溶劑。
X射線粉末繞射:化合物A-可變水合物形式2之XRPD圖譜示出於圖36中,並且XRPD峰列出於表9中。
[表9]:結晶化合物A-可變水合物形式2之XRPD數據。
位置 [°2θ] | FWHM [°2θ] | d- 間距 [Å] | 高度 [cts] | 相對強度 [%] |
3.5259 | 0.0465 | 25.05944 | 3874.4 | 9.47 |
7.0727 | 0.0465 | 12.49861 | 817.33 | 2 |
8.4034 | 0.0697 | 10.52216 | 249.56 | 0.61 |
10.0657 | 0.0465 | 8.78788 | 7370.33 | 18.02 |
10.6175 | 0.0697 | 8.33241 | 210.38 | 0.51 |
11.1919 | 0.0465 | 7.90602 | 13007.2 | 31.81 |
11.6612 | 0.0465 | 7.58891 | 766.31 | 1.87 |
13.1983 | 0.0697 | 6.70835 | 236.22 | 0.58 |
13.858 | 0.0581 | 6.39044 | 16389.41 | 40.08 |
14.7185 | 0.0581 | 6.01871 | 1238.31 | 3.03 |
15.7803 | 0.0465 | 5.61604 | 1430.57 | 3.5 |
16.2049 | 0.0581 | 5.46983 | 40895.73 | 100 |
16.3899 | 0.0465 | 5.40851 | 7422.06 | 18.15 |
17.2502 | 0.0348 | 5.14065 | 3019.89 | 7.38 |
17.3745 | 0.0465 | 5.10417 | 3630.09 | 8.88 |
17.7541 | 0.0581 | 4.99588 | 717.93 | 1.76 |
18.1174 | 0.0581 | 4.8965 | 2212.42 | 5.41 |
18.4171 | 0.0697 | 4.81749 | 3123.43 | 7.64 |
18.6966 | 0.0581 | 4.74611 | 4195.83 | 10.26 |
19.3851 | 0.0465 | 4.57908 | 7495.87 | 18.33 |
19.5557 | 0.0581 | 4.53951 | 18007.58 | 44.03 |
19.9635 | 0.0581 | 4.44769 | 5786.34 | 14.15 |
20.2172 | 0.0581 | 4.39244 | 3988.37 | 9.75 |
20.7733 | 0.0465 | 4.27609 | 400.1 | 0.98 |
21.1641 | 0.0929 | 4.19801 | 1496.44 | 3.66 |
21.9302 | 0.0929 | 4.05307 | 400.41 | 0.98 |
22.4926 | 0.0465 | 3.95297 | 2032.91 | 4.97 |
22.6875 | 0.0465 | 3.91945 | 4501.02 | 11.01 |
22.9495 | 0.0465 | 3.8753 | 3327.64 | 8.14 |
23.2126 | 0.0708 | 3.8288 | 8736.19 | 21.36 |
23.2929 | 0.0425 | 3.82526 | 8096.88 | 19.8 |
24.0078 | 0.1133 | 3.70374 | 821.54 | 2.01 |
25.0842 | 0.0708 | 3.5472 | 683.37 | 1.67 |
25.6238 | 0.0992 | 3.47371 | 1376.56 | 3.37 |
26.0061 | 0.0992 | 3.4235 | 6312.46 | 15.44 |
26.5611 | 0.0708 | 3.35322 | 1159.46 | 2.84 |
27.0761 | 0.085 | 3.29059 | 1684.78 | 4.12 |
27.5641 | 0.085 | 3.23343 | 3930.25 | 9.61 |
27.9337 | 0.0708 | 3.19149 | 961.99 | 2.35 |
28.1181 | 0.0708 | 3.17097 | 1269.02 | 3.1 |
28.5516 | 0.0992 | 3.12381 | 1112.73 | 2.72 |
29.8219 | 0.1417 | 2.99358 | 411.91 | 1.01 |
30.2018 | 0.1133 | 2.95677 | 311.5 | 0.76 |
30.8316 | 0.0992 | 2.8978 | 1695.28 | 4.15 |
31.2945 | 0.085 | 2.85598 | 483.95 | 1.18 |
31.6143 | 0.085 | 2.82782 | 997.71 | 2.44 |
32.0573 | 0.0567 | 2.78974 | 929.07 | 2.27 |
32.2146 | 0.0567 | 2.77648 | 1013.24 | 2.48 |
32.9146 | 0.0567 | 2.71901 | 791.51 | 1.94 |
33.1229 | 0.0567 | 2.70239 | 1184.3 | 2.9 |
33.5895 | 0.1133 | 2.66591 | 219.49 | 0.54 |
34.5176 | 0.0708 | 2.59633 | 365.15 | 0.89 |
35.286 | 0.2267 | 2.54153 | 211.54 | 0.52 |
35.9712 | 0.1133 | 2.49467 | 323.7 | 0.79 |
36.9248 | 0.0567 | 2.43241 | 1163.96 | 2.85 |
37.5393 | 0.1417 | 2.39398 | 184.66 | 0.45 |
38.5019 | 0.0567 | 2.33632 | 401.22 | 0.98 |
39.0919 | 0.1133 | 2.3024 | 351.71 | 0.86 |
熱分析:化合物A-可變水合物形式2之DSC示出於圖37中。化合物A-可變水合物形式2之典型DSC指示出51°C的脫水起始和136°C的熔點。化合物A-可變水合物形式2之TGA示出於圖38中。化合物A-可變水合物形式2之TGA顯示出在100°C以下水分子之2.0%重量損失。
吸濕性分析:化合物A-可變水合物形式2之吸濕曲線示出於圖39中。化合物A-可變水合物形式2之動態蒸汽吸附(DVS)顯示出在95% RH下約3.4%的重量增加。
實例
14
:無水化合物
A
形式
3
。
藉由將化合物A-THF溶劑合物加熱至150°C的溫度,保持3分鐘,然後在RT下平衡來獲得無水化合物A形式3。
X射線粉末繞射:無水化合物A形式3之XRPD圖譜示出於圖40中。
熱分析:無水化合物A形式3之DSC示出於圖41中。無水化合物A形式3之典型DSC指示出196.5°C的熔融起始。
吸濕性分析:將無水化合物A形式3之吸濕曲線示出於圖42中。無水化合物A形式3之動態蒸汽吸附(DVS)顯示出在95% RH下約1.5%的重量增加。
實例
15
:無水化合物
A
形式
4
。
藉由在40°C下將混合的無水化合物A形式3和化合物A-可變水合物形式2(實例13)在庚烷中漿化5天來獲得無水化合物A形式4。
X射線粉末繞射:無水化合物A形式4之XRPD圖譜示出於圖43中。
實例
16
:無水化合物
A
形式
5
。
藉由在70°C的溫度下將350 mg無水化合物A形式3和化合物A-可變水合物形式2(實例13)混合物在18 mL庚烷中漿化一天來獲得無水化合物A形式5。然後將固體從熱板移除並過濾,並且用5 mL庚烷洗滌;然後用氮氣流下乾燥過夜。
X射線粉末繞射:無水化合物A形式5之XRPD圖譜示出於圖44中。
熱分析:無水化合物A形式5之DSC和TGA圖譜示出於圖45中。無水化合物A形式5之典型DSC指示出136.5°C的熔融起始。無水化合物A形式5之TGA顯示出0.17%重量損失。
吸濕性分析:將無水化合物A形式5之吸濕曲線示出於圖46中。無水化合物A形式5之動態蒸汽吸附(DVS)顯示化合物再水合為化合物A-可變水合物形式2(實例13)。
實例
17
:無水化合物
A
形式
6
。
藉由在80°C的溫度下將無水化合物A形式3和化合物A-可變水合物形式2(實例13)混合物在庚烷中漿化過夜來獲得無水化合物A形式6。
X射線粉末繞射:無水化合物A形式6之XRPD圖譜示出於圖47中。
熱分析:無水化合物A形式6之DSC和TGA示出於圖48中。無水化合物A形式6之典型DSC指示出186.4°C的起始。無水化合物A形式6之TGA顯示出0.38%重量損失。
實例
18
:無水化合物
A
形式
7
。
藉由在70°C的溫度下將無水化合物A形式3和化合物A-可變水合物形式2(實例13)在庚烷中漿化3天來獲得無水化合物A形式7。
X射線粉末繞射:無水化合物A形式7之XRPD圖譜示出於圖49中。
實例
19
:無水化合物
A
形式
8
。
藉由在50°C的溫度下將無水化合物A形式3和化合物A-可變水合物形式2(實例13)在甲苯中漿化3天來獲得無水化合物A形式8。
X射線粉末繞射:無水化合物A形式8之XRPD圖譜示出於圖50中。
熱分析:無水化合物A形式8之DSC和TGA示出於圖51中。無水化合物A形式8之典型DSC指示出156.3°C和185.9°C的熔融起始。無水化合物A形式8之TGA顯示出0.73%重量損失。
實例
20
:結晶化合物
A
形式
1
。
為了獲得結晶化合物A形式1,將化合物A藉由使用預裝填的Redi Sep柱(12 g)和使用在庚烷中的20%至100% EtOH作為洗脫液的組合式急速矽膠柱層析法進行純化。然後,將具有期望產物的級分減壓濃縮,並且將殘餘物溶解於乙腈/水溶劑混合物中並冷凍乾燥。
X射線粉末繞射:結晶化合物A形式1之XRPD圖譜示出於圖52中。
實例
21
:結晶化合物
A-THF
溶劑合物。
藉由將化合物A在以下多種溶劑中漿化來製備結晶化合物A-THF溶劑合物:即,a) 50 mg/mL THF溶液;b) 50-50 THF/水混合物;c) 50-50 THF/甲醇混合物;或d) 50-25-25 THF-NMP-水混合物。
X射線粉末繞射:結晶化合物A-THF溶劑合物之XRPD圖譜示出於圖53中。
熱分析:結晶化合物A-THF溶劑合物之DSC和TGA示出於圖54中。結晶化合物A-THF溶劑合物之典型DSC指示出122.6°C的熔融起始和在191.5°C處的去溶劑化起始。結晶化合物A-THF溶劑合物之TGA顯示出11.4%重量損失,這對應於1莫耳當量THF分子之去溶劑化吸熱。
單晶數據:表10示出了結晶化合物A-THF溶劑合物之晶體學數據匯總。
[表10]:結晶化合物A-THF溶劑合物之X射線單晶體學數據匯總:
波長 | 0.71073 Å |
晶系 | 三斜晶系 |
空間群 | P-1 |
晶胞 | a = 9.36460(10) Å |
b = 10.6617(2) Å | |
c = 16.2424(3) Å | |
α = 79.3910(10)° | |
β = 80.7010(10)° | |
γ = 79.6150(10)º | |
體積 | 1553.94(4) Å 3 |
Z | 2 |
密度(計算值) | 1.357 Mg/m 3 |
實例
22
:結晶化合物
A-
乙醇溶劑合物。
藉由將化合物A在乙醇中漿化來製備結晶化合物A-乙醇溶劑合物。
X射線粉末繞射:結晶化合物A-乙醇溶劑合物之XRPD圖譜示出於圖55中。
熱分析:結晶化合物A-乙醇溶劑合物之TGA示出於圖56中。結晶化合物A-乙醇溶劑合物之TGA顯示出7.58%重量損失,這對應於一莫耳當量乙醇分子的損失。結晶化合物A-乙醇溶劑合物之DSC示出於圖57中。結晶化合物A-乙醇溶劑合物之典型DSC指示出131.8°C、165.6°C和198.1°C吸熱事件之起始。
實例
23
:結晶化合物
A-
丙醇溶劑合物。
藉由將化合物A在1-丙醇中漿化來製備結晶化合物A-丙醇溶劑合物。
X射線粉末繞射:結晶化合物A-丙醇溶劑合物之XRPD圖譜示出於圖58中。
熱分析:結晶化合物A-丙醇溶劑合物之TGA和DSC示出於圖59中。結晶化合物A-丙醇溶劑合物之TGA顯示出9.95%重量損失,這對應於一莫耳當量1-丙醇分子的損失。結晶化合物A-丙醇溶劑合物之典型DSC指示出112.2°C和194.2°C的熔融起始。
實例
24
:結晶化合物
A-
異丙醇(
IPA
)溶劑合物。
藉由將化合物A在50-50 1-丙醇/水混合物中漿化來製備結晶化合物A-IPA溶劑合物。
X射線粉末繞射:結晶化合物A-IPA溶劑合物之XRPD圖譜示出於圖60中。
熱分析:結晶化合物A-IPA溶劑合物之TGA和DSC示出於圖61中。結晶化合物A-IPA溶劑合物之TGA顯示出8.5%重量損失,這對應於一莫耳當量異丙醇分子的損失。結晶化合物A-IPA溶劑合物之典型DSC指示出114.6°C、158.7°C和194.9°C吸熱事件之起始。
實例
25
:結晶化合物
A-
甲醇溶劑合物。
藉由將化合物A在甲醇中漿化來製備結晶化合物A-甲醇溶劑合物。
X射線粉末繞射:結晶化合物A-甲醇溶劑合物之XRPD圖譜示出於圖62中。
實例
26
:結晶化合物
A-
乙酸異丙酯(
IPAc
)溶劑合物。
藉由將化合物A在乙酸異丙酯中漿化來製備結晶化合物A-IPAc溶劑合物。
X射線粉末繞射:結晶化合物A-IPAc溶劑合物之XRPD圖譜示出於圖63中。
實例
27
:結晶化合物
A-
丙酮溶劑合物。
藉由將化合物A在丙酮中漿化來製備結晶化合物A-丙酮溶劑合物。
X射線粉末繞射:結晶化合物A-丙酮溶劑合物之XRPD圖譜示出於圖64中。
實例
28
:結晶化合物
A-
環戊基甲基醚(
CPME
)溶劑合物。
藉由將化合物A在環戊基甲基醚中漿化來製備結晶化合物A-CPME溶劑合物。
X射線粉末繞射:結晶化合物A-CPME溶劑合物之XRPD圖譜示出於圖65中。
實例
29
:結晶化合物
A-
二㗁烷溶劑合物。
藉由將化合物A在二㗁烷中漿化來製備結晶化合物A-二㗁烷溶劑合物。
X射線粉末繞射:結晶化合物A-二㗁烷溶劑合物之XRPD圖譜示出於圖66中。
實例
30
:結晶化合物
A-
乙酸乙酯(
EtoAc
)溶劑合物。
藉由將化合物A在乙酸乙酯中漿化來製備結晶化合物A-EtOAc溶劑合物。
X射線粉末繞射:結晶化合物A-EtOAc溶劑合物之XRPD圖譜示出於圖67中。
實例
31
:結晶化合物
A-
乙腈(
MeCN
)溶劑合物。
藉由將化合物A在乙腈中漿化來製備結晶化合物A-MeCN溶劑合物。
X射線粉末繞射:結晶化合物A-MeCN溶劑合物之XRPD圖譜示出於圖68中。
實例
32
:結晶化合物
A-
甲基三級丁基醚(
MTBE
)溶劑合物。
藉由將化合物A在甲基三級丁基醚中漿化來製備結晶化合物A-MTBE溶劑合物。
X射線粉末繞射:結晶化合物A-CMTBE溶劑合物之XRPD圖譜示出於圖69中。
實例
33
:結晶化合物
A-
甲苯溶劑合物。
藉由在25°C下將化合物A在甲苯中漿化18小時來製備結晶化合物A-甲苯溶劑合物。
X射線粉末繞射:結晶化合物A-甲苯溶劑合物之XRPD圖譜示出於圖70中。
實例
34
:結晶化合物
A-
十二烷基硫酸鹽。
藉由在37°C下將100 mg化合物A-HCl在具有或不具有0.01 N HCl的0.5%十二烷基硫酸鈉(SDS)中漿化三小時來製備結晶化合物A-十二烷基硫酸鹽。將固體然後移除並過濾,然後用1 mL DI水洗滌,並且用氮氣流乾燥過夜。獲得新的晶體形式,並且溶液NMR分析指示出1 : 1 API : 十二烷基硫酸鹽比率,並且測定確認69%化合物A含量,這與一當量十二烷基硫酸鹽相關聯。
X射線粉末繞射:結晶化合物A-十二烷基硫酸鹽之XRPD圖譜示出於圖71中。
熱分析:結晶化合物A-十二烷基硫酸鹽之TGA和DSC示出於圖72中。結晶化合物A-十二烷基硫酸鹽之TGA顯示出21.1%重量損失。結晶化合物A-十二烷基硫酸鹽之典型DSC指示出75.8°C的熔融起始和在174.8°C處的分解。
實例
35
:結晶化合物
A-
二甲基甲醯胺(
DMF
)溶劑合物水合物。
藉由將化合物A-HCl形式1溶解於DMF溶劑中來製備結晶化合物A-DMF溶劑合物水合物。然後將溶液過濾以從溶液中除去剩餘固體顆粒。將澄清溶液在室溫下在通風櫃中靜置以進行慢溶劑蒸發。在一週之後觀察到單晶。
X射線粉末繞射:結晶化合物A-DMF溶劑合物水合物之XRPD圖譜示出於圖73中。
熱分析:結晶化合物A-DMF溶劑合物水合物之DSC示出於圖74中。結晶化合物A-DMF溶劑合物水合物之典型DSC指示出107.8°C的熔融起始。
單晶數據:在提供的晶體之單晶結構中,DMF分子顯示為無序的,並且水分子精修0.25的部分占位元率。DMF分子顯示未與化合物A氫鍵合
。表11示出了結晶化合物A-DMF溶劑合物水合物之晶體學數據匯總。
[表11]:結晶化合物A-DMF溶劑合物水合物之X射線單晶體學數據匯總:
波長 | 0.710730 Å |
晶系 | 三斜晶系 |
空間群 | P-1 |
晶胞 | a = 9.289(2) Å |
b = 10.897(2) Å | |
c = 16.619(4) Å | |
α = 100.605(2)° | |
β = 106.204(2)° | |
γ = 99.216(6)º | |
體積 | 1547.5(6)Å 3 |
Z | 2 |
密度(計算值) | 1.378 Mg/m 3 |
實例
36
:結晶化合物
A-
二甲基乙醯胺(
DMAC
)溶劑合物。
藉由將化合物A-HCl形式1溶解於DMAC溶劑中來製備結晶化合物A-DMAC溶劑合物。然後將溶液過濾以從溶液中除去剩餘固體顆粒。將澄清溶液在室溫下在通風櫃中靜置以進行慢溶劑蒸發。在一週之後觀察到單晶。
X射線粉末繞射:結晶化合物A-DMAC溶劑合物之XRPD圖譜示出於圖75中。
熱分析:結晶化合物A-DMAC溶劑合物之DSC示出於圖76中。結晶化合物A-DMAC溶劑合物之典型DSC指示出約150°C的熔融起始。
單晶數據:在提供的晶體之單晶結構中,DMAC分子顯示為無序的。然而,DMAC分子仍顯示與化合物A氫鍵合
。表12示出了結晶化合物A-DMAC溶劑合物之晶體學數據匯總。
[表12]:結晶化合物A-DMAC溶劑合物之X射線單晶體學數據匯總:
波長 | 0.710730 Å |
晶系 | 三斜晶系 |
空間群 | P-1 |
晶胞 | a = 12.5010(15) Å |
b = 12.5268(15) Å | |
c = 13.2651(15) Å | |
α = 77.2990(10)° | |
β = 65.6460(10)° | |
γ = 61.1020(3)º | |
體積 | 1656.2(3) Å 3 |
Z | 2 |
密度(計算值) | 1.3333 Mg/m 3 |
實例
37
:結晶化合物
A-
單苯磺酸鹽水合物形式
1
。
藉由將92.6 mg化合物A和29.3 mg苯磺酸溶解於1 mL甲醇溶劑中來製備結晶化合物A-單苯磺酸鹽水合物形式1。然後將溶液在60°C下攪拌1天。產生漿液,並且藉由真空過濾來分離固體。將固體空氣乾燥1小時並且然後分析。
X射線粉末繞射:結晶化合物A-單苯磺酸鹽水合物形式1之XRPD圖譜示出於圖77中。
熱分析:結晶化合物A-單苯磺酸鹽水合物形式1之DSC和TGA示出於圖78中,該圖指示出約230.8°C的熔融起始。結晶化合物A-單苯磺酸鹽水合物形式1之TGA顯示出高達142.3°C下的約1.3%重量損失。
實例
38
:結晶化合物
A-
咖啡因共晶體形式
1
。
藉由使用1 : 1化合物A : 咖啡因莫耳比在乙腈中從70°C至5°C的慢冷卻實驗來製備化合物A-咖啡因共晶體形式1。所得產物含有與咖啡因共晶體形式1混合的剩餘化合物A起始材料以及未進一步鑒定的其他雜質。然後將所得產物藉由在氮氣流下將混合物在DSC爐中加熱至167°C來進一步純化以形成純化合物A-咖啡因共晶體形式1。
X射線粉末繞射:結晶化合物A-咖啡因共晶體形式1之XRPD圖譜示出於圖79中。結晶化合物A-咖啡因共晶體形式1之單晶結構數據製表於下表13中。
[表13]:結晶化合物A-咖啡因共晶體形式1之單晶數據:
波長 | 1.5418 Å |
晶系 | 三斜晶系 |
空間群 | P-1 |
晶胞 | a = 11.2224 Å |
b = 11.5160 Å | |
c = 14.1909 Å | |
α = 96.317° | |
β = 96.403° | |
γ = 100.279° | |
體積 | 1777.40 Å 3 |
Z | 4 |
密度(計算值) | 1.418 Mg/m 3 |
熱分析:結晶化合物A-咖啡因共晶體形式1之DSC和TGA圖譜示出於圖80中。DSC指示出約169.5°C的熔融起始。結晶化合物A-咖啡因共晶體形式1之TGA顯示出高達135.3°C的約0.39%重量損失。
吸濕性分析:結晶化合物A-咖啡因共晶體形式1之吸濕曲線示出於圖81中。結晶化合物A-咖啡因共晶體形式1之動態蒸汽吸附(DVS)顯示出在約95% RH下低於0.20%的重量增加。
實例
39
:結晶化合物
A-
檸檬酸共晶體形式
1
。
藉由使用1 : 1化合物A : 檸檬酸莫耳比在乙酸乙酯中從70°C至5°C的慢冷卻實驗來獲得結晶化合物A-檸檬酸共晶體形式1。
X射線粉末繞射:結晶化合物A-檸檬酸共晶體形式1之XRPD圖譜示出於圖82中。用Cu-Kα輻射收集結晶化合物A-檸檬酸共晶體形式1,並且指標化結果製表於下表14中。
[表14]:結晶化合物A-檸檬酸共晶體形式1的XRPD數據之指標化結果:
布拉維晶格類型 | 三斜晶系 |
a [Å] | 10.062 |
b [Å] | 13.643 |
c [Å] | 15.685 |
α [度] | 107.03 |
β [度] | 91.86 |
γ [度] | 94.05 |
體積 [Å 3/晶胞] | 2,505.5 |
手性內容? | 未指定 |
消光符號 | P - |
空間群 | P1 (1),PῙ (2) |
熱分析:結晶化合物A-檸檬酸共晶體形式1之DSC和TGA示出於圖83中,該圖指示出約107.7°C的熔融起始。結晶化合物A-檸檬酸共晶體形式1之TGA顯示出高達140.2°C下0.8 mg的約6.3%重量損失。
實例
40
:結晶化合物
A-
檸檬酸共晶體形式
2
。
藉由使用1 : 2化合物A : 檸檬酸莫耳比在乙腈中從70°C至冷藏機溫度的慢冷卻實驗來獲得結晶化合物A-檸檬酸共晶體形式2。最初使樣本出油(oiled out)並且在5°C下攪拌3天,產生灰白色沈澱物。
X射線粉末繞射:結晶化合物A-檸檬酸共晶體形式2之XRPD圖譜示出於圖84中。用Cu-Kα輻射收集結晶化合物A-檸檬酸共晶體形式2,並且指標化結果製表於下表15中。
[表15]:結晶化合物A-檸檬酸共晶體形式2的XRPD數據之指標化結果:
布拉維晶格類型 | 三斜晶系 |
a [Å] | 12.564 |
b [Å] | 13.497 |
c [Å] | 14.075 |
α [度] | 115.41 |
β [度] | 103.54 |
γ [度] | 93.81 |
體積 [Å 3/晶胞] | 2,057.8 |
手性內容? | 未指定 |
消光符號 | P - |
空間群 | P1 (1),PῙ (2) |
熱分析:結晶化合物A-檸檬酸共晶體形式2之DSC和TGA圖譜示出於圖85中。DSC指示出約93.8°C的吸熱起始。結晶化合物A-檸檬酸共晶體形式2之TGA顯示出高達135.3°C下0.6 mg的約5.3%重量損失。
實例
41
:結晶化合物
A-
糖精
-
共晶體形式
1
。
藉由使用1 : 1化合物A : 糖精莫耳比在乙腈中從70°C至5°C的慢冷卻實驗來製備結晶化合物A-糖精共晶體形式1。
X射線粉末繞射:結晶化合物A-糖精共晶體形式1之XRPD圖譜示出於圖86中。用Cu-Kα輻射收集結晶化合物A-糖精共晶體形式1,並且指標化結果製表於下表16中。
[表16]:結晶化合物A-糖精共晶體形式1的XRPD數據之指標化結果:
布拉維晶格類型 | 三斜晶系 |
a [Å] | 10.249 |
b [Å] | 11.000 |
c [Å] | 17.389 |
α [度] | 91.62 |
β [度] | 101.30 |
γ [度] | 113.03 |
體積 [Å 3/晶胞] | 1,757.2 |
手性內容? | 未指定 |
消光符號 | P - |
空間群 | P1 (1),PῙ (2) |
熱分析:結晶化合物A-糖精共晶體形式1之DSC和TGA示出於圖87中。DSC指示出約177.0°C的熔融起始。結晶化合物A-糖精共晶體形式1之TGA顯示出高達100.2°C下0.3 mg的約2.2%重量損失。
吸濕性數據:結晶化合物A-糖精共晶體形式1之吸濕曲線示出於圖88中。結晶化合物A-糖精共晶體形式1之動態蒸汽吸附(DVS)顯示出在95% RH下約0.3%的重量增加。
實例
42
:結晶化合物
A-L-
酒石酸共晶體形式
1
。
藉由使用1 : 1化合物A : L-酒石酸莫耳比在乙腈中從70°C至5°C的慢冷卻實驗來製備結晶化合物A-L-酒石酸共晶體形式1。
X射線粉末繞射:結晶化合物A-L-酒石酸共晶體形式1之XRPD圖譜示出於圖89中。用Cu-Kα輻射收集結晶化合物A-L-酒石酸共晶體形式1,並且指標化結果製表於下表17中。
[表17]:結晶化合物A-L-酒石酸共晶體形式1的XRPD數據之指標化結果:
布拉維晶格類型 | 三斜晶系 |
a [Å] | 10.417 |
b [Å] | 12.106 |
c [Å] | 15.398 |
α [度] | 67.51 |
β [度] | 76.14 |
γ [度] | 81.86 |
體積 [Å 3/晶胞] | 1,739.2 |
手性內容? | 手性 |
消光符號 | P - |
空間群 | P1 (1) |
熱分析:結晶化合物A-L-酒石酸共晶體形式1之DSC和TGA示出於圖90中。DSC指示出約157.0°C的起始。結晶化合物A-酒石酸共晶體形式1之TGA顯示出高達140.2°C下0.2 mg的約2.5%重量損失。
吸濕性數據:結晶化合物A-L-酒石酸共晶體形式1之吸濕曲線示出於圖91中。結晶化合物A-L-酒石酸共晶體形式1之動態蒸汽吸附顯示出在95% RH下約4.75%的重量增加。
實例
43
:結晶化合物
A-
尿素共晶體形式
1
。
藉由使用2 : 1化合物A : 尿素莫耳比在乙腈中從70°C至在-15°C至-25°C之間的冷凍器溫度的慢冷卻實驗來製備結晶化合物A-尿素共晶體形式1。
X射線粉末繞射:結晶化合物A-尿素共晶體形式1之XRPD圖譜示出於圖92中。用Cu-Kα輻射收集結晶化合物A-尿素共晶體形式1,並且指標化結果製表於下表18中。
[表18]:結晶化合物A-尿素共晶體形式1的XRPD數據之指標化結果:
布拉維晶格類型 | 三斜晶系 |
a [Å] | 10.754 |
b [Å] | 11.715 |
c [Å] | 13.612 |
α [度] | 88.37 |
β [度] | 87.73 |
γ [度] | 81.51 |
體積 [Å 3/晶胞] | 1,694.3 |
手性內容? | 未指定 |
消光符號 | P - |
空間群 | P1 (1),PῙ (2) |
熱分析:結晶化合物A-尿素共晶體形式1之DSC和TGA示出於圖93中。DSC指示出約106.4°C的第一吸熱起始和約156.8°C的第二吸熱起始。結晶化合物A-尿素共晶體形式1之TGA顯示出高達155.2°C下0.5 mg的約4.5%重量損失。
吸濕性數據:結晶化合物A-尿素共晶體形式1之吸濕曲線示出於圖94中。結晶化合物A-尿素共晶體形式1之動態蒸汽吸附(DVS)顯示出在95% RH下小於40%的重量增加。
溶解度、粉末溶離度(
PD
)和固有溶離速率(
IDR
)測試
實例
44
:相比於非鹽化合物
A
之各種形式的化合物
A-HCl
形式
1
之
PD
和
IDR
測試
在禁食狀態類比胃液(FaSSGF)、禁食狀態類比腸液(FaSSIF)、進食狀態類比腸液(FaSSIF)和水中測量化合物A和化合物A-HCl形式1之各種形式的溶解度。粉末溶離度測量測試結果顯示,結晶化合物A-HCl形式1表現出比化合物A-可變水合物形式2或化合物A-無水形式3更快的溶離度,但表現出比無定形化合物A更慢的溶離度。溶解度和IDR數據分別列出於表19和20中。數據顯示,結晶化合物A-HCl形式1相比於在此測試的任一種形式具有溶解度和IDR優勢。
[表19]:相比於各種化合物A形式的化合物A-HCl形式1之溶解度測試結果。
Cmp = 化合物。^來自粉末溶離度測量的溶解度。*來自2 h時間點的溶解度,來自實驗結束時的pH
形式 介質 | FaSSGF 溶解度( pH ), µg/mL | FaSSIF 溶解度( pH ), µg/mL | FeSSIF 溶解度( pH ), µg/mL | 水 溶解度( pH ), µg/mL | |
Cmp A1-HCl 形式 1 | 6.3 ± 0.5 (1.6)^ | 62.7 ± 9.0 (6.5)^ | 437.1 ± 16.3 (5.0)^ | 7.9 (1.14) | 13 (1.58) |
Cmp A- 可變水合物形式 2 | 20 (1.6)^ | 10.6 (6.5)^ | 144.5 (5.0)^ | 243 (1.08) | 23 (1.64) |
Cmp A- 無水形式 3 | 99.3 (1.6)* | 87 (6.5)* | 352 (5.0)* | 5.4 (8.0)* |
[表20]:相比於化合物A可變水合物形式2(參見實例13)和無定形化合物A形式的化合物A-HCl形式1之IDR測試結果。
Cmp = 化合物。
形式 | IDR ( ug/min*cm 2 ) |
Cmp A-HCl 形式 1 | 2.14 |
Cmp A- 可變水合物形式 2 | 0.42 |
無定形 Cmp A | 36.2 |
實例
45
:生物學數據
化合物A-HCl形式1、化合物A-無水形式3和無定形化合物A之狗交叉PK研究。
最初分配了總共3隻雄性狗進行研究。所有動物在給藥前至少八小時和在血液樣本收集的前四小時內禁食(如果適用,在以4小時收集間隔收集最後一次血液樣本後,在30分鐘內恢復食物)。
每隻動物接受含有化合物A的適當測試品溶液之口服管飼劑量(PO),如以下研究設計表中概述的。在整個給藥過程中連續攪拌口服管飼給藥溶液。在給藥後(在移除管飼管前)用大約10 mL自來水沖洗管飼管。在每個階段之劑量之間有最少10天清除期。
[表21]:狗交叉PK研究方案匯總
測試品 | 劑量途徑 | 媒介物 | 劑量水平 ( mg/kg ) | 劑量體積 ( mL/kg ) | 收集間隔 |
第1階段 | |||||
Cmp A-HCl 形式 1 | PO | A | 10 | 5 | 血液 a |
第2階段 | |||||
Cmp A- 無水形式 3 | PO | A | 10 | 5 | 血液 a |
第3階段 | |||||
無定形 Cmp A | PO | a | 10 | 5 | 血液 a |
a在給藥前以及在給藥後0.25、0.5、1、2、4、6、8、24、48和72小時收集用於血漿的血液樣本。 |
狗PK交叉研究結果列出於表22中。如圖95所示的數據顯示,化合物A-HCl形式1具有比無定形化合物A形式更低的暴露量。然而,化合物A-HCl形式1相比於化合物A-無水形式3表現出暴露量的約2倍增加,比化合物A-無水形式3顯示出更高的溶解度。
[表22]:狗交叉PK研究結果:
Cmp = 化合物。
形式 | D 50/D 90 ( µm ) | C max ( µM ) | AUC t ( µM*Hr ) | T max ( hr ) |
Cmp A1-HCl 形式 1 | 19.6/36 | 4.7 ± 1.4 | 181 ± 79 | 6.0 ± 0 |
Cmp A- 無水形式 3 | 5.0/13.7 | 2.3 ± 0.2 | 69 ± 6 | 4.7 ± 1.2 |
無定形 Cmp A | 9.9/20 | 6.9 ± 1.3 | 237 ± 68 | 6.7 ± 2.3 |
實例
46
:相比於化合物
A-MsA
和
A1-TsA
之化合物
A-HCl
形式
1
之
PD
和
IDR
測試
在進食狀態類比腸液(FaSSIF)中在pH 6.5下測量化合物A-HCl形式1、化合物A-MsA形式1和化合物A-TsA形式4之溶解度。
所有三種鹽與化合物A相比在FaSSIF中顯示出更大的動力學溶解度和更快的溶離度。甲苯磺酸鹽(A-TsA或A-TSA)鹽形式4之溶離速率優於甲磺酸鹽(A-MsA或A-MSA)鹽形式1(其優於HCl鹽形式1)。所有三種鹽可以轉化為游離鹼,但在FaSSIF中維持過飽和一定時間,這指示在以藥物劑型使用時的潛在良好吸收。溶解度測試結果數據列出於表23中。
[表23]:化合物A-HCl形式1、化合物A-MsA(MSA)形式1和化合物A-TsA(TSA)形式4之溶解度測試結果。
Cmp = 化合物。
形式 介質 | FaSSIF 溶解度( pH ), µg/mL |
Cmp A-HCl 形式 1 | 104.2 (6.5) |
Cmp A-MSA 形式 1 | 133.0 (6.5) |
Cmp A-TSA 形式 4 | 160.6 (6.5) |
提供前述描述僅為了清楚理解,而不應理解為無必要的限制,因為在本發明之範圍內的修改方案對熟悉該項技術者可能是清楚的。
貫穿本說明書及以下申請專利範圍,除非上下文另有要求,否則單詞「包含(comprise)」及變化形式諸如「包含(comprises/comprising)」應理解為隱含包括所陳述的整數或步驟或者整數或步驟的組,而不是排除任何其他整數或步驟或者整數或步驟的組。
貫穿本說明書,在組成物描述為包括組分或材料時,除非另有描述,否則設想該等組成物也可以基本上由或由所敘述的組分或材料之任何組合組成。同樣,在描述方法時,除非另有描述,否則設想該等方法也可以基本上由或由所敘述的步驟之任何組合組成。本文中說明性地揭露的本發明可以在不存在本文中未明確揭露的任何要素或步驟的情況下適當地實踐。
如在閱讀本揭露時對熟悉該項技術者清楚的,本文所述和說明的單獨實施方式中之每一個具有離散組分和特徵,其可以容易地與其他若干實施方式中之任一個之特徵分離或組合而不脫離本揭露之範圍或精神。任何所述方法可以按敘述事件之順序或邏輯上可能的任何其他順序進行。
本文中所揭露的方法及其單獨步驟之實踐可以人工和/或在電子設備輔助或由其提供的自動化下進行。雖然已參考特定實施方式描述了諸多方法,但熟悉該項技術者應容易瞭解到,可以使用執行與該等方法相關的動作的其他方式。例如,除非另有描述,否則可以在不脫離該方法之範圍或精神的情況下改變各步驟之順序。另外,一些單獨步驟可以組合、省略或進一步再分成其他步驟。
除非另有指示,否則本文的揭露內容之上下文中(尤其是在申請專利範圍之上下文中)術語「一個(種)(a/an)」、「該(the)」及類似參考物之使用應解釋為涵蓋單數和複數兩者。除非本文另有指示,否則本文有關值的範圍之敘述僅旨在用作個別地提及在該範圍內的每個單獨值之簡寫方法,並且每個單獨值併入說明書中,就如同在本文個別地敘述該值一般。除非另有指示,否則本文所提供的任何和所有實例、或示例性語言(例如,「諸如」)之使用旨在更好地說明本文之揭露內容且並非對本文之揭露內容的範圍之限制。說明書中的語言不應當被解釋為指示任何未要求保護的要素為實踐本文之揭露內容所必需的。
本文中所引用的所有專利、出版物和參考文獻均藉由援引以其全文併入本文中。在本揭露與所併入的專利、出版物和參考文獻之間出現衝突的情況下,應以本揭露為主。
無
[圖1]描繪了結晶化合物A-HCl形式1之X射線粉末繞射(「XRPD」)圖譜。
[圖2]描繪了結晶化合物A-HCl形式1之微差掃描熱量法(DSC)熱譜圖和熱重分析(TGA)。
[圖3]描繪了結晶化合物A-HCl形式1之動態蒸汽吸附(DVS)曲線。
[圖4]描繪了結晶化合物A-HCl形式1之固態
19F NMR。
[圖5]描繪了結晶化合物A-HCl形式1之單晶X射線晶體結構。
[圖6]描繪了化合物A-無水-形式3、化合物A-可變水合物形式2、化合物A-HCl形式1和化合物A-無定形形式之粉末溶離度。
[圖7]描繪了結晶化合物A-HCl形式2之XRPD圖譜。
[圖8]描繪了結晶化合物A-HCl形式2之DSC熱譜圖。
[圖9]描繪了化合物A-HCl的無定形形式之調製DSC。
[圖10]描繪了結晶化合物A-MsA形式1之XRPD圖譜。
[圖11]描繪了結晶化合物A-MsA形式1之DSC熱譜圖和TGA。
[圖12]描繪了結晶化合物A-MsA形式1之DVS水分吸附曲線。
[圖13]描繪了結晶化合物A-MsA形式1之固態
19F NMR。
[圖14]描繪了結晶化合物A-MsA形式2之XRPD圖譜。
[圖15]描繪了結晶化合物A-MsA形式2之DSC熱譜圖。
[圖16]描繪了結晶化合物A-MsA形式2之TGA。
[圖17]描繪了結晶化合物A-TsA形式1之XRPD圖譜。
[圖18]描繪了結晶化合物A-TsA形式1之可變溫度X射線繞射(VTXRD),其顯示出在 ≥ 180°C處重結晶並形成新的結晶化合物A-TsA形式5。
[圖19]描繪了結晶化合物A-TsA形式1之DSC熱譜圖和TGA。
[圖20]描繪了結晶化合物A-TsA形式2之XRPD圖譜。
[圖21]描繪了結晶化合物A-TsA形式2之DSC熱譜圖和TGA。
[圖22]描繪了結晶化合物A-TsA形式3之XRPD圖譜。
[圖23]描繪了結晶化合物A-TsA形式3之DSC熱譜圖和TGA。
[圖24A]描繪了結晶化合物A-TsA形式4之XRPD圖譜。
[圖24B]描繪了結晶化合物A-TsA形式4之單晶X射線晶體結構。
[圖25]描繪了結晶化合物A-TsA形式4之DSC熱譜圖和TGA。
[圖26]描繪了結晶化合物A-TsA形式4之固態
19F NMR。
[圖27]描繪了結晶化合物A-TsA形式5之XRPD圖譜。
[圖28]描繪了結晶化合物A-DiTsA形式6之XRPD圖譜。
[圖29]描繪了化合物A-HCl鹽形式1、化合物A-甲磺酸鹽形式1和化合物A-甲苯磺酸鹽形式4在禁食模擬小腸液(FaSSIF)中的粉末溶離度和動力溶解度。
[圖30]描繪了結晶化合物A-硫酸鹽形式1之XRPD圖譜。
[圖31]描繪了結晶化合物A-硫酸鹽形式1之DSC熱譜圖和TGA。
[圖32]描繪了結晶化合物A-硫酸鹽形式1之DVS。
[圖33]描繪了化合物A-無定形形式之XRPD圖譜。
[圖34]描繪了DSC熱譜圖,其指示出化合物A-無定形形式在91°C處的玻璃轉換溫度(Tg)。
[圖35]描繪了TGA-IR,其顯示出在100°C以下化合物A無定形形式中水之約1.05%重量損失。
[圖36]描繪了結晶化合物A-可變水合物形式2之XRPD圖譜。
[圖37]描繪了結晶化合物A-可變水合物形式2之DSC熱譜圖。
[圖38]描繪了結晶化合物A-可變水合物形式2之TGA。
[圖39]描繪了結晶化合物A-可變水合物形式2之DVS水分吸附曲線。
[圖40]描繪了結晶化合物A-無水形式3之XRPD圖譜。
[圖41]描繪了結晶化合物A-無水形式3之DSC熱譜圖。
[圖42]描繪了結晶化合物A-無水形式3之DVS曲線。
[圖43]描繪了結晶化合物A-無水形式4之XRPD圖譜。
[圖44]描繪了結晶化合物A-無水形式5之XRPD圖譜。
[圖45]描繪了結晶化合物A-無水形式5之DSC熱譜圖和TGA。
[圖46]描繪了結晶化合物A-無水形式5之DVS曲線,其中無水形式5再水合為化合物A-單水合物。
[圖47]描繪了結晶化合物A-無水形式6之XRPD圖譜。
[圖48]描繪了結晶化合物A-無水形式6之DSC熱譜圖和TGA。
[圖49]描繪了結晶化合物A-無水形式7之XRPD圖譜。
[圖50]描繪了結晶化合物A-無水形式8之XRPD圖譜。
[圖51]描繪了結晶化合物A-無水形式8之DSC熱譜圖和TGA。
[圖52]描繪了結晶化合物A形式1之XRPD圖譜。
[圖53]描繪了結晶化合物A-THF溶劑合物之XRPD圖譜。
[圖54]描繪了結晶化合物A-THF溶劑合物之DSC熱譜圖和TGA。
[圖55]描繪了結晶化合物A-乙醇溶劑合物之XRPD圖譜。
[圖56]描繪了結晶化合物A-乙醇溶劑合物之TGA。
[圖57]描繪了結晶化合物A-乙醇溶劑合物之DSC熱譜圖。
[圖58]描繪了結晶化合物A-1-丙醇溶劑合物之XRPD圖譜。
[圖59]描繪了結晶化合物A-1-丙醇溶劑合物之DSC熱譜圖和TGA。
[圖60]描繪了結晶化合物A-異丙醇(IPA)溶劑合物之XRPD圖譜。
[圖61]描繪了結晶化合物A-IPA溶劑合物之DSC熱譜圖和TGA。
[圖62]描繪了結晶化合物A-甲醇溶劑合物之XRPD圖譜。
[圖63]描繪了結晶化合物A-乙酸異丙酯(IPAc)溶劑合物之XRPD圖譜。
[圖64]描繪了結晶化合物A-丙酮溶劑合物之XRPD圖譜。
[圖65]描繪了結晶化合物A-環戊基甲基醚(CPME)溶劑合物之XRPD圖譜。
[圖66]描繪了結晶化合物A-二㗁烷溶劑合物之XRPD圖譜。
[圖67]描繪了結晶化合物A-乙酸乙酯(EtOAc)溶劑合物之XRPD圖譜。
[圖68]描繪了結晶化合物A-乙腈(MeCN)溶劑合物之XRPD圖譜。
[圖69]描繪了結晶化合物A-甲基三級丁基醚(MTBE)溶劑合物之XRPD圖譜。
[圖70]描繪了結晶化合物A-甲苯溶劑合物之XRPD圖譜。
[圖71]描繪了結晶化合物A-十二烷基硫酸鹽溶劑合物之XRPD圖譜。
[圖72]描繪了結晶化合物A-十二烷基硫酸鹽溶劑合物之DSC熱譜圖和TGA。
[圖73]描繪了結晶化合物A-二甲基甲醯胺(DMF)溶劑合物水合物之XRPD圖譜。
[圖74]描繪了結晶化合物A-二甲基甲醯胺(DMF)溶劑合物水合物之DSC熱譜圖。
[圖75]描繪了結晶化合物A-二甲基乙醯胺(DMAC)溶劑合物之XRPD圖譜。
[圖76]描繪了結晶化合物A-二甲基乙醯胺(DMAC)溶劑合物之DSC熱譜圖。
[圖77]描繪了結晶化合物A-單苯磺酸鹽水合物形式1之XRPD圖譜。
[圖78]描繪了結晶化合物A-單苯磺酸鹽水合物形式1之DSC熱譜圖和TGA。
[圖79]描繪了結晶化合物A-咖啡因共晶體形式1之XRPD圖譜。
[圖80]描繪了結晶化合物A-咖啡因共晶體形式1之DSC熱譜圖和TGA。
[圖81]描繪了結晶化合物A-咖啡因共晶體形式1之DVS曲線。
[圖82]描繪了結晶化合物A-檸檬酸共晶體形式1之XRPD圖譜。
[圖83]描繪了結晶化合物A-檸檬酸共晶體形式1之DSC熱譜圖和TGA。
[圖84]描繪了結晶化合物A-檸檬酸共晶體形式2之XRPD圖譜。
[圖85]描繪了結晶化合物A-檸檬酸共晶體形式2之DSC熱譜圖和TGA。
[圖86]描繪了結晶化合物A-糖精共晶體形式1之XRPD圖譜。
[圖87]描繪了結晶化合物A-糖精共晶體形式1之DSC熱譜圖和TGA。
[圖88]描繪了結晶化合物A-糖精共晶體形式1之DVS曲線。
[圖89]描繪了結晶化合物A-L-酒石酸共晶體形式1之XRPD圖譜。
[圖90]描繪了結晶化合物A-L-酒石酸共晶體形式1之DSC熱譜圖和TGA。
[圖91]描繪了結晶化合物A-L-酒石酸共晶體形式1之DVS曲線。
[圖92]描繪了結晶化合物A-尿素共晶體形式1之XRPD圖譜。
[圖93]描繪了結晶化合物A-尿素共晶體形式1之DSC熱譜圖和TGA。
[圖94]描繪了結晶化合物A-尿素共晶體形式1之DVS曲線。
[圖95]描繪了化合物A-HCl形式1、化合物A-無水形式3和化合物A-無定形之狗交叉PK研究。
無
<![CDATA[<110> 美商安進公司(Amgen Inc.)]]> <![CDATA[<120> KIF18A抑制劑化合物之鹽和固態形式]]> <![CDATA[<130> A-2832-US-PSP]]> <![CDATA[<160> 13 ]]> <![CDATA[<170> PatentIn 3.5版]]> <![CDATA[<210> 1]]> <![CDATA[<211> 2512]]> <![CDATA[<212> DNA]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 1]]> ctcaaaagtc tagagccacc gtccagggag caggtagctg ctgggctccg gggacacttt 60 gcgttcgggc tgggagcgtg ctttccacga cggtgacacg cttccctgga ttggcagcca 120 gactgccttc cgggtcactg ccatggagga gccgcagtca gatcctagcg tcgagccccc 180 tctgagtcag gaaacatttt cagacctatg gaaactactt cctgaaaaca acgttctgtc 240 ccccttgccg tcccaagcaa tggatgattt gatgctgtcc ccggacgata ttgaacaatg 300 gttcactgaa gacccaggtc cagatgaagc tcccagaatg ccagaggctg ctccccccgt 360 ggcccctgca ccagcagctc ctacaccggc ggcccctgca ccagccccct cctggcccct 420 gtcatcttct gtcccttccc agaaaaccta ccagggcagc tacggtttcc gtctgggctt 480 cttgcattct gggacagcca agtctgtgac ttgcacgtac tcccctgccc tcaacaagat 540 gttttgccaa ctggccaaga cctgccctgt gcagctgtgg gttgattcca cacccccgcc 600 cggcacccgc gtccgcgcca tggccatcta caagcagtca cagcacatga cggaggttgt 660 gaggcgctgc ccccaccatg agcgctgctc agatagcgat ggtctggccc ctcctcagca 720 tcttatccga gtggaaggaa atttgcgtgt ggagtatttg gatgacagaa acacttttcg 780 acatagtgtg gtggtgccct atgagccgcc tgaggttggc tctgactgta ccaccatcca 840 ctacaactac atgtgtaaca gttcctgcat gggcggcatg aaccggaggc ccatcctcac 900 catcatcaca ctggaagact ccagtggtaa tctactggga cggaacagct ttgaggtgcg 960 tgtttgtgcc tgtcctggga gagaccggcg cacagaggaa gagaatctcc gcaagaaagg 1020 ggagcctcac cacgagctgc ccccagggag cactaagcga gcactgccca acaacaccag 1080 ctcctctccc cagccaaaga agaaaccact ggatggagaa tatttcaccc ttcagatccg 1140 tgggcgtgag cgcttcgaga tgttccgaga gctgaatgag gccttggaac tcaaggatgc 1200 ccaggctggg aaggagccag gggggagcag ggctcactcc agccacctga agtccaaaaa 1260 gggtcagtct acctcccgcc ataaaaaact catgttcaag acagaagggc ctgactcaga 1320 ctgacattct ccacttcttg ttccccactg acagcctccc acccccatct ctccctcccc 1380 tgccattttg ggttttgggt ctttgaaccc ttgcttgcaa taggtgtgcg tcagaagcac 1440 ccaggacttc catttgcttt gtcccggggc tccactgaac aagttggcct gcactggtgt 1500 tttgttgtgg ggaggaggat ggggagtagg acataccagc ttagatttta aggtttttac 1560 tgtgagggat gtttgggaga tgtaagaaat gttcttgcag ttaagggtta gtttacaatc 1620 agccacattc taggtagggg cccacttcac cgtactaacc agggaagctg tccctcactg 1680 ttgaattttc tctaacttca aggcccatat ctgtgaaatg ctggcatttg cacctacctc 1740 acagagtgca ttgtgagggt taatgaaata atgtacatct ggccttgaaa ccacctttta 1800 ttacatgggg tctagaactt gacccccttg agggtgcttg ttccctctcc ctgttggtcg 1860 gtgggttggt agtttctaca gttgggcagc tggttaggta gagggagttg tcaagtctct 1920 gctggcccag ccaaaccctg tctgacaacc tcttggtgaa ccttagtacc taaaaggaaa 1980 tctcacccca tcccacaccc tggaggattt catctcttgt atatgatgat ctggatccac 2040 caagacttgt tttatgctca gggtcaattt cttttttctt tttttttttt ttttttcttt 2100 ttctttgaga ctgggtctcg ctttgttgcc caggctggag tggagtggcg tgatcttggc 2160 ttactgcagc ctttgcctcc ccggctcgag cagtcctgcc tcagcctccg gagtagctgg 2220 gaccacaggt tcatgccacc atggccagcc aacttttgca tgttttgtag agatggggtc 2280 tcacagtgtt gcccaggctg gtctcaaact cctgggctca ggcgatccac ctgtctcagc 2340 ctcccagagt gctgggatta caattgtgag ccaccacgtc cagctggaag ggtcaacatc 2400 ttttacattc tgcaagcaca tctgcatttt caccccaccc ttcccctcct tctccctttt 2460 tatatcccat ttttatatcg atctcttatt ttacaataaa actttgctgc ca 2512 <![CDATA[<210> 2]]> <![CDATA[<211> 393]]> <![CDATA[<212> PRT]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 2]]> Met Glu Glu Pro Gln Ser Asp Pro Ser Val Glu Pro Pro Leu Ser Gln 1 5 10 15 Glu Thr Phe Ser Asp Leu Trp Lys Leu Leu Pro Glu Asn Asn Val Leu 20 25 30 Ser Pro Leu Pro Ser Gln Ala Met Asp Asp Leu Met Leu Ser Pro Asp 35 40 45 Asp Ile Glu Gln Trp Phe Thr Glu Asp Pro Gly Pro Asp Glu Ala Pro 50 55 60 Arg Met Pro Glu Ala Ala Pro Pro Val Ala Pro Ala Pro Ala Ala Pro 65 70 75 80 Thr Pro Ala Ala Pro Ala Pro Ala Pro Ser Trp Pro Leu Ser Ser Ser 85 90 95 Val Pro Ser Gln Lys Thr Tyr Gln Gly Ser Tyr Gly Phe Arg Leu Gly 100 105 110 Phe Leu His Ser Gly Thr Ala Lys Ser Val Thr Cys Thr Tyr Ser Pro 115 120 125 Ala Leu Asn Lys Met Phe Cys Gln Leu Ala Lys Thr Cys Pro Val Gln 130 135 140 Leu Trp Val Asp Ser Thr Pro Pro Pro Gly Thr Arg Val Arg Ala Met 145 150 155 160 Ala Ile Tyr Lys Gln Ser Gln His Met Thr Glu Val Val Arg Arg Cys 165 170 175 Pro His His Glu Arg Cys Ser Asp Ser Asp Gly Leu Ala Pro Pro Gln 180 185 190 His Leu Ile Arg Val Glu Gly Asn Leu Arg Val Glu Tyr Leu Asp Asp 195 200 205 Arg Asn Thr Phe Arg His Ser Val Val Val Pro Tyr Glu Pro Pro Glu 210 215 220 Val Gly Ser Asp Cys Thr Thr Ile His Tyr Asn Tyr Met Cys Asn Ser 225 230 235 240 Ser Cys Met Gly Gly Met Asn Arg Arg Pro Ile Leu Thr Ile Ile Thr 245 250 255 Leu Glu Asp Ser Ser Gly Asn Leu Leu Gly Arg Asn Ser Phe Glu Val 260 265 270 Arg Val Cys Ala Cys Pro Gly Arg Asp Arg Arg Thr Glu Glu Glu Asn 275 280 285 Leu Arg Lys Lys Gly Glu Pro His His Glu Leu Pro Pro Gly Ser Thr 290 295 300 Lys Arg Ala Leu Pro Asn Asn Thr Ser Ser Ser Pro Gln Pro Lys Lys 305 310 315 320 Lys Pro Leu Asp Gly Glu Tyr Phe Thr Leu Gln Ile Arg Gly Arg Glu 325 330 335 Arg Phe Glu Met Phe Arg Glu Leu Asn Glu Ala Leu Glu Leu Lys Asp 340 345 350 Ala Gln Ala Gly Lys Glu Pro Gly Gly Ser Arg Ala His Ser Ser His 355 360 365 Leu Lys Ser Lys Lys Gly Gln Ser Thr Ser Arg His Lys Lys Leu Met 370 375 380 Phe Lys Thr Glu Gly Pro Asp Ser Asp 385 390 <![CDATA[<210> 3]]> <![CDATA[<211> 4768]]> <![CDATA[<212> DNA]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 3]]> agttgccggg cgggggaggg cgcgtccggt ttttctcagg ggacgttgaa attatttttg 60 taacgggagt cgggagagga cggggcgtgc cccgacgtgc gcgcgcgtcg tcctccccgg 120 cgctcctcca cagctcgctg gctcccgccg cggaaaggcg tcatgccgcc caaaaccccc 180 cgaaaaacgg ccgccaccgc cgccgctgcc gccgcggaac ccccggcacc gccgccgccg 240 ccccctcctg aggaggaccc agagcaggac agcggcccgg aggacctgcc tctcgtcagg 300 cttgagtttg aagaaacaga agaacctgat tttactgcat tatgtcagaa attaaagata 360 ccagatcatg tcagagagag agcttggtta acttgggaga aagtttcatc tgtggatgga 420 gtattgggag gttatattca aaagaaaaag gaactgtggg gaatctgtat ctttattgca 480 gcagttgacc tagatgagat gtcgttcact tttactgagc tacagaaaaa catagaaatc 540 agtgtccata aattctttaa cttactaaaa gaaattgata ccagtaccaa agttgataat 600 gctatgtcaa gactgttgaa gaagtatgat gtattgtttg cactcttcag caaattggaa 660 aggacatgtg aacttatata tttgacacaa cccagcagtt cgatatctac tgaaataaat 720 tctgcattgg tgctaaaagt ttcttggatc acatttttat tagctaaagg ggaagtatta 780 caaatggaag atgatctggt gatttcattt cagttaatgc tatgtgtcct tgactatttt 840 attaaactct cacctcccat gttgctcaaa gaaccatata aaacagctgt tatacccatt 900 aatggttcac ctcgaacacc caggcgaggt cagaacagga gtgcacggat agcaaaacaa 960 ctagaaaatg atacaagaat tattgaagtt ctctgtaaag aacatgaatg taatatagat 1020 gaggtgaaaa atgtttattt caaaaatttt atacctttta tgaattctct tggacttgta 1080 acatctaatg gacttccaga ggttgaaaat ctttctaaac gatacgaaga aatttatctt 1140 aaaaataaag atctagatgc aagattattt ttggatcatg ataaaactct tcagactgat 1200 tctatagaca gttttgaaac acagagaaca ccacgaaaaa gtaaccttga tgaagaggtg 1260 aatgtaattc ctccacacac tccagttagg actgttatga acactatcca acaattaatg 1320 atgattttaa attcagcaag tgatcaacct tcagaaaatc tgatttccta ttttaacaac 1380 tgcacagtga atccaaaaga aagtatactg aaaagagtga aggatatagg atacatcttt 1440 aaagagaaat ttgctaaagc tgtgggacag ggttgtgtcg aaattggatc acagcgatac 1500 aaacttggag ttcgcttgta ttaccgagta atggaatcca tgcttaaatc agaagaagaa 1560 cgattatcca ttcaaaattt tagcaaactt ctgaatgaca acatttttca tatgtcttta 1620 ttggcgtgcg ctcttgaggt tgtaatggcc acatatagca gaagtacatc tcagaatctt 1680 gattctggaa cagatttgtc tttcccatgg attctgaatg tgcttaattt aaaagccttt 1740 gatttttaca aagtgatcga aagttttatc aaagcagaag gcaacttgac aagagaaatg 1800 ataaaacatt tagaacgatg tgaacatcga atcatggaat cccttgcatg gctctcagat 1860 tcacctttat ttgatcttat taaacaatca aaggaccgag aaggaccaac tgatcacctt 1920 gaatctgctt gtcctcttaa tcttcctctc cagaataatc acactgcagc agatatgtat 1980 ctttctcctg taagatctcc aaagaaaaaa ggttcaacta cgcgtgtaaa ttctactgca 2040 aatgcagaga cacaagcaac ctcagccttc cagacccaga agccattgaa atctacctct 2100 ctttcactgt tttataaaaa agtgtatcgg ctagcctatc tccggctaaa tacactttgt 2160 gaacgccttc tgtctgagca cccagaatta gaacatatca tctggaccct tttccagcac 2220 accctgcaga atgagtatga actcatgaga gacaggcatt tggaccaaat tatgatgtgt 2280 tccatgtatg gcatatgcaa agtgaagaat atagacctta aattcaaaat cattgtaaca 2340 gcatacaagg atcttcctca tgctgttcag gagacattca aacgtgtttt gatcaaagaa 2400 gaggagtatg attctattat agtattctat aactcggtct tcatgcagag actgaaaaca 2460 aatattttgc agtatgcttc caccaggccc cctaccttgt caccaatacc tcacattcct 2520 cgaagccctt acaagtttcc tagttcaccc ttacggattc ctggagggaa catctatatt 2580 tcacccctga agagtccata taaaatttca gaaggtctgc caacaccaac aaaaatgact 2640 ccaagatcaa gaatcttagt atcaattggt gaatcattcg ggacttctga gaagttccag 2700 aaaataaatc agatggtatg taacagcgac cgtgtgctca aaagaagtgc tgaaggaagc 2760 aaccctccta aaccactgaa aaaactacgc tttgatattg aaggatcaga tgaagcagat 2820 ggaagtaaac atctcccagg agagtccaaa tttcagcaga aactggcaga aatgacttct 2880 actcgaacac gaatgcaaaa gcagaaaatg aatgatagca tggatacctc aaacaaggaa 2940 gagaaatgag gatctcagga ccttggtgga cactgtgtac acctctggat tcattgtctc 3000 tcacagatgt gactgtataa ctttcccagg ttctgtttat ggccacattt aatatcttca 3060 gctctttttg tggatataaa atgtgcagat gcaattgttt gggtgattcc taagccactt 3120 gaaatgttag tcattgttat ttatacaaga ttgaaaatct tgtgtaaatc ctgccattta 3180 aaaagttgta gcagattgtt tcctcttcca aagtaaaatt gctgtgcttt atggatagta 3240 agaatggccc tagagtggga gtcctgataa cccaggcctg tctgactact ttgccttctt 3300 ttgtagcata taggtgatgt ttgctcttgt ttttattaat ttatatgtat atttttttaa 3360 tttaacatga acacccttag aaaatgtgtc ctatctatct tccaaatgca atttgattga 3420 ctgcccattc accaaaatta tcctgaactc ttctgcaaaa atggatatta ttagaaatta 3480 gaaaaaaatt actaatttta cacattagat tttattttac tattggaatc tgatatactg 3540 tgtgcttgtt ttataaaatt ttgcttttaa ttaaataaaa gctggaagca aagtataacc 3600 atatgatact atcatactac tgaaacagat ttcatacctc agaatgtaaa agaacttact 3660 gattattttc ttcatccaac ttatgttttt aaatgaggat tattgatagt actcttggtt 3720 tttataccat tcagatcact gaatttataa agtacccatc tagtacttga aaaagtaaag 3780 tgttctgcca gatcttaggt atagaggacc ctaacacagt atatcccaag tgcactttct 3840 aatgtttctg ggtcctgaag aattaagata caaattaatt ttactccata aacagactgt 3900 taattatagg agccttaatt tttttttcat agagatttgt ctaattgcat ctcaaaatta 3960 ttctgccctc cttaatttgg gaaggtttgt gttttctctg gaatggtaca tgtcttccat 4020 gtatcttttg aactggcaat tgtctattta tcttttattt ttttaagtca gtatggtcta 4080 acactggcat gttcaaagcc acattatttc tagtccaaaa ttacaagtaa tcaagggtca 4140 ttatgggtta ggcattaatg tttctatctg attttgtgca aaagcttcaa attaaaacag 4200 ctgcattaga aaaagaggcg cttctcccct cccctacacc taaaggtgta tttaaactat 4260 cttgtgtgat taacttattt agagatgctg taacttaaaa taggggatat ttaaggtagc 4320 ttcagctagc ttttaggaaa atcactttgt ctaactcaga attattttta aaaagaaatc 4380 tggtcttgtt agaaaacaaa attttatttt gtgctcattt aagtttcaaa cttactattt 4440 tgacagttat tttgataaca atgacactag aaaacttgac tccatttcat cattgtttct 4500 gcatgaatat catacaaatc agttagtttt taggtcaagg gcttactatt tctgggtctt 4560 ttgctactaa gttcacatta gaattagtgc cagaatttta ggaacttcag agatcgtgta 4620 ttgagatttc ttaaataatg cttcagatat tattgcttta ttgctttttt gtattggtta 4680 aaactgtaca tttaaaattg ctatgttact attttctaca attaatagtt tgtctatttt 4740 aaaataaatt agttgttaag agtcttaa 4768 <![CDATA[<210> 4]]> <![CDATA[<211> 928]]> <![CDATA[<212> PRT]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 4]]> Met Pro Pro Lys Thr Pro Arg Lys Thr Ala Ala Thr Ala Ala Ala Ala 1 5 10 15 Ala Ala Glu Pro Pro Ala Pro Pro Pro Pro Pro Pro Pro Glu Glu Asp 20 25 30 Pro Glu Gln Asp Ser Gly Pro Glu Asp Leu Pro Leu Val Arg Leu Glu 35 40 45 Phe Glu Glu Thr Glu Glu Pro Asp Phe Thr Ala Leu Cys Gln Lys Leu 50 55 60 Lys Ile Pro Asp His Val Arg Glu Arg Ala Trp Leu Thr Trp Glu Lys 65 70 75 80 Val Ser Ser Val Asp Gly Val Leu Gly Gly Tyr Ile Gln Lys Lys Lys 85 90 95 Glu Leu Trp Gly Ile Cys Ile Phe Ile Ala Ala Val Asp Leu Asp Glu 100 105 110 Met Ser Phe Thr Phe Thr Glu Leu Gln Lys Asn Ile Glu Ile Ser Val 115 120 125 His Lys Phe Phe Asn Leu Leu Lys Glu Ile Asp Thr Ser Thr Lys Val 130 135 140 Asp Asn Ala Met Ser Arg Leu Leu Lys Lys Tyr Asp Val Leu Phe Ala 145 150 155 160 Leu Phe Ser Lys Leu Glu Arg Thr Cys Glu Leu Ile Tyr Leu Thr Gln 165 170 175 Pro Ser Ser Ser Ile Ser Thr Glu Ile Asn Ser Ala Leu Val Leu Lys 180 185 190 Val Ser Trp Ile Thr Phe Leu Leu Ala Lys Gly Glu Val Leu Gln Met 195 200 205 Glu Asp Asp Leu Val Ile Ser Phe Gln Leu Met Leu Cys Val Leu Asp 210 215 220 Tyr Phe Ile Lys Leu Ser Pro Pro Met Leu Leu Lys Glu Pro Tyr Lys 225 230 235 240 Thr Ala Val Ile Pro Ile Asn Gly Ser Pro Arg Thr Pro Arg Arg Gly 245 250 255 Gln Asn Arg Ser Ala Arg Ile Ala Lys Gln Leu Glu Asn Asp Thr Arg 260 265 270 Ile Ile Glu Val Leu Cys Lys Glu His Glu Cys Asn Ile Asp Glu Val 275 280 285 Lys Asn Val Tyr Phe Lys Asn Phe Ile Pro Phe Met Asn Ser Leu Gly 290 295 300 Leu Val Thr Ser Asn Gly Leu Pro Glu Val Glu Asn Leu Ser Lys Arg 305 310 315 320 Tyr Glu Glu Ile Tyr Leu Lys Asn Lys Asp Leu Asp Ala Arg Leu Phe 325 330 335 Leu Asp His Asp Lys Thr Leu Gln Thr Asp Ser Ile Asp Ser Phe Glu 340 345 350 Thr Gln Arg Thr Pro Arg Lys Ser Asn Leu Asp Glu Glu Val Asn Val 355 360 365 Ile Pro Pro His Thr Pro Val Arg Thr Val Met Asn Thr Ile Gln Gln 370 375 380 Leu Met Met Ile Leu Asn Ser Ala Ser Asp Gln Pro Ser Glu Asn Leu 385 390 395 400 Ile Ser Tyr Phe Asn Asn Cys Thr Val Asn Pro Lys Glu Ser Ile Leu 405 410 415 Lys Arg Val Lys Asp Ile Gly Tyr Ile Phe Lys Glu Lys Phe Ala Lys 420 425 430 Ala Val Gly Gln Gly Cys Val Glu Ile Gly Ser Gln Arg Tyr Lys Leu 435 440 445 Gly Val Arg Leu Tyr Tyr Arg Val Met Glu Ser Met Leu Lys Ser Glu 450 455 460 Glu Glu Arg Leu Ser Ile Gln Asn Phe Ser Lys Leu Leu Asn Asp Asn 465 470 475 480 Ile Phe His Met Ser Leu Leu Ala Cys Ala Leu Glu Val Val Met Ala 485 490 495 Thr Tyr Ser Arg Ser Thr Ser Gln Asn Leu Asp Ser Gly Thr Asp Leu 500 505 510 Ser Phe Pro Trp Ile Leu Asn Val Leu Asn Leu Lys Ala Phe Asp Phe 515 520 525 Tyr Lys Val Ile Glu Ser Phe Ile Lys Ala Glu Gly Asn Leu Thr Arg 530 535 540 Glu Met Ile Lys His Leu Glu Arg Cys Glu His Arg Ile Met Glu Ser 545 550 555 560 Leu Ala Trp Leu Ser Asp Ser Pro Leu Phe Asp Leu Ile Lys Gln Ser 565 570 575 Lys Asp Arg Glu Gly Pro Thr Asp His Leu Glu Ser Ala Cys Pro Leu 580 585 590 Asn Leu Pro Leu Gln Asn Asn His Thr Ala Ala Asp Met Tyr Leu Ser 595 600 605 Pro Val Arg Ser Pro Lys Lys Lys Gly Ser Thr Thr Arg Val Asn Ser 610 615 620 Thr Ala Asn Ala Glu Thr Gln Ala Thr Ser Ala Phe Gln Thr Gln Lys 625 630 635 640 Pro Leu Lys Ser Thr Ser Leu Ser Leu Phe Tyr Lys Lys Val Tyr Arg 645 650 655 Leu Ala Tyr Leu Arg Leu Asn Thr Leu Cys Glu Arg Leu Leu Ser Glu 660 665 670 His Pro Glu Leu Glu His Ile Ile Trp Thr Leu Phe Gln His Thr Leu 675 680 685 Gln Asn Glu Tyr Glu Leu Met Arg Asp Arg His Leu Asp Gln Ile Met 690 695 700 Met Cys Ser Met Tyr Gly Ile Cys Lys Val Lys Asn Ile Asp Leu Lys 705 710 715 720 Phe Lys Ile Ile Val Thr Ala Tyr Lys Asp Leu Pro His Ala Val Gln 725 730 735 Glu Thr Phe Lys Arg Val Leu Ile Lys Glu Glu Glu Tyr Asp Ser Ile 740 745 750 Ile Val Phe Tyr Asn Ser Val Phe Met Gln Arg Leu Lys Thr Asn Ile 755 760 765 Leu Gln Tyr Ala Ser Thr Arg Pro Pro Thr Leu Ser Pro Ile Pro His 770 775 780 Ile Pro Arg Ser Pro Tyr Lys Phe Pro Ser Ser Pro Leu Arg Ile Pro 785 790 795 800 Gly Gly Asn Ile Tyr Ile Ser Pro Leu Lys Ser Pro Tyr Lys Ile Ser 805 810 815 Glu Gly Leu Pro Thr Pro Thr Lys Met Thr Pro Arg Ser Arg Ile Leu 820 825 830 Val Ser Ile Gly Glu Ser Phe Gly Thr Ser Glu Lys Phe Gln Lys Ile 835 840 845 Asn Gln Met Val Cys Asn Ser Asp Arg Val Leu Lys Arg Ser Ala Glu 850 855 860 Gly Ser Asn Pro Pro Lys Pro Leu Lys Lys Leu Arg Phe Asp Ile Glu 865 870 875 880 Gly Ser Asp Glu Ala Asp Gly Ser Lys His Leu Pro Gly Glu Ser Lys 885 890 895 Phe Gln Gln Lys Leu Ala Glu Met Thr Ser Thr Arg Thr Arg Met Gln 900 905 910 Lys Gln Lys Met Asn Asp Ser Met Asp Thr Ser Asn Lys Glu Glu Lys 915 920 925 <![CDATA[<210> 5]]> <![CDATA[<211> 1954]]> <![CDATA[<212> DNA]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 5]]> aggagcagcc ggcgcggccg ccagcgcggt gtagggggca ggcgcggatc ccgccaccgc 60 cgcgcgctcg gcccgccgac tcccggcgcc gccgccgcca ctgccgtcgc cgccgccgcc 120 tgccgggact ggagcgcgcc gtccgccgcg gacaagaccc tggcctcagg ccggagcagc 180 cccatcatgc cgagggagcg cagggagcgg gatgcgaagg agcgggacac catgaaggag 240 gacggcggcg cggagttctc ggctcgctcc aggaagagga aggcaaacgt gaccgttttt 300 ttgcaggatc cagatgaaga aatggccaaa atcgacagga cggcgaggga ccagtgtggg 360 agccagcctt gggacaataa tgcagtctgt gcagacccct gctccctgat ccccacacct 420 gacaaagaag atgatgaccg ggtttaccca aactcaacgt gcaagcctcg gattattgca 480 ccatccagag gctccccgct gcctgtactg agctgggcaa atagagagga agtctggaaa 540 atcatgttaa acaaggaaaa gacatactta agggatcagc actttcttga gcaacaccct 600 cttctgcagc caaaaatgcg agcaattctt ctggattggt taatggaggt gtgtgaagtc 660 tataaacttc acagggagac cttttacttg gcacaagatt tctttgaccg gtatatggcg 720 acacaagaaa atgttgtaaa aactctttta cagcttattg ggatttcatc tttatttatt 780 gcagccaaac ttgaggaaat ctatcctcca aagttgcacc agtttgcgta tgtgacagat 840 ggagcttgtt caggagatga aattctcacc atggaattaa tgattatgaa ggcccttaag 900 tggcgtttaa gtcccctgac tattgtgtcc tggctgaatg tatacatgca ggttgcatat 960 ctaaatgact tacatgaagt gctactgccg cagtatcccc agcaaatctt tatacagatt 1020 gcagagctgt tggatctctg tgtcctggat gttgactgcc ttgaatttcc ttatggtata 1080 cttgctgctt cggccttgta tcatttctcg tcatctgaat tgatgcaaaa ggtttcaggg 1140 tatcagtggt gcgacataga gaactgtgtc aagtggatgg ttccatttgc catggttata 1200 agggagacgg ggagctcaaa actgaagcac ttcaggggcg tcgctgatga agatgcacac 1260 aacatacaga cccacagaga cagcttggat ttgctggaca aagcccgagc aaagaaagcc 1320 atgttgtctg aacaaaatag ggcttctcct ctccccagtg ggctcctcac cccgccacag 1380 agcggtaaga agcagagcag cgggccggaa atggcgtgac caccccatcc ttctccacca 1440 aagacagttg cgcgcctgct ccacgttctc ttctgtctgt tgcagcggag gcgtgcgttt 1500 gcttttacag atatctgaat ggaagagtgt ttcttccaca acagaagtat ttctgtggat 1560 ggcatcaaac agggcaaagt gttttttatt gaatgcttat aggttttttt taaataagtg 1620 ggtcaagtac accagccacc tccagacacc agtgcgtgct cccgatgctg ctatggaagg 1680 tgctacttga cctaagggac tcccacaaca acaaaagctt gaagctgtgg agggccacgg 1740 tggcgtggct ctcctcgcag gtgttctggg ctccgttgta ccaagtggag caggtggttg 1800 cgggcaagcg ttgtgcagag cccatagcca gctgggcagg gggctgccct ctccacatta 1860 tcagttgaca gtgtacaatg cctttgatga actgttttgt aagtgctgct atatctatcc 1920 attttttaat aaagataata ctgtttttga gaca 1954 <![CDATA[<210> 6]]> <![CDATA[<211> 410]]> <![CDATA[<212> PRT]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 6]]> Met Pro Arg Glu Arg Arg Glu Arg Asp Ala Lys Glu Arg Asp Thr Met 1 5 10 15 Lys Glu Asp Gly Gly Ala Glu Phe Ser Ala Arg Ser Arg Lys Arg Lys 20 25 30 Ala Asn Val Thr Val Phe Leu Gln Asp Pro Asp Glu Glu Met Ala Lys 35 40 45 Ile Asp Arg Thr Ala Arg Asp Gln Cys Gly Ser Gln Pro Trp Asp Asn 50 55 60 Asn Ala Val Cys Ala Asp Pro Cys Ser Leu Ile Pro Thr Pro Asp Lys 65 70 75 80 Glu Asp Asp Asp Arg Val Tyr Pro Asn Ser Thr Cys Lys Pro Arg Ile 85 90 95 Ile Ala Pro Ser Arg Gly Ser Pro Leu Pro Val Leu Ser Trp Ala Asn 100 105 110 Arg Glu Glu Val Trp Lys Ile Met Leu Asn Lys Glu Lys Thr Tyr Leu 115 120 125 Arg Asp Gln His Phe Leu Glu Gln His Pro Leu Leu Gln Pro Lys Met 130 135 140 Arg Ala Ile Leu Leu Asp Trp Leu Met Glu Val Cys Glu Val Tyr Lys 145 150 155 160 Leu His Arg Glu Thr Phe Tyr Leu Ala Gln Asp Phe Phe Asp Arg Tyr 165 170 175 Met Ala Thr Gln Glu Asn Val Val Lys Thr Leu Leu Gln Leu Ile Gly 180 185 190 Ile Ser Ser Leu Phe Ile Ala Ala Lys Leu Glu Glu Ile Tyr Pro Pro 195 200 205 Lys Leu His Gln Phe Ala Tyr Val Thr Asp Gly Ala Cys Ser Gly Asp 210 215 220 Glu Ile Leu Thr Met Glu Leu Met Ile Met Lys Ala Leu Lys Trp Arg 225 230 235 240 Leu Ser Pro Leu Thr Ile Val Ser Trp Leu Asn Val Tyr Met Gln Val 245 250 255 Ala Tyr Leu Asn Asp Leu His Glu Val Leu Leu Pro Gln Tyr Pro Gln 260 265 270 Gln Ile Phe Ile Gln Ile Ala Glu Leu Leu Asp Leu Cys Val Leu Asp 275 280 285 Val Asp Cys Leu Glu Phe Pro Tyr Gly Ile Leu Ala Ala Ser Ala Leu 290 295 300 Tyr His Phe Ser Ser Ser Glu Leu Met Gln Lys Val Ser Gly Tyr Gln 305 310 315 320 Trp Cys Asp Ile Glu Asn Cys Val Lys Trp Met Val Pro Phe Ala Met 325 330 335 Val Ile Arg Glu Thr Gly Ser Ser Lys Leu Lys His Phe Arg Gly Val 340 345 350 Ala Asp Glu Asp Ala His Asn Ile Gln Thr His Arg Asp Ser Leu Asp 355 360 365 Leu Leu Asp Lys Ala Arg Ala Lys Lys Ala Met Leu Ser Glu Gln Asn 370 375 380 Arg Ala Ser Pro Leu Pro Ser Gly Leu Leu Thr Pro Pro Gln Ser Gly 385 390 395 400 Lys Lys Gln Ser Ser Gly Pro Glu Met Ala 405 410 <![CDATA[<210> 7]]> <![CDATA[<211> 7088]]> <![CDATA[<212> DNA]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 7]]> gctgagactt cctggacggg ggacaggctg tggggtttct cagataactg ggcccctgcg 60 ctcaggaggc cttcaccctc tgctctgggt aaagttcatt ggaacagaaa gaaatggatt 120 tatctgctct tcgcgttgaa gaagtacaaa atgtcattaa tgctatgcag aaaatcttag 180 agtgtcccat ctgtctggag ttgatcaagg aacctgtctc cacaaagtgt gaccacatat 240 tttgcaaatt ttgcatgctg aaacttctca accagaagaa agggccttca cagtgtcctt 300 tatgtaagaa tgatataacc aaaaggagcc tacaagaaag tacgagattt agtcaacttg 360 ttgaagagct attgaaaatc atttgtgctt ttcagcttga cacaggtttg gagtatgcaa 420 acagctataa ttttgcaaaa aaggaaaata actctcctga acatctaaaa gatgaagttt 480 ctatcatcca aagtatgggc tacagaaacc gtgccaaaag acttctacag agtgaacccg 540 aaaatccttc cttgcaggaa accagtctca gtgtccaact ctctaacctt ggaactgtga 600 gaactctgag gacaaagcag cggatacaac ctcaaaagac gtctgtctac attgaattgg 660 gatctgattc ttctgaagat accgttaata aggcaactta ttgcagtgtg ggagatcaag 720 aattgttaca aatcacccct caaggaacca gggatgaaat cagtttggat tctgcaaaaa 780 aggctgcttg tgaattttct gagacggatg taacaaatac tgaacatcat caacccagta 840 ataatgattt gaacaccact gagaagcgtg cagctgagag gcatccagaa aagtatcagg 900 gtagttctgt ttcaaacttg catgtggagc catgtggcac aaatactcat gccagctcat 960 tacagcatga gaacagcagt ttattactca ctaaagacag aatgaatgta gaaaaggctg 1020 aattctgtaa taaaagcaaa cagcctggct tagcaaggag ccaacataac agatgggctg 1080 gaagtaagga aacatgtaat gataggcgga ctcccagcac agaaaaaaag gtagatctga 1140 atgctgatcc cctgtgtgag agaaaagaat ggaataagca gaaactgcca tgctcagaga 1200 atcctagaga tactgaagat gttccttgga taacactaaa tagcagcatt cagaaagtta 1260 atgagtggtt ttccagaagt gatgaactgt taggttctga tgactcacat gatggggagt 1320 ctgaatcaaa tgccaaagta gctgatgtat tggacgttct aaatgaggta gatgaatatt 1380 ctggttcttc agagaaaata gacttactgg ccagtgatcc tcatgaggct ttaatatgta 1440 aaagtgaaag agttcactcc aaatcagtag agagtaatat tgaagacaaa atatttggga 1500 aaacctatcg gaagaaggca agcctcccca acttaagcca tgtaactgaa aatctaatta 1560 taggagcatt tgttactgag ccacagataa tacaagagcg tcccctcaca aataaattaa 1620 agcgtaaaag gagacctaca tcaggccttc atcctgagga ttttatcaag aaagcagatt 1680 tggcagttca aaagactcct gaaatgataa atcagggaac taaccaaacg gagcagaatg 1740 gtcaagtgat gaatattact aatagtggtc atgagaataa aacaaaaggt gattctattc 1800 agaatgagaa aaatcctaac ccaatagaat cactcgaaaa agaatctgct ttcaaaacga 1860 aagctgaacc tataagcagc agtataagca atatggaact cgaattaaat atccacaatt 1920 caaaagcacc taaaaagaat aggctgagga ggaagtcttc taccaggcat attcatgcgc 1980 ttgaactagt agtcagtaga aatctaagcc cacctaattg tactgaattg caaattgata 2040 gttgttctag cagtgaagag ataaagaaaa aaaagtacaa ccaaatgcca gtcaggcaca 2100 gcagaaacct acaactcatg gaaggtaaag aacctgcaac tggagccaag aagagtaaca 2160 agccaaatga acagacaagt aaaagacatg acagcgatac tttcccagag ctgaagttaa 2220 caaatgcacc tggttctttt actaagtgtt caaataccag tgaacttaaa gaatttgtca 2280 atcctagcct tccaagagaa gaaaaagaag agaaactaga aacagttaaa gtgtctaata 2340 atgctgaaga ccccaaagat ctcatgttaa gtggagaaag ggttttgcaa actgaaagat 2400 ctgtagagag tagcagtatt tcattggtac ctggtactga ttatggcact caggaaagta 2460 tctcgttact ggaagttagc actctaggga aggcaaaaac agaaccaaat aaatgtgtga 2520 gtcagtgtgc agcatttgaa aaccccaagg gactaattca tggttgttcc aaagataata 2580 gaaatgacac agaaggcttt aagtatccat tgggacatga agttaaccac agtcgggaaa 2640 caagcataga aatggaagaa agtgaacttg atgctcagta tttgcagaat acattcaagg 2700 tttcaaagcg ccagtcattt gctccgtttt caaatccagg aaatgcagaa gaggaatgtg 2760 caacattctc tgcccactct gggtccttaa agaaacaaag tccaaaagtc acttttgaat 2820 gtgaacaaaa ggaagaaaat caaggaaaga atgagtctaa tatcaagcct gtacagacag 2880 ttaatatcac tgcaggcttt cctgtggttg gtcagaaaga taagccagtt gataatgcca 2940 aatgtagtat caaaggaggc tctaggtttt gtctatcatc tcagttcaga ggcaacgaaa 3000 ctggactcat tactccaaat aaacatggac ttttacaaaa cccatatcgt ataccaccac 3060 tttttcccat caagtcattt gttaaaacta aatgtaagaa aaatctgcta gaggaaaact 3120 ttgaggaaca ttcaatgtca cctgaaagag aaatgggaaa tgagaacatt ccaagtacag 3180 tgagcacaat tagccgtaat aacattagag aaaatgtttt taaagaagcc agctcaagca 3240 atattaatga agtaggttcc agtactaatg aagtgggctc cagtattaat gaaataggtt 3300 ccagtgatga aaacattcaa gcagaactag gtagaaacag agggccaaaa ttgaatgcta 3360 tgcttagatt aggggttttg caacctgagg tctataaaca aagtcttcct ggaagtaatt 3420 gtaagcatcc tgaaataaaa aagcaagaat atgaagaagt agttcagact gttaatacag 3480 atttctctcc atatctgatt tcagataact tagaacagcc tatgggaagt agtcatgcat 3540 ctcaggtttg ttctgagaca cctgatgacc tgttagatga tggtgaaata aaggaagata 3600 ctagttttgc tgaaaatgac attaaggaaa gttctgctgt ttttagcaaa agcgtccaga 3660 aaggagagct tagcaggagt cctagccctt tcacccatac acatttggct cagggttacc 3720 gaagaggggc caagaaatta gagtcctcag aagagaactt atctagtgag gatgaagagc 3780 ttccctgctt ccaacacttg ttatttggta aagtaaacaa tataccttct cagtctacta 3840 ggcatagcac cgttgctacc gagtgtctgt ctaagaacac agaggagaat ttattatcat 3900 tgaagaatag cttaaatgac tgcagtaacc aggtaatatt ggcaaaggca tctcaggaac 3960 atcaccttag tgaggaaaca aaatgttctg ctagcttgtt ttcttcacag tgcagtgaat 4020 tggaagactt gactgcaaat acaaacaccc aggatccttt cttgattggt tcttccaaac 4080 aaatgaggca tcagtctgaa agccagggag ttggtctgag tgacaaggaa ttggtttcag 4140 atgatgaaga aagaggaacg ggcttggaag aaaataatca agaagagcaa agcatggatt 4200 caaacttagg tgaagcagca tctgggtgtg agagtgaaac aagcgtctct gaagactgct 4260 cagggctatc ctctcagagt gacattttaa ccactcagca gagggatacc atgcaacata 4320 acctgataaa gctccagcag gaaatggctg aactagaagc tgtgttagaa cagcatggga 4380 gccagccttc taacagctac ccttccatca taagtgactc ttctgccctt gaggacctgc 4440 gaaatccaga acaaagcaca tcagaaaaag cagtattaac ttcacagaaa agtagtgaat 4500 accctataag ccagaatcca gaaggccttt ctgctgacaa gtttgaggtg tctgcagata 4560 gttctaccag taaaaataaa gaaccaggag tggaaaggtc atccccttct aaatgcccat 4620 cattagatga taggtggtac atgcacagtt gctctgggag tcttcagaat agaaactacc 4680 catctcaaga ggagctcatt aaggttgttg atgtggagga gcaacagctg gaagagtctg 4740 ggccacacga tttgacggaa acatcttact tgccaaggca agatctagag ggaacccctt 4800 acctggaatc tggaatcagc ctcttctctg atgaccctga atctgatcct tctgaagaca 4860 gagccccaga gtcagctcgt gttggcaaca taccatcttc aacctctgca ttgaaagttc 4920 cccaattgaa agttgcagaa tctgcccaga gtccagctgc tgctcatact actgatactg 4980 ctgggtataa tgcaatggaa gaaagtgtga gcagggagaa gccagaattg acagcttcaa 5040 cagaaagggt caacaaaaga atgtccatgg tggtgtctgg cctgacccca gaagaattta 5100 tgctcgtgta caagtttgcc agaaaacacc acatcacttt aactaatcta attactgaag 5160 agactactca tgttgttatg aaaacagatg ctgagtttgt gtgtgaacgg acactgaaat 5220 attttctagg aattgcggga ggaaaatggg tagttagcta tttctgggtg acccagtcta 5280 ttaaagaaag aaaaatgctg aatgagcatg attttgaagt cagaggagat gtggtcaatg 5340 gaagaaacca ccaaggtcca aagcgagcaa gagaatccca ggacagaaag atcttcaggg 5400 ggctagaaat ctgttgctat gggcccttca ccaacatgcc cacagatcaa ctggaatgga 5460 tggtacagct gtgtggtgct tctgtggtga aggagctttc atcattcacc cttggcacag 5520 gtgtccaccc aattgtggtt gtgcagccag atgcctggac agaggacaat ggcttccatg 5580 caattgggca gatgtgtgag gcacctgtgg tgacccgaga gtgggtgttg gacagtgtag 5640 cactctacca gtgccaggag ctggacacct acctgatacc ccagatcccc cacagccact 5700 actgactgca gccagccaca ggtacagagc cacaggaccc caagaatgag cttacaaagt 5760 ggcctttcca ggccctggga gctcctctca ctcttcagtc cttctactgt cctggctact 5820 aaatatttta tgtacatcag cctgaaaagg acttctggct atgcaagggt cccttaaaga 5880 ttttctgctt gaagtctccc ttggaaatct gccatgagca caaaattatg gtaatttttc 5940 acctgagaag attttaaaac catttaaacg ccaccaattg agcaagatgc tgattcatta 6000 tttatcagcc ctattctttc tattcaggct gttgttggct tagggctgga agcacagagt 6060 ggcttggcct caagagaata gctggtttcc ctaagtttac ttctctaaaa ccctgtgttc 6120 acaaaggcag agagtcagac ccttcaatgg aaggagagtg cttgggatcg attatgtgac 6180 ttaaagtcag aatagtcctt gggcagttct caaatgttgg agtggaacat tggggaggaa 6240 attctgaggc aggtattaga aatgaaaagg aaacttgaaa cctgggcatg gtggctcacg 6300 cctgtaatcc cagcactttg ggaggccaag gtgggcagat cactggaggt caggagttcg 6360 aaaccagcct ggccaacatg gtgaaacccc atctctacta aaaatacaga aattagccgg 6420 tcatggtggt ggacacctgt aatcccagct actcaggtgg ctaaggcagg agaatcactt 6480 cagcccggga ggtggaggtt gcagtgagcc aagatcatac cacggcactc cagcctgggt 6540 gacagtgaga ctgtggctca aaaaaaaaaa aaaaaaaagg aaaatgaaac tagaagagat 6600 ttctaaaagt ctgagatata tttgctagat ttctaaagaa tgtgttctaa aacagcagaa 6660 gattttcaag aaccggtttc caaagacagt cttctaattc ctcattagta ataagtaaaa 6720 tgtttattgt tgtagctctg gtatataatc cattcctctt aaaatataag acctctggca 6780 tgaatatttc atatctataa aatgacagat cccaccagga aggaagctgt tgctttcttt 6840 gaggtgattt ttttcctttg ctccctgttg ctgaaaccat acagcttcat aaataatttt 6900 gcttgctgaa ggaagaaaaa gtgtttttca taaacccatt atccaggact gtttatagct 6960 gttggaagga ctaggtcttc cctagccccc ccagtgtgca agggcagtga agacttgatt 7020 gtacaaaata cgttttgtaa atgttgtgct gttaacactg caaataaact tggtagcaaa 7080 cacttcca 7088 <![CDATA[<210> 8]]> <![CDATA[<211> 1863]]> <![CDATA[<212> PRT]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 8]]> Met Asp Leu Ser Ala Leu Arg Val Glu Glu Val Gln Asn Val Ile Asn 1 5 10 15 Ala Met Gln Lys Ile Leu Glu Cys Pro Ile Cys Leu Glu Leu Ile Lys 20 25 30 Glu Pro Val Ser Thr Lys Cys Asp His Ile Phe Cys Lys Phe Cys Met 35 40 45 Leu Lys Leu Leu Asn Gln Lys Lys Gly Pro Ser Gln Cys Pro Leu Cys 50 55 60 Lys Asn Asp Ile Thr Lys Arg Ser Leu Gln Glu Ser Thr Arg Phe Ser 65 70 75 80 Gln Leu Val Glu Glu Leu Leu Lys Ile Ile Cys Ala Phe Gln Leu Asp 85 90 95 Thr Gly Leu Glu Tyr Ala Asn Ser Tyr Asn Phe Ala Lys Lys Glu Asn 100 105 110 Asn Ser Pro Glu His Leu Lys Asp Glu Val Ser Ile Ile Gln Ser Met 115 120 125 Gly Tyr Arg Asn Arg Ala Lys Arg Leu Leu Gln Ser Glu Pro Glu Asn 130 135 140 Pro Ser Leu Gln Glu Thr Ser Leu Ser Val Gln Leu Ser Asn Leu Gly 145 150 155 160 Thr Val Arg Thr Leu Arg Thr Lys Gln Arg Ile Gln Pro Gln Lys Thr 165 170 175 Ser Val Tyr Ile Glu Leu Gly Ser Asp Ser Ser Glu Asp Thr Val Asn 180 185 190 Lys Ala Thr Tyr Cys Ser Val Gly Asp Gln Glu Leu Leu Gln Ile Thr 195 200 205 Pro Gln Gly Thr Arg Asp Glu Ile Ser Leu Asp Ser Ala Lys Lys Ala 210 215 220 Ala Cys Glu Phe Ser Glu Thr Asp Val Thr Asn Thr Glu His His Gln 225 230 235 240 Pro Ser Asn Asn Asp Leu Asn Thr Thr Glu Lys Arg Ala Ala Glu Arg 245 250 255 His Pro Glu Lys Tyr Gln Gly Ser Ser Val Ser Asn Leu His Val Glu 260 265 270 Pro Cys Gly Thr Asn Thr His Ala Ser Ser Leu Gln His Glu Asn Ser 275 280 285 Ser Leu Leu Leu Thr Lys Asp Arg Met Asn Val Glu Lys Ala Glu Phe 290 295 300 Cys Asn Lys Ser Lys Gln Pro Gly Leu Ala Arg Ser Gln His Asn Arg 305 310 315 320 Trp Ala Gly Ser Lys Glu Thr Cys Asn Asp Arg Arg Thr Pro Ser Thr 325 330 335 Glu Lys Lys Val Asp Leu Asn Ala Asp Pro Leu Cys Glu Arg Lys Glu 340 345 350 Trp Asn Lys Gln Lys Leu Pro Cys Ser Glu Asn Pro Arg Asp Thr Glu 355 360 365 Asp Val Pro Trp Ile Thr Leu Asn Ser Ser Ile Gln Lys Val Asn Glu 370 375 380 Trp Phe Ser Arg Ser Asp Glu Leu Leu Gly Ser Asp Asp Ser His Asp 385 390 395 400 Gly Glu Ser Glu Ser Asn Ala Lys Val Ala Asp Val Leu Asp Val Leu 405 410 415 Asn Glu Val Asp Glu Tyr Ser Gly Ser Ser Glu Lys Ile Asp Leu Leu 420 425 430 Ala Ser Asp Pro His Glu Ala Leu Ile Cys Lys Ser Glu Arg Val His 435 440 445 Ser Lys Ser Val Glu Ser Asn Ile Glu Asp Lys Ile Phe Gly Lys Thr 450 455 460 Tyr Arg Lys Lys Ala Ser Leu Pro Asn Leu Ser His Val Thr Glu Asn 465 470 475 480 Leu Ile Ile Gly Ala Phe Val Thr Glu Pro Gln Ile Ile Gln Glu Arg 485 490 495 Pro Leu Thr Asn Lys Leu Lys Arg Lys Arg Arg Pro Thr Ser Gly Leu 500 505 510 His Pro Glu Asp Phe Ile Lys Lys Ala Asp Leu Ala Val Gln Lys Thr 515 520 525 Pro Glu Met Ile Asn Gln Gly Thr Asn Gln Thr Glu Gln Asn Gly Gln 530 535 540 Val Met Asn Ile Thr Asn Ser Gly His Glu Asn Lys Thr Lys Gly Asp 545 550 555 560 Ser Ile Gln Asn Glu Lys Asn Pro Asn Pro Ile Glu Ser Leu Glu Lys 565 570 575 Glu Ser Ala Phe Lys Thr Lys Ala Glu Pro Ile Ser Ser Ser Ile Ser 580 585 590 Asn Met Glu Leu Glu Leu Asn Ile His Asn Ser Lys Ala Pro Lys Lys 595 600 605 Asn Arg Leu Arg Arg Lys Ser Ser Thr Arg His Ile His Ala Leu Glu 610 615 620 Leu Val Val Ser Arg Asn Leu Ser Pro Pro Asn Cys Thr Glu Leu Gln 625 630 635 640 Ile Asp Ser Cys Ser Ser Ser Glu Glu Ile Lys Lys Lys Lys Tyr Asn 645 650 655 Gln Met Pro Val Arg His Ser Arg Asn Leu Gln Leu Met Glu Gly Lys 660 665 670 Glu Pro Ala Thr Gly Ala Lys Lys Ser Asn Lys Pro Asn Glu Gln Thr 675 680 685 Ser Lys Arg His Asp Ser Asp Thr Phe Pro Glu Leu Lys Leu Thr Asn 690 695 700 Ala Pro Gly Ser Phe Thr Lys Cys Ser Asn Thr Ser Glu Leu Lys Glu 705 710 715 720 Phe Val Asn Pro Ser Leu Pro Arg Glu Glu Lys Glu Glu Lys Leu Glu 725 730 735 Thr Val Lys Val Ser Asn Asn Ala Glu Asp Pro Lys Asp Leu Met Leu 740 745 750 Ser Gly Glu Arg Val Leu Gln Thr Glu Arg Ser Val Glu Ser Ser Ser 755 760 765 Ile Ser Leu Val Pro Gly Thr Asp Tyr Gly Thr Gln Glu Ser Ile Ser 770 775 780 Leu Leu Glu Val Ser Thr Leu Gly Lys Ala Lys Thr Glu Pro Asn Lys 785 790 795 800 Cys Val Ser Gln Cys Ala Ala Phe Glu Asn Pro Lys Gly Leu Ile His 805 810 815 Gly Cys Ser Lys Asp Asn Arg Asn Asp Thr Glu Gly Phe Lys Tyr Pro 820 825 830 Leu Gly His Glu Val Asn His Ser Arg Glu Thr Ser Ile Glu Met Glu 835 840 845 Glu Ser Glu Leu Asp Ala Gln Tyr Leu Gln Asn Thr Phe Lys Val Ser 850 855 860 Lys Arg Gln Ser Phe Ala Pro Phe Ser Asn Pro Gly Asn Ala Glu Glu 865 870 875 880 Glu Cys Ala Thr Phe Ser Ala His Ser Gly Ser Leu Lys Lys Gln Ser 885 890 895 Pro Lys Val Thr Phe Glu Cys Glu Gln Lys Glu Glu Asn Gln Gly Lys 900 905 910 Asn Glu Ser Asn Ile Lys Pro Val Gln Thr Val Asn Ile Thr Ala Gly 915 920 925 Phe Pro Val Val Gly Gln Lys Asp Lys Pro Val Asp Asn Ala Lys Cys 930 935 940 Ser Ile Lys Gly Gly Ser Arg Phe Cys Leu Ser Ser Gln Phe Arg Gly 945 950 955 960 Asn Glu Thr Gly Leu Ile Thr Pro Asn Lys His Gly Leu Leu Gln Asn 965 970 975 Pro Tyr Arg Ile Pro Pro Leu Phe Pro Ile Lys Ser Phe Val Lys Thr 980 985 990 Lys Cys Lys Lys Asn Leu Leu Glu Glu Asn Phe Glu Glu His Ser Met 995 1000 1005 Ser Pro Glu Arg Glu Met Gly Asn Glu Asn Ile Pro Ser Thr Val 1010 1015 1020 Ser Thr Ile Ser Arg Asn Asn Ile Arg Glu Asn Val Phe Lys Glu 1025 1030 1035 Ala Ser Ser Ser Asn Ile Asn Glu Val Gly Ser Ser Thr Asn Glu 1040 1045 1050 Val Gly Ser Ser Ile Asn Glu Ile Gly Ser Ser Asp Glu Asn Ile 1055 1060 1065 Gln Ala Glu Leu Gly Arg Asn Arg Gly Pro Lys Leu Asn Ala Met 1070 1075 1080 Leu Arg Leu Gly Val Leu Gln Pro Glu Val Tyr Lys Gln Ser Leu 1085 1090 1095 Pro Gly Ser Asn Cys Lys His Pro Glu Ile Lys Lys Gln Glu Tyr 1100 1105 1110 Glu Glu Val Val Gln Thr Val Asn Thr Asp Phe Ser Pro Tyr Leu 1115 1120 1125 Ile Ser Asp Asn Leu Glu Gln Pro Met Gly Ser Ser His Ala Ser 1130 1135 1140 Gln Val Cys Ser Glu Thr Pro Asp Asp Leu Leu Asp Asp Gly Glu 1145 1150 1155 Ile Lys Glu Asp Thr Ser Phe Ala Glu Asn Asp Ile Lys Glu Ser 1160 1165 1170 Ser Ala Val Phe Ser Lys Ser Val Gln Lys Gly Glu Leu Ser Arg 1175 1180 1185 Ser Pro Ser Pro Phe Thr His Thr His Leu Ala Gln Gly Tyr Arg 1190 1195 1200 Arg Gly Ala Lys Lys Leu Glu Ser Ser Glu Glu Asn Leu Ser Ser 1205 1210 1215 Glu Asp Glu Glu Leu Pro Cys Phe Gln His Leu Leu Phe Gly Lys 1220 1225 1230 Val Asn Asn Ile Pro Ser Gln Ser Thr Arg His Ser Thr Val Ala 1235 1240 1245 Thr Glu Cys Leu Ser Lys Asn Thr Glu Glu Asn Leu Leu Ser Leu 1250 1255 1260 Lys Asn Ser Leu Asn Asp Cys Ser Asn Gln Val Ile Leu Ala Lys 1265 1270 1275 Ala Ser Gln Glu His His Leu Ser Glu Glu Thr Lys Cys Ser Ala 1280 1285 1290 Ser Leu Phe Ser Ser Gln Cys Ser Glu Leu Glu Asp Leu Thr Ala 1295 1300 1305 Asn Thr Asn Thr Gln Asp Pro Phe Leu Ile Gly Ser Ser Lys Gln 1310 1315 1320 Met Arg His Gln Ser Glu Ser Gln Gly Val Gly Leu Ser Asp Lys 1325 1330 1335 Glu Leu Val Ser Asp Asp Glu Glu Arg Gly Thr Gly Leu Glu Glu 1340 1345 1350 Asn Asn Gln Glu Glu Gln Ser Met Asp Ser Asn Leu Gly Glu Ala 1355 1360 1365 Ala Ser Gly Cys Glu Ser Glu Thr Ser Val Ser Glu Asp Cys Ser 1370 1375 1380 Gly Leu Ser Ser Gln Ser Asp Ile Leu Thr Thr Gln Gln Arg Asp 1385 1390 1395 Thr Met Gln His Asn Leu Ile Lys Leu Gln Gln Glu Met Ala Glu 1400 1405 1410 Leu Glu Ala Val Leu Glu Gln His Gly Ser Gln Pro Ser Asn Ser 1415 1420 1425 Tyr Pro Ser Ile Ile Ser Asp Ser Ser Ala Leu Glu Asp Leu Arg 1430 1435 1440 Asn Pro Glu Gln Ser Thr Ser Glu Lys Ala Val Leu Thr Ser Gln 1445 1450 1455 Lys Ser Ser Glu Tyr Pro Ile Ser Gln Asn Pro Glu Gly Leu Ser 1460 1465 1470 Ala Asp Lys Phe Glu Val Ser Ala Asp Ser Ser Thr Ser Lys Asn 1475 1480 1485 Lys Glu Pro Gly Val Glu Arg Ser Ser Pro Ser Lys Cys Pro Ser 1490 1495 1500 Leu Asp Asp Arg Trp Tyr Met His Ser Cys Ser Gly Ser Leu Gln 1505 1510 1515 Asn Arg Asn Tyr Pro Ser Gln Glu Glu Leu Ile Lys Val Val Asp 1520 1525 1530 Val Glu Glu Gln Gln Leu Glu Glu Ser Gly Pro His Asp Leu Thr 1535 1540 1545 Glu Thr Ser Tyr Leu Pro Arg Gln Asp Leu Glu Gly Thr Pro Tyr 1550 1555 1560 Leu Glu Ser Gly Ile Ser Leu Phe Ser Asp Asp Pro Glu Ser Asp 1565 1570 1575 Pro Ser Glu Asp Arg Ala Pro Glu Ser Ala Arg Val Gly Asn Ile 1580 1585 1590 Pro Ser Ser Thr Ser Ala Leu Lys Val Pro Gln Leu Lys Val Ala 1595 1600 1605 Glu Ser Ala Gln Ser Pro Ala Ala Ala His Thr Thr Asp Thr Ala 1610 1615 1620 Gly Tyr Asn Ala Met Glu Glu Ser Val Ser Arg Glu Lys Pro Glu 1625 1630 1635 Leu Thr Ala Ser Thr Glu Arg Val Asn Lys Arg Met Ser Met Val 1640 1645 1650 Val Ser Gly Leu Thr Pro Glu Glu Phe Met Leu Val Tyr Lys Phe 1655 1660 1665 Ala Arg Lys His His Ile Thr Leu Thr Asn Leu Ile Thr Glu Glu 1670 1675 1680 Thr Thr His Val Val Met Lys Thr Asp Ala Glu Phe Val Cys Glu 1685 1690 1695 Arg Thr Leu Lys Tyr Phe Leu Gly Ile Ala Gly Gly Lys Trp Val 1700 1705 1710 Val Ser Tyr Phe Trp Val Thr Gln Ser Ile Lys Glu Arg Lys Met 1715 1720 1725 Leu Asn Glu His Asp Phe Glu Val Arg Gly Asp Val Val Asn Gly 1730 1735 1740 Arg Asn His Gln Gly Pro Lys Arg Ala Arg Glu Ser Gln Asp Arg 1745 1750 1755 Lys Ile Phe Arg Gly Leu Glu Ile Cys Cys Tyr Gly Pro Phe Thr 1760 1765 1770 Asn Met Pro Thr Asp Gln Leu Glu Trp Met Val Gln Leu Cys Gly 1775 1780 1785 Ala Ser Val Val Lys Glu Leu Ser Ser Phe Thr Leu Gly Thr Gly 1790 1795 1800 Val His Pro Ile Val Val Val Gln Pro Asp Ala Trp Thr Glu Asp 1805 1810 1815 Asn Gly Phe His Ala Ile Gly Gln Met Cys Glu Ala Pro Val Val 1820 1825 1830 Thr Arg Glu Trp Val Leu Asp Ser Val Ala Leu Tyr Gln Cys Gln 1835 1840 1845 Glu Leu Asp Thr Tyr Leu Ile Pro Gln Ile Pro His Ser His Tyr 1850 1855 1860 <![CDATA[<210> 9]]> <![CDATA[<211> 11954]]> <![CDATA[<212> DNA]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 9]]> agaggcggag ccgctgtggc actgctgcgc ctctgctgcg cctcgggtgt cttttgcggc 60 ggtgggtcgc cgccgggaga agcgtgaggg gacagatttg tgaccggcgc ggtttttgtc 120 agcttactcc ggccaaaaaa gaactgcacc tctggagcgg acttatttac caagcattgg 180 aggaatatcg taggtaaaaa tgcctattgg atccaaagag aggccaacat tttttgaaat 240 ttttaagaca cgctgcaaca aagcagattt aggaccaata agtcttaatt ggtttgaaga 300 actttcttca gaagctccac cctataattc tgaacctgca gaagaatctg aacataaaaa 360 caacaattac gaaccaaacc tatttaaaac tccacaaagg aaaccatctt ataatcagct 420 ggcttcaact ccaataatat tcaaagagca agggctgact ctgccgctgt accaatctcc 480 tgtaaaagaa ttagataaat tcaaattaga cttaggaagg aatgttccca atagtagaca 540 taaaagtctt cgcacagtga aaactaaaat ggatcaagca gatgatgttt cctgtccact 600 tctaaattct tgtcttagtg aaagtcctgt tgttctacaa tgtacacatg taacaccaca 660 aagagataag tcagtggtat gtgggagttt gtttcataca ccaaagtttg tgaagggtcg 720 tcagacacca aaacatattt ctgaaagtct aggagctgag gtggatcctg atatgtcttg 780 gtcaagttct ttagctacac cacccaccct tagttctact gtgctcatag tcagaaatga 840 agaagcatct gaaactgtat ttcctcatga tactactgct aatgtgaaaa gctatttttc 900 caatcatgat gaaagtctga agaaaaatga tagatttatc gcttctgtga cagacagtga 960 aaacacaaat caaagagaag ctgcaagtca tggatttgga aaaacatcag ggaattcatt 1020 taaagtaaat agctgcaaag accacattgg aaagtcaatg ccaaatgtcc tagaagatga 1080 agtatatgaa acagttgtag atacctctga agaagatagt ttttcattat gtttttctaa 1140 atgtagaaca aaaaatctac aaaaagtaag aactagcaag actaggaaaa aaattttcca 1200 tgaagcaaac gctgatgaat gtgaaaaatc taaaaaccaa gtgaaagaaa aatactcatt 1260 tgtatctgaa gtggaaccaa atgatactga tccattagat tcaaatgtag caaatcagaa 1320 gccctttgag agtggaagtg acaaaatctc caaggaagtt gtaccgtctt tggcctgtga 1380 atggtctcaa ctaacccttt caggtctaaa tggagcccag atggagaaaa tacccctatt 1440 gcatatttct tcatgtgacc aaaatatttc agaaaaagac ctattagaca cagagaacaa 1500 aagaaagaaa gattttctta cttcagagaa ttctttgcca cgtatttcta gcctaccaaa 1560 atcagagaag ccattaaatg aggaaacagt ggtaaataag agagatgaag agcagcatct 1620 tgaatctcat acagactgca ttcttgcagt aaagcaggca atatctggaa cttctccagt 1680 ggcttcttca tttcagggta tcaaaaagtc tatattcaga ataagagaat cacctaaaga 1740 gactttcaat gcaagttttt caggtcatat gactgatcca aactttaaaa aagaaactga 1800 agcctctgaa agtggactgg aaatacatac tgtttgctca cagaaggagg actccttatg 1860 tccaaattta attgataatg gaagctggcc agccaccacc acacagaatt ctgtagcttt 1920 gaagaatgca ggtttaatat ccactttgaa aaagaaaaca aataagttta tttatgctat 1980 acatgatgaa acatcttata aaggaaaaaa aataccgaaa gaccaaaaat cagaactaat 2040 taactgttca gcccagtttg aagcaaatgc ttttgaagca ccacttacat ttgcaaatgc 2100 tgattcaggt ttattgcatt cttctgtgaa aagaagctgt tcacagaatg attctgaaga 2160 accaactttg tccttaacta gctcttttgg gacaattctg aggaaatgtt ctagaaatga 2220 aacatgttct aataatacag taatctctca ggatcttgat tataaagaag caaaatgtaa 2280 taaggaaaaa ctacagttat ttattacccc agaagctgat tctctgtcat gcctgcagga 2340 aggacagtgt gaaaatgatc caaaaagcaa aaaagtttca gatataaaag aagaggtctt 2400 ggctgcagca tgtcacccag tacaacattc aaaagtggaa tacagtgata ctgactttca 2460 atcccagaaa agtcttttat atgatcatga aaatgccagc actcttattt taactcctac 2520 ttccaaggat gttctgtcaa acctagtcat gatttctaga ggcaaagaat catacaaaat 2580 gtcagacaag ctcaaaggta acaattatga atctgatgtt gaattaacca aaaatattcc 2640 catggaaaag aatcaagatg tatgtgcttt aaatgaaaat tataaaaacg ttgagctgtt 2700 gccacctgaa aaatacatga gagtagcatc accttcaaga aaggtacaat tcaaccaaaa 2760 cacaaatcta agagtaatcc aaaaaaatca agaagaaact acttcaattt caaaaataac 2820 tgtcaatcca gactctgaag aacttttctc agacaatgag aataattttg tcttccaagt 2880 agctaatgaa aggaataatc ttgctttagg aaatactaag gaacttcatg aaacagactt 2940 gacttgtgta aacgaaccca ttttcaagaa ctctaccatg gttttatatg gagacacagg 3000 tgataaacaa gcaacccaag tgtcaattaa aaaagatttg gtttatgttc ttgcagagga 3060 gaacaaaaat agtgtaaagc agcatataaa aatgactcta ggtcaagatt taaaatcgga 3120 catctccttg aatatagata aaataccaga aaaaaataat gattacatga acaaatgggc 3180 aggactctta ggtccaattt caaatcacag ttttggaggt agcttcagaa cagcttcaaa 3240 taaggaaatc aagctctctg aacataacat taagaagagc aaaatgttct tcaaagatat 3300 tgaagaacaa tatcctacta gtttagcttg tgttgaaatt gtaaatacct tggcattaga 3360 taatcaaaag aaactgagca agcctcagtc aattaatact gtatctgcac atttacagag 3420 tagtgtagtt gtttctgatt gtaaaaatag tcatataacc cctcagatgt tattttccaa 3480 gcaggatttt aattcaaacc ataatttaac acctagccaa aaggcagaaa ttacagaact 3540 ttctactata ttagaagaat caggaagtca gtttgaattt actcagttta gaaaaccaag 3600 ctacatattg cagaagagta catttgaagt gcctgaaaac cagatgacta tcttaaagac 3660 cacttctgag gaatgcagag atgctgatct tcatgtcata atgaatgccc catcgattgg 3720 tcaggtagac agcagcaagc aatttgaagg tacagttgaa attaaacgga agtttgctgg 3780 cctgttgaaa aatgactgta acaaaagtgc ttctggttat ttaacagatg aaaatgaagt 3840 ggggtttagg ggcttttatt ctgctcatgg cacaaaactg aatgtttcta ctgaagctct 3900 gcaaaaagct gtgaaactgt ttagtgatat tgagaatatt agtgaggaaa cttctgcaga 3960 ggtacatcca ataagtttat cttcaagtaa atgtcatgat tctgttgttt caatgtttaa 4020 gatagaaaat cataatgata aaactgtaag tgaaaaaaat aataaatgcc aactgatatt 4080 acaaaataat attgaaatga ctactggcac ttttgttgaa gaaattactg aaaattacaa 4140 gagaaatact gaaaatgaag ataacaaata tactgctgcc agtagaaatt ctcataactt 4200 agaatttgat ggcagtgatt caagtaaaaa tgatactgtt tgtattcata aagatgaaac 4260 ggacttgcta tttactgatc agcacaacat atgtcttaaa ttatctggcc agtttatgaa 4320 ggagggaaac actcagatta aagaagattt gtcagattta acttttttgg aagttgcgaa 4380 agctcaagaa gcatgtcatg gtaatacttc aaataaagaa cagttaactg ctactaaaac 4440 ggagcaaaat ataaaagatt ttgagacttc tgatacattt tttcagactg caagtgggaa 4500 aaatattagt gtcgccaaag agtcatttaa taaaattgta aatttctttg atcagaaacc 4560 agaagaattg cataactttt ccttaaattc tgaattacat tctgacataa gaaagaacaa 4620 aatggacatt ctaagttatg aggaaacaga catagttaaa cacaaaatac tgaaagaaag 4680 tgtcccagtt ggtactggaa atcaactagt gaccttccag ggacaacccg aacgtgatga 4740 aaagatcaaa gaacctactc tattgggttt tcatacagct agcgggaaaa aagttaaaat 4800 tgcaaaggaa tctttggaca aagtgaaaaa cctttttgat gaaaaagagc aaggtactag 4860 tgaaatcacc agttttagcc atcaatgggc aaagacccta aagtacagag aggcctgtaa 4920 agaccttgaa ttagcatgtg agaccattga gatcacagct gccccaaagt gtaaagaaat 4980 gcagaattct ctcaataatg ataaaaacct tgtttctatt gagactgtgg tgccacctaa 5040 gctcttaagt gataatttat gtagacaaac tgaaaatctc aaaacatcaa aaagtatctt 5100 tttgaaagtt aaagtacatg aaaatgtaga aaaagaaaca gcaaaaagtc ctgcaacttg 5160 ttacacaaat cagtcccctt attcagtcat tgaaaattca gccttagctt tttacacaag 5220 ttgtagtaga aaaacttctg tgagtcagac ttcattactt gaagcaaaaa aatggcttag 5280 agaaggaata tttgatggtc aaccagaaag aataaatact gcagattatg taggaaatta 5340 tttgtatgaa aataattcaa acagtactat agctgaaaat gacaaaaatc atctctccga 5400 aaaacaagat acttatttaa gtaacagtag catgtctaac agctattcct accattctga 5460 tgaggtatat aatgattcag gatatctctc aaaaaataaa cttgattctg gtattgagcc 5520 agtattgaag aatgttgaag atcaaaaaaa cactagtttt tccaaagtaa tatccaatgt 5580 aaaagatgca aatgcatacc cacaaactgt aaatgaagat atttgcgttg aggaacttgt 5640 gactagctct tcaccctgca aaaataaaaa tgcagccatt aaattgtcca tatctaatag 5700 taataatttt gaggtagggc cacctgcatt taggatagcc agtggtaaaa tcgtttgtgt 5760 ttcacatgaa acaattaaaa aagtgaaaga catatttaca gacagtttca gtaaagtaat 5820 taaggaaaac aacgagaata aatcaaaaat ttgccaaacg aaaattatgg caggttgtta 5880 cgaggcattg gatgattcag aggatattct tcataactct ctagataatg atgaatgtag 5940 cacgcattca cataaggttt ttgctgacat tcagagtgaa gaaattttac aacataacca 6000 aaatatgtct ggattggaga aagtttctaa aatatcacct tgtgatgtta gtttggaaac 6060 ttcagatata tgtaaatgta gtatagggaa gcttcataag tcagtctcat ctgcaaatac 6120 ttgtgggatt tttagcacag caagtggaaa atctgtccag gtatcagatg cttcattaca 6180 aaacgcaaga caagtgtttt ctgaaataga agatagtacc aagcaagtct tttccaaagt 6240 attgtttaaa agtaacgaac attcagacca gctcacaaga gaagaaaata ctgctatacg 6300 tactccagaa catttaatat cccaaaaagg cttttcatat aatgtggtaa attcatctgc 6360 tttctctgga tttagtacag caagtggaaa gcaagtttcc attttagaaa gttccttaca 6420 caaagttaag ggagtgttag aggaatttga tttaatcaga actgagcata gtcttcacta 6480 ttcacctacg tctagacaaa atgtatcaaa aatacttcct cgtgttgata agagaaaccc 6540 agagcactgt gtaaactcag aaatggaaaa aacctgcagt aaagaattta aattatcaaa 6600 taacttaaat gttgaaggtg gttcttcaga aaataatcac tctattaaag tttctccata 6660 tctctctcaa tttcaacaag acaaacaaca gttggtatta ggaaccaaag tgtcacttgt 6720 tgagaacatt catgttttgg gaaaagaaca ggcttcacct aaaaacgtaa aaatggaaat 6780 tggtaaaact gaaacttttt ctgatgttcc tgtgaaaaca aatatagaag tttgttctac 6840 ttactccaaa gattcagaaa actactttga aacagaagca gtagaaattg ctaaagcttt 6900 tatggaagat gatgaactga cagattctaa actgccaagt catgccacac attctctttt 6960 tacatgtccc gaaaatgagg aaatggtttt gtcaaattca agaattggaa aaagaagagg 7020 agagcccctt atcttagtgg gagaaccctc aatcaaaaga aacttattaa atgaatttga 7080 caggataata gaaaatcaag aaaaatcctt aaaggcttca aaaagcactc cagatggcac 7140 aataaaagat cgaagattgt ttatgcatca tgtttcttta gagccgatta cctgtgtacc 7200 ctttcgcaca actaaggaac gtcaagagat acagaatcca aattttaccg cacctggtca 7260 agaatttctg tctaaatctc atttgtatga acatctgact ttggaaaaat cttcaagcaa 7320 tttagcagtt tcaggacatc cattttatca agtttctgct acaagaaatg aaaaaatgag 7380 acacttgatt actacaggca gaccaaccaa agtctttgtt ccacctttta aaactaaatc 7440 acattttcac agagttgaac agtgtgttag gaatattaac ttggaggaaa acagacaaaa 7500 gcaaaacatt gatggacatg gctctgatga tagtaaaaat aagattaatg acaatgagat 7560 tcatcagttt aacaaaaaca actccaatca agcagtagct gtaactttca caaagtgtga 7620 agaagaacct ttagatttaa ttacaagtct tcagaatgcc agagatatac aggatatgcg 7680 aattaagaag aaacaaaggc aacgcgtctt tccacagcca ggcagtctgt atcttgcaaa 7740 aacatccact ctgcctcgaa tctctctgaa agcagcagta ggaggccaag ttccctctgc 7800 gtgttctcat aaacagctgt atacgtatgg cgtttctaaa cattgcataa aaattaacag 7860 caaaaatgca gagtcttttc agtttcacac tgaagattat tttggtaagg aaagtttatg 7920 gactggaaaa ggaatacagt tggctgatgg tggatggctc ataccctcca atgatggaaa 7980 ggctggaaaa gaagaatttt atagggctct gtgtgacact ccaggtgtgg atccaaagct 8040 tatttctaga atttgggttt ataatcacta tagatggatc atatggaaac tggcagctat 8100 ggaatgtgcc tttcctaagg aatttgctaa tagatgccta agcccagaaa gggtgcttct 8160 tcaactaaaa tacagatatg atacggaaat tgatagaagc agaagatcgg ctataaaaaa 8220 gataatggaa agggatgaca cagctgcaaa aacacttgtt ctctgtgttt ctgacataat 8280 ttcattgagc gcaaatatat ctgaaacttc tagcaataaa actagtagtg cagataccca 8340 aaaagtggcc attattgaac ttacagatgg gtggtatgct gttaaggccc agttagatcc 8400 tcccctctta gctgtcttaa agaatggcag actgacagtt ggtcagaaga ttattcttca 8460 tggagcagaa ctggtgggct ctcctgatgc ctgtacacct cttgaagccc cagaatctct 8520 tatgttaaag atttctgcta acagtactcg gcctgctcgc tggtatacca aacttggatt 8580 ctttcctgac cctagacctt ttcctctgcc cttatcatcg cttttcagtg atggaggaaa 8640 tgttggttgt gttgatgtaa ttattcaaag agcataccct atacagtgga tggagaagac 8700 atcatctgga ttatacatat ttcgcaatga aagagaggaa gaaaaggaag cagcaaaata 8760 tgtggaggcc caacaaaaga gactagaagc cttattcact aaaattcagg aggaatttga 8820 agaacatgaa gaaaacacaa caaaaccata tttaccatca cgtgcactaa caagacagca 8880 agttcgtgct ttgcaagatg gtgcagagct ttatgaagca gtgaagaatg cagcagaccc 8940 agcttacctt gagggttatt tcagtgaaga gcagttaaga gccttgaata atcacaggca 9000 aatgttgaat gataagaaac aagctcagat ccagttggaa attaggaagg ccatggaatc 9060 tgctgaacaa aaggaacaag gtttatcaag ggatgtcaca accgtgtgga agttgcgtat 9120 tgtaagctat tcaaaaaaag aaaaagattc agttatactg agtatttggc gtccatcatc 9180 agatttatat tctctgttaa cagaaggaaa gagatacaga atttatcatc ttgcaacttc 9240 aaaatctaaa agtaaatctg aaagagctaa catacagtta gcagcgacaa aaaaaactca 9300 gtatcaacaa ctaccggttt cagatgaaat tttatttcag atttaccagc cacgggagcc 9360 ccttcacttc agcaaatttt tagatccaga ctttcagcca tcttgttctg aggtggacct 9420 aataggattt gtcgtttctg ttgtgaaaaa aacaggactt gcccctttcg tctatttgtc 9480 agacgaatgt tacaatttac tggcaataaa gttttggata gaccttaatg aggacattat 9540 taagcctcat atgttaattg ctgcaagcaa cctccagtgg cgaccagaat ccaaatcagg 9600 ccttcttact ttatttgctg gagatttttc tgtgttttct gctagtccaa aagagggcca 9660 ctttcaagag acattcaaca aaatgaaaaa tactgttgag aatattgaca tactttgcaa 9720 tgaagcagaa aacaagctta tgcatatact gcatgcaaat gatcccaagt ggtccacccc 9780 aactaaagac tgtacttcag ggccgtacac tgctcaaatc attcctggta caggaaacaa 9840 gcttctgatg tcttctccta attgtgagat atattatcaa agtcctttat cactttgtat 9900 ggccaaaagg aagtctgttt ccacacctgt ctcagcccag atgacttcaa agtcttgtaa 9960 aggggagaaa gagattgatg accaaaagaa ctgcaaaaag agaagagcct tggatttctt 10020 gagtagactg cctttacctc cacctgttag tcccatttgt acatttgttt ctccggctgc 10080 acagaaggca tttcagccac caaggagttg tggcaccaaa tacgaaacac ccataaagaa 10140 aaaagaactg aattctcctc agatgactcc atttaaaaaa ttcaatgaaa tttctctttt 10200 ggaaagtaat tcaatagctg acgaagaact tgcattgata aatacccaag ctcttttgtc 10260 tggttcaaca ggagaaaaac aatttatatc tgtcagtgaa tccactagga ctgctcccac 10320 cagttcagaa gattatctca gactgaaacg acgttgtact acatctctga tcaaagaaca 10380 ggagagttcc caggccagta cggaagaatg tgagaaaaat aagcaggaca caattacaac 10440 taaaaaatat atctaagcat ttgcaaaggc gacaataaat tattgacgct taacctttcc 10500 agtttataag actggaatat aatttcaaac cacacattag tacttatgtt gcacaatgag 10560 aaaagaaatt agtttcaaat ttacctcagc gtttgtgtat cgggcaaaaa tcgttttgcc 10620 cgattccgta ttggtatact tttgcttcag ttgcatatct taaaactaaa tgtaatttat 10680 taactaatca agaaaaacat ctttggctga gctcggtggc tcatgcctgt aatcccaaca 10740 ctttgagaag ctgaggtggg aggagtgctt gaggccagga gttcaagacc agcctgggca 10800 acatagggag acccccatct ttacaaagaa aaaaaaaagg ggaaaagaaa atcttttaaa 10860 tctttggatt tgatcactac aagtattatt ttacaagtga aataaacata ccattttctt 10920 ttagattgtg tcattaaatg gaatgaggtc tcttagtaca gttattttga tgcagataat 10980 tccttttagt ttagctacta ttttagggga ttttttttag aggtaactca ctatgaaata 11040 gttctcctta atgcaaatat gttggttctg ctatagttcc atcctgttca aaagtcagga 11100 tgaatatgaa gagtggtgtt tccttttgag caattcttca tccttaagtc agcatgatta 11160 taagaaaaat agaaccctca gtgtaactct aattcctttt tactattcca gtgtgatctc 11220 tgaaattaaa ttacttcaac taaaaattca aatactttaa atcagaagat ttcatagtta 11280 atttattttt tttttcaaca aaatggtcat ccaaactcaa acttgagaaa atatcttgct 11340 ttcaaattgg cactgattct gcctgcttta tttttagcgc tatcacagga cccagagcct 11400 atgccctttt aaacttacca caaaagcaga agattaattc aatttaagat gatactctca 11460 tttgttacgt cctttttttt tttttttgga gatggagtct tgctttgtcg cccatgctgg 11520 agtgcagtgg catgatcctg gctcactgca gcctccactt cccgggttca cgtaattctc 11580 ccacctcaag cctccctagt agctgggatt acagggacgc accaccatgc ccagctaatt 11640 tttgcatttt tagtagagac tgggttttac catgttggcc aagctggtct caaactcctg 11700 atgtcaggtg atccatctgc ctcagcctcc caaagtgctg ggattatagg cgtgagccac 11760 tgtgcccggc caatatttgt tactttctta ggtttaatag agaaaaggga taaaacattt 11820 ctaactggga gttaattgca tggagaaggt cttaaatcag atgttttaat gccttaaatg 11880 tctgtataat atcatgtttt caaatctaat tataaatacg tttaaagcca agaataaatc 11940 ttttaaaaaa ttga 11954 <![CDATA[<210> 10]]> <![CDATA[<211> 3418]]> <![CDATA[<212> PRT]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 10]]> Met Pro Ile Gly Ser Lys Glu Arg Pro Thr Phe Phe Glu Ile Phe Lys 1 5 10 15 Thr Arg Cys Asn Lys Ala Asp Leu Gly Pro Ile Ser Leu Asn Trp Phe 20 25 30 Glu Glu Leu Ser Ser Glu Ala Pro Pro Tyr Asn Ser Glu Pro Ala Glu 35 40 45 Glu Ser Glu His Lys Asn Asn Asn Tyr Glu Pro Asn Leu Phe Lys Thr 50 55 60 Pro Gln Arg Lys Pro Ser Tyr Asn Gln Leu Ala Ser Thr Pro Ile Ile 65 70 75 80 Phe Lys Glu Gln Gly Leu Thr Leu Pro Leu Tyr Gln Ser Pro Val Lys 85 90 95 Glu Leu Asp Lys Phe Lys Leu Asp Leu Gly Arg Asn Val Pro Asn Ser 100 105 110 Arg His Lys Ser Leu Arg Thr Val Lys Thr Lys Met Asp Gln Ala Asp 115 120 125 Asp Val Ser Cys Pro Leu Leu Asn Ser Cys Leu Ser Glu Ser Pro Val 130 135 140 Val Leu Gln Cys Thr His Val Thr Pro Gln Arg Asp Lys Ser Val Val 145 150 155 160 Cys Gly Ser Leu Phe His Thr Pro Lys Phe Val Lys Gly Arg Gln Thr 165 170 175 Pro Lys His Ile Ser Glu Ser Leu Gly Ala Glu Val Asp Pro Asp Met 180 185 190 Ser Trp Ser Ser Ser Leu Ala Thr Pro Pro Thr Leu Ser Ser Thr Val 195 200 205 Leu Ile Val Arg Asn Glu Glu Ala Ser Glu Thr Val Phe Pro His Asp 210 215 220 Thr Thr Ala Asn Val Lys Ser Tyr Phe Ser Asn His Asp Glu Ser Leu 225 230 235 240 Lys Lys Asn Asp Arg Phe Ile Ala Ser Val Thr Asp Ser Glu Asn Thr 245 250 255 Asn Gln Arg Glu Ala Ala Ser His Gly Phe Gly Lys Thr Ser Gly Asn 260 265 270 Ser Phe Lys Val Asn Ser Cys Lys Asp His Ile Gly Lys Ser Met Pro 275 280 285 Asn Val Leu Glu Asp Glu Val Tyr Glu Thr Val Val Asp Thr Ser Glu 290 295 300 Glu Asp Ser Phe Ser Leu Cys Phe Ser Lys Cys Arg Thr Lys Asn Leu 305 310 315 320 Gln Lys Val Arg Thr Ser Lys Thr Arg Lys Lys Ile Phe His Glu Ala 325 330 335 Asn Ala Asp Glu Cys Glu Lys Ser Lys Asn Gln Val Lys Glu Lys Tyr 340 345 350 Ser Phe Val Ser Glu Val Glu Pro Asn Asp Thr Asp Pro Leu Asp Ser 355 360 365 Asn Val Ala Asn Gln Lys Pro Phe Glu Ser Gly Ser Asp Lys Ile Ser 370 375 380 Lys Glu Val Val Pro Ser Leu Ala Cys Glu Trp Ser Gln Leu Thr Leu 385 390 395 400 Ser Gly Leu Asn Gly Ala Gln Met Glu Lys Ile Pro Leu Leu His Ile 405 410 415 Ser Ser Cys Asp Gln Asn Ile Ser Glu Lys Asp Leu Leu Asp Thr Glu 420 425 430 Asn Lys Arg Lys Lys Asp Phe Leu Thr Ser Glu Asn Ser Leu Pro Arg 435 440 445 Ile Ser Ser Leu Pro Lys Ser Glu Lys Pro Leu Asn Glu Glu Thr Val 450 455 460 Val Asn Lys Arg Asp Glu Glu Gln His Leu Glu Ser His Thr Asp Cys 465 470 475 480 Ile Leu Ala Val Lys Gln Ala Ile Ser Gly Thr Ser Pro Val Ala Ser 485 490 495 Ser Phe Gln Gly Ile Lys Lys Ser Ile Phe Arg Ile Arg Glu Ser Pro 500 505 510 Lys Glu Thr Phe Asn Ala Ser Phe Ser Gly His Met Thr Asp Pro Asn 515 520 525 Phe Lys Lys Glu Thr Glu Ala Ser Glu Ser Gly Leu Glu Ile His Thr 530 535 540 Val Cys Ser Gln Lys Glu Asp Ser Leu Cys Pro Asn Leu Ile Asp Asn 545 550 555 560 Gly Ser Trp Pro Ala Thr Thr Thr Gln Asn Ser Val Ala Leu Lys Asn 565 570 575 Ala Gly Leu Ile Ser Thr Leu Lys Lys Lys Thr Asn Lys Phe Ile Tyr 580 585 590 Ala Ile His Asp Glu Thr Ser Tyr Lys Gly Lys Lys Ile Pro Lys Asp 595 600 605 Gln Lys Ser Glu Leu Ile Asn Cys Ser Ala Gln Phe Glu Ala Asn Ala 610 615 620 Phe Glu Ala Pro Leu Thr Phe Ala Asn Ala Asp Ser Gly Leu Leu His 625 630 635 640 Ser Ser Val Lys Arg Ser Cys Ser Gln Asn Asp Ser Glu Glu Pro Thr 645 650 655 Leu Ser Leu Thr Ser Ser Phe Gly Thr Ile Leu Arg Lys Cys Ser Arg 660 665 670 Asn Glu Thr Cys Ser Asn Asn Thr Val Ile Ser Gln Asp Leu Asp Tyr 675 680 685 Lys Glu Ala Lys Cys Asn Lys Glu Lys Leu Gln Leu Phe Ile Thr Pro 690 695 700 Glu Ala Asp Ser Leu Ser Cys Leu Gln Glu Gly Gln Cys Glu Asn Asp 705 710 715 720 Pro Lys Ser Lys Lys Val Ser Asp Ile Lys Glu Glu Val Leu Ala Ala 725 730 735 Ala Cys His Pro Val Gln His Ser Lys Val Glu Tyr Ser Asp Thr Asp 740 745 750 Phe Gln Ser Gln Lys Ser Leu Leu Tyr Asp His Glu Asn Ala Ser Thr 755 760 765 Leu Ile Leu Thr Pro Thr Ser Lys Asp Val Leu Ser Asn Leu Val Met 770 775 780 Ile Ser Arg Gly Lys Glu Ser Tyr Lys Met Ser Asp Lys Leu Lys Gly 785 790 795 800 Asn Asn Tyr Glu Ser Asp Val Glu Leu Thr Lys Asn Ile Pro Met Glu 805 810 815 Lys Asn Gln Asp Val Cys Ala Leu Asn Glu Asn Tyr Lys Asn Val Glu 820 825 830 Leu Leu Pro Pro Glu Lys Tyr Met Arg Val Ala Ser Pro Ser Arg Lys 835 840 845 Val Gln Phe Asn Gln Asn Thr Asn Leu Arg Val Ile Gln Lys Asn Gln 850 855 860 Glu Glu Thr Thr Ser Ile Ser Lys Ile Thr Val Asn Pro Asp Ser Glu 865 870 875 880 Glu Leu Phe Ser Asp Asn Glu Asn Asn Phe Val Phe Gln Val Ala Asn 885 890 895 Glu Arg Asn Asn Leu Ala Leu Gly Asn Thr Lys Glu Leu His Glu Thr 900 905 910 Asp Leu Thr Cys Val Asn Glu Pro Ile Phe Lys Asn Ser Thr Met Val 915 920 925 Leu Tyr Gly Asp Thr Gly Asp Lys Gln Ala Thr Gln Val Ser Ile Lys 930 935 940 Lys Asp Leu Val Tyr Val Leu Ala Glu Glu Asn Lys Asn Ser Val Lys 945 950 955 960 Gln His Ile Lys Met Thr Leu Gly Gln Asp Leu Lys Ser Asp Ile Ser 965 970 975 Leu Asn Ile Asp Lys Ile Pro Glu Lys Asn Asn Asp Tyr Met Asn Lys 980 985 990 Trp Ala Gly Leu Leu Gly Pro Ile Ser Asn His Ser Phe Gly Gly Ser 995 1000 1005 Phe Arg Thr Ala Ser Asn Lys Glu Ile Lys Leu Ser Glu His Asn 1010 1015 1020 Ile Lys Lys Ser Lys Met Phe Phe Lys Asp Ile Glu Glu Gln Tyr 1025 1030 1035 Pro Thr Ser Leu Ala Cys Val Glu Ile Val Asn Thr Leu Ala Leu 1040 1045 1050 Asp Asn Gln Lys Lys Leu Ser Lys Pro Gln Ser Ile Asn Thr Val 1055 1060 1065 Ser Ala His Leu Gln Ser Ser Val Val Val Ser Asp Cys Lys Asn 1070 1075 1080 Ser His Ile Thr Pro Gln Met Leu Phe Ser Lys Gln Asp Phe Asn 1085 1090 1095 Ser Asn His Asn Leu Thr Pro Ser Gln Lys Ala Glu Ile Thr Glu 1100 1105 1110 Leu Ser Thr Ile Leu Glu Glu Ser Gly Ser Gln Phe Glu Phe Thr 1115 1120 1125 Gln Phe Arg Lys Pro Ser Tyr Ile Leu Gln Lys Ser Thr Phe Glu 1130 1135 1140 Val Pro Glu Asn Gln Met Thr Ile Leu Lys Thr Thr Ser Glu Glu 1145 1150 1155 Cys Arg Asp Ala Asp Leu His Val Ile Met Asn Ala Pro Ser Ile 1160 1165 1170 Gly Gln Val Asp Ser Ser Lys Gln Phe Glu Gly Thr Val Glu Ile 1175 1180 1185 Lys Arg Lys Phe Ala Gly Leu Leu Lys Asn Asp Cys Asn Lys Ser 1190 1195 1200 Ala Ser Gly Tyr Leu Thr Asp Glu Asn Glu Val Gly Phe Arg Gly 1205 1210 1215 Phe Tyr Ser Ala His Gly Thr Lys Leu Asn Val Ser Thr Glu Ala 1220 1225 1230 Leu Gln Lys Ala Val Lys Leu Phe Ser Asp Ile Glu Asn Ile Ser 1235 1240 1245 Glu Glu Thr Ser Ala Glu Val His Pro Ile Ser Leu Ser Ser Ser 1250 1255 1260 Lys Cys His Asp Ser Val Val Ser Met Phe Lys Ile Glu Asn His 1265 1270 1275 Asn Asp Lys Thr Val Ser Glu Lys Asn Asn Lys Cys Gln Leu Ile 1280 1285 1290 Leu Gln Asn Asn Ile Glu Met Thr Thr Gly Thr Phe Val Glu Glu 1295 1300 1305 Ile Thr Glu Asn Tyr Lys Arg Asn Thr Glu Asn Glu Asp Asn Lys 1310 1315 1320 Tyr Thr Ala Ala Ser Arg Asn Ser His Asn Leu Glu Phe Asp Gly 1325 1330 1335 Ser Asp Ser Ser Lys Asn Asp Thr Val Cys Ile His Lys Asp Glu 1340 1345 1350 Thr Asp Leu Leu Phe Thr Asp Gln His Asn Ile Cys Leu Lys Leu 1355 1360 1365 Ser Gly Gln Phe Met Lys Glu Gly Asn Thr Gln Ile Lys Glu Asp 1370 1375 1380 Leu Ser Asp Leu Thr Phe Leu Glu Val Ala Lys Ala Gln Glu Ala 1385 1390 1395 Cys His Gly Asn Thr Ser Asn Lys Glu Gln Leu Thr Ala Thr Lys 1400 1405 1410 Thr Glu Gln Asn Ile Lys Asp Phe Glu Thr Ser Asp Thr Phe Phe 1415 1420 1425 Gln Thr Ala Ser Gly Lys Asn Ile Ser Val Ala Lys Glu Ser Phe 1430 1435 1440 Asn Lys Ile Val Asn Phe Phe Asp Gln Lys Pro Glu Glu Leu His 1445 1450 1455 Asn Phe Ser Leu Asn Ser Glu Leu His Ser Asp Ile Arg Lys Asn 1460 1465 1470 Lys Met Asp Ile Leu Ser Tyr Glu Glu Thr Asp Ile Val Lys His 1475 1480 1485 Lys Ile Leu Lys Glu Ser Val Pro Val Gly Thr Gly Asn Gln Leu 1490 1495 1500 Val Thr Phe Gln Gly Gln Pro Glu Arg Asp Glu Lys Ile Lys Glu 1505 1510 1515 Pro Thr Leu Leu Gly Phe His Thr Ala Ser Gly Lys Lys Val Lys 1520 1525 1530 Ile Ala Lys Glu Ser Leu Asp Lys Val Lys Asn Leu Phe Asp Glu 1535 1540 1545 Lys Glu Gln Gly Thr Ser Glu Ile Thr Ser Phe Ser His Gln Trp 1550 1555 1560 Ala Lys Thr Leu Lys Tyr Arg Glu Ala Cys Lys Asp Leu Glu Leu 1565 1570 1575 Ala Cys Glu Thr Ile Glu Ile Thr Ala Ala Pro Lys Cys Lys Glu 1580 1585 1590 Met Gln Asn Ser Leu Asn Asn Asp Lys Asn Leu Val Ser Ile Glu 1595 1600 1605 Thr Val Val Pro Pro Lys Leu Leu Ser Asp Asn Leu Cys Arg Gln 1610 1615 1620 Thr Glu Asn Leu Lys Thr Ser Lys Ser Ile Phe Leu Lys Val Lys 1625 1630 1635 Val His Glu Asn Val Glu Lys Glu Thr Ala Lys Ser Pro Ala Thr 1640 1645 1650 Cys Tyr Thr Asn Gln Ser Pro Tyr Ser Val Ile Glu Asn Ser Ala 1655 1660 1665 Leu Ala Phe Tyr Thr Ser Cys Ser Arg Lys Thr Ser Val Ser Gln 1670 1675 1680 Thr Ser Leu Leu Glu Ala Lys Lys Trp Leu Arg Glu Gly Ile Phe 1685 1690 1695 Asp Gly Gln Pro Glu Arg Ile Asn Thr Ala Asp Tyr Val Gly Asn 1700 1705 1710 Tyr Leu Tyr Glu Asn Asn Ser Asn Ser Thr Ile Ala Glu Asn Asp 1715 1720 1725 Lys Asn His Leu Ser Glu Lys Gln Asp Thr Tyr Leu Ser Asn Ser 1730 1735 1740 Ser Met Ser Asn Ser Tyr Ser Tyr His Ser Asp Glu Val Tyr Asn 1745 1750 1755 Asp Ser Gly Tyr Leu Ser Lys Asn Lys Leu Asp Ser Gly Ile Glu 1760 1765 1770 Pro Val Leu Lys Asn Val Glu Asp Gln Lys Asn Thr Ser Phe Ser 1775 1780 1785 Lys Val Ile Ser Asn Val Lys Asp Ala Asn Ala Tyr Pro Gln Thr 1790 1795 1800 Val Asn Glu Asp Ile Cys Val Glu Glu Leu Val Thr Ser Ser Ser 1805 1810 1815 Pro Cys Lys Asn Lys Asn Ala Ala Ile Lys Leu Ser Ile Ser Asn 1820 1825 1830 Ser Asn Asn Phe Glu Val Gly Pro Pro Ala Phe Arg Ile Ala Ser 1835 1840 1845 Gly Lys Ile Val Cys Val Ser His Glu Thr Ile Lys Lys Val Lys 1850 1855 1860 Asp Ile Phe Thr Asp Ser Phe Ser Lys Val Ile Lys Glu Asn Asn 1865 1870 1875 Glu Asn Lys Ser Lys Ile Cys Gln Thr Lys Ile Met Ala Gly Cys 1880 1885 1890 Tyr Glu Ala Leu Asp Asp Ser Glu Asp Ile Leu His Asn Ser Leu 1895 1900 1905 Asp Asn Asp Glu Cys Ser Thr His Ser His Lys Val Phe Ala Asp 1910 1915 1920 Ile Gln Ser Glu Glu Ile Leu Gln His Asn Gln Asn Met Ser Gly 1925 1930 1935 Leu Glu Lys Val Ser Lys Ile Ser Pro Cys Asp Val Ser Leu Glu 1940 1945 1950 Thr Ser Asp Ile Cys Lys Cys Ser Ile Gly Lys Leu His Lys Ser 1955 1960 1965 Val Ser Ser Ala Asn Thr Cys Gly Ile Phe Ser Thr Ala Ser Gly 1970 1975 1980 Lys Ser Val Gln Val Ser Asp Ala Ser Leu Gln Asn Ala Arg Gln 1985 1990 1995 Val Phe Ser Glu Ile Glu Asp Ser Thr Lys Gln Val Phe Ser Lys 2000 2005 2010 Val Leu Phe Lys Ser Asn Glu His Ser Asp Gln Leu Thr Arg Glu 2015 2020 2025 Glu Asn Thr Ala Ile Arg Thr Pro Glu His Leu Ile Ser Gln Lys 2030 2035 2040 Gly Phe Ser Tyr Asn Val Val Asn Ser Ser Ala Phe Ser Gly Phe 2045 2050 2055 Ser Thr Ala Ser Gly Lys Gln Val Ser Ile Leu Glu Ser Ser Leu 2060 2065 2070 His Lys Val Lys Gly Val Leu Glu Glu Phe Asp Leu Ile Arg Thr 2075 2080 2085 Glu His Ser Leu His Tyr Ser Pro Thr Ser Arg Gln Asn Val Ser 2090 2095 2100 Lys Ile Leu Pro Arg Val Asp Lys Arg Asn Pro Glu His Cys Val 2105 2110 2115 Asn Ser Glu Met Glu Lys Thr Cys Ser Lys Glu Phe Lys Leu Ser 2120 2125 2130 Asn Asn Leu Asn Val Glu Gly Gly Ser Ser Glu Asn Asn His Ser 2135 2140 2145 Ile Lys Val Ser Pro Tyr Leu Ser Gln Phe Gln Gln Asp Lys Gln 2150 2155 2160 Gln Leu Val Leu Gly Thr Lys Val Ser Leu Val Glu Asn Ile His 2165 2170 2175 Val Leu Gly Lys Glu Gln Ala Ser Pro Lys Asn Val Lys Met Glu 2180 2185 2190 Ile Gly Lys Thr Glu Thr Phe Ser Asp Val Pro Val Lys Thr Asn 2195 2200 2205 Ile Glu Val Cys Ser Thr Tyr Ser Lys Asp Ser Glu Asn Tyr Phe 2210 2215 2220 Glu Thr Glu Ala Val Glu Ile Ala Lys Ala Phe Met Glu Asp Asp 2225 2230 2235 Glu Leu Thr Asp Ser Lys Leu Pro Ser His Ala Thr His Ser Leu 2240 2245 2250 Phe Thr Cys Pro Glu Asn Glu Glu Met Val Leu Ser Asn Ser Arg 2255 2260 2265 Ile Gly Lys Arg Arg Gly Glu Pro Leu Ile Leu Val Gly Glu Pro 2270 2275 2280 Ser Ile Lys Arg Asn Leu Leu Asn Glu Phe Asp Arg Ile Ile Glu 2285 2290 2295 Asn Gln Glu Lys Ser Leu Lys Ala Ser Lys Ser Thr Pro Asp Gly 2300 2305 2310 Thr Ile Lys Asp Arg Arg Leu Phe Met His His Val Ser Leu Glu 2315 2320 2325 Pro Ile Thr Cys Val Pro Phe Arg Thr Thr Lys Glu Arg Gln Glu 2330 2335 2340 Ile Gln Asn Pro Asn Phe Thr Ala Pro Gly Gln Glu Phe Leu Ser 2345 2350 2355 Lys Ser His Leu Tyr Glu His Leu Thr Leu Glu Lys Ser Ser Ser 2360 2365 2370 Asn Leu Ala Val Ser Gly His Pro Phe Tyr Gln Val Ser Ala Thr 2375 2380 2385 Arg Asn Glu Lys Met Arg His Leu Ile Thr Thr Gly Arg Pro Thr 2390 2395 2400 Lys Val Phe Val Pro Pro Phe Lys Thr Lys Ser His Phe His Arg 2405 2410 2415 Val Glu Gln Cys Val Arg Asn Ile Asn Leu Glu Glu Asn Arg Gln 2420 2425 2430 Lys Gln Asn Ile Asp Gly His Gly Ser Asp Asp Ser Lys Asn Lys 2435 2440 2445 Ile Asn Asp Asn Glu Ile His Gln Phe Asn Lys Asn Asn Ser Asn 2450 2455 2460 Gln Ala Val Ala Val Thr Phe Thr Lys Cys Glu Glu Glu Pro Leu 2465 2470 2475 Asp Leu Ile Thr Ser Leu Gln Asn Ala Arg Asp Ile Gln Asp Met 2480 2485 2490 Arg Ile Lys Lys Lys Gln Arg Gln Arg Val Phe Pro Gln Pro Gly 2495 2500 2505 Ser Leu Tyr Leu Ala Lys Thr Ser Thr Leu Pro Arg Ile Ser Leu 2510 2515 2520 Lys Ala Ala Val Gly Gly Gln Val Pro Ser Ala Cys Ser His Lys 2525 2530 2535 Gln Leu Tyr Thr Tyr Gly Val Ser Lys His Cys Ile Lys Ile Asn 2540 2545 2550 Ser Lys Asn Ala Glu Ser Phe Gln Phe His Thr Glu Asp Tyr Phe 2555 2560 2565 Gly Lys Glu Ser Leu Trp Thr Gly Lys Gly Ile Gln Leu Ala Asp 2570 2575 2580 Gly Gly Trp Leu Ile Pro Ser Asn Asp Gly Lys Ala Gly Lys Glu 2585 2590 2595 Glu Phe Tyr Arg Ala Leu Cys Asp Thr Pro Gly Val Asp Pro Lys 2600 2605 2610 Leu Ile Ser Arg Ile Trp Val Tyr Asn His Tyr Arg Trp Ile Ile 2615 2620 2625 Trp Lys Leu Ala Ala Met Glu Cys Ala Phe Pro Lys Glu Phe Ala 2630 2635 2640 Asn Arg Cys Leu Ser Pro Glu Arg Val Leu Leu Gln Leu Lys Tyr 2645 2650 2655 Arg Tyr Asp Thr Glu Ile Asp Arg Ser Arg Arg Ser Ala Ile Lys 2660 2665 2670 Lys Ile Met Glu Arg Asp Asp Thr Ala Ala Lys Thr Leu Val Leu 2675 2680 2685 Cys Val Ser Asp Ile Ile Ser Leu Ser Ala Asn Ile Ser Glu Thr 2690 2695 2700 Ser Ser Asn Lys Thr Ser Ser Ala Asp Thr Gln Lys Val Ala Ile 2705 2710 2715 Ile Glu Leu Thr Asp Gly Trp Tyr Ala Val Lys Ala Gln Leu Asp 2720 2725 2730 Pro Pro Leu Leu Ala Val Leu Lys Asn Gly Arg Leu Thr Val Gly 2735 2740 2745 Gln Lys Ile Ile Leu His Gly Ala Glu Leu Val Gly Ser Pro Asp 2750 2755 2760 Ala Cys Thr Pro Leu Glu Ala Pro Glu Ser Leu Met Leu Lys Ile 2765 2770 2775 Ser Ala Asn Ser Thr Arg Pro Ala Arg Trp Tyr Thr Lys Leu Gly 2780 2785 2790 Phe Phe Pro Asp Pro Arg Pro Phe Pro Leu Pro Leu Ser Ser Leu 2795 2800 2805 Phe Ser Asp Gly Gly Asn Val Gly Cys Val Asp Val Ile Ile Gln 2810 2815 2820 Arg Ala Tyr Pro Ile Gln Trp Met Glu Lys Thr Ser Ser Gly Leu 2825 2830 2835 Tyr Ile Phe Arg Asn Glu Arg Glu Glu Glu Lys Glu Ala Ala Lys 2840 2845 2850 Tyr Val Glu Ala Gln Gln Lys Arg Leu Glu Ala Leu Phe Thr Lys 2855 2860 2865 Ile Gln Glu Glu Phe Glu Glu His Glu Glu Asn Thr Thr Lys Pro 2870 2875 2880 Tyr Leu Pro Ser Arg Ala Leu Thr Arg Gln Gln Val Arg Ala Leu 2885 2890 2895 Gln Asp Gly Ala Glu Leu Tyr Glu Ala Val Lys Asn Ala Ala Asp 2900 2905 2910 Pro Ala Tyr Leu Glu Gly Tyr Phe Ser Glu Glu Gln Leu Arg Ala 2915 2920 2925 Leu Asn Asn His Arg Gln Met Leu Asn Asp Lys Lys Gln Ala Gln 2930 2935 2940 Ile Gln Leu Glu Ile Arg Lys Ala Met Glu Ser Ala Glu Gln Lys 2945 2950 2955 Glu Gln Gly Leu Ser Arg Asp Val Thr Thr Val Trp Lys Leu Arg 2960 2965 2970 Ile Val Ser Tyr Ser Lys Lys Glu Lys Asp Ser Val Ile Leu Ser 2975 2980 2985 Ile Trp Arg Pro Ser Ser Asp Leu Tyr Ser Leu Leu Thr Glu Gly 2990 2995 3000 Lys Arg Tyr Arg Ile Tyr His Leu Ala Thr Ser Lys Ser Lys Ser 3005 3010 3015 Lys Ser Glu Arg Ala Asn Ile Gln Leu Ala Ala Thr Lys Lys Thr 3020 3025 3030 Gln Tyr Gln Gln Leu Pro Val Ser Asp Glu Ile Leu Phe Gln Ile 3035 3040 3045 Tyr Gln Pro Arg Glu Pro Leu His Phe Ser Lys Phe Leu Asp Pro 3050 3055 3060 Asp Phe Gln Pro Ser Cys Ser Glu Val Asp Leu Ile Gly Phe Val 3065 3070 3075 Val Ser Val Val Lys Lys Thr Gly Leu Ala Pro Phe Val Tyr Leu 3080 3085 3090 Ser Asp Glu Cys Tyr Asn Leu Leu Ala Ile Lys Phe Trp Ile Asp 3095 3100 3105 Leu Asn Glu Asp Ile Ile Lys Pro His Met Leu Ile Ala Ala Ser 3110 3115 3120 Asn Leu Gln Trp Arg Pro Glu Ser Lys Ser Gly Leu Leu Thr Leu 3125 3130 3135 Phe Ala Gly Asp Phe Ser Val Phe Ser Ala Ser Pro Lys Glu Gly 3140 3145 3150 His Phe Gln Glu Thr Phe Asn Lys Met Lys Asn Thr Val Glu Asn 3155 3160 3165 Ile Asp Ile Leu Cys Asn Glu Ala Glu Asn Lys Leu Met His Ile 3170 3175 3180 Leu His Ala Asn Asp Pro Lys Trp Ser Thr Pro Thr Lys Asp Cys 3185 3190 3195 Thr Ser Gly Pro Tyr Thr Ala Gln Ile Ile Pro Gly Thr Gly Asn 3200 3205 3210 Lys Leu Leu Met Ser Ser Pro Asn Cys Glu Ile Tyr Tyr Gln Ser 3215 3220 3225 Pro Leu Ser Leu Cys Met Ala Lys Arg Lys Ser Val Ser Thr Pro 3230 3235 3240 Val Ser Ala Gln Met Thr Ser Lys Ser Cys Lys Gly Glu Lys Glu 3245 3250 3255 Ile Asp Asp Gln Lys Asn Cys Lys Lys Arg Arg Ala Leu Asp Phe 3260 3265 3270 Leu Ser Arg Leu Pro Leu Pro Pro Pro Val Ser Pro Ile Cys Thr 3275 3280 3285 Phe Val Ser Pro Ala Ala Gln Lys Ala Phe Gln Pro Pro Arg Ser 3290 3295 3300 Cys Gly Thr Lys Tyr Glu Thr Pro Ile Lys Lys Lys Glu Leu Asn 3305 3310 3315 Ser Pro Gln Met Thr Pro Phe Lys Lys Phe Asn Glu Ile Ser Leu 3320 3325 3330 Leu Glu Ser Asn Ser Ile Ala Asp Glu Glu Leu Ala Leu Ile Asn 3335 3340 3345 Thr Gln Ala Leu Leu Ser Gly Ser Thr Gly Glu Lys Gln Phe Ile 3350 3355 3360 Ser Val Ser Glu Ser Thr Arg Thr Ala Pro Thr Ser Ser Glu Asp 3365 3370 3375 Tyr Leu Arg Leu Lys Arg Arg Cys Thr Thr Ser Leu Ile Lys Glu 3380 3385 3390 Gln Glu Ser Ser Gln Ala Ser Thr Glu Glu Cys Glu Lys Asn Lys 3395 3400 3405 Gln Asp Thr Ile Thr Thr Lys Lys Tyr Ile 3410 3415 <![CDATA[<210> 11]]> <![CDATA[<211> 898]]> <![CDATA[<212> PRT]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 11]]> Met Ser Val Thr Glu Glu Asp Leu Cys His His Met Lys Val Val Val 1 5 10 15 Arg Val Arg Pro Glu Asn Thr Lys Glu Lys Ala Ala Gly Phe His Lys 20 25 30 Val Val His Val Val Asp Lys His Ile Leu Val Phe Asp Pro Lys Gln 35 40 45 Glu Glu Val Ser Phe Phe His Gly Lys Lys Thr Thr Asn Gln Asn Val 50 55 60 Ile Lys Lys Gln Asn Lys Asp Leu Lys Phe Val Phe Asp Ala Val Phe 65 70 75 80 Asp Glu Thr Ser Thr Gln Ser Glu Val Phe Glu His Thr Thr Lys Pro 85 90 95 Ile Leu Arg Ser Phe Leu Asn Gly Tyr Asn Cys Thr Val Leu Ala Tyr 100 105 110 Gly Ala Thr Gly Ala Gly Lys Thr His Thr Met Leu Gly Ser Ala Asp 115 120 125 Glu Pro Gly Val Met Tyr Leu Thr Met Leu His Leu Tyr Lys Cys Met 130 135 140 Asp Glu Ile Lys Glu Glu Lys Ile Cys Ser Thr Ala Val Ser Tyr Leu 145 150 155 160 Glu Val Tyr Asn Glu Gln Ile Arg Asp Leu Leu Val Asn Ser Gly Pro 165 170 175 Leu Ala Val Arg Glu Asp Thr Gln Lys Gly Val Val Val His Gly Leu 180 185 190 Thr Leu His Gln Pro Lys Ser Ser Glu Glu Ile Leu His Leu Leu Asp 195 200 205 Asn Gly Asn Lys Asn Arg Thr Gln His Pro Thr Asp Met Asn Ala Thr 210 215 220 Ser Ser Arg Ser His Ala Val Phe Gln Ile Tyr Leu Arg Gln Gln Asp 225 230 235 240 Lys Thr Ala Ser Ile Asn Gln Asn Val Arg Ile Ala Lys Met Ser Leu 245 250 255 Ile Asp Leu Ala Gly Ser Glu Arg Ala Ser Thr Ser Gly Ala Lys Gly 260 265 270 Thr Arg Phe Val Glu Gly Thr Asn Ile Asn Arg Ser Leu Leu Ala Leu 275 280 285 Gly Asn Val Ile Asn Ala Leu Ala Asp Ser Lys Arg Lys Asn Gln His 290 295 300 Ile Pro Tyr Arg Asn Ser Lys Leu Thr Arg Leu Leu Lys Asp Ser Leu 305 310 315 320 Gly Gly Asn Cys Gln Thr Ile Met Ile Ala Ala Val Ser Pro Ser Ser 325 330 335 Val Phe Tyr Asp Asp Thr Tyr Asn Thr Leu Lys Tyr Ala Asn Arg Ala 340 345 350 Lys Asp Ile Lys Ser Ser Leu Lys Ser Asn Val Leu Asn Val Asn Asn 355 360 365 His Ile Thr Gln Tyr Val Lys Ile Cys Asn Glu Gln Lys Ala Glu Ile 370 375 380 Leu Leu Leu Lys Glu Lys Leu Lys Ala Tyr Glu Glu Gln Lys Ala Phe 385 390 395 400 Thr Asn Glu Asn Asp Gln Ala Lys Leu Met Ile Ser Asn Pro Gln Glu 405 410 415 Lys Glu Ile Glu Arg Phe Gln Glu Ile Leu Asn Cys Leu Phe Gln Asn 420 425 430 Arg Glu Glu Ile Arg Gln Glu Tyr Leu Lys Leu Glu Met Leu Leu Lys 435 440 445 Glu Asn Glu Leu Lys Ser Phe Tyr Gln Gln Gln Cys His Lys Gln Ile 450 455 460 Glu Met Met Cys Ser Glu Asp Lys Val Glu Lys Ala Thr Gly Lys Arg 465 470 475 480 Asp His Arg Leu Ala Met Leu Lys Thr Arg Arg Ser Tyr Leu Glu Lys 485 490 495 Arg Arg Glu Glu Glu Leu Lys Gln Phe Asp Glu Asn Thr Asn Trp Leu 500 505 510 His Arg Val Glu Lys Glu Met Gly Leu Leu Ser Gln Asn Gly His Ile 515 520 525 Pro Lys Glu Leu Lys Lys Asp Leu His Cys His His Leu His Leu Gln 530 535 540 Asn Lys Asp Leu Lys Ala Gln Ile Arg His Met Met Asp Leu Ala Cys 545 550 555 560 Leu Gln Glu Gln Gln His Arg Gln Thr Glu Ala Val Leu Asn Ala Leu 565 570 575 Leu Pro Thr Leu Arg Lys Gln Tyr Cys Thr Leu Lys Glu Ala Gly Leu 580 585 590 Ser Asn Ala Ala Phe Glu Ser Asp Phe Lys Glu Ile Glu His Leu Val 595 600 605 Glu Arg Lys Lys Val Val Val Trp Ala Asp Gln Thr Ala Glu Gln Pro 610 615 620 Lys Gln Asn Asp Leu Pro Gly Ile Ser Val Leu Met Thr Phe Pro Gln 625 630 635 640 Leu Gly Pro Val Gln Pro Ile Pro Cys Cys Ser Ser Ser Gly Gly Thr 645 650 655 Asn Leu Val Lys Ile Pro Thr Glu Lys Arg Thr Arg Arg Lys Leu Met 660 665 670 Pro Ser Pro Leu Lys Gly Gln His Thr Leu Lys Ser Pro Pro Ser Gln 675 680 685 Ser Val Gln Leu Asn Asp Ser Leu Ser Lys Glu Leu Gln Pro Ile Val 690 695 700 Tyr Thr Pro Glu Asp Cys Arg Lys Ala Phe Gln Asn Pro Ser Thr Val 705 710 715 720 Thr Leu Met Lys Pro Ser Ser Phe Thr Thr Ser Phe Gln Ala Ile Ser 725 730 735 Ser Asn Ile Asn Ser Asp Asn Cys Leu Lys Met Leu Cys Glu Val Ala 740 745 750 Ile Pro His Asn Arg Arg Lys Glu Cys Gly Gln Glu Asp Leu Asp Ser 755 760 765 Thr Phe Thr Ile Cys Glu Asp Ile Lys Ser Ser Lys Cys Lys Leu Pro 770 775 780 Glu Gln Glu Ser Leu Pro Asn Asp Asn Lys Asp Ile Leu Gln Arg Leu 785 790 795 800 Asp Pro Ser Ser Phe Ser Thr Lys His Ser Met Pro Val Pro Ser Met 805 810 815 Val Pro Ser Tyr Met Ala Met Thr Thr Ala Ala Lys Arg Lys Arg Lys 820 825 830 Leu Thr Ser Ser Thr Ser Asn Ser Ser Leu Thr Ala Asp Val Asn Ser 835 840 845 Gly Phe Ala Lys Arg Val Arg Gln Asp Asn Ser Ser Glu Lys His Leu 850 855 860 Gln Glu Asn Lys Pro Thr Met Glu His Lys Arg Asn Ile Cys Lys Ile 865 870 875 880 Asn Pro Ser Met Val Arg Lys Phe Gly Arg Asn Ile Ser Lys Gly Asn 885 890 895 Leu Arg <![CDATA[<210> 12]]> <![CDATA[<211> 87562]]> <![CDATA[<212> DNA]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 12]]> cactttaaaa tctacatctt taatatatca agtagcaagg gacaatattt tatttgtgat 60 gactaaataa tatttacaat gattttatgg gcacatatat ttacacttgt acattaaagt 120 atttttgaaa aggaaagtca tatatatgat taaaataatg tatcaaaaca taatagagaa 180 ccaaatacat cttgggccat aattttacca cttctaaatt cttattttta aaaaataata 240 aagataattt aactcactac catttactaa aatgtcctag tcaacttgtt gtggcatagt 300 aaaactaagc tgccaccatg gtaacttaca ctcagggatt ttaaaaggca acaaatattt 360 aaaaaactta aaagacaacc ttttcttttg aaattttatt tttttagaac acaaaagaag 420 aaaacaaaga gtttcatttt tctgcttgct gaaagtactt gggtaaactt agctttaaga 480 tgggtcttct ttcaaagatt ttaaatatat ttttgaaagg gtattgataa actttgaaaa 540 gcagatttga tcaacttcat tttgcttggt tttgaagtga tttatcttag atttcctttt 600 gaaatatttc ttccaaattt tctaaccatg cttggattta ttttacagat gtttctttta 660 tgttctagag aagaaataaa aagatgcata aatatggcat aaatatcatt caaaaagttt 720 tcatcgttca acttataaaa attatgacca tagaaagaaa aatttactct tgaaattcat 780 agttgttagt taacataatt taaaatataa caacaacaaa gagacattaa tacctttggt 840 ttaaaagctg ttcaaattca tattgcaaac taaagtttca gtgagtgcgt gcacatacac 900 agacatcggg tgaagtcgct gaattaaata ctatgttcat tttctttctt tctgactaat 960 aaaagaccat ttctacaagc atttcttcat tttctttgtt gtatcaccat tttttctcat 1020 tccttggatt atatttcccc agggatttaa acttccatat ttttccaatt ttaaaattat 1080 catttgcatc tagtacttcc taaagggctg atcttaatcc tatagctctt ttttctttta 1140 ctgccacctc tcaagtatgt tctatttatg cccattcttc tggttcttca ttagctttca 1200 ccgtcatttt ctactcaaca aagtgttgtt acaacagggt gccattgact tttttcagga 1260 ttagtttaat tgcttatcca ctttgttggc catattaggt tttagtttta gagggacata 1320 ttcccttaac actctctgtt atttctctaa ctgctaagtt aacaggagtt gcctttttcc 1380 ctactgatgg tcctatgttt ctttatttgt acattgttag ttagaaaact ggtttaatac 1440 atttttcact tgaacattat aatgtatata aaatatcttt ccttacaaac taatacctct 1500 ttggcaagca ttgtggttta ttatcatctc ccactttttt ttccccatag tagatatttt 1560 tactcacatc tctttataca tgaaatattt gatgaatttg tatcttcaga taataagcat 1620 attagaaaaa gccaagttct atgatttgag tttttttttt ttttgagacg gagttttgct 1680 cagtcgccca ggctggagtg cagtggtgcg atctcggctc actgcaagct ccgcctccca 1740 ggttcacgcc attctcctgc ctcagcttcc cgagtagctg ggactacagc cgcctgccac 1800 catgcccggc taatttttta aaattttttt ggtagagacg gggtttcacc atgttagcca 1860 ggatggtctc gatctcctga cctcgtgatc cacccgcctc agcctcccaa agtgctggga 1920 ttacaggcgt gagccacggc gcccggccaa tttgagagtt tttataaatt tattatttgg 1980 ctgtagaatt atgattcttg aagaactttt taagaagatc agtggggcag tacacaccta 2040 aactaactac agatacacat ttttaagcat tattaaatac aacatgtcaa accaaatgat 2100 caaggtaaat tttgtacttt actaccttac tgtctgatgt ttcaatttgc tgtctgatgc 2160 ttcaatttcc attgaactta aggtaaacac tggctactac aggaagcagg catttaccaa 2220 tatagtttga caaagttact gaggaatttt atattactct aatcaaaggg catcgacaga 2280 aaaaaactaa caatagcttt catgttatcc ttagaaaaat tatatcatga gacaccttta 2340 aattgcattt gctataatta tcagttccta tagagaacaa tcaaactgtg tcttactgct 2400 ctctgtattc atcacaggac atggtaaatg cctagtgaat aaatagtttc tgaatgaagt 2460 cttaggaact gtagtatcag agacagaggt ctagatgttg gggcctgaaa actggctggc 2520 atgatacacc actagtttaa ctgaagtggt tttgttacca taaactcatg tcactcccat 2580 atgcggttga tggaatgtag tatctttcat actgatggga aagatccatc agtatctttt 2640 ccaacttgcc aatgggagtt acaatatgat tgtaactaga tacagactgg aatctgtgta 2700 gtagttacac attgagttag aggccaaatt attcaaaata ttacgctaag agaaaaattt 2760 aaagtgggta tagtttatct gcaaaataca cttaattagt aacattaagt aatacattta 2820 gccaattatt tcaattatta tgagacagta gggataacta aaagggtgta gaaagtagag 2880 ttttaagatc tggttcttga gttttggctc taccaatata atatctgtgt gatcttgggt 2940 aaatgctttt gtgttttaaa gtttccttat ctataatatg tggataatca tacttgttct 3000 accacatagt aaaggtgatg aataaaggga gattcttatg aaaacacaat aaaaaacgta 3060 aagtactata tgtgtgttac agagtcatac cattaaatat caaattaaaa gctgagacat 3120 acccattgtt ggtttgtttt cttgtaagtg cttctcactt gaattatctt gtcgaacacg 3180 tttggcaaat ccagaattta cgtctgcagt taacgaactg tttgatgtag aacttgagag 3240 gaaaagtttt taatttagtt aagcattttt tttatacctc aaagttctaa tacatattgt 3300 acatgcgaca atgattaaag aaataaaaca caaaaatatt aagttgtgaa atctcacaga 3360 agtggaggta ctaaatacat ttttggccca cagagaaatt tagctgtgtg tgattttaaa 3420 ttggatattt tatattttta ttcaaattga atgttatgat tgtaggtgta tgttacaatt 3480 ctgtagcaga atattccagg gtgctttgct ggcagataag taagcactat tattcaaaat 3540 gtagagatca gtagcacata gtcacaagag gttaaaaaaa aaaaaaaaaa aaactaagct 3600 catgttacaa atttggacca agaatcctaa tgtgaaaggt ataaacaagt gagattgttt 3660 gaaaaacctt gttttaaaat gaaagcaggg taacaataaa aatctctaat tattacaatc 3720 acagaaactg aaataaaaag aatgacctgt tttcatttgc tctagcttca aaaatttaat 3780 cagtcttaca ctgctgatgg ttcaactttc ttactcaatt tgagttgcca tattagtaaa 3840 cacctattat ggccttgtgt tacatgatat acaagtaaac aaggcacaaa aatccctgtc 3900 ctaaaaactt atagaataga catacagtgg agatgagaaa aaaataagat aaatacatga 3960 aataatataa ggtaaagtaa aaatatagtg ccaaggtttc cataatacaa ggagctatag 4020 attcttgagt gtagagtaag aaagaataat ggaaattttg tggatgcaat gaatttgatc 4080 tgggtcctga aaaacagcaa tccttcctag tcctaaagag gatcaatttt taacaggtag 4140 gattgggggg ggttgggtgg aaaaagaaca tccttccacg ctgattcaaa caacctaagc 4200 ttagggaaat tctggctaat aaagatacta tatagtaatc ccccttatcg acggggggga 4260 tatcttctaa gatcgccagt ggatgcctgc aaccgaggat agtatcaaac cggatatata 4320 ctatgtattc tcctacacat atctatgata aagtttaaat tataaattag gcacagtaag 4380 agattaacaa taataataaa atagagcaat tataattata attattataa ggttatgtga 4440 atgtggtctc gctctctatt aaaatatctt attgttctac aatcgcctgt ttttgaactg 4500 cggttgacca tgggtaactg aaaccacaga aagcaaaact tgaataaggg gtgactactc 4560 agtggaagta atgaaaatga cacagtttaa gaagataaaa tcacaaattt gtatgcacaa 4620 atattatatc aactacagta gtccccactt cttaaatggt gataaattac tatgattctg 4680 ttttgcatat taaacacact tttgtatata tcagctgtcc aaggcagaaa ttcttttttg 4740 atcatttggt gattttattt tttcaaatat aaagatcaat attattagtt acttttgata 4800 aaacattgtt ttttcttaaa tttatcccaa agttgtcttt attatttcat agtacgatta 4860 tgcattatgg ctagttccag gaccctactt tttactcata gcatgttctt tcttgaaaat 4920 taggcttttg aataaagcca tttgattaga actcatattt ctagaaatca aatccaaccc 4980 taataaattg cgtatttata taaaagtaaa atatacccaa acatgtttac gatttagtta 5040 aatagtccac tgatgaaatg tttaacattt atgttgtagg tcataaacta caaagactta 5100 aaactgatga gcgcaagttc aaattatgtt aaaggctata ctgaaaaatc caaagacact 5160 tccagttgtg cacaaaacat attcccataa ctataaataa agttaagaat taaccttttg 5220 ctcccttata taggtagaat gtttctactc aacataatac ctcttctact attttatctg 5280 aaataatttc tagttgaaat aattagacat ctttcaaaac aaaataaaag tgtatggcaa 5340 atatgaaact gctttggggt gctcagaaga ttgtggacaa acaaaaaacc aatcaaccaa 5400 acaaatacaa aacaaacaat ccaaaactct gattaatata attgagaagt aaaagctaac 5460 attatgtatg cattatattt aaatatttga taggctaatc aatttagtaa aatagtgtgc 5520 tagagaaata ttaaataaat tgttaagatt aaaaatctaa tatactcaat tatttaaaca 5580 aatctgttgg gtaggttttg gaatatccag tgctttcaaa ctctaatgcc attttatgca 5640 aaataaatga aatacatata tagagagctt ccccttcttt attttaaaaa ctatattaga 5700 atatatacac aactaaatat gtatataaag ctgctaaatg gaaaatacca cagtttatta 5760 ctctgaagcg catgtaactt taattgggga aaaagaagat taaaaaaagt aatcatgtac 5820 atttctagca ttaatctctt ttaaccttag ttaatggcag gatctaatta ctggtaccag 5880 agggaatgta atagaacaat taataggcta taagaaatca agttactttc tttacatgtc 5940 ctttaatatt atttcacaat attagttgtt catgtggaag ccctttaact tatctaaaat 6000 cactccaaat acacaattca catacctgga catttcctga aaaactattt gattttataa 6060 tagctaagtt catatttaaa aattattctt atctataaac atttgtgaca tcttagtaaa 6120 cacaacatac taccagtgaa ggacaagaaa actcactaaa attaattaat ggaacaaatg 6180 acaaaactga cactatgcaa attagtgata aaagtagacg aaacagatga ttgtggttag 6240 ctaggctcac tcataaagtg acagacttct gtatataaac cagaataatt gtacaaatca 6300 aatttgtacc ttagcaaata taaaatttta aatgtcatag atgagacatt taggaaaaat 6360 ccataaattt taaatttaca cattccaagt ctctgttata ctttgtttag gagggacaag 6420 gacagatatt aaattcactt atgagaagat actctatgta gcacaaataa gtaggctact 6480 tgtaaattcg cttcctgtta cttaaatgat aacaggctcc tggtggaaaa tacatttaaa 6540 aagagtcatt ttaaggtctt ctataaactt ttctccccat aatcacatag caaagaaaaa 6600 gaggtagagg aagtcagatc cattttatat ttattgagta tatttgtcat tgcattcaat 6660 ttataggata taaagaatgc atcatgaact tctagtcata taactcaata tatttaagat 6720 ttttccttat ctttagtttt tagttgtttt actactatat acctaggtat gtttctcttt 6780 atattaaccc ggcttttggt ttgcagtgct actcaaatcc atggtttaat gtcttttgtt 6840 agttttgaat aagtattagc catcatctca aatattactt ttccctattc tttctctcac 6900 tcccttctga gacacaaaat acatattttc tagactttta aaaattgtgt cccatgtctc 6960 tttcacttct tcccatattt ttatcatact gcacatcagt ttggatattt tcctaccagt 7020 ctatctttca gaaaaaattc caaaacctga acaaatgaat aataagtaac aaaatcaaag 7080 tcataataaa gtctcccagc aaagaaaagc ttggaatttg atggcttcac tgctgatttt 7140 taccaaacat ttaaaaaaga accaatacca atcttactca aactattctg aaaaacagag 7200 gcggaaggaa tacttccaaa atcattatat gaggccagta ttactctgat accaaaacca 7260 gacaaggaca catcaaaaca agaaaactcc aggccaatat ccctgatgaa cacatgcaca 7320 aatccttaac aaaatactag caaactgaat ccaataacaa acctgaaaga tcattcatca 7380 tggccaagtg ggatttatcc cagggatgca agatggttca acatatgcaa attaaccaat 7440 gtgatacatt gtatcaatag aatgaagaac aaaaaccata tgatcatttc aatagatgct 7500 gaaaaagtat ttgataaaat tcaacatccc tttatgataa aaactctcac caagcggact 7560 taatagacgt ctacagaact ctccacccac aatcaacaga atatacattc ttttcagcac 7620 cacactgcac ttattccaaa attgaccaca tagttggaag taaagcactc ctcagcaaat 7680 ataaaagaac agaaattaga acaatctgtc tctcagaata cagtgcaatc aaactagaac 7740 tcaggattaa gacactcact caaaaccact caactacatg gaaactgaac aacctgctcc 7800 tgaatgacta ctgggtacat aacgaaatga aggcagaaat aaagacgttc tttgaaacca 7860 acgagaacaa agacatgaca taccagaatc tctgggacac atttaaagca gtgtgtagag 7920 ggaaatttat agcagtaaat gcccacaaga gaaagcagga aagatctaaa attgacaccc 7980 taacatcaca attaaaagaa ctagagaagc aagagcaaac acattaaaaa gccagcagaa 8040 ggcaagaaat aactaagatc agagcagaac tgaaggagat agagacgcaa aaaacccttc 8100 aaaaaatcaa tgaatccagg agctggtttt ttgaaaagat caacaaaatt gatagactgc 8160 tagcaagact aagaaagagg aaaagagaga agaatcaaat agacacaata aaaaaagata 8220 aaggggatat caccaccgat cccacagaaa tacaaactac catcagagaa tactacaaac 8280 acctctatgc aaataaacta gaaaatctag aagaaatgga taaattcctg gacacataca 8340 ccctcccaag actaaaccag gacgaagttg aatctctgaa tagaccaata ataggctctg 8400 aaattgaggc aataattaat agcataccaa ccgaaaaaag tccaggaccg ggcggattca 8460 cagctgaatt ctaccagagg tacaaagagg agctggtacc attccttctg aaactatttc 8520 aatctataga aaaagaggga atcctcccta actcatttta tgagaccagc atcatcctga 8580 taccaaagcc tggcagagac acaacaaaaa aagagaattt tagaccaata tccctgaaga 8640 acattgatgc aaaaatcctc aataaactac tggcaagccc aatccagcag cacatcaaaa 8700 agcttatcca ccatgagcaa gtgggcttca tccctgggat gcaaggctgg ttcaatatac 8760 gcaaatcaat aaatgtaatc cagcatatac acagaaccaa agacaaaaac cacatgatta 8820 tctcaataga tgcagaaaag gcctttgaca aaattcaaca gcccttcatg ctaaaaactc 8880 tcaataaatt aggtattgat gggacgtatc tcaaaataat aagagctatc tatgacaaac 8940 ccacagccaa tatcatactg aatgtgcaaa aactggaagc attccctttg aaaactggca 9000 caagacaggg atgccctctc tcaccactcc tactcaatat agtgtgggaa gttctggcca 9060 gggcaatgag gcaagagaag gaaataaaag gtattcaatt aggaaaagaa gaagtcaaat 9120 tgtccctgtt tgcagatgac atgattgtat atctagaaaa ccccatcgtc tcagcccaaa 9180 atctccttaa gctgataagc aacttcagca aagtctcagg atacaaaatc aatatacaaa 9240 aatcacaagc attcttatac accaataaca gacaaacaga gagacaaatc atgagtgaac 9300 tcccattcac aactgcttca aagagaataa aatacctagg aatccaactt acaagggatg 9360 tgaaggacct cttcaaggag aactacaaac cactgctcaa tgaaataaaa gaggacacaa 9420 acaaatggaa gaacattcca tgctcatgga taggaagaat caatatcatg aaaatgtcca 9480 tactgcccaa ggtaatttat agattcagtg ccatccccat caagctacca atgactttct 9540 tcacagaatt ggaaaagact actttaaagt tcatatggaa ccagaaaaca gcccgcattg 9600 ccaagacaat cctaaggcaa aagaacaaaa ctggaggcat cacgctacct gacttcaaac 9660 tatactacaa ggctacagta accaaaacag cctggtactg gtaccaaaac agagatatag 9720 accaatggaa cagaacagag ccctcagaaa taataccata catctacaac catctgatct 9780 ttgacaaatc tgacaaaaac aagaaatggg gaaaggattc cccatttaat aaatggtgct 9840 gggaaaactg gctagccata tgtagaaagc tgaaactgga tcccttcctt acaccttata 9900 caaaaattaa ttcaagatgg attaaagact taaatgttag agctaaaacc ataaaaaccc 9960 cagaagaaaa cctaggcaat accattcagg acataggcat gggtaaggac ttcatgtcta 10020 aaacaccaaa agcaatggca acaaaagcca aaattgacaa atgggatcta attaaactaa 10080 agagcttctg cacagcaaaa gaaactacca tcagagtgaa caggcaacct acagaatggg 10140 agaaaatttt cgcaacctac tcatctgaca aagggctaat atccagaatc tacaatgaac 10200 tcaaacaaat ttacaagaaa aaaacaaaca accccatcaa aaagtgggcg aaggacatga 10260 acagacactt ctcaaaagaa gacatttatg cagccaaaaa acacatgaaa aaatgctcat 10320 gatcactggc catcagagaa atgcaaatca aaaccacaat gagataccat ctcacaccag 10380 ttagaatggc aatcattaaa aagtcaggaa acaacaggtg ctggagagga tgtggagaaa 10440 taggaacact tttacactgt tggtgggact gtaaactagt tcaaccattg tggaagacag 10500 tgtggcgatt tctcaaggat ctagaactag aaataccatt tgacccagcc atgtcgttac 10560 tgggtatata cccaaaggat tataaatcat gctgctataa agacacatgc acacgtatgt 10620 ttattgcggc actattcaca atagcaaaga cttgtaccca atccaaatgt ccatcaatga 10680 tagactggat taagaagatg tggcacatat acaccatgga agactatgca gccataaaaa 10740 aggatgagtt catgtccttt gtagggacag gatgaagctg aaaaccatca ttctcagcaa 10800 actatcgcaa ggacaaaaaa ccaaacaccg catgttctca ctcataggtg ggaactgaac 10860 aatgagaaca catggacaca ggaaggtgaa catcacacac cggggcctgt tgtggggtag 10920 ggggagcgca gagggaaagc attaggagat ataccaaatg taaataacga gttaatgggt 10980 gcagcacacc aacatggcac atgtatacat atgtaacaaa cctgcacgtt atgcacatgt 11040 accgtggaac ttaaagcata aaaaaaaaaa acaactctca aaaaactggg tatagaagga 11100 acatatctca acacgataaa agccatacac gacagaccca cagctggtac tatcctgaat 11160 gcagaaaatc tgaaattctt ttctctaagt tgtggaacat gacaaggatg cccactttca 11220 ccagtattta ttatttaaca tattactgga agtcctaagt agagcaatca gacaagagaa 11280 agaaaagaaa gaaagaacat ccaaattgga aaggaagaag tgaaattatc cttgtttgca 11340 gatgacatga tcttatcata tatttggaaa aacgtagagt ccacaaaaaa ctatgagaac 11400 ctagaaacaa attcagtaga gttccagaat acaaaatcaa tatacaaaaa tcagtagcat 11460 atctatatac aaacactgaa ataatttgaa aaaaaaagta atccccttta caaaagctaa 11520 aaataaaata agtaggagtt aaccaaagaa gtaaaagagc tccataatga aaactataaa 11580 acactgatgt aagaaaagca gatacaaaaa aatagaaaga tattccatgt tcatggattg 11640 gaagaatcaa tattgttaaa atgtccacac tactcacagt ggtctacaga atcaatgcaa 11700 tccctatcaa aataccaatg acactcttca tagaaataga aaaaacaatc ctaaaattta 11760 tatggaatca caaaagaccc agaatagcca aagctatcct gagcaaaaag atcaaaactg 11820 gaggaatcac attacctgac ttcaaattac actacagagc tatagtaacc aaaaaagcac 11880 gggactggca taaaaccaga cacacaaacc agtggaacag aatagagagc cccaaaataa 11940 atctacatat ttacaataaa cttatttttg acaaagctgc caagaacata cattgggaaa 12000 aaagatagtc tcttcaataa acagtgctgg aaaactgttt atccatatgc agaagaatga 12060 agctagatcc ctatctcttg caatatacag aaatgaaatc aaaatggata aaaatttaaa 12120 tttaagacct caaactatga aactgctaaa agaaaacatt ggggaaactc tccaggacac 12180 tggactggac aaagatttct tgagtaatac cctacacagg gaaccaaagc aaaaatggat 12240 aaatgggatc acatcaagtt aaaaagcttc tgtaaagcaa aggaaacaat caataaagtg 12300 aagagacaac ccacagaatt acagaaaata cctgcaaact atctatctga caagggatta 12360 ataaccataa tacataagga gctcaaacaa ctctaggaaa aaaatctaat gatctgattt 12420 ttaaaatggg caaaagaata gacatttctc aaaagaagac ataaatggca aagaagctta 12480 tgaaaaggta ctcaacatca ctgattatca gaaaaatgta aatcaaaact acaatgagat 12540 atcatctcac cccagttaaa atggcttttt ttccaaaaga cagtcaacaa caaacactgg 12600 caaggatatg gagaaaaggg aacacttgta tactgttcat ggggatgtaa attagtacaa 12660 ccactataaa gaaaagtttg aagagtcctc aaaaaactaa aaatagtgct accatacgat 12720 ccagcaatgc ccctactaga tacatgccaa aatgaaagga aatcagtata ctgaagagat 12780 atctgcacta ccatgtttat tgcaacacta ctcacaatag ccaagatttg gaagcaacct 12840 aagtgccaat caacagatga atagaaaaag aaaatatagt acctatacac aatagagtac 12900 cattcagcca tgaaacaaga atgagaccct gtcatttgca acagcatgga tggaactgat 12960 ggtaattatg ttaagtgaaa taagccaggt acagaaagat aagcttggca tgttctcact 13020 tattttgggg agctaaaaaa taaattgaac tcatggagat agagagtaga atgatggtta 13080 ccagaggctg ggaagggttt ttcgggagat tggggaggat ggttaatggg gggatgctta 13140 atctaaatat aacgaataag atctagtatt tgatagcaca acagggtaac tacagtcaac 13200 aataatgtat tgtacattta aaaaataact aagagtataa ttagattgtt tataacacaa 13260 aggataaatg gatgaatact ccatttacac tgatgtgatt attacacatt gtatgcttgt 13320 atcaaaatat cccatgcacc ccctaatata tacacctact acgtacccac aaaaataaaa 13380 agtaaaaaac aaatccatct ttcagttcac taatactctc ttctgctgta tgtaatctgc 13440 tgaattgatt tattgagttc ttcatctcag taaattctat attttcagtt ctagaatatc 13500 cacttgatta attttaatag aatctggttc tttggggaag tatctatttg ttgaaattat 13560 tacagttaaa atttttaaat tcctatctga taattccaat atctgcctca cgtatgaatc 13620 actgctccca tgatgttttt ttctcttaat ttttagtcat ttggtcctgt ctcctggcat 13680 actttgtaat ttttgtttaa gtgccaaaca ttgatgcaga gcaaagataa atcaccttga 13740 tccaatcaag aattaagttg gtctaaggtc tgtttcagac tttcaagaac tggcctattt 13800 ctaggttgcc ctactcctag tgaaacaccc ttcagggatc tcaaataaaa tcctaatgtg 13860 tttaacaggg tcttttcttc atggtggtcc ctgaactcca atttttctgt gaaagcctca 13920 taagaacatc aaaactctgc ttaatacttt agcctcttag cagctacttt cagctaggca 13980 tcttagcctc tcattccaca aagctgagaa cttggcgaat accttgagga caaaacctgt 14040 acagaataat tttgtttccc tagctcagag taagacagct gatagctcta agtttccatt 14100 ttctgttcgg cctctatgcc ttatgccata aattggcaaa tgctaaataa aaaacagagg 14160 cagagaaagt ctagctgtct atagcatgtt tctcttttct ctgggatctc aggctctcca 14220 tcctggctat catggttgtt ctccattgcc ttcaagcagc tgttggttct attttatgca 14280 ctttttacaa ctgttcttga taggtagctt ggtctgatac aagctacact gtcttaggca 14340 gaaataaaag tctcttcact cattatattt tagtcatata tcttaatcca ttaaaataac 14400 ataattctat gatggaagaa atttggtaat gtttaaaaag gataatgaag taagtagaaa 14460 taacgaaata agtaaaaatt gtcaccccag aaaagttaaa attaagtagt ttttgacaga 14520 aaacttttca atttattttt aagtctgtaa tatgaaatat tttataaaat atcaagtgaa 14580 atacttgagt ttttcaagat ctccctttga taatataaat ccagtacccc attcagagaa 14640 atttatccta agtatgctta aacatgaatt gagagtctaa ttataaaaaa taaaaaagca 14700 atagcatata atatataaag attatcttat ataactacag aaccaaacca gtttatgttt 14760 aatcatacct tgttaatttc cgtttccttt tggcagcagt agtcattgcc atgtaggatg 14820 gcaccatgct tggtacaggc atagaatgct tagttgagaa tgaagaagga tcaagcctgt 14880 atattaatag tgacaaataa aaaataataa ttttgatttg aactatgaag agaaaaggaa 14940 gcaaatgtgt ccataattag aaaaccattt ggtattaata tataaagaaa aacattctgc 15000 tatactgtaa agattccctt gcttgtcctg gggtattctt ttctctttat aacacaggta 15060 aagttgctat caagagattt ctgcattccc agtggcatag aatagtgaag gtatttttct 15120 ttccatattt agattgggta tgattatgca gataaagtga gaaggatatg tttgcttgga 15180 tgacacacat tcaaccatac tttaggggta tgaccatttc agagtaagtt gaggtttgct 15240 aaacatcaat agaaagtgtg aaatttcctt cagtgaaaat attaatgaat aataaacatg 15300 ataatcctcc aacaatagct tgtataatcc accttcagag taagaagaac aaactaaaca 15360 tatcttaagg tctctcctag actaacgacg gtcaactgac ttaagatatc aaatttaaga 15420 ctttaaaata ttttgttagt gaattaatat tcagagagaa agataattaa aatttaatga 15480 aaataaaaca gactgtttta taatcaaaat ggcacacttg gtttatgaaa taaacctcaa 15540 ctaatagttg aaagtctatg ttaaaaaaaa agaattggca aatattattt ttttgtaccg 15600 ttgtaaaatg tctttgttat catttggtag tgattcttgt tcgggtaatt tacacttcga 15660 gctcttgatg tcttcacata tagtaaatgt agagtccaag tcctcctgtc cacattcttt 15720 tcttctatta tgagggatag ctacttcaca caacattttc agacaattat cactgtttat 15780 gtttgagctg atagcctgaa aacttgtagt aaatgatgat ggtttcatta aggttactgt 15840 agacggattt tgaaaagctt ttctacagtc ttctggtgta tatacaatag gctgaagttc 15900 tttgctaaga gaatcattga gctgcacact ttgagatggt ggagacttta gagtatgctg 15960 tcctttcaag ggagatggca ttagttttct ccgagttctt ttttctgtag gaatcttaac 16020 cagattagtt ccacctgaag atgagcctat tcaaaaaaat aaaaaaagac actcgataat 16080 gtttcctagt tttttaaata acccccatta cttttaaaac taagaaaccc taataataag 16140 gtatttttat gccaattgat aaaaatctga aaaatataag ttggaaagga aaatatcacg 16200 gtttactgct aaaaacttta aataaagata aactcattat aaagaaattc tataacaaaa 16260 gaatatattg ctaatatcaa tattaattta taggtatagc tttcttgaga tattgggtaa 16320 ttaggaaaca aattatcaat caattccaat aaaattcaca atttctagct ttcatgtttg 16380 atttgggttt aagatgaaaa cagtattaaa cttttatagg cacagaggtt aacacttgtt 16440 ccattgtaaa atattaccag tttattactt ttgttttgcc ttgtttttta gatttgcggg 16500 tacacgtaca ggtttgttat atgagtatac tgggtgatgc tagggtttgg gtgtcagtga 16560 ccagtttatt actaattgag tggaagtcta gtctaaatga acaagaatgg caataaccag 16620 taaaattctg ggtgaatgaa agcattgttt ctgttacagt gtcaggtata cagagttgac 16680 cctcagtagc tgcagattct gcatctgtgg attcaaccaa ccagagactg aaaatattca 16740 caaaacaaac aaacaaataa accaaaacaa ttaaaaaaat atacaatata acaaccactt 16800 aatggcattt gtattgtatt aggtattata agtaatctag agatgattta aagtacacag 16860 aaggatacat gtaggctata tactatgcca ttttatgtaa gggacttgag tatccatgga 16920 ttttggtatc tgggagggtt cctggaatca acttgcctgt ccccaggata ttgagagaaa 16980 actgtagtca attaagcatt ctagttaact gatttgtctc ctgtatcata cataactcat 17040 aggtttgtaa aaacaagatt taatactaaa gataaatgaa ataattcaga gagttcagag 17100 tactttcacc ctcatcactc tggagaagtc agtctcccaa atgtcaagag gtcactaagt 17160 ctgatgatct ttctcagcct tatctgataa ttcctgtagc ttttcaaaat tatatctgta 17220 ctattctaac atctgtgtta ttctcttctt ccatctagta aatgtacaca tttccctaag 17280 gagctgtact tgaccctcta gttgccttgt tctacacagt ttctcatatt tctaattatc 17340 ctcttaccat taccttctct gtcacctggg ttccaaatta ctagattttt ttttctacct 17400 tttcccttgc attttccaat gtataccaat tctgtctttt ttatgcttat agttaaaaca 17460 taattctgtt catgtcatcc ttctgattaa agacttttta gtaatcttta aatagaaaca 17520 aaatatgctg atatttttag ttgggtaatt cttggtcctt ggtccaaaat taagaaacaa 17580 attgtttcat tagaatttat taccacaata ctagatttag tatttaatgt ttaacattta 17640 aaaacacaaa catctggtaa acacctttta ttaatgcccc aaataatgac atatgtaaca 17700 atacacttga tcaacttcag tgtgattatc ttatattttt caattaactt ttttctactc 17760 tacctacttc attctggtga acttcatggt gtctgacatg aaataccttt gcttggagtg 17820 tacggtcaat ggaagaaact attacgtgta tttccattca cgttgtctaa tcatgaagta 17880 aaattcccag ttgatattta ctttactgta taatactaac ttaaagaaca ttgaaagcag 17940 aataagataa gtgttatgca tttcaataaa gcaattcaaa ctttcaacca agttagaaaa 18000 tacacttaaa caatcagcaa cagtacaagc actattctta ttatattagt tgacaatatg 18060 ctctgctttg gctaggttga caattaccct ctaggaaata aaattcaaaa acagaagaaa 18120 aatatgatcc ctgttctact gaggaatttt acttttctga gaactagata aatgagatcc 18180 agatcttaaa ataattttcc actcccttta acatgacatt tgtcaaattt tccattacca 18240 gatattttta tactaatgct gcagagtaaa gacagttact tttctccact gtgctgctac 18300 caccaatttg gtggctatta atagctggca gattaacttc ttttcccatg agaggcagca 18360 ggggtatagg ggatagaaaa ctacatggag ggtagaggac tgaattggga gtcaggagac 18420 ttggattcta tttctggctc caccaacagc tcaccaagtg accttgggca actcacttaa 18480 gcagtgtggg cattaatatc ccctagaaaa aagcggatat taccttttta tatatgaata 18540 ggattatatg ataagggttc aaagaaaggc tctagaaatg caaatatgtt tcaactgtta 18600 atattacaac ttttacaagg agagttgtaa tttactttcc aatcatcaaa aacttactgt 18660 tatctctaaa acaatatatt tcaaacagtg cttcactttc agtttatcag atatccagtt 18720 tatcaaggct gatgattaat ataaaccaca ggtattattg aaacaggtat atatgttctt 18780 tgcaaatgca gaccttataa taacatttta aactttaaaa tacaatggaa catgaaatct 18840 caagggacaa gaattataga gtcattattt tttaaaatac atacttagca ggtataatct 18900 ctgggagtgg caactgggca aattcccatc atggtggacc acattttccc tactgctagt 18960 aaagagtgat aaaaatcaca gtcttctggt agaacactga agaaatatcc acgtgtcctc 19020 tgggataatc taagcataca cccgacatca aatttagtat gatcagactg actaacaatt 19080 tgtcagtaaa aggaatagtg gtgttacagt gatatatctt tagctataat cctgctctcc 19140 tggcagagta taagctgaag gaatagcatg gagatgtggt agttaatgtg gatttacata 19200 caattgtttt actgggccta gaagaagaga tgctacagac acacaacatg tatatgatat 19260 aaatctaaag agttcttttc attctctcaa ttattaagtt cagataaaat aaaagggcag 19320 aaggcagatg gtcaattcag aactacttag gctgattagt tgcttagaaa gcttcaggag 19380 ctaaccagag caaaaacaaa atttaaaggt ttaaataaaa atttaagtca atcttctgta 19440 actataaaca taaaaggaaa atgacccaac ttaatgaaaa ctaaaagcat aaacaactaa 19500 attttactct gaatacaatt tttataatat ataaatacaa ttacataaca aataattatt 19560 atcctttagc taagttaggt aataaagaac tttatgtggg tatggcaagt ggagagtgtt 19620 gagttggggg atcagaaagt tcaataggct ataagaactg ttggatatgt taggtctatg 19680 tctataaaag agatctgctg tacttttcca ttagaggaaa agggtgtaca gtaaatttcc 19740 agaagagcag gcatgggaca gttgtagttt cccctgattc agcttgggaa aacactatct 19800 aacaatattc cataattctt gtgcttatag agtagaagtg ataagaagga acttggaggc 19860 agattataat tccttcagaa aggccccata aaatgagaaa atgaatcaca aagttgcagg 19920 ctgtgccttg cagaacaaga gaccatatag atgatgatag cccataaaat accctagcaa 19980 cgtgggtgct acacagaagg gaacaggaaa ttaaaaatgc attgttataa ggcacgctct 20040 tgcaaactgg aatagggaag actggcagtc acttgggaag acatatctct agggtctatc 20100 taaggaacta gtccagtgta tcatatactt aaatataaga ggtagtgggt agcaatgtat 20160 gttatggttt ctgagtaatt ttgctatttc cacaacatct cttgagactt taactcctca 20220 acatattgta agtgtgctcc atttctatta ccttgaatga ttatgaccca tgggatgtaa 20280 gtgaatagga ctttttgaaa tttatgccca aataataaca ggaagcataa tgtcaaaaaa 20340 tttaaaagaa aaaaatcact actactattt tgaatccagg atcaacatat gttttattta 20400 tgaaaaaaag ttgtagtcag ctatggtaca aaagcaacaa tctaaaagga gtacacctgc 20460 ataaaaagaa ttcactgttc atcccaccca atatttatta agtacctacc ataccatgct 20520 aggtacagtg gtaaacaaga cagttaagaa tttacatttt tgaggggaga aggcagatga 20580 caataaacaa ataaaataaa ttaggatgat aaattaattg taaagacaat aaaacagaga 20640 aatggaatag acagtgatgg gagataggat gttttaacta tgatggctag aataacaatt 20700 ctaaggatgg aatatgtgat ctgagacttg aatggctaag gaggcagttc tatgaagatc 20760 tgggggaaaa ggcagaaaaa atagcatgtg cagagatcca acggcaacaa tgaatttgtt 20820 gagctcgagg aaaagaggct agtttgattg aagtgctgtg agttagaggg acaggcagaa 20880 taagaggcta gagagatcaa aaggggcaac ttatgttagg atttatggac aagacaaggg 20940 tttttattta ttccaagtgt aaagggagat ctgtggaggg tttcaaatat ggatataatg 21000 tgatctgatt gatgtttagg aaaaagagtg atttgcttgc tgtgtcaaga atggtcaaga 21060 gagaaaacag aaaaatcggt aacaaggcta ttgctatagc ttaagcaaga aatgacagct 21120 tgggtaagag tggtaggagc agtgatggag agatgtgaga agggtattat aatatctata 21180 tatgtaatta gctgccttat aataaagagt tcacagaaag tagtatatat taattctaca 21240 taagtaaatt aagagaaatt gacaatgctc cataaaacca tgaaccattt atgcatgtca 21300 ttccctcaac tttggcattc tttttttttt gacatcccct tccctctact cccactcatc 21360 aagcttggga tcctgtcctc tattcaggag ttctgatcca tgtaactgta ggagtcctgg 21420 aatctgcatt tttccctttc tagtttggac actcatagag acttgaggca gtagaaactc 21480 tttggggttt gaggctgtga tttcttattc agagacgatg agtgttatta ttatgctgag 21540 gtaggggaaa ggaaagaaaa ggagtaagga taagtaggaa acagtcctag aacaaaagta 21600 gcagatagag acagtattga aaatgaagtt cacctcctag gaagttgtac caaaggcaat 21660 taatgggtaa gatttaagtt ggtagaatga tgttaaaaac agcatctctt tttaggttag 21720 gcaccctact gtctctgcat attcatctct ggacactccc aaacaattaa aacaggttta 21780 tagacagttc caggcataga catactatgt tttcagatac aaggtctaat tgctcctctt 21840 ataatatttt gttagtatag cattcagttc tttaaaaagg agccaatgca ttttgatcca 21900 tgtttaagga agcttgaaaa tgcaaaatgc aaacttgtaa tgaatgagtt ttgataaaag 21960 aatatacata ttagaatctt ttctttttga tagggaagga atttagaaag acactggctg 22020 cttgaagaat ttctcactag aaacagtact tggttggcac acttgagaaa tacccatagt 22080 acaaggaggc atttgaaggt taactgcaaa agacaatttt aaccaaagtg ataacctgaa 22140 tagaggcatc tagcgcccac tcagattccc tttaaaatga tcacatcatt aaaaaaaggg 22200 taaacttgac ctaatgttgg taatgggaaa acattatcat ctgagtgcca gaacattaga 22260 ggactttcta aagagtattg tatagctcag actcttaagg gaaggcatgg aggagaatga 22320 cttatagtac tccctatcct ttacccttca gtgctatccc aaggagttaa gtaaaagaca 22380 ctggcagata tcagtaaagg gccttaaatt agaaccaggg atgatggggt aaggtgggag 22440 ttggggagaa tgagtgagac acagctatgc aatatagtaa aatggcaaca tctgaacact 22500 aaaagtagcg ctaagaggct ctaaaattca gtcctggctc agttgtttca gtgcagaaaa 22560 aaaatattaa aaagtacccg atattatcag gcttgttccc atcactgttg gctatatcac 22620 acatggatga gatactcttg ggcaaagggg cagatttcta gctgagacta cctgtggctc 22680 tggttccttc cctacattcc ctgggctgtt ggatcagtgg acaggaatat attttttccc 22740 cttaatttta caggaaaaaa cataattata ataagcaaac agaaaactca ctggacctat 22800 aaaaagaaaa tgtaaagaaa tgacagaact ggcatacaaa ctcagacctt ttgctaatcc 22860 agatgccaag ttcttcacca ccacacaatg ctgagcccct accacagaag ttaattaaat 22920 cacttaggca atgactaaat aactaaatga acatgaacat ccacaattac actgatattt 22980 aaaactatat tttatagatt atttgatgat ataaaaaaat gttcattaat gaggtagtat 23040 acagtatgat cccaattttg acaaaacaaa aacaaaaaca aaaacaaaaa ccaaatcaaa 23100 gcgcacaaac ctcctgagca aaaatggggg gaaaagtaat agaaaacaga gaaggaaata 23160 taatccaatt catcaaaatg ttaacacagg tttatagctc actgggaaaa taatgaatta 23220 ttttattttc ctttttatac atttgattat tttatataat aaatataatc ctgctctgta 23280 aaataataaa tgaccaaaaa aaaaaagggg gaataatgtt tggggtggtg ggtaggaagc 23340 caataaaaaa tcagctcttt caaacctctg aagatctcag gaactgaagg catgaggttg 23400 tctctgaaag cacagggtgg agttaaaaca ggagaattct tggaagtctg tataaggaag 23460 ttggattccc agatctccct taccccatta ccatcaccta cattgctagg taactgctcc 23520 tttgttaccc tattaaaaga catgaagttt tactctctgg ataggctgta gactggggcc 23580 aacatgcaca gctgacacta ggtgcattaa ataatttctt aataataaat atatgctgat 23640 ttttctccca cttctctgta atactggtag ccaggcccat atacccccta aatggaaaat 23700 caaaaagttc tttgtaaatg aaacataaaa ataaaaaaga tggacatctg taggttcccc 23760 cagattgact agttttctgg agataactat aaatcagagc tttgtttaat aagtccaacc 23820 ctagttttgt aatagttact cattaatagt ttagcaaaca tttttaaaat atttatatga 23880 tgctttaagg catcctataa aaaactgaaa gtatgcgttt caggataaag tggcgagtgt 23940 tctattcatc tgttcctgca ttatggctag agattcccgc ttcaaaaagt ttgtttactg 24000 taagtccaaa gacagactta aaaaggaagt tagacaaaaa cattttgttg agactgccaa 24060 gttttagaag cctctcaaaa gacttttaag tattaaaacc acttttaaaa ttaactgtaa 24120 atgcatgcac tgaaatcatg gattagatgg agaagaaata caaatatttt catcaataac 24180 ccaggttcta aaacaatgta acatggatta caacagaagt atattaacat tagtattata 24240 gagtattaaa tttgctatta ataaaaccac agctaaaaat aaaaacaaaa acagtgaaat 24300 cataatgaaa acataattaa tttgcatgac aaactacatt tgctaagtgg ttataaaaat 24360 tataaataaa tatttggtga gtggttaagt ggttaaaaaa gtaaacaaag tttggatatt 24420 catctgccat tcactatctc tcaaatgtgt aggattttaa gacatataat tgatgaatgg 24480 tagtgtaata aaagcaataa attgggcatt ttgattttga caataaaaca taggataatc 24540 tgatgaagta cataaaaaag acttgaaaaa agtttgataa attgactgcc tatacctcaa 24600 gagaaacatc tacaaatgta tttattggtg gtattgctct ttaagctact taagtctacc 24660 tataaggaca atcaatctac ttcagtattt gcatctttca aatatttcaa ttctccagga 24720 agtctatctc acagatttgg ctgaggactg tgaaacgttt ccagtaaaaa gcagaaaaaa 24780 aggaaaaaaa aaaagagatg cttcatgtct gtttccctaa aattagtttt aagaaatgtc 24840 agtatattct tacttctaat aaatgtttta aataatattt tatttaatta taaaatattt 24900 ccttaagtag gctctaaatg ttacacatat taacatatgt ataaatataa tgtgaaattg 24960 catactttat gtatatatta tataacatac acatgtcact tcttacctga tcctgctaaa 25020 atacattagc aaaaccagag aagaaataag gtggcggtgt tgtaagtgag ctaattcttc 25080 atctctcatg attagaagtt ataacatcta aacactaatg aatcaagaaa cagcagtata 25140 gcatactgtt tagaaatatt gtaggttgca acctactcat ctgacaaagg gctaatatcc 25200 agaatctaca atgaactcaa acaaatttac aagaaaaaaa caaccccatc aaaaagtggg 25260 tgaaggacat gaacagacac ttctcaaaag aagacattta tgcagccaaa aaacacatga 25320 aaaaatgctc atcatcactg gccatcagag aaatgcaaat caaaaccaca atgagatacc 25380 atctcacacc agttagaatg gcaatcatta aaaagtcagg aaacaacagg tgctggagag 25440 gatgtagaga aataggaaca cttttacact gttggtggga ctgtcaacta gttcaaccat 25500 tgtggaagtc agtgtggcga ttcctcaggg atctagaact agaagtacca tttgacccag 25560 ccatcccatt actgggtata tatacccaaa ggactataaa tcatgctgct ataaagacac 25620 atgcacacgt atgtttattg cggcactatt cacaatagca aagacttgga accaacccaa 25680 atgtccaaca atgatagact ggattaagaa aatgtggcac atatacacca tggaagacta 25740 tgcagccata aaaaatgatg agttcatgtc ctttgtaggg acatggatga aattggaaat 25800 catcattctc agtaaactat tgcaagaaca aaaaaccaaa caccgcatat tctcactcat 25860 aggtgggaat tgaacaatga gatcacatgg acacaggaag gggaacatca cactctgggg 25920 actgttgtgg ggtaggggga ggggggaggg atagcattgg gagatatacc taatgctaga 25980 tgacgagtta gtgggtgcag cgcaccagca tggcacatgt atacatatgt aactaacctg 26040 cacaatgtgc acatgtaccc taaaacttaa agtataataa taaaagaaaa aaaaaaagaa 26100 aaaaaatatt gaaattaaat gaaaaaaaaa aaaagaaata ttgtaaatac tgtctggctg 26160 tggtggctca tgcctgtaat cccagcactt tgggaggctg agataggtgg atcaccggag 26220 gtcaggagtt taagaccagc ctggtaaatg tggtgaaacc ccttctctac taaaaataca 26280 aaaaaattag ccgggcctgg tggtgggcgc ctgtaatccc agctatttgg gaggctgagg 26340 gaggagaatc gcttgaacct gggatgcaga ggttgcagtg agcctaggtc atgccattgc 26400 agtccagcct gggcaacaag agcaacactt cgtctcagaa aaaaaaaaaa aaaaaaaaaa 26460 gagaaagaaa tattgtaaat attgtaagtt tgttatatat aatcatccag catatattcc 26520 aatagaaaac agaaaaatcc ccagtaattt tatatcttcc taaggatagt tttaagaaat 26580 gttggaaatg tccttaaaac agttgtcaat gacaagtcaa atccaaataa tttgaaacca 26640 aatgcttggt tttagtccat cgctacaaga aaaaaggaat aaacttacac acaaatgttt 26700 cctaatagca aaaactgaaa ggctcaagca agataaggcc ttacgtactt taactatgac 26760 atttctatgt catgggaatt atatagttta gcaatctata tctatttttc actgaatctc 26820 tactttaaaa gagtggtcct aactactggc caccaggaaa gttacaatgg ggatcatctt 26880 atacaaacaa ccagaattta gtactagatg gttttagtgt ttatttaaac ttcattattt 26940 tataatttgt tgctcacagc aagaaaatga cattctcaaa gtcatgatag caattatatt 27000 tgttgttgcc agagttggag tcatgtttct tattttccag gtagaagtca ggtaaaaagt 27060 aatgcaagta atacagagta ataacatata taataaacat aatggagact taaaaaaata 27120 aaactttctt cacagactca aaaatatgaa taggaggcaa catactactt cattgctccc 27180 aaaatgaaat gctatttcct attattactg aaaagagaaa gtaggcaaat aaaatatgaa 27240 tatcttcata acttaaaatt gggttacata aaaatcaaaa ccaaccatga ataagagaga 27300 aaaaaataca tgtaacacat ttggcaaagg atttagagct cgtgtatgtg tatgtatgta 27360 tgtctatgta tacatgtgta tataggttgg ctggtctgtc tctgagagaa ataattctta 27420 caaaacaaaa tggataagag caaaataagg caaaggaaga ggcagttaat tcagaacaaa 27480 ctataactag acaaaaagca catgaaaaaa tgttcacctt caccttcatt acccacttac 27540 aatggtagac tacacttata atagttctgg gggtggggaa tctgacaatg catatctaat 27600 gcctttaaag tatacatact gtttgattaa gctattcttc ttctaagggc ttagcctaag 27660 gaaataatta ggcaagttgc aaaataaata cacatgcaca gacatttaat ggggtgtcgc 27720 ttgtaataat aaagtgaaaa caaactaaat gttaattagc aggagattag gcaaatataa 27780 tatgcagcta ttaaaaatga cttaaattca tattcgttga tagcaaaatg tgtctacagc 27840 aagtagttca gtgaaaaaga ggctggttat caactatata tatataatag attccactgt 27900 tcttgtttta aaaaagcaaa ccacaaatgt atgcttagaa aaaaagttca gtaggctatt 27960 aaaactaaat actaatataa gttaataaag tatatcttgt ttcttttggc ttcacttttt 28020 tccaaattaa aataaacaaa tatttattgc taagacagta acaaggttaa aacactagtg 28080 aaaggaataa aaaacttaaa agccatggga atacagatga atatatgcag gcaaaggaaa 28140 gatgatccat taaaaggaag atttaataaa gaaggaagta tctgaattgg actctcattg 28200 tggagaaaga tttaggccaa gaagtgggat ggatgtagag aaaacaagca tttgaaattg 28260 atggaaaagc ttggaaattg cagaggccag aaacagaaat catgataaca gaaggttggg 28320 atacaaggtg ctggacaaaa gtatgcctat agcttgacac tggacttgga aagcctttga 28380 agactcttct gagaggtcta cactttatta ggaagatcac tttgttggca gtgtgaagtg 28440 tagactgcag tggaaagaga caagagaaat taaaactagt ttagatgtca ctatattatt 28500 catttcttat gccaaatttt ctaaaaatat tttaaaataa attaagaaac atctttttct 28560 ctctttgttt taaataaatc tctaaaacat aattgctaaa tggcaattca tgtggtttct 28620 taagtagagg gggctttata tttatttttc agcttttgga aatatttcac agatggttcc 28680 tttacataaa ataaagagac tagataattt atcactaatg ggtttaaaat ccctctctta 28740 aaaatgggca gggcttttgg ggtcatcttt tgatgtgcca tatcatgtgt tctgaatgat 28800 tttacccaga ggaagtaatt tatcaaaagt ttaagactgt aaacgttaag agatttatag 28860 agctgtatgt tattgtaaag gaagaatgcg gtatttagca aacatgagtc ataggctgca 28920 aagtagggtt catgacaggg agacattgat gaatgggatt agatctaatt gaggtttggt 28980 acaaaacgat ggcaaggatt cttcctttgc aagcaagcac tcctgttaat atgtacgtga 29040 ggagaaattc tgggaaactg tgctaaatca aaattagttg gcaaagttct aaagtgaaat 29100 caaatattaa tgtatacatt tcaataaaaa cttctaggct acaaatgatt gatacaatta 29160 gtgtactcat cataaatctg gattcttttt aacagcctta tgactcatgg aattcatagt 29220 tgcaaatgat acaggtaaat gaattttaac tatttataag atacgtaaac ttatcttata 29280 agataaagta ccattaaatt aaccaaatat aagataaggt accactaaat taaccaaact 29340 aataaacatt ttataataca cttatgagac actctcatgg ttagggatgt ataatagttc 29400 cctaatacat agggaactat tgtcctaata catagggaac tattatagtc ctttaaatta 29460 atccagcact ttgaataata aatcaaccca taaccttttg atattttttc tgtgggaaat 29520 agcagatatc atgtttctct ctcagtttca ttttctcagt atttacactt accaaagatg 29580 gaaaagaagg gacaatacaa agaacctttt aattcacagt aatatttgca gctatagatg 29640 aataactaaa tactgtctta tgtacatggg gatgataagt caaacaaaat gtatttaggg 29700 atacaagcat gatttccatt gtttcatgat taaattttgt tgccaaatgg aaaaaatatg 29760 gaagatttgg tttattaaca ttttcctgct ttatatttgt tatatgagaa attagtatag 29820 agatttccta tctttcaaat gaaatttcct tgtattcaag taattttagg ggaaacttaa 29880 acttatgtgt gaactctata ttcaatcaga atattggtac tatgttaaga gactggttct 29940 cctagtatct tttattgtac tttaagataa aatcactgac attgggtgca aaattttaaa 30000 aaaggaaagg ttacagacag aagtattacc aaatgtgagt ttccagatgg ataatgagga 30060 aatcttgact tttcatttaa tgtcagaaat tttatcagtt ccataaataa attttgctgt 30120 cagcaccccc gtcttgcact acacttagtg agtgtgctat ctattttcca gaccccaaaa 30180 taggtacata ttttactctt agtcaataca cttgtagttt gaaggtaaag atttcacgtc 30240 aaataaatat ctattcaaaa atcaagtcta tttattagaa aataattaaa attcataaaa 30300 tttacaaaat tagtttcttc caaaataaga atttaggctt attaatttaa gaaaagtaaa 30360 aagtagtcta tgtcacaaaa atacaaaata ttgtatctag ggatctattc agtcaaattt 30420 ataaaacact tacgaagaaa actctgaaac tttgctgagg aacatacaaa aagatatgca 30480 tacagggaga caaactattc tagagtacga agatttgata ttggaaatat gtgaagtcaa 30540 tttatgaatt aaaaaaattt catttccttg aaactggaaa ttattctgat attcatttcc 30600 tagacaaagc aaagaatatt tttcagacaa agaataatga agaagggcta gcatactata 30660 taaaaaaaac tataaagtat cacatattaa aataatagct actggcccta agacagacaa 30720 acaggtgaaa caatagagta gaaattgagt aaacagaatt atatatgact acttactgta 30780 caaaaaacac agtggctgtt aaggatgcat tgccaatata tctatataag aatgctagtc 30840 tccttggaaa aaataaattt agattcttgc ctatcattta acaccaacat aaattaggag 30900 aaagtggaaa caaaaattta aaagcttatg aatggaaagg ccttttgagg aaagatcccg 30960 aaggcagtaa gagagagaaa aaagctattt tactacataa atgttttaac tttcagcatt 31020 aaaaaggaaa cctcaaacaa aagcaagaat aagtggcaaa tcttgaaggg tatagttata 31080 ctatgtatat tacaggaaaa agttaatatc ccttagtgat ttcatcctgt cctatggctt 31140 taaatatcat ctaaatgtta acaactctcg aatttatgtt ttagcttaga cttctctcct 31200 gaacttcaga ttcttaactg cctacatgat gtctccactt ggatgtatct tagacaaatt 31260 taacatgcct agaactgaac tcctaatttt ctacaacctc caccctgtat acctgctcca 31320 tctgaagtct tccttatctc tctgaaggtg actcaattct tttagatgct aagttccaaa 31380 attttagatt cagtcttaag catttctttc tctcctattc caaatctaat tttcttggaa 31440 atcttgctgg ctctaccttc aaaacatttt agaatctgac cacttctcac cagctccaat 31500 gctattatcc tggtctgaat aacctccatc ttttgcctgg gttattctag tgcctcctca 31560 tgtttcagcc cttgccatag tataatctat tctcaccaca gcagtcagag agatctttta 31620 agagcacaat tgaggtatgt tacatttctg ctcagaccat gtcatggctc cttgttttat 31680 tcagagtaaa agactaatta agtcctgata gtaacctaca aggccctatg tgatctgcct 31740 tccttccctt tatctctctg atctcctcac tactttcatt ctctttttct ttgtaccagt 31800 tatatatcct caccagcctt tgaatatgtc aggcaaattc ctatgttaga gattttgcac 31860 tgtgattgtg tccctctacc taaaaaagtt tcttctccca gatattcata tagctagtcc 31920 tgtgaagtcc ttcaagtttt atcagtgaga tcctccctga ccatgctact gaaaatagca 31980 atctctctcc tccctggcca cactcctgaa ctccctttat ttctttctta tagcatgtag 32040 tacctcctag cattctgttt aatttattta ctatattatt gtctttctct actagaagtg 32100 agctccttga gggtggtgga gtttgtttca tactttgatc cctatcatca gacaagtgcc 32160 tgaaatactg ctgtaagtta aacactgttg aatgaatgaa aaaaaaccta cacttaagat 32220 cttgtaaaaa agtaacgatt gttactaaag atgactatat cagaaaaatg tcaaaggatg 32280 gctgggcaat tcacagaaaa aagactcttc aattaaaaaa aacacactca actatattag 32340 taatgaatat ggaaaaaaga tagtatttat gactattggc aaagtatcaa caagcattgc 32400 cattactttc aatgatgaaa accacaatta cttctgcact aacctaaaaa ttagcaaaga 32460 caaaagtggg agagagtgtc caagattaaa aaagactgca taggcatgaa ccttgtttgt 32520 atcttaattc aaacaaatca tagaaacaaa taatttatga gacaatgggg gaaatttgca 32580 cacattagat atttgatgac atttttcttt tatacacact tgatgtaaat ggaagaaatg 32640 atgtgctgtc tgagatctac ttttttttgt tttgtttttt gaaataaaac tttatttatt 32700 aacactgaaa tttgaatgtt ttataattat caggtgtcac aaaatatttt tctaattttt 32760 tccagtcata tacaaatgtg aaaaaaaaaa tcttggcaca tgggacataa aaaacagata 32820 gtgaatcagc tttggcctgc aagctacaac taaatgaatc ctaatctttt tttaatttta 32880 ttatttattt attttttaat tatactttaa gttttagggt acatgtgcac aacgtgcagg 32940 ttagttacat atgtatacat gtgccatgtt ggtgtgctgc acccattaac ttgtcattta 33000 acattaggta tacctcctaa tgctatccct cccccctttc ccccacccca taacaggccc 33060 cagtgtatga tgttcccctt cctgtgtcca tgtgttctcc gagatctact ttaaaataat 33120 ctagtgtaag agctggggtg gaggaaagca gatgggtttt caagactaga catgagctga 33180 taagttttaa agttaggtgt tgggcacatg gtactcatag tattctttgt gcttatatac 33240 atgtttgtaa ttgatttact aaaggtagaa attaaaaata ttttaacatc aaaagctggt 33300 gaggctaaaa aaaaaaaaaa agctccttca tttatactgc ttgatggggg ttaaatcact 33360 tgaaggagga gagttatttg gcaatatata tttcaaattt tgcataatgg gcatttatct 33420 tgagccagaa attttacttc taagaattta ttgtagggat agtcagatat gagcacaaag 33480 ataaatatac atatttgctt actaaaacat tattggcaat aatagtgaaa atttattaaa 33540 caacccaaat gcccaacaat atagactata ttcattatag ttaatctcat cagatttttt 33600 tttttttttt gagacagagt cttgctttgt tgcctaggct gaagtgcaat ggtgcaatct 33660 cggctcactg cagcctcaac ttcccaagct gaagtgttcc tcccagttca gcctcccaag 33720 tagctaggat tacaggcatg ggccacaatg ccttgccaag ttttgtattt tttgtagaga 33780 cagggtttcg ccctgttgct caggctggtc ttgaactcct gactcaagcg atcggcctgc 33840 gtcagtctcc caaaatactg ggattgcagg cgtaagccac tgtccctggc ccagattctt 33900 aaaagcactg catgtgtgtg tatttaagta aaaagaatat agttaatcta gtaaatactt 33960 ttaaaggtcc ctaaggcact tgaactcact tataaacacc gttcctatta ttcctccttg 34020 acactattag tcatgtatac aacatacata attcatgaaa tggaaaatac ataataaata 34080 aatagttgat ctctaaaatc atttgaatga aatagtaaag taacgaacca agaacaaaac 34140 attataaaaa caaaactcac cttctaatat gtgttcaaga gaaaacacgt taattataaa 34200 atgtaacatg gcttcaagtc tttccttcaa aaatatcatg agaaggaatt aagagtcaag 34260 taaattcttt tgttttattg ttgacaagta tagtctgtgc aattatactg tatgtgaaat 34320 atagattttt aaataaggaa taatgagcat catatagcag gtggtcagta tttctcaatc 34380 ttggtgttaa aatcctattt cctttctaac atcttgagta cattataaaa aatgaatcat 34440 gcccgaaagg tatgagagaa tctgaaaaaa acttaagttt tgctttccag agatcacaac 34500 taggtcaggt ctaatgcttt attaaaagaa aaagaataca tatgtgtata tacaatatat 34560 atgttttaag ataatctatc caacttccgt attttcttaa tgtaaaggta taatataggg 34620 aacttctgct aataataaag atggagataa ctcagaccaa cctttcttct gaaggcaact 34680 aaaagtctgg acaaaatata aaaaacatct gtttgaaggc actggattat taataagatg 34740 gtgaaaaatt acaggtgagt atcaggagga agctggaggc tcaggaaagt aatttctgca 34800 atttcagcta atttcccctt gaggttgttt gcttatgctg gaagagctgg cagaaaagca 34860 tagcaacagt gctaagagct ttgggggaat agggtgctgg aactggaatt taggatcttt 34920 gtaaatcttc cttgctttga gttgggactc tgaacagcta tactgtagag ggcaaatcag 34980 aaataggcag gacctcagga aactacagtt tagtatcaaa ttacctcagt ctctgaaata 35040 ggactgaggt gattctgaat tgctaatgct acctagaata tgaaagaagg aactgtaaat 35100 attctctgag atatttaata tcatgatcag atgcatcaaa atattctgca aataattttg 35160 caaatacctg actggcacac aaaaaatttg catgcatatg aggaattaag accacatgca 35220 agaaaatcag tctaaacaga tccagtggtt acagactttg gaattctcag acacagactt 35280 taaattatag ttgtctctca gtatctgtga gggataggtt gcatgaccat actaaaattc 35340 atggatgctc atatccttta tatataaaat aatacagcat ttgcacacaa cctatacaat 35400 cctcccatat gctttaataa tctctagatt acttacaata cctaatacta tatatatata 35460 ctatgtaaat agttatgatg cattgttcag ggaataatga ccaaaaaaag tctatatgtt 35520 cagtacagat gaaaccatcc atgttttttt tttttttgat tagttggttg aatccatgga 35580 tgcagaaccc atggaatatg gatggctgac tataattata ccctttgtgc ttaataacaa 35640 tttttgcaaa gatatgaaac tataaaaaag aataaaatgg aaattccaga attggaaata 35700 tagcgactga aattaaaaat tttatggatt taaggatcat ttgataaagc tgaaaaaaga 35760 aagtaaactg aagaatgtga gaaacaaaat tatccaggaa gagaaaaaaa cattaaaagc 35820 aaaagagtaa agggcataga caatacaatg ggaaagtgcc atgcaatata attggagtcc 35880 cagaagtaga ggagagagca aaagtgacaa aagcaatagg tgaggagata atggttaaga 35940 attttccaaa acaaacaaaa gataatgcag aaacaaattc agaaagtcag gaacccactt 36000 aagagaagta aaaataaagt caactaggca taacataata aaactattac aagccaaaga 36060 ctgaggaaat atttcaataa gccagaagac agattgtatt cagaggggca acacttaaca 36120 taaaatctga cttcaacaga ctattattct ctgtgaataa ggtcttacat attagccctt 36180 cactcccaac tatttgtcta tttgtcttag gtgagctaaa tgtgtgctgg gacacatttg 36240 agccaaatgt cccagcacac atttagctca cataagaaaa atggactcta gttgggagtg 36300 aggggctaat aaacaccaga tcccaagaaa attccccata atggaaaata taggcagatt 36360 tgactatata aaagttaaaa gtccaataaa ttgatcaatt attgctcaac atatatataa 36420 aaaaaagcag caccaaatga acaaagagtt attagatacg aagtgccaag taaaaaacca 36480 agcaaacaaa aagcccctca aacccataac aaataaacaa aaatttccac tagtgtgaat 36540 gagcaaagga tacctgacag gggatgaatt ggcctcatcg ataatctgag agttacacat 36600 tttaaaagac tatgcagctg ggcgcggtgg ctcacgcctg taatcccagc actttgggag 36660 gccgaggtgg atggatcacg aggtcaggag attgagacca tcctggctaa catggtgaaa 36720 ctctgtctct actaaaaatg caaaaaatta gccaggcatg atggcgggca cctgtagtcc 36780 cagcttcttt ggaggctgag gcaggagaat ggtgtgaacc caggagacgg agcttgcagt 36840 gagcagagat cgcgccactg cactccagcc tgggtgacag agcgagactc ggtctcaaaa 36900 caaaacaaaa caaaaaaaac aaaacaaaaa agactatgca ttattattgc tgttgttact 36960 atttttggtt taggtaaaga tgaaacagtt actctcatgg gtactaagta cagaaaaaaa 37020 ttatgaaaag cagtttaaca tgatgcatta aaaaaaaaat gatatgtcct ttaacctggc 37080 aaatcagctt ctaggattct gctatgcacg cacaaatgtg aatacacaga tgtgttctct 37140 gatgtactgt tcactaatag aaaaaaggtt aattaaatta tggtacatct attctctgga 37200 ttctcaaaaa caataaaaaa atgaggtaga ttcttcatgt atgcacccta aaaatgttca 37260 taataaacaa ataaaaccaa taaacataat aaactaaaca aaaaagttgc aggtcactat 37320 gtgtaatgtg ctagcattca cgtgaaacct aacaaaaagc tttatgtaat acatgtgtat 37380 tacacacata ctgcaaagat aaatatttaa cagcatttaa tctctgagat agggcataaa 37440 attgaggttc tgagaagagt tgaaggtggc agtctacttc ttttcttcta cattgtctga 37500 atttttttct taactaagat tatatgttag ctttgcaatt aaaatgtctc acacatactt 37560 ttatgagaga aagagaaata tcaagtgatt tgtcaataga aaaatagtaa actctacact 37620 gttagttgat cttaagaaca gattattatc ataaaatatg atatgattaa ttataatttc 37680 ctgcccttaa tagaggttac attttaaaga aggatgggaa gcaaaattgt tccatcaaaa 37740 atagataaaa tgggttaggc acagcagctc atgcctataa tctcagcaat ttgggaggcc 37800 aggggagaca actgcttgag cccaggagtt tgaggtcagc ctgggtaaca gtgatacttt 37860 gtttctacag gaaaaaaaaa aaaaaaaaaa aaaaaagcca ggagtggtgg tgcatgcctg 37920 taattcctag ctacttgtgg ggctgaagtg gaaggattgc tagagcccag gaggtggagg 37980 ctgcagcaag ctttgattgc accactggac tccaggctgg gcaacagggt gagaccctgt 38040 caccaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaagaaa agagttgtaa aatgaatttt 38100 actgctagag ttatatagaa catcaatgca tacttgttct agatctttgg aagatactgg 38160 ttaattgaaa tgactataaa gctaattttc ccattaattt tcataaaata gacaaaccta 38220 ttaaaattaa ctgttctata gattgatata caaaggttct ctttagaaat aatgttacta 38280 tttacttaaa acgaaagtta tacttacaac aaggaatagg ctgaactggt ccaagttgtg 38340 gaaaggtcat aagaacagaa atccctggta gatcgttttg ctttggttgt tcggcagttt 38400 ggtcagccca aactaccact tttttcctct ctaccaaatg ttcgatctct ttgaagtcag 38460 attcaaaagc agcatttgac aggccggctt cttttaatgt gcaatattgt tttcttaggg 38520 ttggaagtaa agcattcaat actctatata cagaagatga gaagaaagga gagataaata 38580 tgacatttta aacacattat tttagttctt ttatgtaaca cccaaagcat tagcatatca 38640 ttaaaataat ttcccatgta tgaactgagt tctagtctca gattgtcttc acttgcttcc 38700 atatgacctt ggacaaggca aaaactgaag tttttcctct gtaatgtgag ggacagataa 38760 atagccacta cttataatag gagattgctt tgagggctaa atgagttaag tatatttgtt 38820 tatttatttt ttagagacag ggtctcactc tgtggcccag gctggagtgt agtggcatga 38880 tcatctcatt gcagcctcga actcctggcc tcacttgatc ctcccacctt aggctcccaa 38940 gttgctggga ccacagatgt gtgccactac actgactaat ttttttattt tttggtagag 39000 atggggtctt gctatgttgt ccaggttggt ctcaaacact tagcctcaag agatcttctt 39060 gcctccacct cccaaagtgc tgggattaca gggatgagcc actgtcccta gctaaatgaa 39120 ttaaatgtac ataaaagctt tttgcaaaac ataatgtgat ttccaaacta cagatgttgt 39180 tactgctact aattatcata aaattgaaat gaaaaattaa tatactatgt gaaatgatga 39240 gacatatttt aggtatacaa cattaaaaca cacacacaca cacaaacaca taacaaaata 39300 acaaaaccta cctctccttt aagttaaatg acctaaagaa atggcttttg gaatggcact 39360 taaagggatt ttaaggagaa aagttgtgga taaggatggg gagtataaat aatcgttagg 39420 gcactggatt cacggcttta actcaaaatc tcccttatta gcaacaatta cagcagcacc 39480 gaatgtaatt ttttgtgtat cagacctctg tgtaagtgtt cattgaagaa atgtcacagc 39540 taaacagtta taaatttata cactcaatca gtggttccca aattttctat aaagaaatat 39600 gtctaacaac atgaatgatc ttgaaatgat tcagtcctgg aatcctgagt ccatcaatag 39660 atgatgttcc agttgactca taacatcgag gagaagagaa ccattagaag tatggatagg 39720 gtagtgggaa aagactaatc gggcattcac tttcatacac aaagaaatac caccttttaa 39780 cctacaagtc ttaaatattt caatagcagc acaagaaatt gtgacctttt tccttttggt 39840 gggggtggct ggagggtgct gcatttaagt caagtaggta acaagtacaa gaaaaagtta 39900 ttaatcaaag tcatttaaac aattacttat ttagcatcta cactaatcag gtactgtgca 39960 ggaaagttat catagtaggt ctgacactgc taagaaaggc ttggttataa ggttgatacc 40020 tggctggtat tttaaaatat ggattttagg agggttccca gcatttccag aactcatatg 40080 acaagagtgg ctcactgtgc ttaaactgtt tgcacaaaca atgtggttta tgctaaaaca 40140 ccttctctcc ttttgaaaag tctggaattt tgatacatcc tggcagaaag tgcctatgca 40200 accagctccc aataaaaacc tgggacatgg aactcaaaag agcttccaaa gcagagaaca 40260 tttcacatgt gctgccacaa ctttttgctg gaggaattgt gcacattctg tgtgattcca 40320 ctggaggaag actcttgaaa ctctgtgtca gggttcctgc agactttgcg ccctgtacct 40380 tttccctttg ccgaatgtgc tttgtagcct cttgctgaaa taaagcacag ctaagaatac 40440 aactatctga tgagtcctgt gagtcctcct aatgaatcac tgaacctgaa agtagtccta 40500 ggcacctata acacaggaat tatatcatgt tatttatttt tatgtttaat cttttcaaaa 40560 actttatatg aaatgtatta taatctattc ataaccttta tatgaactgt attataatct 40620 atttttatat aagaaaacta tagcttagca aagctaaata atcagcgtaa ggttatattg 40680 ctcatataag ctagaattca agattgattc caaaactcat cctctttctt ctatgctaca 40740 tttcctctgt gatcctctgg ttcaccagtt ttctaaattg ttgagttagt ctttttcccc 40800 ccattttaag gtaaatgttt atcttaagat agtatattca tctggggtct gatatagcaa 40860 atgtaatatg gttaaaagaa attattgttt cttgatgact tcagctcttg taagtggttt 40920 gagtgttagt aaatgaatat tcaatatctg ctctaggaat agacacagaa agtataaaga 40980 gattagtctg aacttccatc cacataagag taactccctg aagtttttca tttttctttt 41040 ttaaaaaaag ctatactaat atgatttcct ctaaatcaag ataattatca gttatttgag 41100 cataccagta gaacatgaat agattcttag agtagcagaa agcacttaga gaaataaata 41160 tcccatttgc atggaacatc aaagtgatgc ctaaggagtt gactgacgta tccaatgtga 41220 caaaaaaaag attaagccat actttttatt attatgtttt aaaaactaaa tgactaatgt 41280 tactactgag ctagaagaga gaacataaaa ggtctgttat agcatcacat aaaaatcagg 41340 acacctgata tttagcaact tcactgtaat gacagcaaaa aattctggaa ttatgaataa 41400 ttaacaattg cctacttaaa aattcaagtg atgttaacag caattgcttc taagtggaga 41460 aatggatggc tagaagatag aggtagaagg cagatttctt ttcaatgtgt gtaggtactt 41520 atgaaatttt gtattacata gcatatatta agtaaaagta acatactttt aaagaaaaac 41580 actttcaaat ttataaacca atgtaaaaac tttgttggaa ggaaataact ctcttaatgt 41640 tttctggttc agacagacac ttaaaaataa tgtatcctgt aacacataaa actcaacttt 41700 ctggcagtgg aaaattgaac ttctgtgctt cagatatagt gttaaaattg gaaaataggt 41760 aaatgtatgt actcacgctt cagtctgcct gtgttgctgt tcctgaagac aagctagatc 41820 catcatatgt ctaatttgtg ctttcaaatc tttgttctgg aggtgcaaat ggtgacaatg 41880 aagatctttc ttgagttcct agggcaaaca atacaaaatg tacttcagat cactctaaga 41940 atattgaaat taaatcagtt taataatttt atattgttgc caatagtttt aattcttttt 42000 agatattaaa taatatgttt agaaacaatt tgaaaaataa gagttctgga aaaggtggtc 42060 tataatttac aagcaagata agttttcatg tttcctcaga aactgaatgt taggaattca 42120 gaagaaattt tactatgatg acagcttctt ggtctatcca acttgttcac aatgttgtaa 42180 aaatacataa atatgaccag tttttgctta aatgtcactt cctcagaaag gctttccttg 42240 agcattgtat ttggatagac actctccacc cctcaatatt gtcatagcat ttactctatt 42300 gatgagtaac aatttcattg atgtattcat ttatttataa tttctctgtt cacaccagaa 42360 catatagttt accaccagga caggcaccga gtcaggttag ttcagtgtta aagccccagt 42420 gtacaaagtc ttgagttgtg tgcaataaaa atttctgttt ttgcatgaaa caaaagatca 42480 tatggttgat atcacctttg gttggatgac atggttagag cactggccta tgagtcatgt 42540 gattttagag atgggcttat aaggccttga aacaaatgct accttaagtt gaatatacag 42600 cctttatgga gatcagttta ctggactaaa atttaagagc tggatcagat gatctcttca 42660 gtcctttcca gttagaaaat taaatgatcc taatagtgtg aacatgtttg ccaaatatta 42720 cgtctgttct cctttaaaag aaaaatatcc tttatataca tcctctcata atctccttta 42780 tcttcttgaa tctttcttct tttaaagaga caagacttga gacccactct tgatattagc 42840 tccatcctag gcaaaagtgt gaaaatgttt ttttgcaggc tccattttcc taagcctcat 42900 ctgtctaggg ccaggtgtcc tgtaatctac cacctaaagt tacttgtctt tccttaaacc 42960 tactaaacct tatctacaga atatatcagc gaagggatta caccaaagta taaatggtga 43020 taatctagta acattctcag aaattttatt ggaaaaattt caaacaatac aatgaaaaaa 43080 atttaaattc tttggacatt ttgaatggct aagacaggaa ccccatatgc aggggagcta 43140 tgcctggaaa ctggaaactt cctcctaggg acaattctca taatccatct tagctttagc 43200 gagtggaaac aatgcaaagt attcttcaga ttcttttaaa gaatattaag attaaatcaa 43260 ttttaataaa ataattttaa taaatcaaat ttaataaaac tcctttccaa tctgcagttg 43320 accaataatt ttctaaaatg tcaaagttat ttttctcctt tttagaaagt acttccaatg 43380 ccagttattg agactatgac agagaacaat gtcactcatc ctatttatat attaaagtta 43440 ggagttattt atatatatta aagttaggat atattaaatt taggagttat ttatataatt 43500 cattatactt caagaaatat agtatattta tatattaaag ttaggagtta tttatataat 43560 tcattatact tcaagaaata tagcaaatgt tttagaaaaa aatttatctt tatggaggca 43620 ggacgatacg gctagagtca tgtgatttta gagacgggct tagccttgaa acaaatgtca 43680 ccttaagcca aatatatgcc ctttatggag atcagtttac ttgactaaaa tttaagagct 43740 ggatcagatg atctcttcag ttctttctat tactagttag aaaattggat gatcataata 43800 gtgtgaacat gtttgccaca tattgcatct tttttccttt aaaaaaatct ctccttatag 43860 cattaggaga aatacctaat gtaaatgatg aattgatggg tgcagcaaac caatatggta 43920 catgtatacc tatgtaacaa acctacatgt tgtgctcatg taccctaaaa cttaaagtat 43980 aaagaaaaaa caatccctcc tttatataca tcctctgata atcttattcc tttatcttct 44040 tgagtcattc ttttaaagag acaagacttg attgtataat tgtattagta ataatgggtc 44100 tttggctagc ctgttaactt tggaaaatca agtttacaat ttaagtcttt cttgacatac 44160 taatgactaa atctgattgg aagaacatgg cttattttga gaactataag taggccagta 44220 atggctaaag tatagagtat aatgaaaggt gatatacaag ccttgagaag tattcaggtg 44280 ccagaccatg ctaggcttgg taaatcacaa tggagaattt attctaggga gaaggcagtg 44340 aagaacaaca agatcagttt tgcgttttaa aaacttgctt tggttgcagt ggagagaatg 44400 aattgcagta gaacatgaac gaaagcagaa ggaccaaacg tagcagtcca ataatggggc 44460 ataggagtct gcattaggat agcagcagag gggcataaag agaagtggat agattcagaa 44520 tattgaagag taaataatgc aggagagtac agagaaaaca gcaccaattt gaaagtcaga 44580 agttctgggt atctgtccag agttgtgtga ccttggataa gtccctttat cgtaaagtta 44640 tgtctcaatt tgcttatgta aaaaataatg gcttataact agataatttt ctcagctatt 44700 ttttcagcta taaatatctg cacaaaaaag aattgagggt tagatttggg tgatggcaat 44760 gaaaatggtt ttaattttat ttgctcaagt tatttgtgat aaaatgcata aaaatcaaag 44820 atacaaaaat caattccagg ttcacattca ggtgtacaaa agttcttcgt aagagaaatc 44880 tagaagacag attgctagaa aaattagatt tgaccatatt gaaaaagttt taatttatta 44940 aaaatccaga caatattgat taacttcata aacactacta agtagacaaa aaagcaaaca 45000 caaaatagcg ataataatga tatcagaaac aataccatac catttttaaa attggaagct 45060 tacggtaatg tgggatagaa aaggcaaact agtaaatttc tacaatcgac ttttttgcct 45120 gcttaatact tcataagttc ttagtacttc tgtagttgga atgctgatta catggacaaa 45180 catataatac aagcataatg taaattaagt taggatcttg agaggtgaaa atactctagc 45240 aatatcattt aaaacttata tacacaaaca tatttaaaat ttttaatgaa tatacttaat 45300 gccactgaac tgtatatgta cacatggtta agatggtaaa ttttatttta tattttacta 45360 cacacaaaaa attgtttcaa gactcttctt gagaaaattt ttgccaacta taaggggtaa 45420 ataatctatg agaatatcac agccataagt aaacaaacaa attaaggaag cttcagtagt 45480 taattttaaa tgaggtcaaa gtttaatact aaccaaaaga cttagtttta tgtagtttag 45540 aaaatgataa tcttgagaat atgactgctt tagatataca gtctccaaat aaactattaa 45600 ataataagtg aaataaactg aaaagtactg tcaacattcc acacctgcta ccaatccaag 45660 agaatcaact cttgtgtatt aaatgagaaa cactcatttg gccagggtta tccagctgtt 45720 ttctttgaag tgattttatc aacaacataa ccatatttca gtattcctac aggcactgtg 45780 atagagcctg ttgcattcta tgatgagcct ctatggcttt atatggaatt tcagaagtta 45840 tatcctctga tcctagctaa cttatattat agtttattaa tgaatcttgt ctttttttgc 45900 ttactccttt tgagtcatta tatcatctta agatggacac aacgtttaaa aaaaacgtgc 45960 tatagtttcc ttctgaagta gatattctta atcttgtgtc aatggaaggg ctttaggaaa 46020 cccaatgact taggaaatat gcaaaattgt ataaatttga cctccccaat ctcccagctg 46080 gaagaaaatc tacacagctt tgaacagatt ctcaaaggca tctatgaccc ccaaaaaggt 46140 cagaatcatt gttctggaag agaaattata ttatattata ttatattata ttatattata 46200 ttatattata ttatatgatg cagttaactc tgttgttaac tatgtacact tttctttgta 46260 caacttgctt ggatattgat gtctatgcta ttgttgctta gaatagtatt aaactattat 46320 ttatcatcca ttattatttg ttaagtgttg ctaggttttg aatgtagcac tccacttaag 46380 ctcataatat cttaaataca tttacagatg acaaattaag acatcaatgt taaacacact 46440 gtccaaagtc atataattat tgttagagtt gttattcaaa acaactacta tatgccagaa 46500 ttaccaaaca ctccaactcc aaagtctatc cttttcccaa tgtttacatt atttttgtgg 46560 ggaatatttt aaagtgcctt acaaactaag ttatattatt gcaaaatatt actagaatgt 46620 gctgtattct atgtttaatg tcctaatcta cttaactaac tgactggtat gcttttatca 46680 agatattttg aggtgcagat taaattgttg gctcaataaa tatccacaat aaggaaatac 46740 tgtctttggt ttccttctta ggaaacagga tatctgctgc ttgctccttt cactactttg 46800 aactgtcatc attaactact actgctagtc ttttctctcc agtcatgtct gagcttccat 46860 attaacagaa taatcattta cagccattgc tagcccatca gagaatccat tccccagtca 46920 taatgcattg actagtatct ttgaattata aaaaaattag tacttttgaa catttaaaga 46980 tctctggcat ttgttggtaa atatttcata ttttccttca cctgtatttt ctgtctggtg 47040 cctttctagg aattcaaaga ttttagaagt ttccatatca attagctgat acagagttat 47100 agaatttcag aagagcatca ccaaagtaga gactgtagat attttttctt ttagaaaaag 47160 actgaaaaga agttgttctt ttaaactatt aagtatttgg gtgaaaatta gttatttcat 47220 agcagttgct cctagttgct tagcccacat ttactttctt cttctttctt attaagagat 47280 ctccaatccc attactgggt atatactcaa aggattataa attattctac tataaagaca 47340 catgcacaca tatgtttatt gcagtgctat ttacaatagc aaagacttga aaccaaccca 47400 aatgcccatc aatgataggc tggataaaga aaaggtatat tgcacatata taccatgcaa 47460 tactatgcag ccataaaaaa gaatgagttc acgtcctttg cagggacatg gatgaagctg 47520 gaagccatca ttctcagcaa actaacacag gaacagaaaa ctaaacactg cacgttctca 47580 ctcacaagtg ggagttgaac aatgagaaca catggacaca gggaggggaa catcacatgc 47640 cagaggctgt caggggtagg gggcaagggg agggagagca ttaggacaaa tacctaatgc 47700 atgccgggct taaaacatag atgacgagtt gataggtgca gcaaaccacc acagcacatc 47760 tatacctatg taacaaacct gcacattctg catatgtatc ccagaactta aagttaaaaa 47820 aaaaaaaaag ggagctccaa tactgttcag agtaattatg caaaaaaaaa aaaagacaat 47880 cttttcagag tgtcttctat ctacagatag ccatgtgaca tatttctagc caatacatta 47940 gtctgttagg aatttttgga aacatctttg ctctcctgat atagacatcc ctcctccttt 48000 ctttcctctt cttctggctt aggtgtgtaa acttgagact agatatgaaa cagtaatatt 48060 acaatcatga aacgacaagc acgataatga cattttaaag gtactgcatt agaaatgaac 48120 tgcatacttc caagacttat tgttaagaga acaaaagaca gcccacacta gttaaggcac 48180 taaagttaga ctactgcaac cttgtagcag aacataattc taatatgata ctgtcattac 48240 ccatcactac acttcaaaaa taaaaccttt tgccattcta aggtggaata tcttcagtta 48300 cacacacaca ccccctttca aatcaacttt ctttaaccat aacacattta atgttgacct 48360 catttaaact atttttgcat aaaatatcaa gatttcaaac aaattaccta cataatgaat 48420 cctcaagtgc aggttgaaat agaattgttt attttaacct aaaagctacc ttataaaagg 48480 atgcaatcac ttagaaataa catttaaaag taaattaaat ctcagagtta tgaggcaata 48540 atagttgtct tatgaaagac atttactcaa taagaaaaag aacacatttt aggagctcag 48600 ttcctacaaa ttaaatctga acatacagag atatttgtac ctttggaata tgaccgtttt 48660 gacttaagag tcccatttct ttttcgacac gatggagcca attagtattc tcatcaaatt 48720 gcttcaattc ctcctccctc cttttctcca ggtaggagcg acgagttttc aacattgcaa 48780 gtctatgatc tcgttttcca gtggcctgaa acacgattca tttaacagta aatctaattt 48840 ttatgatatt tgatgtacat gatattagta aactagtata ttttcttatg tgtactattg 48900 tagtaaatta agttaggcta catttttgta tttaaagcta tttccccctt gaaatctcag 48960 aatactactg cttgcaagaa aataggaaat tgagctgtga gtcattttta taaaattaca 49020 ggttgagagt ttatggcttt aagaaataca acgaccaaat caaagactat aacttttttt 49080 ttttttggcg ttaaagtaca gtcccttcag tatgtttcat ttgaaaagtt catacaaggt 49140 cagatacatt ccatgatctc cttactcaaa atcaaagcag atgcatatat tgctcttgtc 49200 tttgatgtga agaaataatg tgttctattg ttctgtgttt gcctataagg cctcaaattg 49260 gctgatataa atcacagaaa aaagagctta tatcagagtg cttatcagta tctgatcttg 49320 cctgtagctt ggttcaggag ccataatgag tattcaaaat atttttggtg ttttacctag 49380 gcacaaattg aaattaaaat tagtctttga tttcttaccc taagggtctt gcacactatc 49440 atgaaaacaa tgggccagaa catcttgacg tctctggggt atttgcccac agacactaaa 49500 gtcaataatt atcagatagg atgggtagac ctgaaacagt ggatccccaa aggttaaaat 49560 aagcatttgc agctggttct ggaagcagga aatcaaaaaa aagaagagca gaaactagat 49620 ttgaatttgg tcgaagaact ccccctcttt gggagataaa tatctcttaa ttttgacaaa 49680 agatgtacta ttgagacttg ggcatataat agaaaaatat ggttatcttc atctggatag 49740 aggatatgag cttataaatg atttaaggtc aggcaaaggt ggctatcatg aagtcataac 49800 caaatcttag atattcataa aattttactt accttcccct caagggaaat acaagagtca 49860 gagagaagca gattccattt caggctagag tcatagataa gggaaaaata gttgatagcc 49920 accgtcattc tcactaaggt tcctgactct tttttatggc ttctctggtt aattataata 49980 tcctagtctc tgtctgtcac agtaagacag taacaaaaac aaaacaaatg tctcaaagaa 50040 acaaaaacct ggatagtcaa gaagagaaaa caaaacaaaa tgtaacccat caaactgacc 50100 acagcgctag gatgagaatt gtgacagaat gctacaatgc aggctgggat ggtggctcat 50160 gccagtaatt ctagcacttt gggaggctga ggcaggagga ctgcttgagg ccagaagtgc 50220 aagaccatcc tggacaacat agagagaccg tgtctccaca caaaaattaa aaaataaatt 50280 taggctggtt tcgtggcatg tgcctgtagt tccagctact tggtggggtg gaggggctga 50340 tgtgggagca tcacttgagt ccgggaggtt gaggctgcag tgcagtgagc catgactgca 50400 tgattgtgcc actgcactct agcctaggca acaaagtgag accctgacag caaaaactaa 50460 aaaaagaatg ctatcatgca aaggttaccc aagcatggta cagggacccc taaggattcc 50520 tgagatcctt tcagagagtt cacaaggtta aaactatcaa aaccattttt ataatatcag 50580 gaaaatgtta ttagtctttt aaaattcttg tttgctcata cagttagttg cacagtagtt 50640 ttctagaggc taaatgatgt gtaacatcac aacagaataa caattcagca gttatgagaa 50700 tagagctgat atgaaaagcc aggcattaaa gaaatttgca aacatgtaaa acaacgccac 50760 tcttctattt tcactatttt tgagaaaata aaattattta tgtaaccaca cataattttt 50820 attttaatta ttatttaaca tttaattatt tataatttat tgctatttat tatattttat 50880 taatataatt tttattattt acaattaagc tattatttaa tattatttat tttaaaatga 50940 atcaatgcat aaatatattt ttataaatct gttttaattt ctaatataga aatattggta 51000 gagggaatac atataaacaa aagctctttg aagtcctaaa taatttttaa aagcagaaag 51060 gggtcctgaa acttgaagtt tagagccact gctataacag aaggtgggag gtgtgaccta 51120 ttgacttttc tctgctattc agcagatgta aaaatttagg caaacagatt ttagtgggtc 51180 ttcagttact tcgtctgaaa aatgaagatg aaaatattgt acctaactga aggcaggcag 51240 ctaattaaat catctttatt ttgctttagc atttacagtc gtagggactc ttagaaacca 51300 gggcatgtgg gtctggtggc agcaatattt aatatcagaa aatcctaaat gaaacctcaa 51360 aaagtccatt tatgactttt tacttctaat gtccatcaaa tgtatcctct gtgatggttc 51420 tcagaggaca ttttccatca gaatactacc accacccatt gctctaaaat ggcaagtaag 51480 tgtttgggaa tacattctaa aatatgcatg ttaaaccctg acattagagt gaaatgtttc 51540 ccattaagtt ttaaaaaagc tttacatatt tcattaacaa aatcccctgc acaccacaaa 51600 agtcttgcga gagaacaaac ataattctac aattttagtt gttactactg ctttgtgtaa 51660 aataattgct aatatggtaa attcatattt ttacattaaa aacaatctta cagattattt 51720 ttatggggtc atgaaattac ccaggagctt ccctttaata gtaatttcaa aatccatact 51780 ccagaactat ttatagctga atcgatgtta tgagattctt tcagcacttc tgataacaaa 51840 cctctattgg agagaatcca aaacataaaa ttccttgcct tagaaaagca gtttactcat 51900 actacagttt gacacttctg tgtaaaaaca aaacgaatca acctctagat gtcttcctat 51960 gtttttcagt gggttaacta cacccaataa ctcaagagtt tttatctcca ctgcttacct 52020 agtctcataa gaatagctat gataattggg aacctgagga ttgaaatgac caaaagtaag 52080 agatcagaaa aggcaattgg gttgaaaaaa gtctaagcta ctgtgcagaa aaataaggat 52140 gaaaacagaa aaaaaaaaaa caaaaccata aaaccagtca aacccattct attactctat 52200 gtcttaatct ttctagataa ccacattcaa aattcaatgg aggaattaag acagtaaaat 52260 aacaattatc taaattactt tgggattaca tagtccaagc tcattaatta tactaaataa 52320 taatattcaa gtgtttaaaa aatggaactc aaagttttga taatgctact cccttgcttg 52380 aaagactgca ttttggctac aaaaatagat tttagactcc tagcaaccaa caatttcaca 52440 atctatacca atatcctacc ttcccaatct attgttaata attcctaaca tggcaaatat 52500 gtttaacatc atgtgccaac tccagtccat tcattgtggt tctggctact ttcaaattct 52560 gagagaaggt atggccacag atcagtgaaa tttgctgtgg gtaagggagt gggaattggc 52620 acgaagtttt gagtatagtt atgcatttct acacgtattg tccaacaaat gtgacctgct 52680 ctggtcaaac tcagcagagc aagtcacatt tgttggacaa tatgtataga aatgcaaggc 52740 ccagtacaaa tctcatcttt ccaccaggaa gccttcttac taaaaatagg aagtcactgc 52800 ttacttttct gaatagctat agcattcacg gtacttagaa tatagcagag tgattaagag 52860 tgcaggctct gaagccagac agctggggtt taatattggt tcagccacat taattaggta 52920 agtaactcca gacaacctac ttgagttctc agtgcctctg ttcctcacaa atggtgataa 52980 tattagatct atctcatagg cttgttataa atactaaatt aattaatcca tgcaaaaaac 53040 tttgaaaaat gtctggcaaa tagcgttcaa tatcagctgt ttttattatt actatttata 53100 tgacaagcat atagtgcctt atcattttta ttatttttat tgctccaact agtatgtaaa 53160 taattgaagg acaaacactt ctctttcttt acctccattg tgtcaagcac aagggtttta 53220 catgtaaaca agtgttcaat aagagtttcg ttaaagttga gatgttaagt caatatcagc 53280 ttcctatggc tgcatttctt gccttttgtc aaaaagtaaa tcttagataa ctgcacattc 53340 aaataattga cacttatata atctacacaa aactgagaag aattattacc cactgaagat 53400 tactatgtaa tataagtgct aataattgaa ataaaccagg catggtggtg gacacctgta 53460 gtctcagcta cttgggagtc tgagctactt gggaggtttg tgtgagttgt ggagtgagac 53520 cttatctcca aaaataaaat aaaataaaca taaaaaataa agaaaagaag aaaaacatct 53580 taaaaatttg aaataaaata tataattctt atataatatg gtactattcc agaattctgt 53640 tcagcaacca tatgaaagaa gttcacaaca acaaattgat aaattaatcc aatgagatag 53700 ttatttggaa gtcattacat ttatcaaaga atattggcaa caatttgaag ttcatgaaag 53760 tgaaagtaca aatatagcag caagatataa attcgaagaa ataaattgtt tcctttctgc 53820 cttaaaagaa tgcaaggaac atcttaaatg catctcaaaa cacaaaattg aaaagaaaat 53880 ttcattaagg cataaaaagc acacactcaa taaatatatt actaattttg ataatatagt 53940 ttaatagcta ctgacaaact ggtatcaatg atacattact gaatgcttta tgattaattt 54000 ccggtacagc gtatctttcc catttcatag gctaacaaaa atctaaaatg ttagctttga 54060 aaagcactct ttaaaatctg acagcttctg gacattaaga aatgcaaaat ttttctatat 54120 aattattact tctgtgaaag taggaaaaga agaaaacatg tttggggtgg tagtttgaga 54180 ggaatgggtt gttacttata agataaagct ttttaataag tagtatttga acatcatatg 54240 tctatgtaat taaattacat aaaatacata aaaatacaaa taaactcatc accaatgaat 54300 atcgaaactg gggagaattg tcagtatttt caaaatattt atttttctga tctttggtgc 54360 tccgtagttt cacacgttta ggtatatatt tatcttatac tgcttagaac tcatgcttct 54420 tgaatttaca tcttattagt cctagataat tctcaaccac aaatttttgc atattgctct 54480 ttttcactaa atatctcctt ctgaaatgcc tattagatgc atgtatgact tttcttcttg 54540 ttacatgaag tctatccttt atacaacatc ttgtccacat gtgttatctt tatcctgcat 54600 ttggtgtaat tttctcaaat ctgtctccca gctcatgtaa aaaagcataa acataagagc 54660 acaggctcta gatctggcat gctgcagatc aaatcagaac tcagcaccta ggagctgtgt 54720 caccttggac aaaatgactt gtattttggt ttcctcattg attattagga taatattact 54780 aaatatttca tggggttttc tgagaattaa aaagagtcaa tatatgtaaa gtgctttaac 54840 attttctgat attgtatcaa taaggtgagt ttttaatttt aatgaataaa tttttaattt 54900 ctggaagttt catgtgtttt ttacctcata tttgaaagtt ctttttttgt ggtgtcttta 54960 tctttgattc ctttatcttt gttcattctt atattttcta ttagattgct ctagtatcta 55020 aagatttggg agttctgtca tatttgctaa gagtactgaa tcttgtctag agtgaattat 55080 ttctccatct gttttgtaat tttgaaagtt gaatttatta gtggctagag ttgagaatct 55140 gtttctctta agaggctgat ttttgcattg cttctgccag gttttctagt ggtatcattg 55200 gtttgataat gtgcattgta attgaccaac tttaggggtt ttctatacaa aatacatggg 55260 ttgtaacaat ttaaacctca atcattgtga aaagcaagcc tataatggta gtgttcaaat 55320 gacttttttt tcttacccca ggcatggtta cttggggtaa gaaaagcaac catccttgcc 55380 aacagtgatg gttggcaaga attttttttt tcctggtata cccctagtat aaaggatata 55440 ggccactgaa atttcaggct ttagatagga gctctcattt ctaactcacc gtctcctttg 55500 ggtctcttat ctaagtagtg atgtaatcaa agttagaaga gtgggagtgg tctgtgtttg 55560 gaagggagag ggcagtatat tattgtatta aaaaaaatag taaaactgat taaatgtttg 55620 gtctgctttt cattaggccc ctgccctggc acatctaaca atttcagtga taaaattctt 55680 ctctgacaac aaaaatctcc tgttggtcta agttgtaagc tactgcctgc atccaggata 55740 gactgcttct attgctctac ctttagtaac tggctaacct gagtgggtaa acttcgtgtt 55800 aaaagttcca taaaatgccc agaaaaacaa cagttgtaac tgagattctg ttgtttttgt 55860 ttatttcctt tttgttactg acatccagga attaaaattt ctttcttgtg cacttaacta 55920 tgtattttaa aaaatgtttg ctacattttc tccaacattt ccagatgtct gtaaagaatg 55980 ggtgagtaag tagccttgac tataaaattt ccagagttag aaccaccgcc accaggccgg 56040 gcacagtggc tcagcctgta atcccagcac tttgggaggc tgaggcggat ggatcacctg 56100 aagtcaggag ttcaagacta gcatggccaa cattgtgaaa catcatctct actaaaaata 56160 caaaaattag ctgggcgtag tggtgcacgc ttgtaatacc agctagctgg gaggctgagg 56220 caggagaatt gcttgaatcc ggaaggcaga ggttgcagtg agctgaggtt gtgccactgc 56280 actccagctt gggcaacaga agaagagact ccttctgaaa aaaaaaaaaa aaaaaaagcc 56340 cccatgtttt tatactttct aaaatttaat tataaaattg ttaattacct tttctacttt 56400 gtcttcagaa cacatcattt ctatttgttt atggcactgt tgttggtaga atgatttaag 56460 ttcattttct ttaagtaaca tttccaactt cagatattct tgtctaattt cttctcgatt 56520 ctggaacaag cagttcagga tttcttgaaa cctaccaaaa ttaaaacaca ttacagaatc 56580 tcactaattt tgtagcaaat catacaaagt ttacttaaga gaaatgcata aacaaaggaa 56640 tatatgtaat tcacagaact acactcaatg ataaacagca aataggtaaa aatgactatt 56700 tcctattata aaaaatgttt agaaaaagtt attaacttta cttatactac attaggtttc 56760 tttctcaccc aaggaagatc atgttgctga aagatatggg catcataagg tgtctggtat 56820 tgctaacata ctgcattttg tctatgctta catctatatg taatcctatt gcttagcaaa 56880 aataaaataa tttttgtttg ttggaaaagg atgataacct gggcatgcac tatccaaatt 56940 cacaaggccc tattagcaac acagcattat gtgttgttac ggtgttggct caccgtgaag 57000 gaataagcag taggaggcat aatcatatgg tgcctccatg gccccctagg gaaagtgaca 57060 gagccagttt ttagcttcag aatttgttat agtgaaaaca gaccatacgg ttaggtaccc 57120 cctacagcct ggctaagaat caactgacac ttccaggact taaaacatcc aagtttataa 57180 tgtggtaaac ctagaaaagc tgctgcagtg tgcttcctcc taagggcaat gtaggtctag 57240 aatatcaaag atgaggagtt tgattcatat ttccaaatgg ccacagactt caagctgatt 57300 aaattttatg aaaactctgg atggaacctg caatcctgta tccttctggg tcagtagaac 57360 actggtcaca gtaatatttt aattttttaa aatatattca tggttttaag tcatagatca 57420 gctctgagct acagtaacag tataaacatt cataacagtg aagactttaa aataaagtaa 57480 aatcaagtac atgcatttaa aaaaaatgtt ctaaactggc cagaatttta gatatactca 57540 taaggatcag cggtaaaaac actgccaatt tacgtcagta gctcttaatg aaactctatt 57600 gggaatgaat ataagccaca aaacactgac tttactgcag ttttgtcaaa ctgataaata 57660 tttcatagga aatatgtaca gacactgtga tttcattgca ttatattaca ccaacggtaa 57720 tgccagtaaa tgaattgata agttatcttt aggttatact taaagagata atttcttagt 57780 ttttctataa ctttttattc aaggacaaag ttaatatttg tcaattttgt gatctagact 57840 tattttaggt ggtggtgttc actgattagg atgaaaggaa gggaattggt atcaaaggtt 57900 tctagagagc tccttaacaa caccaaaaaa agctatcgtt ttaaaactga aagagttcta 57960 agcaaacatt caagttaaaa gtatctgcac caatattttt aggtaataca tgagtattaa 58020 actccacaat tttcttggta tagtcataag tgaagtttta taattactct ttataaaaga 58080 acaattgtgt tttcttttta tgatttcctt ttgagaatta cctttccaaa tagctctgat 58140 agacagaaaa tactgcagat tcttcctttt atctgtttaa acttcataaa aatgttattt 58200 aagttttata acaaaagaca ctttgaaaat tcatggcatt aaaaaagtcc catgtaacag 58260 tatgatggat aaaataaaag atatttcata catttatttc aaaaggcagt aatttttagg 58320 ggaaataaca aaagttattt ggtacataat ttttatcatt aacttcttca taaatacaag 58380 taagttactt aacatattgc cagaattaaa atcaaagctt ttattgttgg tcaaaagtca 58440 ggttgaaata tgaaaaacat ccaaataaat acttatttca tagctcaggc ccttccctcc 58500 tgagaggagg gccttaccag aaagaaaggt tcaattattt aaagccatca actccagaaa 58560 agtttactaa tctgtaaggt tttaattggt atagtagact tggttaagca gtgctgagca 58620 attttatgga atcagttact ctaaatttga gaagctggag aattctaata gatatccaat 58680 tacatgagga ccgctcccac atttaactaa caaaatgaaa taacaacaac taataatact 58740 atatcagagt taaaagtttt ctttgatgag atgaaaaacc agaaatcatt tttacttatt 58800 tcttaagaaa tactgtaaaa tattttatgt aaaacttcaa cacacaaatg caattttaaa 58860 aaattatagc tgaatcaggt ctgaaagcca cttttgacta taatcttgtt ttccttatag 58920 atactgagac actttctact aattctagag ctccaaaaca gtatgaataa ccattggttt 58980 aagttgtagt tggtttctca tactaataac agataactgg ctctgcagaa tgtcaaataa 59040 gtttaccttt actcaatttt aatgaaagtt gaacagattc ctttactaca ggttttccct 59100 ttaataagct gatgtacttt ggaagtttcc tagattcctt atggagtaat ttccaaactt 59160 gtttatacag gaattcctta ttgtcctcct agaagtactc aagattaaca tcttgatcca 59220 gtgtctcaat gggtcaattt ggaaaactgt cttagctgct tgaggaaaaa gtacttttgc 59280 atactgtatt actaactgct ttctttttaa aaatttacct gctaagaagc ttagtagaaa 59340 cctctcaaaa ttctgtattg gtttatatca ctgacagatg ttcattcaaa taattaccca 59400 ttcaggctca ataagtagat tagttaagct atagagagtt aataaaatga agaatagagt 59460 agatttacat gaaatataca aataatgatt atgtcagaaa agaacaatat gagcgccact 59520 aaaattaaac taagtctaca gggtgacata actggctttg tctccactat cttataccta 59580 agttctggtt ctcttcaata tatgtaaaat aaaaactaaa attacttgat ctacaaagtg 59640 tgaaatataa agagaaatca ctgacttctt gaattcagtt gagaatatat atacaggcat 59700 accttgtttt attgtgcttt gcagacactg tttttttttt ttttttttaa acaaactgaa 59760 ggtttgtggc aatcttgctg tgagcaagtc tataagcatc atttttccta cagcatgagc 59820 attcagtgtc acattttggc aattcttgaa atattgtaaa ctttttcatt attacatatc 59880 tgtcatggtg atttgtgacc aatgatcttt gatgttacca ttgtaattgc tttagagtgt 59940 cacaaattgt gcccatataa gacagtaaac ttaatcaagt gttgtgtgtg ctctgacggc 60000 tccactgact ggctgtttcc ctacctctcc tcagccctcc ctattccttg aaacacgttg 60060 aaatcgggca aattaataac cctaaaatgg cctccaagtg ttcaagtgaa agagttagtt 60120 gcatgtctat cattttaaat caaaagctgg aaattactaa gcttctaagg aaggcttgta 60180 gaaagccaag ataggcgaaa agctaggtct cttgcacaaa acatttagcc aagttgtgaa 60240 tgcaaaggaa aaattcttga aggaaattaa aagtgctact ccagtgaaca cacacactaa 60300 gaaagtgaaa cagccttatt gctgatatgg aaaaagtttc aatggtctgg atagattaaa 60360 ctagctatca catttcttta agtcaaagcc ttatccagag caagccttct aaatctgttc 60420 aattctacaa aggctgagag aggtgaggaa gttgcagagg aaaattctga aactagcagg 60480 tgttggttca taaagtttaa aagtgtaaga aaaaaagcct tctctagaac ataaaagtct 60540 aggtgaagca gcaagtgctg atgtagaagc tgcagcaagt tatcgagaaa atttaggtaa 60600 gatcactgat gaaggtggct acactaaaca acagattttc aagatagaca aatcagcttt 60660 taattggaac aatatgccat ctaggacctt catatctaga gagaagtaaa tacctacttt 60720 caaagcttta aagaacaggc tgactctctt gtcaggggct tttgcagctg gtgactttaa 60780 gttgaagtcg atgttcattt accatttaca aacatcctag ggcccttatg aaatatgcta 60840 aatttaactc tgcttgtgct ctacaaatag aacaacaaag tctagaggac agcacatccg 60900 tttacttaat aattttaagc ccactgttaa gacctattgc tcagaaaaaa agattccttt 60960 caaaatacta atgctcactg acaatacacc tggtcactca ggagttctca tggagatgga 61020 cgagaagatt aatgttgttt tcatgtctgc taactcaaca cccagtctgc agctcatgga 61080 tcatgcaatt ttgacttttg tgtcttctta tttaggaaat acattttgta gggctatagc 61140 tgctatagat actttctttc atggatcatg cttctctgac ggatctaggc aaaataaatt 61200 gaaaagcatc tgaaaagaat ttgccattgt agatgccatt aagaacattt gtgatatgtg 61260 taaggaggtc aaaatatcaa cattaatagg aatttggagg aagtagattc caatcctcat 61320 ggataactat gaggggttca agatttcagt gaagaaacta actgcagatg tggtggacat 61380 gaaagagaac tagaattaga agtggagcct gaagacagga ctgaattgct gcaatctcat 61440 gattaaactt gaagaaatga agagctgctt ctatggataa ccaaagaaaa tggtttcttg 61500 agaaagttta ccacctactc cctataaaga tgctatctac gttgaaataa caaaggattt 61560 agaatatgac ataaatatag ctgatagagc agtggcaagg tttgaaaaga ttgtctcaaa 61620 tttttaaaga agttctaccg tgggtaaaat gctatcaaag agcatcacac actacagata 61680 aatctttcat gaaaggacga gtcaatctat gcagtaaact tcattgttgc cttattttca 61740 gaaattgtca cagccactcc aacttgcagc aaccattact cttactagtc agatgccata 61800 aacattgagg gaagacctcc accagcaaaa agattatgac ttgctgaagg ttcagattat 61860 cattagcatg ttttagcaat aaagtatgtc taaaattaaa gcaaggcatt atcttttcag 61920 atataatgct attgcacact taatagacta tagtgtagtg taaacataat ttttatatgc 61980 accggaaaac caaaacattt gtgtgactca ttttattatg atatttcatt tattgcagtg 62040 gtctggagaa ctaaatctgc aatatctctg agtcaagcct gttatgtatg tatgtatgta 62100 tgtgtgtata tataaaatta taaacataca tatctatgta catataaaag acataacaaa 62160 tgataattaa cataaaatac ttaacaaaat tttaaaacaa taaattcctc aaaattagat 62220 cttaatgtaa tgtttacctt tcgatttctt tttcctgagg gtttgaaatc attaactttg 62280 cttggtcatt ttcattagtg aaggctttct gttcttcata ggcttttagt ttttctttta 62340 acaataaaat ctagtagaga gaaatcacta gttaaaatac aaaagaagtc atttacatgg 62400 ccacagccaa atttagctgt aaaaaataac tgaattaacc agattttaat tttaatagaa 62460 aaatatgtta aatttttgga caattaagat tataaaattc tataaatgaa gaactgcgca 62520 agactagcat aaaaatataa acagacatac ctctgccttc tgctcattac agatctttac 62580 atattgagtt atatgattat tgacattaag aacattgctc ttcaactgtt gaaagataga 62640 aattatgatt gtttatagag agataataat cacagagata aatacatgaa taacatgaca 62700 ttgcattttc attgagttcc atgaattcag aatttgtgat aattatgctc acatttaaaa 62760 tctatgacaa gaggatctgc tgagcacatt aataatgtaa atgaaattat aaagaaatta 62820 ctttattgag aaaaggtatt tataagcatg taattgcaat ataataaaat tccctacttt 62880 cttactcctt tgacttctaa gtaatgcaga gatagttttt catgctaccc tttcaggaat 62940 tcagttggtt ttcactgagt tcttactata ttttaacatt tttatcatag tatgggcccc 63000 ttgacattta tggtatagta gagaggatat taaacatata aatccaaata cttgatattg 63060 agaccttgcc tacttctcac ttaacctgac ttagaattcg aactgtttga tgtttgggtt 63120 actcatctgt aaagtggagc taagaattca ttcctcaagg ggctagtgta agggctacat 63180 gaaaatcatg tgttacaaac ctttctgtac acccatatag tatgaccttt tacaattaat 63240 tatataatga gcctgggaac atttttctta agatgacaat aacatgctca tcttcagaca 63300 cttaaggaga gtggcagagg ggaaagggag aagaggagga gtcatcacaa cagcttaact 63360 ctaggttttt tcaaccccga tatattataa tttaaacata catattttga tatacatgtt 63420 tttaagtaca acacatcttt ggcaaaaata ctaatgtaac caattattat tattatattt 63480 ctggagaaat acagagattg gtacatcaac atcatgaatg tggactataa attatgtaga 63540 aaagactttt taaaaaataa gctttatacc tattttacag atgaaataat aggcttggaa 63600 agcttaacta acatatccaa gattttcagg tgaaagtttt ggttctcagc taaagcagag 63660 catcatcctg ggctgcaaca aatgtgttca agttttgagt gattactcca agatgccatc 63720 caaatacaat acgccatgac atcaaagagg ttagggagaa agccactcaa gtaccatagt 63780 acccaaaaga tcgaataata gtatctatta tatatatata tatataatca agatgcttta 63840 tggtttaacc gtctaaatta atgttcgact aagcaggtta gcaaagaccc ttctaaccct 63900 cagctgccta actcattatg tagaaacata acctgaatta atactttcat tacaattata 63960 aaaatcatat gcagacaata ccttcacaac aaaggcagag taaacagact tacagaagat 64020 ttaatgtcct ttgcccggtt agcatactta agagtgttat atgtgtcatc gtagaataca 64080 gaggaaggac taacagcagc tatcattata gtttgacagt ttcctccaag agaatccttt 64140 aacaagcgag taagcttact atttctgtaa gggatatgct gattctttct ctgaaagcac 64200 aaaaaagaga tcttatgtca ttttccacat ttaaatgcaa acctgctacc actttagcac 64260 ttcactgtgg ggggaggatt acctaggtgc cgaggcaaga gactgaaggt ataaactgtt 64320 tcagtataat gaaaaaaata gctagaataa gaatagtcat aatacaactt agatatagag 64380 atgatcatgg acaattatca atcactatta taaacattat taatcattag cttttaatat 64440 tactctttgt tgcattacga atataaccta ggaataaccg gcgggtatgg ggtcagctgc 64500 tgaagggaca ttgtgagaag tgatctagaa ggcaagaggt gagccttctg ttatgccggc 64560 acaaacgccg cttgagggct ccttggtcaa gtggtaatgc cagtgtctgg gaagacaccc 64620 attacttaga agaccgcgaa agggagtctc ctttccttgg aggagtcagg gaacactctg 64680 ctccaccagc ttcctgtgga aggctggata ttatccaggc ctgcccgcag tcatccggag 64740 gcctaaaccc ctccctgtgg tgctgtgctt caatggtcat gctccttgtc cactttcatg 64800 ttcctcctgt actcctggtt cctctttgaa gttcacagta gacagcaaca gaagaaatag 64860 tgaaagtctt aaagtctttg atctttctta taagtgcaca gaagaaaaca cggatgtatg 64920 cgccatctct ctctctgtta tcggctacct aagagggaag ggtcccctgt cctatgatca 64980 cgtgacttgc ctcaccttgt caatcactta gaagattcac cctccttacc ctgccccctt 65040 gtcttgtatg caataaatat cagcgcgccc agctgttcgg ggccactacc ggtctccgtg 65100 tcttgatggt agtggtcccc tggggcccag ctgttttctc tttatctctt tgtcttgtgt 65160 ctttatttat tacaatctct cgtctccgca cacggggagg acacctgcca agtcccgtag 65220 ggcttgaccc tacacttcac tataagaact taagcgctac ccaattttat ccagacttat 65280 aattggtgat tgaggtgatg acaaagaatc ttacaggatt attcagtgaa tatatgaaac 65340 aaatatcata tttaaaaata tctgcatctg agtaagtatg aactttagtt caaaataaaa 65400 taatacatta atattggttc attagttgtg atatatgtac catattaata taaaaaatta 65460 acaataggga aaaccaggtg tggagcatat ttaacaaaat ctgtatcatc ttagtaactt 65520 ttctgtaaat ctaaaactat ttgaaaatgt ctatttaaaa atatttccaa tcattgaaaa 65580 aaattaaaac acaaaagtaa acagatgtcc tatacaaata tactagagga ataataactg 65640 catggcttag agctactttt ctccttaaat aaccatctaa tatcgatatg aaataaatta 65700 taattacaat gttacagaca tttctcctga aatcactata gtgttctaaa agaacctaat 65760 acttcaagat tttcttttac ctaaaaagaa aaaagtaaaa gtaacaaata aattttgtta 65820 agttttgttt ctgattttga agtaacaaat aaattttcca gaaagtagaa tgtttatata 65880 agaacagatt ctttacaatg ttaagctaaa agcaacctaa tgttatccaa tgtatacctt 65940 tcatattgca aaacaggaaa ttgaagctaa gcataaagtg aaatgatttg actagggtca 66000 caaagctagt agttcaaaga gccagaaata ggtcctagtt cccccaattc tcagtagcaa 66060 tgtgcttcca ccatagcagt ctttcccaaa cagtgtgaaa tatgcactgc tggtgctatt 66120 ttaagtgatt ttacatgtac aagacatata ttaaacattg actcacaaat gactcaatag 66180 gagtcattat taaaaaatta tagattagtt catatggcaa aaatcttatg aatggcttaa 66240 gtttacaaaa tccgtctctg tgtcatgctg tctgcttaca agtttgagat tttaactcag 66300 aatataaaag acatcttgct tttgcaatct tcatgtgatt tcagtaattt gccttttttt 66360 aaaaaaaaaa cctgctccaa ttattttaat atacttattc taaatcaaag gtaacatttt 66420 gaacagttta acaagccaaa gcttttttaa aaaaattaaa tttaattttt taattatatt 66480 ttaagttctg ggatacatgt gcagaacgtg caggtttctt acataggtat acatgtgcca 66540 tggtggtttg ctgcacccat caacctgtaa tctacattag gtatttctcc taatgctatc 66600 cctcccctag cccccacacc ccctgacagg ccctgcctgg cgtgtaatgt tcccctccct 66660 gtgtccatgt gttctcattg ttcaactccc acttatgagt gagaacctgc tatgcagtgt 66720 ttggttttct gttcctgtgt tagtttgctg aaaatgatgg tttctagctt aatccatgtg 66780 cctgtaaagg acatgaactc atcctttttc atggctgcat agtattgcat ggtgtatatg 66840 tgccacattt tctttatcta gtctatcatt gatgggcatt tgggttggtt tcaagtcttt 66900 gctactgtga atagtgctgc aataaacata ggtgtgcatg tgtctttcta gtaatgattt 66960 ataattcttt gggcgtatat acccagtaat gggatggctg ggtcaaatgg tatttctggt 67020 tctagatcct tgaggaatcg ccacactgtc ttccacaatg gttcaactaa tttacactcc 67080 caccaacagt gtaaaagtgt tcctatttct ccacatcctc tccagcatct gttgtttcct 67140 gactttttaa tgatcgccat tctaactggc atgagatggt atctcattgt ggttttgatt 67200 tgcatttttc taatgactaa tgatgagctt ttcgaacagt ttaacaagct aaagctttcg 67260 agtatggttt aacttaaatt gccatattat aatttttttg aaaggatgtc atttttacaa 67320 atatctatgt tgtgaaatac actgtgttct aggtaagcac ttctggcata tggtatatgt 67380 aaactatatt taaatatgcc cagaagcatc tagtaaacat taccttatta ggtgatttca 67440 tgacatttta taacttaaac cccccttaaa aaaaaatcaa cactctttaa tacttaaccc 67500 tattttataa tatataaaat actaaacaac agaatttagt ttttaaaaat atggttagtt 67560 tgtcttcatg ccaatttaat taacatgttt gctgtgtagt gatcacttta aaaaccaagt 67620 tcaaaataag tgatgagaat gtaccataaa atattaacta tcaatctggt attcattact 67680 ttctatttaa ccaattctca ttataaaact ggaaattaaa aaagaaataa aaatcagttt 67740 aatacactag gttttctgag gtctttgatc tatatattaa cattactgat atacccttga 67800 aatgtgatat atatcagacc tttaaaacaa aatcatatta aatagtatct ttcttatcta 67860 tttcaatatt tcaaactatt taacaaataa acatataatg cctacctttg aatctgctaa 67920 ggcattgatg acattcccaa gagctaaaag tgatctatta atatttgtgc cttctacaaa 67980 tcgggtcccc ttagcaccgg aagtacttgc tcgctcagat cctgccaggt caatgagtga 68040 catcttggca atacggacat tttgattgat acttgctgtt ttgtcttgtt gtcgcaagta 68100 aatctttttg aaattacaaa atagaaaaaa atgaggataa gatttaacaa aattaaaagg 68160 gaaatatata ctttaataga gcacaaaatc aaaattattt tcattttaaa aaacaactga 68220 acaaggtata atctaattga tatttaagag cactataagt aatcactata gctgagaaaa 68280 atataaaaat gaaaagactt tctatatgtg taccagagga aaaataactc ttgacttgat 68340 agaagatcaa aacttccatt tctattctgg taccccttga accaggacat ggaattatca 68400 gaggtgatgg ttagaaacac aggtcctata gaaataacgt tcctaagaaa aaaccaaagc 68460 tactcgttag aatgccttgt atgtatctag agattgcccc tcaagggaag ctgaattcga 68520 atcttgatcc aaactgaaga gtaaatttat tctaatcccc caaacctgta tatgtcctca 68580 taattaaaat atcatatata aaaaagatag tacagtcttg catcacttaa caacacagct 68640 actttctgag aaatgcactg ttaggtgatt tcctcattgt gaaaatatca taaatcaaac 68700 atgagagaaa atgataaaat ccacagactt ggtaaacaga atgtagcaga ctgcttttgg 68760 ggtaataagt aggagcatac tctaaaataa caataaaaag taaatacata aaccagtaac 68820 acagtcattt attaccaagt ctcatgtact gtacataatt gtatgtacta tattttcata 68880 tgactggcag tgcaggttcg tttacaccaa caacaccaca aacatttgag taatgtgtta 68940 cgccacgaca ttatgatgag tatgacatca ctagatgaat aggaactttt cagctctgtt 69000 gtaatcttat gggaccactg ttgtatatgt ggactgttgt tgactgaaat gtcgttatgc 69060 ggcacatgac tatacagtaa agtctacttg tcattttcaa ctgcctagta aagcataatt 69120 tattcaaata ttttaagcta ctctgtaagg attatctgaa ctacattagg tggcaaacaa 69180 aagatgagga aagtaagata ttacttaatt ataaacccat ttattaaatt gttttataaa 69240 gcaggatcta agatatttca gagacatctc agtttcacag agaaacattt ctctcaagac 69300 tattaataac cgaagagtta gtggtaagaa caaaaaagat taatgaaatt tttgttgacc 69360 agggactata tgaatggttt gattgccttc aatatcaatt ctttcaacta taacaatttc 69420 tttcttataa gatgtatctc agatggcata atactaaaag aagctttata ttatcatttg 69480 ggtattaaaa ggactagaaa ctataagaaa taatagctat taacctatgc tttagctctt 69540 tctggaattg tattcctaag acttactgtg ccaactgaat catacttcct taaggaatgc 69600 gactatttac atggtcctta tggtgaaatc ttttaaagat gaatcagtat gttcccaaat 69660 tattagttct acaagtctag atttatagag ataagtttta ctgtgaatat aagattattt 69720 attggaaaga ttaaatattt tcagcaaaaa caaaactttt attactacaa ctttatcctc 69780 ctgtatgttt acaaaggtag aaattttgta tttttgtttt aagcatctca attataaata 69840 ctcttggtga cagaaacttt tcaaagctat aaaggaaagt actgacaagt gaagtctaca 69900 gacagatttt tttcacatgt atgaaaatga tgattcatga atttagcttc atttatttta 69960 aatccaattt taagagtgat agtctagtgg cctcttactt ggaaaacagc atgagaacga 70020 gaagatgtgg cattcatatc agtgggatgt tgtgtcctgt ttttgtttcc attatccaat 70080 aaatgtaaaa tttcttctga ggatttgggc tggagaagtt taagtagaag caaaatttaa 70140 aaatcagcaa tatatcttta aatttttcaa taaatgttca aaaaacaaaa agatttaaag 70200 gtaaaagaaa atgttttcta taaattcaat cctattaaat actaactttg tctcatctgc 70260 ttagtattgt gtgtgtttat atgaagaata aaagataaaa tctagtttct caggagtgga 70320 gtctattgag tagaataata tgacattaaa tgttcaagca gatttttgaa agaaaagctc 70380 actcattggg aggctgaggc aggcagatct tgagccccag agtttgagac cagcctgaat 70440 aacatggtga actcccgctt tctaccaaaa atacaaaaat tagccagtct catagcccgg 70500 tcacaaaata aataaataaa taaataaata aatacataca tacatacata catacataca 70560 tacatacgta gattaaaatt taaaaataaa atttaaaaaa tgtttttaaa aagttcactc 70620 tattttaaaa gaaaacaaaa taagactaaa aatataccct aatcatttaa attctgtacc 70680 tcattagttt tttttctcaa acaggatgga aagtaagtgc atggctggtg aaaatagctt 70740 aatagtcaca tttgctattc taacagggaa aaagatgttt atatacatac ctggtgtaaa 70800 gtaagtccat gaacgaccac ccctttttgg gtatcttccc ggacagcaag tggccctgaa 70860 tttactaaga gatcacgaat ctgttcatta tataccttaa aataaaaaga actgctttag 70920 cattgatgta aaaaaaaaaa atggtgatta catcacacat acactgctaa tttaaagtta 70980 ttagaatttt atcctaaaga caagcagcac ctcactttta ttcacctcat accttcgatc 71040 tcatgttgcc attaattttc tatcattcca gaaaattgaa gagtttgatt acctaggttt 71100 gaaattgaaa cttaaagttg gagtcatccc ctcactcata attcctgcct tgatgactat 71160 ggtgaaacag agataagtaa gatagctgaa gtgcattttc ttcttttctt tttttttgag 71220 acggagtctc gctgtctccc aggctggagt acagtggcgc aatctcggct cactgcaagc 71280 tccgcctccc gggttctcac cattctgctg cctcagcctc cccagtagct gggactactg 71340 gcgcctgcca ccacgcctgg ctaatttttt gtatttttag tggagacagg gtttcaccat 71400 gttagccagg atggtcttga tcttctgacc tcgtgatccg cccacctcgg cctcccaaag 71460 tgctgggatt acaggcgtga gccaccgcgc ccggcccatt ttcttatttt caggaaatgt 71520 atggaacaca cggtactggg aaactctggg aaatgcaggt tgtatggaga tggcatggtt 71580 cttactgtgg aagatatcta ttatttcaca atgtccaagt agtccaaact tttgaaattt 71640 tagagcttaa atgttacaga aaacccatac caaggacagg tggtatttgt ttcggttatc 71700 cttcaattac attaattttg acatataatt actaataata aatttcaaaa ggagacccat 71760 ttgaatgatg agggaactaa gactctgaga ggttaaatga tttgtccatg gtcataaagg 71820 tattagcaga gtaggaactg gagcctagac agcttcactc tactgcatca tactgaatac 71880 atatctgtag tttatatctc tggccatttt ttaaaaagta atttttataa gtaacacaca 71940 tttctatgta gtactagtga cccgatttta tgaatttatt aaaggtataa agtttattac 72000 ttgctaacca aatgacaatt acaactatta ctgacaagat ttaagaaaaa aaataacaaa 72060 atttagtctc taaaaaatta ttttgtgtta tttccttctg tgttctaata agtagctcat 72120 agtgataatt cattgctggt acaattctct acaatgaatg ataggcatta gaatgtaata 72180 aacccttaaa agtagtaaaa tgataatatg aagaaatatt tttaaatcat atctttttga 72240 tgagcagcag tcactttact attgcttccc cttacccact tcaatcataa caaatcaaaa 72300 attagaataa ttgttctcaa gctggtctat gtatgacact caccaaggag catttaaaaa 72360 acacagatgc ctcagccaca ccccagacct actaaattaa aatatcccaa gtgtgaggcc 72420 taggcctatt tttaaaaagt tctataggca attctggtgc acagcttgag tagaaaacca 72480 tattatacac tgccttatca ttaataatat gaaagtagat taaaagaaaa aataaaaatt 72540 gtgaaaataa ccaaacttca aaattctccc agttataaaa aggatctaag gaaaaaataa 72600 tgaatgctgg caccctcttt tcccaattga gttcagaaca attcttttca tagttaacca 72660 accaaagaaa atgagtttta cttctttttt atctataagt tctaatgaag aaatttttag 72720 caacatatat gattttaatc aatctttgga agaaattctc agtagggacc aaactacaag 72780 atgttaataa gagagaaatt ttatggcacc agaaataaat aggcaatgaa atcagggttt 72840 ttatgtttct gcactggttt ctgaaacact atttgaatgc aaagttagag tgtctgccac 72900 ttagttacca tttgttgact attaagaggg tagaaggcct caaagaatga tggggtattt 72960 caaaaggaca caagagacaa catgaagaag tctcaactag ccaaatctta cacaatttga 73020 acatacaaaa aatgattaca gaaagggatt ataatctatt caataaagta aaaatgcagg 73080 aggctgatat aataagggga aaactcttcc ttatagtaga aagtcaataa agaaatgtac 73140 aagaaatgat ggaatttaaa aatcaccatc atctaccatc ataatagtaa ttgattcagt 73200 caccaatcat cagtggatac taataacaat agataaaagt ttgaggagta aggaatattt 73260 acattgtcta catacatagt acttactaat tataaatggt aaaacgtatc ttcaaagtgg 73320 agaaactcta cagaccacag cataataaaa ctgatcaaag ttaacattcc cagtatgggg 73380 actaatcaac ggcttaagcc ttttttgatg cagtaagaag tgaacatcac tttgcttgtg 73440 ttactgtcag tgcataatct gaatctaatc atgataaatc caaactaagg atttttatgg 73500 cagtgttata aaagacaaaa aattacagat taaggagact aagatataac aactgaatac 73560 aattttcttt tacaataaag ggtattaatg aaataactag caaaatctca ctaagatcta 73620 cagataatta tattgtatca ttgctaattt cctgattttg gtacctattt agcagttatt 73680 tttaaaaagt cctgttttta caagtctgca acctagctca gaaagaaaga aatgtataca 73740 cacacataga aagcaaatgc agtaaaatgc taacatatgg gggatctgta tgaagggtat 73800 ctggaagttc tttgtactat tgttgcaact tctctataag tctgaaattt tgccaaagta 73860 aaaaaaaaaa aaattaacag aaaaagatgc ataacaaata ttcaagacaa ggaattttaa 73920 tgattttata tattcaccgg aaaactctta tataataaaa tcatttgtat gaatcatgtc 73980 aatgatttcc caaaactatt gattaatcta aattcccaac ttacctccag atatgaaact 74040 gcagtactac atattttctc ttctttaatc tcatccatgc atttgtaaag gtgtaacatt 74100 gttagataca tcactccagg ttcatcagct gatcctagca tagtgtgggt cttcccagca 74160 ccagtggcac cataggcaag tactgagttt ttaagaaagg gatcaaaact ctttgttatg 74220 aaatataact ctattatatc tactatctag tggatagttc catctggata tcctgaacag 74280 tatctttaaa ccctacaaat ccaaaattat agtcttatcc ttaaaacctg ggaatgttac 74340 cacaaatcta ctcttactcc tatgttcttt actctgataa atggtatcac tacccccggc 74400 cccccactct aacaactact ctttcaaagc aatcttaaaa tctccctaca gattagtctt 74460 catcttccat cttctttatc ctttgcaatt tgtagtcatc tttatgaaaa agaaattgga 74520 atacgttaaa ccttcttaat tgttccaggt ttacataagt tcaaattcct cactttggaa 74580 tattataaag cactcagagg gtgcctgctt attttgccag cctactgctt ccttgctgtg 74640 atctagggat acttaattat tcaatactct cagcatttgc tgctcctttc tactctgctg 74700 tctttgttct gaggagtccc tctacttgat ccagctggaa aacttccacc tgcttctaaa 74760 tgctcagcac aaatatcatt tttctctgcc ttccctcatt gtcctaggca gacacatcca 74820 ctctttcact tcagccctta gtatatgctg catatccaca tccctctctt ctggcatgta 74880 tcacactgta tttccaattg agtgctccac caaggcagag gccatgtatc cttatcacct 74940 aacaaatcac ttgccacaaa gcaggtactt gaataaatac cagatagatg ccatttataa 75000 gattcctttt taagtttttg ttttaggtga attactttgt ttcctagatt ctattcagta 75060 caagaaagtc atgtgaattt cttccaatgt ataaaaaatc cactctgtgg gccaggctcg 75120 gtggctcatc cctacaatcc cagtactttg gacagctaag gtgggaggac tgcttgagcc 75180 caggagtttg agaccagcct gggcaacaca gtgagaccct gtatccacaa aaattttcaa 75240 aaaattagct gagggcagtg gctcattcct gtagtccagc tattcaggag gctaagatgg 75300 gaggattgct taagcccagc aggttgaggc tgcagtgagc tgtgattgta ccagcgcact 75360 ccagcctggg caacacagca agacttcatc aaaaaaaaaa aaaagacaaa gaaaaagaaa 75420 aaaatccact ctgtgaatta catatggtaa atacccaata caataatcag ttaaggcaat 75480 aacttctcat atcattgcag tgagctgtga ttgcaccagc gcactccagc ctgggcaaca 75540 cagcaagact tcatcaaaaa aaaaaaaaaa aaaaaaaaga caaagagaaa gaaaaaaatc 75600 cactctgtga attacatatg gtaaacaccc aatacaataa tcagttaagg caataacttc 75660 tcatatcatt attggttgaa aatattttta taaattcaat ctgtctgcta aaccaaatgt 75720 taacaaacca caaaaatact tttcagtagg atgaattaag atggtgtata ttttactttg 75780 ttctatttta tgtaagctgg tatataagga aggtttaaaa tggcttattc ttaagcttat 75840 tcttaagctg tcttaaagac agggtaagaa tataaagaaa gccaaaaaga aaccaaaaat 75900 tcaatagtag tttgatagag agtctacttt ttttcttaga gttaagaaga tttcaaaatc 75960 tctagagaca tatgaagttt catgaaagag gaaaagaata tcttcttaaa aatgggaatc 76020 acagtagtac caatcaataa accacactcc atccttactt gatcaagagg gtatgtcttc 76080 catgataaaa ctgaaatgaa tcaggaaaag acagtgaaac atgttatagt tgtgagctgt 76140 cttggggaaa atatcataaa tactaataat tacaaaaata agatattaat aatggtgttt 76200 agtgcctggt aggcactgaa aaactggcca ttttgcatct tgggtatctc tctctctctc 76260 tctctttttt tttttttaaa aaggaaatca acatggcttt cttgaaaggc caaaaaaagc 76320 actaaagatg cttcttgggc taacaatgag ctaaagggca tgagataatt aacatgggat 76380 cttaacactt ttaccccctt tccaattttt attttaggtt tgggggtaca gtgcaggttt 76440 gttacatggg taaattgcat gctgcggggt ttagtgtaca gattttttca tcactcaggt 76500 aaggagtgta gtaccccata ggtagttttt tgatcctcag tctcctccta tccttcgcca 76560 acttaaacat ttttatttca atgtgccatg aagaaaaact gctgaaaaga aactgtcaaa 76620 tgttcagaaa tgtctgacta ctctccagga atagataatt acataggtaa gctgtaggaa 76680 aagttataaa tacaggttat gagaaaactg atgttaattg caataagcat gtggtttaat 76740 aacataggca actgaaagga cagatgtcta taggggccac agtaaggccc tggaagagaa 76800 aggtttacaa atgatgtata agttatatat gataactaaa atttcaaagt ctatatttac 76860 agttcaagtc tattgaattt cttaagaatt tttagcatac aagctcctta aatttgatta 76920 tatttagaag ggtcaagtag atgtccgtcc taatgcaaaa gtgaaatcgg atagagaaat 76980 taaatcccaa attgaaacaa atacctgtgc aattatatcc attcaaaaaa ctacgaagaa 77040 ttggcttagt agtgtgttca aaaacttctg actgagttga cgtttcatca aaaacagcat 77100 caaatacaaa tttaagatcc ttattttgtt tctttataac attttgattt gtagttttct 77160 ttccatggaa aaaactgact tcttcttgtt tgggatcaaa aactaggata tgtttatcca 77220 caacatgaac cactttatga aatccagctg ctttttcttt agtgttttcc ggacgtacac 77280 gaactactac tttcatatgg tggcacaggt cttcctcagt gacagacatt gttgattatc 77340 ttgattccta tctgtataaa tacttgaata cttctctgaa attaaaaaag aaaataaagt 77400 tttaatatca gtttttactt tcatgcaaaa caactggcat gtagtattca ttcaaaaaag 77460 atgttaataa ttctgtttca ctcactaggt aaacactggg ggaaaaatac atacatacgt 77520 aggcacacac aacacacaca cacaaatata tgcacacata cacacatatg cacttaagta 77580 ccctaaaaca aacaattaaa tggcacatac gtacacacaa ctacgataaa aatctcttta 77640 cctgaaatat tagtaggata tttggcttaa actcaaatac tatagctgaa ccatatataa 77700 tcacagatat gctatcctaa aacccagatt tgattttcac aagccctcca gcactatttc 77760 agcttaggtc atgggaatga atagaaaagg atctcccaga accatatcaa ggtatgattg 77820 gagagcctta gcttgtgaac tatttttagt aaaagtgatc ttggctgcaa gccccttggc 77880 cgtggaaagt gatacaccca ggctggtctc tacctgtatc tcagaagccc atagggttaa 77940 aaatagttcc aaggatgcat tcaactagat agctcaggtc tgaaggtgat agagatggca 78000 tagactcctt ggtgtattca gagacctagt ctctgaatat tgatcctact ctctgctttc 78060 taattgtgtg caagtttaag gaatcaatga tagcaggttt aaaaattatg gtctgatttt 78120 atgactggtt cacatgcaaa gaagaaaagt aaagtaacaa agatcaataa tttggaagtc 78180 tcaactatcc agaaaatact ctagaatctg cagacccaaa aaccaaaaca aaaaaacaaa 78240 caacaacaac aacaaaaaga caaaaaaaaa ccaaaccaca aaacaaaata aaacacccca 78300 aaacaacaag atctgagtaa ggaccaaaag gtgagactta ggacgatcct gcaatcccac 78360 ttctgagtat atatccaaag gaattaaaat cagtatgttg aagagatatt tgccctgcca 78420 tgttcgctac aacattattc acaataacta agatatataa acaatctaag tgcctatcaa 78480 cagataaata gatcgaaaaa atgtggtata tgcactcaat gaaatactat tcagccttaa 78540 aaaagactaa aattctgtca tttatgacga catgaatgaa tctagggggc attatgctaa 78600 gtaaaataag ccaggtacaa aaagacaaat atcacatgat ctcactttta tgcagaatct 78660 aaaaatatga acacagagaa gtagagtaat ggttaccaga ggctgaggag ggtggggtgg 78720 gtggtaaaag gggaaatgtt ggtcaaaggg tacaaagttt cagttataca agaggaatag 78780 ttttggtgat ctattgcaca gcaaggtgac catggttaat tgctaagagt acattttaaa 78840 tgttctcaca acaaaaaaat ggtatgtgag gtgatggata tgttaattaa ttagcctgat 78900 atgctcattc cactgtgtac acatgtatca aaacattaca ttgtatccta taaacttaca 78960 catttttttt gtcatttgta agttaaaata aaagagacaa aaataataaa ttcacccaaa 79020 acaacattta agtaaggact tgaaggaggt gagggagtta gtcatacagg tattgtagga 79080 agcttttccc catagagaga aggacccagg gtgctacttt atgttggcca gaatggagtg 79140 agcaaagggg agtgtagtaa gacatgagag gagaaatgga ggccattaaa agaactttgg 79200 cttgtactct gagtaagaca aagaacaact ggaagtcgtt ttgagcacag gagtgacata 79260 atctatcact ctcactgcta tgtggataat ataatagact agtctattga agtaatgtag 79320 acaagagaca actctgtcag ctcagaatag ggtagtggca gcagaggtgg taagtggtca 79380 gattatgggt gtattctgag ggtaaaggtg acagaattta ctgacaggta gatgtagagt 79440 gaaagagaga gacaggattg aagaataact ccaaggtttt tggcttgaga attagaagga 79500 taaagtagtc accaactgag atggaaataa gaagcagggc ttttttcagc agggcgggaa 79560 gtggtgggag gcagggtcag atcagttcag ttttggatag cttaagtctc agagttttga 79620 cagacatcca ggtggaaatg tcagggcagg tggaagttaa gaaaataaga aaataaaggc 79680 tgtcctcagt cttaatgcag tattaagctt taaaaacttt cgggaaatcc taaatgaagg 79740 aggaaacagc gatctattgt gttaaatact gctaataggt caagtactta ctgagaatta 79800 accatgggat ttactaacac agaggccatc gagaaaagca attttggggc agtagtgggg 79860 aaaaaacccg aaaggagaag atccatagac aaggtatatg gaaaggactg tttcaaaggg 79920 aggagaaaaa tggtgtgagt gaaggggggg ggtggtgtca agatgttttg tttgtatttt 79980 tttttaaatg ggagaaatag caatattcaa gctgaaatat gtcacaaaac cacttagcca 80040 tatactttcg gacagaattc aaataaggac agaattcaaa ggaatctaaa agcagtagat 80100 gctagacata tctttgcctt tttaggactc tgtctttggc caaaaataga atactgaaaa 80160 ggaagggatg gtcatttgga ttctaagtca ggtcccaggt gaattactac tttgtttttc 80220 atccctgagc ttccgtctag ccaagtgtca caaagcacct acacctcact tttatgacct 80280 tggacaagtt acttaacccc atgagtctca ggtttctatt tgtataaaag agataataat 80340 acctcaatgt ttgttgcaaa ggctaaaagg ggtaagtatt aaggtattca gtaaatacca 80400 attctcttcc tatctgcccc actcctgctt cttcttgcca aagagactga gttcatcttt 80460 tgagtttttc tcaatgggct tatgactagc actttgggta ggccaattct tccttgctta 80520 gaactgccct gttatagggc atttagaact gccctattag aggatgtttg gcatttctct 80580 cccctgtcta ttaaaggcca gcagtgtccc atattccttg tgataacaaa aactatctcc 80640 tatacacatt tctaaaagct tttagaaata ttcaacaata ttttaacaga tatactattt 80700 ttaaatgata gattaaatat acataaatga aattgttaac aaagtaaaca taaaatacta 80760 agtgattatt tcaaaataaa ccttagaatc tcaaggctgg aggatatccc tccctaatta 80820 attagttaat taattcatga caactattac atgttggagc caggcagcct aggttaaaat 80880 ctcagctcta tgacgtactg actgtgatag tggataagtt acttaacctc cttgtggctc 80940 agcttcccca tctgtaaagt aagactaaca acagtaccta tctcataaag ttgtaaagat 81000 tacacactta gaacaatact ttgtacagag tatgaactac aagtgtttgc tattattatt 81060 tacagtgtag tgagggaaac agatattaat aaaatattga cacaaacatg taaaggtata 81120 actgtgacaa gtgccattat agggaaaagg ttaacagtgc tttataagac tataatgagg 81180 ggattattta agtaacattc cagggagaaa tttggacaat tacctaaagg aatgaggact 81240 aaactctgat tttttatttt gcccaaattc ctatctaagg ggtctgggga gtcacgccct 81300 ataaatcatg gattttcatt agatgcgttt tatttgaccc cgtatattgt gacttgcttt 81360 tcaattgact ctggcataac attatgagac aaagaaaaaa tatttaacac ccaaaataga 81420 tttacttgcc aagccttgaa attgccctgc aaagtttctt gttggaaaag tccacgttct 81480 atagagaatc cccttccctc tttgttttcc tcttttcttt gcagatccag tagataatca 81540 actaaaagcc aggcaccctt ttagctctgc ggagaaacat tttacaacct gctctctctc 81600 tctgaaattt gctgagagct tcctctgcaa aataaaactt ggtctccaca attattttta 81660 acctgaacat tcctttctat caatcccagg tctttagaca aactcaacca attgtcaacc 81720 agaaaatgtt taaatttacc tatagcttgg aagcccccgc tttgagttgt cccgcctttc 81780 tgaaccaaac caacgtattt cttaaatgta tttgattgat gtctcatgcc tctctaaaat 81840 ataaaaaacc acgctgtaca ctgaccactt tgggcacatg ctctcaggac ctcctgaggg 81900 ctgagtcatg ggccatggtc actcatattt ggctcagaat aaatctcttc aaatatttta 81960 cagagtttga ctctttcagt caatagaatt taagtataat gtcaaatata actttgtttc 82020 acaactagtt gcatatttta acaaagacat ggatgttaat ttttaaagta tcatgtattt 82080 ccctatcttt taaaaacaaa tatgtggata gaattttctt aataaaaatg cctaaggtca 82140 acagaatcat caaatgtaaa aattaatcta tgttcaaata tacttacatc tgcaggaatt 82200 aatgagatcg ttcctacatt attatgtggt gccttctttg ttttctagga tggctgacta 82260 aaagaaatga gcatttagtt gattctgaat aaggcacaga gagagtaaat tcttcaacca 82320 tgtttaatat gaagcagcaa aagaaaagcc taaatatcgt tatctgcgca agaatgtgtg 82380 gattcacaaa ttcttttcag acagctgttc agaagatagt attatagcct ctgatcaatt 82440 ttgtcctatc tacccctaag tggtatttac tgaacagaat caaaagagca aactggtagg 82500 atttcattgg tggaactaaa acatgaaaga caaatacttc caacgtgatt attcattata 82560 atcaggttga gcattccaaa tttgaaaatc taaaatctaa aactttgtga gcaccaacat 82620 gacactcaaa ggaaatgctc attagagtat tttggatttt cagattagag atcctcaacc 82680 agtaagcaca atgcaaaaat taaaaaaaaa aaaaaattcc aaaattcaaa aaaacttctg 82740 gtaccaagca ttttatataa tagatactaa acctgaagaa gaatatttgt ctagtctaga 82800 gagagtaggg tatcaaaaaa gaagaatgaa ggggctaagg aaaggggctt tacttgctaa 82860 tgtataaaac aaaagggtta gattatatga tacggaaagt ctttttctag ctccaaaatt 82920 ttatgattat tatgcatgat tagaaaaggg tacaagagaa taagaaatga cagttaatag 82980 acttttactt tatatcccta ttctctcata gagagtctag tatatagtaa attttcaaat 83040 ataccaatga atgaattaat aaactataaa aaatgctcac agaccccaaa aagcaattta 83100 ctcacttaga gtagaaggaa aaagaaaatg tatatctcca agagaaacaa catattagag 83160 tacaatagtt gacaacaaca ggcaatcaca atgagaaccc tgaggcatca aaaagaaaaa 83220 aataagaaag aaataatgtt cccaatttct tgtttagaaa attaaagaaa tggcaagatc 83280 atgttttatt ttcatcatta agtgtggtta aaatacttta ttacttagca aagctaatat 83340 tcaattttct ggaagattca tttatgtaga acagctcatg cctctgcaat gtttaatgag 83400 gtattaaaat ctatttatcc tgaatacttg catggtaata agccaagttg aacaggtcaa 83460 tttttaactt ataacatatg tagctagtgc tcatcccaga ttaaagattc acccctaatt 83520 atatgcaagt acaataaatt ttatttaatt cattgattgt atgcactgat actttcttca 83580 aaagcattca gatcatgata tgtattgcat gtcatttacc tgctccaaac tatccaatga 83640 cttctcatca taagaataaa atacaaactc cttaccatgg cctataaatt ccacatatgg 83700 ccctgcctac ctctctgaca atgacttcta ctgctgtctc cccatttcat tattctgctt 83760 cagctgcaat gactttctta gcattcctaa aacacttcag tcttgttttg gcctcctggc 83820 ttttttattt ttgcttactg gcaggcatta cctccagata tttgcaaatt gtaatccctc 83880 acttcattat tcaggtctct tcaaatgcca ctttacagag gctttcccta aagaatctat 83940 ctaagatagt gtcaccctgc ctttgcttct ccaatccctt actaggttta tttttctttc 84000 ttgagtttag cactaattgg aaagtatatg ttatctggtt acatatttat tgcttgtttt 84060 ccctctagaa tgtaagcact gtgagagcac ggagttcatc tgcacaccag cacctaggac 84120 actgcttgtc aaatatttag gacccaataa atacttgttg aataaatgaa tgaataaacc 84180 agtacagttt taatagactt atagcatgtt accatttgta tttttaaaag atatatatgt 84240 atatgcatgg tcattcccag aagggtacac aagaaattga taataccact ttccctatag 84300 aagggaaata tgaaggtctg agtgagagac aggtttattt tccatttcat attcttttgt 84360 aatatttaaa ttttaaacaa ggtctaggta tttttatttc aaaacagaca aacaacaaca 84420 acaaaaccac tattaaaatt taccttaatc gcaacattta atttagtaac aataagttat 84480 attttctatt gagctcatat cccacaaata gaaatgtact aacaattgac atactcttac 84540 taaatcgtca taacaaccta tgacataaac cctgtactgt cattcctatt ttattaaggc 84600 agaaagtgta atacagagaa attaactggc taaagtcaca caactgagga agcacatgcc 84660 atgggatttg aactcagact gactgaatct aaaggccaaa tacttaatca ctactctccc 84720 tgatgtaaat atataaccct cagaaatttt cttatagaag ttaaaaatat atatattgct 84780 tactttttta gaaattttaa aacatttaat tggcaaagat tgtataaaac gaagatgtac 84840 aatgtgatgg tctcatattc ttatacacaa tggaatgatt accacaatta aattaatacg 84900 tctatcacca ttgatgctgt acattaaatg ccatgaactt atttatctta taacttaaag 84960 tgtacccttt gaccaaaatc tccctatttc ccccaaaact cagcttctgg taccactctc 85020 ttatatttcc ttacttttga tagaaacctc agggcctggc acaggagctc ttgaatgtga 85080 aaataaaact gattatgatt tctctgtact tgtcagatat cacagagtgg ccattctcaa 85140 taagtatgct ttaacaatgc ttagattagg ttgatatggt gataattatt aataatgaac 85200 aacaatgctt ttcatttgag tatgtacact ctgtctcatg cattatagta aacacttgac 85260 attcgtcatt gcattcaatc cttataataa tcacgtaagg taggttgtag tagtatttcc 85320 attttacaaa aacaaagact tagccttagg ataagtaact tttccaagat gacgtaacaa 85380 gtgggcaacc aaatgtcaaa tataagtcaa ttcagtcaaa gattcacccc taattttatg 85440 aaagtactat aataaattta attcattgat tgtattcact gatacgttca tcaaaagcat 85500 tcagatcatg tgatgcatca catggcattc acctgctcta aagtctccaa tgacttctca 85560 ccagaagaat aaaacacaaa ctccttaacg ggtacaaatc taaagtccat gttattaaca 85620 gctaggttct actggaatca gaagagaatg cttccaaaca atgatacaga agtagagtga 85680 cagttatgat atattaaata caaactcaaa cctgaattag attcagattc aacaaacact 85740 gtataggact gaaaacgata ctcaacacta tcatctacag tccatcttaa agctcttttt 85800 ggaatatcag tcttgggggc actactccca ccaacttaca accatcaggg aagaataaaa 85860 ggttcaactg gagggaaggc cggcactgac agctgagcta ttttttttcc tcttagtttt 85920 cacagttgtc agcaaaaaaa aaaaaaaaaa aaaaatcatt tttatcgtgt ctcttaattg 85980 atttggggta tttctatgat gggacaagat gcactttcaa tataaaaata ttatgtattt 86040 gtaaatactt ttcaatagta gaagaggaag ggctgggtgc cctgcctcac acctgtaatt 86100 cctgcacttt aggaggccga ggcgggcaga tggcttgagg tcaggagttc gagaccagcc 86160 tggccaacac agtgaatccc cgtctctacc aaagatacaa aaattagccg agtgtggtgg 86220 caaacgcctg taatcccagc tactcgggag gctgaggcac gagaattgct tgaacctggg 86280 aggtggaggt tgcagtgagc agcgatcacg tcactgcact ccagcttgga ccacagagcg 86340 agactctgtc tcaaataaat gaataaataa tagaaaagga gattaattac tactattaaa 86400 ggcagataat cttttaagtt tttttctttg tgattgtgct ttgtagataa tctttgttta 86460 ttgaaatagt tcttacaaac tatgaactta ataagaagca ctatctagtc attggatatc 86520 acattctcta gcatcaaagt ttataaaaac cttacaaaaa cgaaacagga ggctagacgt 86580 ggtggaatga cactaaaaat taaaatctgt agagtgccta aatttctacc taattatcca 86640 taatctaaac tatatattat accacaaaat cagttcattc tggtcaaata ctctcttctc 86700 atataataaa cagcagtcag tcttggcttc tctgtaactg agtgactaat gagctcctaa 86760 aaaaaaaaaa aagtcctgcg gaaaccaaga acagactata ggactgattc taaatgttta 86820 cagtttaatt tcatctgcag agcatttgcc aaacagtatc tcttccgtac ctcatctgat 86880 cctcggcaat cccgttaggc agtcagagcg gcttttatct cgatgctacc tacaactggg 86940 gctcaggagg ggttcccgat tgaccagtgc aagactaaca gttaaagctc ttcagacaaa 87000 aattttatgc agtgatgaac aaaagctcct cgtttgatag gtaagcccct gggtacgctt 87060 atatgtgagt ctgaaacaaa acactcccaa tttggagtcc ggaaaaaagc tgacactaca 87120 aggtgctggg cagttaaagt tctctgccag tctgggaaag gggccaagat gccctttaaa 87180 acttaagact tcctctcagg acttaaggag atccctgccc ttccagctga gcagtcgagg 87240 attacggtca agcagagctg tgctcttagc aggttctcga atcccttttt cctttcactt 87300 tctccccagg taccctgatc ccccacccct caacgcttct gtgtttgtca agaagcccac 87360 ctggtcttct agacctgaag cggcaggacc ctccgttccc aataatacaa gtcaccaaaa 87420 ggagcgtccc agagtccagt tttaccttca tgtgcctctc actcacttca ggcccaggcc 87480 aggttaccgc aaccacttca ctttaatgtc cgcctcccag cgcttcagac tcaaccacaa 87540 tattcaaacc caagccactt tc 87562 <![CDATA[<210> 13]]> <![CDATA[<211> 3435]]> <![CDATA[<212> DNA]]> <![CDATA[<213> 智人]]> <![CDATA[<400> 13]]> gtggttgagt ctgaagcgct gggaggcgga cattaaagtg aagtggttgc ggtaacctgg 60 cctgggcctg aagtgagtga gaggcacatg aagagaagta ttcaagtatt tatacagata 120 ggaatcaaga taatcaacaa tgtctgtcac tgaggaagac ctgtgccacc atatgaaagt 180 agtagttcgt gtacgtccgg aaaacactaa agaaaaagca gctggatttc ataaagtggt 240 tcatgttgtg gataaacata tcctagtttt tgatcccaaa caagaagaag tcagtttttt 300 ccatggaaag aaaactacaa atcaaaatgt tataaagaaa caaaataagg atcttaaatt 360 tgtatttgat gctgtttttg atgaaacgtc aactcagtca gaagtttttg aacacactac 420 taagccaatt cttcgtagtt ttttgaatgg atataattgc acagtacttg cctatggtgc 480 cactggtgct gggaagaccc acactatgct aggatcagct gatgaacctg gagtgatgta 540 tctaacaatg ttacaccttt acaaatgcat ggatgagatt aaagaagaga aaatatgtag 600 tactgcagtt tcatatctgg aggtatataa tgaacagatt cgtgatctct tagtaaattc 660 agggccactt gctgtccggg aagataccca aaaaggggtg gtcgttcatg gacttacttt 720 acaccagccc aaatcctcag aagaaatttt acatttattg gataatggaa acaaaaacag 780 gacacaacat cccactgata tgaatgccac atcttctcgt tctcatgctg ttttccaaat 840 ttacttgcga caacaagaca aaacagcaag tatcaatcaa aatgtccgta ttgccaagat 900 gtcactcatt gacctggcag gatctgagcg agcaagtact tccggtgcta aggggacccg 960 atttgtagaa ggcacaaata ttaatagatc acttttagct cttgggaatg tcatcaatgc 1020 cttagcagat tcaaagagaa agaatcagca tatcccttac agaaatagta agcttactcg 1080 cttgttaaag gattctcttg gaggaaactg tcaaactata atgatagctg ctgttagtcc 1140 ttcctctgta ttctacgatg acacatataa cactcttaag tatgctaacc gggcaaagga 1200 cattaaatct tctttgaaga gcaatgttct taatgtcaat aatcatataa ctcaatatgt 1260 aaagatctgt aatgagcaga aggcagagat tttattgtta aaagaaaaac taaaagccta 1320 tgaagaacag aaagccttca ctaatgaaaa tgaccaagca aagttaatga tttcaaaccc 1380 tcaggaaaaa gaaatcgaaa ggtttcaaga aatcctgaac tgcttgttcc agaatcgaga 1440 agaaattaga caagaatatc tgaagttgga aatgttactt aaagaaaatg aacttaaatc 1500 attctaccaa caacagtgcc ataaacaaat agaaatgatg tgttctgaag acaaagtaga 1560 aaaggccact ggaaaacgag atcatagact tgcaatgttg aaaactcgtc gctcctacct 1620 ggagaaaagg agggaggagg aattgaagca atttgatgag aatactaatt ggctccatcg 1680 tgtcgaaaaa gaaatgggac tcttaagtca aaacggtcat attccaaagg aactcaagaa 1740 agatcttcat tgtcaccatt tgcacctcca gaacaaagat ttgaaagcac aaattagaca 1800 tatgatggat ctagcttgtc ttcaggaaca gcaacacagg cagactgaag cagtattgaa 1860 tgctttactt ccaaccctaa gaaaacaata ttgcacatta aaagaagccg gcctgtcaaa 1920 tgctgctttt gaatctgact tcaaagagat cgaacatttg gtagagagga aaaaagtggt 1980 agtttgggct gaccaaactg ccgaacaacc aaagcaaaac gatctaccag ggatttctgt 2040 tcttatgacc tttccacaac ttggaccagt tcagcctatt ccttgttgct catcttcagg 2100 tggaactaat ctggttaaga ttcctacaga aaaaagaact cggagaaaac taatgccatc 2160 tcccttgaaa ggacagcata ctctaaagtc tccaccatct caaagtgtgc agctcaatga 2220 ttctcttagc aaagaacttc agcctattgt atatacacca gaagactgta gaaaagcttt 2280 tcaaaatccg tctacagtaa ccttaatgaa accatcatca tttactacaa gttttcaggc 2340 tatcagctca aacataaaca gtgataattg tctgaaaatg ttgtgtgaag tagctatccc 2400 tcataataga agaaaagaat gtggacagga ggacttggac tctacattta ctatatgtga 2460 agacatcaag agctcgaagt gtaaattacc cgaacaagaa tcactaccaa atgataacaa 2520 agacatttta caacggcttg atccttcttc attctcaact aagcattcta tgcctgtacc 2580 aagcatggtg ccatcctaca tggcaatgac tactgctgcc aaaaggaaac ggaaattaac 2640 aagttctaca tcaaacagtt cgttaactgc agacgtaaat tctggatttg ccaaacgtgt 2700 tcgacaagat aattcaagtg agaagcactt acaagaaaac aaaccaacaa tggaacataa 2760 aagaaacatc tgtaaaataa atccaagcat ggttagaaaa tttggaagaa atatttcaaa 2820 aggaaatcta agataaatca cttcaaaacc aagcaaaatg aagttgatca aatctgcttt 2880 tcaaagttta tcaataccct ttcaaaaata tatttaaaat ctttgaaaga agacccatct 2940 taaagctaag tttacccaag tactttcagc aagcagaaaa atgaaactct ttgttttctt 3000 cttttgtgtt ctaaaaaaat aaaatttcaa aagaaaaggt tgtcttttaa gttttttaaa 3060 tatttgttgc cttttaaaat ccctgagtgt aagttaccat ggtggcagct tagttttact 3120 atgccacaac aagttgacta ggacatttta gtaaatggta gtgagttaaa ttatctttat 3180 tattttttaa aaataagaat ttagaagtgg taaaattatg gcccaagatg tatttggttc 3240 tctattatgt tttgatacat tattttaatc atatatatga ctttcctttt caaaaatact 3300 ttaatgtaca agtgtaaata tatgtgccca taaaatcatt gtaaatatta tttagtcatc 3360 acaaataaaa tattgtccct tgctacttga tatattaaag atgtagattt taaagtggat 3420 gtagatttta aagtg 3435
Claims (20)
- 如請求項1之鹽、水合物、溶劑合物或共晶體,其選自鹽酸鹽(化合物A-HCl)、甲磺酸鹽(化合物A-MsA)、甲苯磺酸鹽(化合物A-TsA)、硫酸鹽(化合物A-硫酸鹽)、可變水合物(化合物A-可變水合物)、四氫呋喃溶劑合物(化合物A-THF)、乙醇溶劑合物(化合物A-乙醇)、1-丙醇溶劑合物(化合物A-1-丙醇)、異丙醇溶劑合物(化合物A-IPA)、甲醇溶劑合物(化合物A-甲醇)、乙酸異丙酯溶劑合物(化合物A-IPAc)、丙酮溶劑合物(化合物A-丙酮)、環戊基甲基醚溶劑合物(化合物A-CPME)、二㗁烷溶劑合物(化合物A-二㗁烷)、乙酸乙酯溶劑合物(化合物A-EtOAc)、乙腈溶劑合物(化合物A-MeCN)、甲基三級丁基醚溶劑合物(化合物A-MTBE)、甲苯溶劑合物(化合物A-甲苯)、十二烷基硫酸鹽(化合物A-十二烷基硫酸鹽)、二甲基甲醯胺(DMF)溶劑合物水合物(化合物A-DMF-水合物)、二甲基乙醯胺(DMAC)溶劑合物(化合物A-DMAC)、單苯磺酸鹽水合物(化合物A-苯磺酸鹽-水合物)、咖啡因共晶體(化合物A-咖啡因)、檸檬酸共晶體(化合物A-檸檬酸)、糖精共晶體(化合物A-糖精)、L-酒石酸共晶體(化合物A-L-酒石酸)或尿素共晶體(化合物A-尿素);或其固體形式。
- 如請求項2之化合物A-HCl之固體形式。
- 如請求項3之化合物A-HCl之固體形式,該固體形式係結晶形式1,其特徵在於,在-91和-103 ± 0.5 ppm處的固態 19F NMR峰。
- 如請求項4之化合物A-HCl之結晶形式1,其特徵進一步在於,使用Cu Kα輻射在7.5、16.9和20.2 ± 0.2° 2θ處的XRPD圖譜峰。
- 如請求項5之化合物A-HCl之結晶形式1,其特徵進一步在於,使用Cu Kα輻射在12.8、18.2、22.7、23.6、24.8和26.1 ± 0.2° 2θ處的XRPD圖譜峰。
- 如請求項6之化合物A-HCl之結晶形式1,其特徵進一步在於,使用Cu Kα輻射在10.9、14.5、15.7、15.9、19.8、20.6、21.6、23.2、26.1和26.8 ± 0.2° 2θ處的XRPD圖譜峰。
- 如請求項4至7中任一項之化合物A-HCl之結晶形式1,其具有基本上如圖1所示的XRPD圖譜。
- 如請求項4至8中任一項之化合物A-HCl之結晶形式1,其具有在268.5°C至274.5°C處的吸熱轉變,此係藉由微差掃描熱量法測量。
- 如請求項9之化合物A-HCl之結晶形式1,其中該吸熱轉變係在271.5°C ± 3°C處。
- 如請求項10之化合物A-HCl之結晶形式1,其具有基本上如圖2所示的熱重分析(TGA)。
- 如請求項4至11中任一項之化合物A-HCl之結晶形式1,其具有基本上如圖5所示的單晶結構。
- 一種藥物組成物,該藥物組成物包含如請求項2至12中任一項之化合物A-HCl之固體形式或如請求項13之化合物A之HCl鹽、和藥學上可接受的賦形劑。
- 一種治療罹患由KIF18A抑制介導的疾病的個體之方法,該方法包括向有需要的個體投與藥學有效量的如請求項14之藥物組成物。
- 如請求項15之方法,其中該由KIF18A抑制介導的疾病係癌症,該癌症選自卵巢癌、乳癌、肺癌或子宮內膜癌。
- 如請求項15所述之方法,其中該個體對至少一線的全身性化學療法已復發或係難治性。
- 如請求項16之方法,其中該癌症包含對於失活的TP53基因呈陽性和/或對於以下中之至少一項呈陽性的細胞:(i) 失活的Rb基因,(ii) 擴增的CCNE1基因或過表現的CCNE1基因產物,(iii) 失活的BRCA基因或 (iv) 其組合。
- 一種用於製備如請求項2之化合物A-HCl鹽或其固體形式之方法,該方法包括:將鹽酸、化合物A和合適的溶劑合併以形成該化合物A-HCl或其固體形式。
- 如請求項19之方法,其中該合適的溶劑選自乙腈/水、乙腈/1,4-二㗁烷、四氫呋喃/水、N-甲基-2-吡咯啶酮/乙醇、或丙酮/水。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163224208P | 2021-07-21 | 2021-07-21 | |
US63/224,208 | 2021-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202321213A true TW202321213A (zh) | 2023-06-01 |
Family
ID=83148993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111126873A TW202321213A (zh) | 2021-07-21 | 2022-07-18 | Kif18a抑制劑化合物之鹽和固態形式 |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR20240051338A (zh) |
CN (1) | CN117940416A (zh) |
AR (1) | AR126537A1 (zh) |
AU (1) | AU2022313961A1 (zh) |
CA (1) | CA3226614A1 (zh) |
IL (1) | IL310234A (zh) |
TW (1) | TW202321213A (zh) |
UY (1) | UY39866A (zh) |
WO (1) | WO2023004075A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023198209A1 (zh) * | 2022-04-15 | 2023-10-19 | 武汉人福创新药物研发中心有限公司 | 一种kif18a抑制剂及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8576985B2 (en) | 2009-09-01 | 2013-11-05 | Aptuit (West Lafayette) Llc | Methods for indexing solid forms of compounds |
CR20210387A (es) | 2018-12-20 | 2021-08-19 | Amgen Inc | Inhibidores de kif18a |
KR20230011932A (ko) * | 2020-04-14 | 2023-01-25 | 암젠 인크 | 신생물 질환의 치료를 위한 kif18a 저해제 |
-
2022
- 2022-07-18 TW TW111126873A patent/TW202321213A/zh unknown
- 2022-07-21 KR KR1020247005985A patent/KR20240051338A/ko unknown
- 2022-07-21 AU AU2022313961A patent/AU2022313961A1/en active Pending
- 2022-07-21 AR ARP220101934A patent/AR126537A1/es unknown
- 2022-07-21 IL IL310234A patent/IL310234A/en unknown
- 2022-07-21 CA CA3226614A patent/CA3226614A1/en active Pending
- 2022-07-21 UY UY0001039866A patent/UY39866A/es unknown
- 2022-07-21 CN CN202280060739.4A patent/CN117940416A/zh active Pending
- 2022-07-21 WO PCT/US2022/037928 patent/WO2023004075A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
UY39866A (es) | 2023-01-31 |
KR20240051338A (ko) | 2024-04-19 |
IL310234A (en) | 2024-03-01 |
AR126537A1 (es) | 2023-10-18 |
CA3226614A1 (en) | 2023-01-26 |
CN117940416A (zh) | 2024-04-26 |
AU2022313961A1 (en) | 2024-02-08 |
WO2023004075A1 (en) | 2023-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112220797B (zh) | C/EBPα组合物和使用方法 | |
KR102291355B1 (ko) | Pd-l1 억제제 공동치료를 필요로 하는 환자의 식별방법 | |
CN115667551A (zh) | 用于治疗赘生性疾病的kif18a抑制剂 | |
US20190300967A1 (en) | Compositions and methods for predicting response and resistance to ctla4 blockade in melanoma using a gene expression signature | |
KR101778036B1 (ko) | 전립선암 마커로서의 포스포디에스테라제 4d7 | |
KR102110469B1 (ko) | 악성의 호르몬 민감성 전립선 암에 대한 마커로서의 포스포디에스테라제 4d7 | |
CN107223159A (zh) | 源自特定细胞类型的dna的检测及相关方法 | |
WO1998045436A2 (en) | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) | |
CA2936612A1 (en) | Atf6 polymorphisms associated with myocardial infarction, method of detection and uses thereof | |
EP0973898A2 (en) | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) | |
KR20210138587A (ko) | 개선된 면역요법을 위한 조합 유전자 표적 | |
AU2018223879A1 (en) | An inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease | |
KR101621273B1 (ko) | 카텝신 c의 용도 | |
KR20230034198A (ko) | 종양 침윤 림프구의 활성화 및 확장 방법 | |
KR20070099564A (ko) | 급성 골수성 백혈병 환자를 평가하는 방법 | |
KR20220113743A (ko) | 병태 및 질환의 치료를 위한 안티센스 올리고머 | |
TW202321213A (zh) | Kif18a抑制劑化合物之鹽和固態形式 | |
JP2001245666A (ja) | 新規ポリペプチド | |
KR20220025806A (ko) | 핵산의 무작위 구성 표적화 통합 | |
KR20190126812A (ko) | 질환 진단용 바이오마커 | |
TW202227102A (zh) | 治療脂肪肝病之方法 | |
KR20230005933A (ko) | Atxn1을 조정하는 화합물 및 방법 | |
KR102477906B1 (ko) | 유도만능 줄기세포 분화 특이적 lncRNA, 및 이의 용도 | |
KR101804678B1 (ko) | Bis 억제제 스크리닝용 마커, 이를 포함하는 스크리닝 키트 및 이를 이용한 bis 억제제 스크리닝 방법 | |
CN112534265A (zh) | 预选个体的抗癌治疗及鉴定易患病个体的筛选方法 |